Case_ID,tumor_code,tumor_sample_id_protein,normal_sample_id_protein,is_excluded_from_pancancer_studies,reason_for_exclusion,is_gtex,specimen/aliquout_id_protein_normal,specimen/aliquout_id_protein_tumor,specimen/aliquout_id_RNA_Tumor,specimen/aliquout_id_RNA_Normal,specimen/aliquout_id_DNA_Tumor,specimen/aliquout_id_DNA_Normal,specimen/aliquout_id_DNA_Blood,Age,Sex,Race,Ethnicity,Inferred Ancestry based on Genomic data,Participant Country,consent/case_stopped,baseline/tumor_site,baseline/tumor_laterality,baseline/tumor_focality,baseline/tumor_size_cm,baseline/histologic_type,cptac_path/histologic_grade,baseline/tumor_stage_pathological,baseline/tumor_necrosis,baseline/margin_status,baseline/ajcc_tnm_cancer_staging_edition_used,baseline/pathologic_staging_primary_tumor_pt,baseline/pathologic_staging_regional_lymph_nodes_pn,baseline/number_of_lymph_nodes_examined,baseline/number_of_lymph_nodes_positive_for_tumor_by_ihc_staining,baseline/number_of_lymph_nodes_positive_for_tumor_by_he_staining,baseline/clinical_staging_distant_metastasis_cm,baseline/pathologic_staging_distant_metastasis_pm,baseline/specify_distant_metastasis_documented_sites,baseline/residual_tumor,baseline/ancillary_studies_immunohistochemistry_type_and_result,medical_history/height_at_time_of_surgery_cm,medical_history/weight_at_time_of_surgery_kg,medical_history/bmi,medical_history/history_of_cancer,medical_history/alcohol_consumption,medical_history/tobacco_smoking_history,medical_history/number_of_pack_years_smoked,medical_history/was_the_participant_exposed_to_secondhand_smoke,cancer_history/cancer_type,cancer_history/history_of_any_treatment,medications/medication_name_vitamins_supplements,medications/history_source,procurement/tumor_tissue_collection_frozen_with_oct,follow-up/number_of_days_from_date_of_initial_pathologic_diagnosis_to_date_of_last_contact,follow-up/number_of_days_from_date_of_initial_pathologic_diagnosis_to_date_of_death,follow-up/cause_of_death,follow-up/number_of_days_from_date_of_collection_to_date_of_last_contact,follow-up/number_of_days_from_date_of_collection_to_date_of_death,follow-up/adjuvant_post-operative_radiation_therapy,follow-up/adjuvant_post-operative_pharmaceutical_therapy,follow-up/adjuvant_post-operative_immunological_therapy,follow-up/measure_of_success_of_outcome_at_the_completion_of_initial_first_course_treatment,follow-up/measure_of_success_of_outcome_at_date_of_last_contact_or_death,follow-up/new_tumor_after_initial_treatment,follow-up/number_of_days_from_date_of_initial_pathologic_diagnosis_to_date_of_new_tumor_event_after_initial_treatment,follow-up/type_of_new_tumor,follow-up/site_of_new_tumor,follow-up/other_site_of_new_tumor,follow-up/diagnostic_evidence_of_recurrence_or_relapse,follow-up/additional_surgery_for_new_tumor_loco-regional,follow-up/additional_surgery_for_new_tumor_metastasis,follow-up/residual_tumor_after_surgery_for_new_tumor,follow-up/additional_treatment_radiation_therapy_for_new_tumor,follow-up/additional_treatment_pharmaceutical_therapy_for_new_tumor,follow-up/additional_treatment_immuno_for_new_tumor,follow-up/number_of_days_from_date_of_initial_pathologic_diagnosis_to_date_of_additional_surgery_for_new_tumor_event_loco-regional,follow-up/number_of_days_from_date_of_initial_pathologic_diagnosis_to_date_of_additional_surgery_for_new_tumor_event_metastasis,"Recurrence-free survival, days","Recurrence status (1, yes; 0, no)","Overall survival, days","Survival status (1, dead; 0, alive)","Time between collection and diagnosis, days"
11BR047,BRCA,11BR047-T,,,,0.0,,81116212-b7e6-454b-9579-105cf3,ef52c640-13a9-4855-9ce2-0be77a_D7_1,,ef52c640-13a9-4855-9ce2-0be77a_D6_1,,0bfd3ae8-d275-4dab-9360-d1df30_D1_1,59,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,5,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,369.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,369.0,0.0,
11BR043,BRCA,11BR043-T,,,,0.0,,6d34d499-167e-42aa-9790-316fca_D2,6d34d499-167e-42aa-9790-316fca_D7_1,,6d34d499-167e-42aa-9790-316fca_D6_1,,a1338e3d-598a-45b5-838f-9b6206_D1_1,36,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N1,10,Not Reported/ Unknown,2,,M0,,,,,,,No,,,,,,No,,,,374.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,374.0,0.0,
11BR049,BRCA,11BR049-T,,,,0.0,,2e700669-85b0-43fa-a9c7-3eaf5a_D2,2e700669-85b0-43fa-a9c7-3eaf5a_D1,,2e700669-85b0-43fa-a9c7-3eaf5a_D6,,ad85fadf-31b7-44f3-b6ea-73c55d_D1,45,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N2a,6,Not Reported/ Unknown,6,,M0,,,,,,,No,,,,,,No,,,,379.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,379.0,0.0,
11BR023,BRCA,11BR023-T,,,,0.0,,0a80d3c4-0758-447a-958c-ea868c,079b5600-6afc-4785-bb22-48cfab_D7_1,,079b5600-6afc-4785-bb22-48cfab_D6_1,,70ee4720-f4dc-4b91-a6aa-c0efd9_D1_1,58,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,398.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,398.0,0.0,
18BR010,BRCA,18BR010-T,,,,0.0,,0bb9d596-774e-452b-9c89-a6643c_D2,0bb9d596-774e-452b-9c89-a6643c_D7_1,,0bb9d596-774e-452b-9c89-a6643c_D6_1,,feab8720-9694-4679-917f-f1287c_D1_1,41,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N2a,10,Not Reported/ Unknown,7,,M0,,,,,,,No,,,,,,No,,,,410.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,410.0,0.0,
06BR003,BRCA,06BR003-T,,,,0.0,,31b13596-554e-452f-91a4-7e67a8_D2,"['31b13596-554e-452f-91a4-7e67a8_D7', 'not run']",,"['31b13596-554e-452f-91a4-7e67a8_D6', 'not run']",,"['31da4db6-8404-43f0-995d-ebc10b_D1', 'not run']",75,Female,Unknown,Hispanic or Latino,Ad_Mixed_American,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,13,Not Performed,0,,MX,,,,,,,No,,,,,,No,,,,323.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,323.0,0.0,
11BR074,BRCA,11BR074-T,,,,0.0,,3367406e-d39c-4641-a3e7-44e1f3,12ce8313-6c54-4bee-a996-1aa7f8_D7,,12ce8313-6c54-4bee-a996-1aa7f8_D6_1,,93f961e1-fe4c-4dfc-8cbe-1dff31_D1_1,66,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N2,10,Not Reported/ Unknown,10,,M0,,,,,,,No,,,,,,No,,,,367.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,367.0,0.0,
18BR017,BRCA,18BR017-T,,,,0.0,,392b8aa4-9f99-4250-b693-326260_D2,392b8aa4-9f99-4250-b693-326260_D7_1,,392b8aa4-9f99-4250-b693-326260_D6_1,,f49705bd-129b-4bfe-a944-a7eb51_D1_1,72,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,Not Applicable,,T1,N0,8,0,0,,M0,,,,,,,No,,,,,,No,,,,445.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,445.0,0.0,
01BR017,BRCA,01BR017-T,,,,0.0,,09659708-7747-4d59-a3b9-e221e0_D2,09659708-7747-4d59-a3b9-e221e0_D7,,09659708-7747-4d59-a3b9-e221e0_D6,,b76c68fc-2403-4e79-ad46-4ae336_D1,45,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Negative (-),,T3,N1,,,,,MX,,,,,,,No,,,,,,No,,,,413.0,,,,,Yes,Yes,,,,No,,,,,,,,,,,,,,,0.0,413.0,0.0,
06BR006,BRCA,06BR006-T,,,,0.0,,3799eeb5-c966-4059-a78f-ace269_D2,3799eeb5-c966-4059-a78f-ace269_D7,,3799eeb5-c966-4059-a78f-ace269_D6,,7e168c2a-f22a-44d9-ac7d-1a4c42_D1,51,Female,Unknown,Hispanic or Latino,Ad_Mixed_American,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,Not Reported/ Unknown,,Not Performed,Not Performed,,,,,Not Performed,,,,,,,No,,,,,,No,,,,137.0,,,,,No,Yes,,,,Yes,,Distant Metastasis,Liver,,,Not Reported/ Unknown,,,No,Not Reported/ Unknown,,,,,1.0,137.0,0.0,
09BR005,BRCA,09BR005-T,,,,0.0,,150c2086-1815-40d2-bc5d-8eeb48_D2,8dc13656-a9c0-4b99-b02d-650893_D7_1,,150c2086-1815-40d2-bc5d-8eeb48_D6_1,,fb2f019d-a181-4939-916a-5dccbd_D1_1,38,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N1a,13,0,3,,MX,,,,,,,No,,,,,,No,,,,337.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,337.0,0.0,
11BR017,BRCA,11BR017-T,,,,0.0,,241ecd0e-89bd-4d3a-81b3-55a250,241c8dec-b317-4794-8cc2-07c14c_D7_1,,241c8dec-b317-4794-8cc2-07c14c_D6_1,,e324df92-19fa-41f1-bf90-638803_D1,74,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N2a,10,Not Reported/ Unknown,9,,M0,,,,,,,No,,,,,,No,,,,,221.0,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,221.0,1.0,
01BR015,BRCA,01BR015-T,,,,0.0,,42cc89e1-a896-4f57-b8d9-e7fe56_D2,42cc89e1-a896-4f57-b8d9-e7fe56_D7,,42cc89e1-a896-4f57-b8d9-e7fe56_D6,,f99563c8-f45c-4508-a41c-620e7c_D1,35,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Negative (-),,T2,N1,,,,,M0,,,,,,,No,,,,,,No,,,,347.0,,,,,Yes,Yes,,,,No,,,,,,,,,,,,,,,0.0,347.0,0.0,
11BR025,BRCA,11BR025-T,,,,0.0,,1740224c-32d1-4c9f-98c6-653363,8d7fc1ef-a0ac-44bb-8381-1444a0_D7_1,,8d7fc1ef-a0ac-44bb-8381-1444a0_D6_1,,af148751-8390-4acc-8ef9-8cb829_D1_1,77,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,,,,,M0,,,,,,,No,,,,,,No,,,,393.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,393.0,0.0,
01BR001,BRCA,01BR001-T,,,,0.0,,17d55745-4ab3-4a80-a182-af938b_D2,17d55745-4ab3-4a80-a182-af938b_D7,,17d55745-4ab3-4a80-a182-af938b_D6,,60439729-0ee4-431a-a8db-3325a2_D1,55,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Negative (-),,T2,N1c,,,,,M0,,,,,,,No,,,,,,No,,,,421.0,,,,,Yes,Yes,,,,No,,,,,,,,,,,,,,,0.0,421.0,0.0,
11BR031,BRCA,11BR031-T,,,,0.0,,3fdf0dbe-e05c-465f-8bed-4a92dd_D2,3fdf0dbe-e05c-465f-8bed-4a92dd_D7,,3fdf0dbe-e05c-465f-8bed-4a92dd_D6_1,,567b7b28-c132-4d78-a181-e2d340_D1_1,50,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,11,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,370.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,370.0,0.0,
01BR032,BRCA,01BR032-T,,,,0.0,,e5e1306b-719e-4c3e-b85b-fd1231_D2,e5e1306b-719e-4c3e-b85b-fd1231_D7_1,,e5e1306b-719e-4c3e-b85b-fd1231_D6_1,,67ebb699-4493-40ac-8aa2-2e7852_D1_1,46,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Negative (-),,T4,N0,,,,,M0,,,,,,,No,,,,,,No,,,,363.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,363.0,0.0,
05BR045,BRCA,05BR045-T,,,,0.0,,92862537-5f30-47db-a3e2-cc9d0c_D2,92862537-5f30-47db-a3e2-cc9d0c_D7_1,,92862537-5f30-47db-a3e2-cc9d0c_D6_1,,4e998bbe-c506-4778-b321-135dae_D1_1,60,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T2,N0,2,Not Performed,0,,MX,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
11BR053,BRCA,11BR053-T,,,,0.0,,fb526979-ee2d-4edf-b41d-01074f_D2,28be2eb2-1c1c-4799-b5af-e4b447_D7_1,,28be2eb2-1c1c-4799-b5af-e4b447_D6_1,,a5ecd1b1-8075-4d46-9a4f-18b8b1_D1_1,61,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,371.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,371.0,0.0,
01BR027,BRCA,01BR027-T,,,,0.0,,64ee175f-f3ce-446e-bbf4-9b6fa8_D1,1990853a-0e82-40b3-a025-91cdc1_D7,,1990853a-0e82-40b3-a025-91cdc1_D6,,71f40378-962e-4a4b-b0de-6ec414_D1,80,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Negative (-),,T2,N1,,,,,MX,,,,,,,No,,,,,,No,,,,351.0,,,,,Yes,Yes,,,,No,,,,,,,,,,,,,,,0.0,351.0,0.0,
14BR008,BRCA,14BR008-T,,,,0.0,,ca14c6dd-2069-4bc5-b1f2-6f2297_D2,99df02e0-56b3-4b00-80b7-ea58ce_D7,,99df02e0-56b3-4b00-80b7-ea58ce_D6,,5d7892a4-966e-44e4-b4d1-83173f_D1_1,66,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T3,N2a,11,0,9,,MX,,,,,,,No,,,,,,No,,,,505.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,505.0,0.0,
18BR002,BRCA,18BR002-T,,,,0.0,,fe591474-99d7-44d3-be73-c3b8ed_D2,fe591474-99d7-44d3-be73-c3b8ed_D7_1,,fe591474-99d7-44d3-be73-c3b8ed_D6_1,,bfcfa737-bf42-4249-b016-7d5ce1_D1_1,64,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N2a,10,Not Reported/ Unknown,7,,M0,,,,,,,No,,,,,,No,,,,431.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,431.0,0.0,
03BR013,BRCA,03BR013-T,,,,0.0,,01f203fd-e664-4d78-bea0-7c40cf_D2,d0dd0347-9b0f-46fe-8d62-bf17f3_D7,,01f203fd-e664-4d78-bea0-7c40cf_D6_1,,24c38c22-1518-40bf-9f39-043d7d_D1_1,52,Female,Unknown,Unknown,Ad_Mixed_American,,No,,,,,IDC and DCIS,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0(i-),2,0,0,,MX,,,,,,,No,,,,,,No,,,,355.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,355.0,0.0,
11BR032,BRCA,11BR032-T,,,,0.0,,314de592-f356-4801-8ace-278173_D2,314de592-f356-4801-8ace-278173_D7_1,,314de592-f356-4801-8ace-278173_D6_1,,560627f2-6763-475a-8c1d-009ef9_D1_1,49,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,13,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,369.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,369.0,0.0,
21BR010,BRCA,21BR010-T,,,,0.0,,68ef4aa9-00b0-4528-8828-4d3e43_D2,68ef4aa9-00b0-4528-8828-4d3e43_D7_1,,68ef4aa9-00b0-4528-8828-4d3e43_D6_1,,22bb2418-f3a9-4a2e-aceb-5f2c02_D1_1,71,Female,White,Hispanic or Latino,Ad_Mixed_American,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Negative (-),,T2,N1a,8,Not Applicable,1,,MX,,,,,,,No,,,,,,No,,,,327.0,,,,,No,No,,,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,327.0,0.0,
03BR004,BRCA,03BR004-T,,,,0.0,,4683de9c-49ca-4ddd-9d1a-be8121_D2,4683de9c-49ca-4ddd-9d1a-be8121_D7,,4683de9c-49ca-4ddd-9d1a-be8121_D6,,195a74d7-12c8-498d-9b63-c67177_D1,88,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N1mi,1,1,1,,MX,,,,,,,No,,,,,,No,,,,358.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,358.0,0.0,
11BR003,BRCA,11BR003-T,,,,0.0,,2dc74c29-2e89-4600-80bf-1e3637_D2,"['2dc74c29-2e89-4600-80bf-1e3637_D7', 'not run']",,"['2dc74c29-2e89-4600-80bf-1e3637_D6', 'not run']",,"['df724f1a-ea3d-4a56-bef5-aa0307_D1', 'not run']",53,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,394.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,394.0,0.0,
11BR028,BRCA,11BR028-T,,,,0.0,,885fe794-a98e-4f81-a284-ac4bb8,3b177fd6-e7d2-4312-bec7-4a253d_D7_1,,3b177fd6-e7d2-4312-bec7-4a253d_D6_1,,82887429-6fff-4bb0-8664-ce4d22_D1_1,55,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,380.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,380.0,0.0,
18BR004,BRCA,18BR004-T,,,,0.0,,b292e992-0611-4254-872f-af8275_D2,b292e992-0611-4254-872f-af8275_D7_1,,b292e992-0611-4254-872f-af8275_D6_1,,f2d0d540-c092-4404-9ce2-bd5e15_D1_1,76,Female,White,Not Hispanic or Latino,European,,No,,,,,Infiltrating Ductal and Mucinous Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,426.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,426.0,0.0,
20BR005,BRCA,20BR005-T,,,,0.0,,2f398497-d53e-4838-8006-d60f3e_D2,2f398497-d53e-4838-8006-d60f3e_D7_1,,2f398497-d53e-4838-8006-d60f3e_D6_1,,36b40856-2603-4e84-a7a1-e12e6f_D1_1,47,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Negative (-),,T2,N1,4,0,1,,MX,,,,,,,No,,,,,,No,,,,357.0,,,,,Yes,Yes,,,,No,,,,,,,,,,,,,,,0.0,357.0,0.0,
11BR073,BRCA,11BR073-T,,,,0.0,,1664b920-5e60-4e3b-9aab-fe121c,5d27516f-58d7-4155-80b4-4c7f39_D7_1,,5d27516f-58d7-4155-80b4-4c7f39_D6_1,,ba46cb26-65c0-4c5d-95de-ef7d41_D1_1,64,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N2,10,Not Reported/ Unknown,6,,M0,,,,,,,No,,,,,,No,,,,368.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,368.0,0.0,
11BR009,BRCA,11BR009-T,,,,0.0,,3324361b-df55-4e53-a2ef-4f8df2_D2,3324361b-df55-4e53-a2ef-4f8df2_D7,,3324361b-df55-4e53-a2ef-4f8df2_D6,,af5441ab-b2ad-4a62-9973-6b3f9c_D1,44,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N3b,11,Not Reported/ Unknown,4,,M0,,,,,,,No,,,,,,No,,,,406.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,406.0,0.0,
18BR019,BRCA,18BR019-T,,,,0.0,,0edcba67-0714-4b04-b433-77834e_D2,0edcba67-0714-4b04-b433-77834e_D7_1,,0edcba67-0714-4b04-b433-77834e_D6_1,,89b91c31-8d75-42cb-bb72-a97657_D1_1,68,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2a,N2,16,0,7,,M0,,,,,,,No,,,,,,No,,,,437.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,437.0,0.0,
20BR001,BRCA,20BR001-T,,,,0.0,,358296ad-e2a7-40cd-849e-8590fd_D2,358296ad-e2a7-40cd-849e-8590fd_D8_1,,358296ad-e2a7-40cd-849e-8590fd_D6_1,,cee1c3f1-6fab-4d2c-9982-27406d_D1_1,82,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Negative (-),,T2,N0,1,0,0,,MX,,,,,,,No,,,,,,No,,,,87.0,,,,,Yes,No,,,,No,,,,,,,,,,,,,,,0.0,87.0,0.0,
09BR007,BRCA,09BR007-T,,,,0.0,,6cb5d29a-9437-430d-b91c-57ee3d_D2,6cb5d29a-9437-430d-b91c-57ee3d_D7_1,,6cb5d29a-9437-430d-b91c-57ee3d_D6_1,,a86ecd9a-10fd-4eed-b246-12d587_D1_1,77,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N2a,8,Not Applicable,6,,MX,,,,,,,No,,,,,,No,,,,329.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,329.0,0.0,
11BR020,BRCA,11BR020-T,,,,0.0,,428de0d4-7f84-4075-bae1-352af6,94176301-9658-4151-9110-5139de_D7_1,,94176301-9658-4151-9110-5139de_D6_1,,04bb91d9-92af-4fe1-b02a-9972ac_D1_1,37,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,367.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,367.0,0.0,
20BR002,BRCA,20BR002-T,,,,0.0,,abee08ca-606d-4e2a-a2e6-24780f_D2,9462caa5-13e8-4997-a4f7-294f16_D7,,9462caa5-13e8-4997-a4f7-294f16_D6_1,,ea2fbf6a-45bc-445b-9bd1-341311_D1_1,>=90,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Negative (-),,T2,NX,,,,,MX,,,,,,,No,,,,,,No,,,,9.0,,,,,No,Not Reported/ Unknown,,,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,9.0,0.0,
11BR019,BRCA,11BR019-T,,,,0.0,,8dd1d8be-dc7e-44f5-9f44-77ecf0_D2,8dd1d8be-dc7e-44f5-9f44-77ecf0_D7_1,,8dd1d8be-dc7e-44f5-9f44-77ecf0_D6_1,,0819e79c-6e11-4c5a-826b-6a3de0_D1_1,61,Female,White,Not Hispanic or Latino,European,,No,,,,,Infiltrating Ductal and Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,377.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,377.0,0.0,
20BR008,BRCA,20BR008-T,,,,0.0,,acf022b3-7f01-43b3-ac14-86f97d,b87e7f88-a1f2-425a-8cff-8ae4b9_D7,,b87e7f88-a1f2-425a-8cff-8ae4b9_D6_1,,393ad6ef-250a-493c-8c41-e47504_D1_1,71,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,invasive ductal carcinoma with extensive high-grade DCIS with comedonecrosis and features of papillary carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Negative (-),,T4b,N2,30,0,6,,MX,,,,,,,No,,,,,,No,,,,347.0,,,,,Yes,Yes,,,,No,,,,,,,,,,,,,,,0.0,347.0,0.0,
01BR033,BRCA,01BR033-T,,,,0.0,,c646b902-e1e0-4e3e-a4c5-daca71_D2,3329b802-e49f-4494-b645-868a25_D7,,3329b802-e49f-4494-b645-868a25_D6_1,,0ab89209-3cf4-4082-a5d8-684c84_D1_1,40,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Negative (-),,T3,N2,,,,,M0,,,,,,,No,,,,,,No,,,,351.0,,,,,Yes,No,,,,No,,,,,,,,,,,,,,,0.0,351.0,0.0,
11BR022,BRCA,11BR022-T,,,,0.0,,da3d7876-ca79-4f21-a00e-27e6b6_D2,da3d7876-ca79-4f21-a00e-27e6b6_D7_1,,da3d7876-ca79-4f21-a00e-27e6b6_D6_1,,19a415b6-f700-44ae-b704-348eda_D1_1,48,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,13.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,13.0,0.0,
11BR013,BRCA,11BR013-T,,,,0.0,,faadb553-9437-42cb-b469-498d67_D2,faadb553-9437-42cb-b469-498d67_D7_1,,faadb553-9437-42cb-b469-498d67_D6_1,,51de6425-8c2f-486c-8073-2d60fa_D1_1,70,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,378.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,378.0,0.0,
03BR010,BRCA,03BR010-T,,,,0.0,,49f55bd6-a89a-4d18-b732-139c3d_D2,49f55bd6-a89a-4d18-b732-139c3d_D7,,49f55bd6-a89a-4d18-b732-139c3d_D6,,04fa7dba-53a4-4696-94e4-75efc5_D1,78,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,4,0,0,,MX,,,,,,,"Yes, History of Other Cancer Greater Than One Year",,,,,,No,,,,357.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,357.0,0.0,
20BR007,BRCA,20BR007-T,,,,0.0,,33adae13-5dbd-4530-a5d5-3763e4,547f521a-5851-426c-a125-d9d82c_D7_1,,547f521a-5851-426c-a125-d9d82c_D6_1,,58f39d9c-9c17-4268-a206-564f83_D1_1,55,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Negative (-),,T2,N0,2,0,0,,MX,,,,,,,No,,,,,,No,,,,357.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,357.0,0.0,
11BR030,BRCA,11BR030-T,,,,0.0,,4749ba99-d3b8-4ae3-b6f6-458bc7,63a05d68-f0f7-42d9-a45f-df0f7e_D7_1,,63a05d68-f0f7-42d9-a45f-df0f7e_D6_1,,2e1881a6-2228-4f07-883c-e25c6a_D1_1,50,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,377.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,377.0,0.0,
18BR007,BRCA,18BR007-T,,,,0.0,,1ae5772a-ba49-4c00-b890-7513d0_D2,1ae5772a-ba49-4c00-b890-7513d0_D7,,1ae5772a-ba49-4c00-b890-7513d0_D6_1,,1389064d-3882-462c-ab2d-407775_D1_1,64,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,431.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,431.0,0.0,
11BR050,BRCA,11BR050-T,,,,0.0,,d8a5467b-549b-48ed-9ae5-c9c39d_D2,d8a5467b-549b-48ed-9ae5-c9c39d_D11,,d8a5467b-549b-48ed-9ae5-c9c39d_D6_1,,d5298917-e497-4c47-a604-645708_D1_1,54,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Mucinous Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,8,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,386.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,386.0,0.0,
05BR001,BRCA,05BR001-T,,,,0.0,,55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D2,55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D7,,55d3d4bb-0bf5-4b4e-8ef8-d77a5d_D6,,90128f2d-2a4c-4514-bcc8-e39be7_D1,70,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N1a,12,0,1,,MX,,,,,,,No,,,,,,No,,,,363.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,363.0,0.0,
11BR014,BRCA,11BR014-T,,,,0.0,,ddc680ad-63cf-4807-b535-9ccc88_D2,ddc680ad-63cf-4807-b535-9ccc88_D7_1,,ddc680ad-63cf-4807-b535-9ccc88_D6_1,,5da4ac87-0990-419c-88c1-acd047_D1_1,39,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N2a,10,Not Reported/ Unknown,8,,M0,,,,,,,No,,,,,,No,,,,408.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,408.0,0.0,
22BR005,BRCA,22BR005-T,,,,0.0,,12110cb8-8da4-4461-ac1a-1af490_D2,12110cb8-8da4-4461-ac1a-1af490_D7_1,,12110cb8-8da4-4461-ac1a-1af490_D6_1,,7604cab5-d108-4fbd-8bc7-2bee52_D1_1,46,Female,White,Not Hispanic or Latino,European,,No,,,,,Mixed ductal and lobular features,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N1a,15,0,2,,M0,,,,,,,No,,,,,,No,,,,348.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,348.0,0.0,
11BR010,BRCA,11BR010-T,,,,0.0,,436db08d-c316-44b5-b0de-62617d_D2,436db08d-c316-44b5-b0de-62617d_D7_1,,436db08d-c316-44b5-b0de-62617d_D6_1,,b6c9faff-5782-45d1-895c-3e9cf5_D1_1,35,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N1,8,Not Reported/ Unknown,1,,M0,,,,,,,No,,,,,,No,,,,394.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,394.0,0.0,
01BR031,BRCA,01BR031-T,,,,0.0,,96c52a27-3d9a-49e7-8ae8-a71e7c_D2,96c52a27-3d9a-49e7-8ae8-a71e7c_D7_1,,96c52a27-3d9a-49e7-8ae8-a71e7c_D6_1,,107c4d84-cd05-487c-a3aa-bbe849_D1_1,61,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Negative (-),,T3,N3,,,,,M1,,,,,,,No,,,,,,No,,,,363.0,,,,,Yes,Yes,,,,No,,,,,,,,,,,,,,,0.0,363.0,0.0,
11BR011,BRCA,11BR011-T,,,,0.0,,bc9fe67f-c4a2-43ba-87bd-438bda_D2,bc9fe67f-c4a2-43ba-87bd-438bda_D7_1,,bc9fe67f-c4a2-43ba-87bd-438bda_D6_1,,85252bdd-206b-486f-b12a-705fcb_D1_1,71,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N2a,6,Not Reported/ Unknown,4,,M0,,,,,,,No,,,,,,No,,,,402.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,402.0,0.0,
03BR005,BRCA,03BR005-T,,,,0.0,,96c95de1-514b-44a5-b487-dc390b_D2,96c95de1-514b-44a5-b487-dc390b_D7,,96c95de1-514b-44a5-b487-dc390b_D6,,b66903d8-088e-496e-97b7-348a9e_D1,61,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,2,0,0,,MX,,,,,,,No,,,,,,No,,,,304.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,304.0,0.0,
18BR003,BRCA,18BR003-T,,,,0.0,,e3d45dc6-66ef-4e0b-9d96-1b5db5,436297af-feb7-4754-96b7-c5bfb5_D7_1,,436297af-feb7-4754-96b7-c5bfb5_D6_1,,a0935138-0a31-4b38-a750-2914be_D1_1,65,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,426.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,426.0,0.0,
11BR024,BRCA,11BR024-T,,,,0.0,,53723086-8858-4395-93d7-0baa68,9efd41a5-3db1-445b-accb-040c2b_D7_1,,9efd41a5-3db1-445b-accb-040c2b_D6_1,,e2366c0d-43f0-4761-9b7b-7a94ac_D1_1,80,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,,,,,M0,,,,,,,No,,,,,,No,,,,393.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,393.0,0.0,
05BR016,BRCA,05BR016-T,,,,0.0,,3f957017-d081-45f4-b458-ec3f8d_D2,3f957017-d081-45f4-b458-ec3f8d_D7,,3f957017-d081-45f4-b458-ec3f8d_D6,,7a087328-9980-4488-ac9b-ba9550_D1,78,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N1a,14,2,2,,MX,,,,,,,No,,,,,,No,,,,308.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,308.0,0.0,
01BR030,BRCA,01BR030-T,,,,0.0,,1f5a9aad-61a1-4a64-a9b0-38cd2b_D2,1f5a9aad-61a1-4a64-a9b0-38cd2b_D7_1,,1f5a9aad-61a1-4a64-a9b0-38cd2b_D6_1,,a2b1c102-3c96-4e75-bd12-e6b33f_D1_1,84,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Negative (-),,T3,N1a,13,Not Reported/ Unknown,2,,MX,,,,,,,No,,,,,,No,,,,389.0,,,,,No,Yes,,,,No,,,,,,Not Applicable,,,Not Applicable,Not Applicable,,,,,0.0,389.0,0.0,
01BR018,BRCA,01BR018-T,,,,0.0,,d154d194-2b08-46d4-a199-84cfb8_D8,d154d194-2b08-46d4-a199-84cfb8_D7,,d154d194-2b08-46d4-a199-84cfb8_D6,,f0359550-c332-466b-badd-310292_D1,66,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Negative (-),,T3,N1,,,,,M0,,,,,,,No,,,,,,No,,,,384.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,384.0,0.0,
05BR042,BRCA,05BR042-T,,,,0.0,,8ab1a564-9a18-43bf-aee3-7fceb0_D2,8ab1a564-9a18-43bf-aee3-7fceb0_D7_1,,8ab1a564-9a18-43bf-aee3-7fceb0_D6,,9c427144-07ba-4190-bbe4-ec7faf_D1_1,40,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T2,N1mi,4,Not Performed,2,,MX,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
11BR054,BRCA,11BR054-T,,,,0.0,,b10c7b72-1d44-4668-a637-a536b2_D2,b10c7b72-1d44-4668-a637-a536b2_D7_1,,b10c7b72-1d44-4668-a637-a536b2_D6_1,,4c811274-4185-4b8b-93dd-93dbaf_D1_1,84,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,376.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,376.0,0.0,
05BR044,BRCA,05BR044-T,,,,0.0,,d01714eb-22bf-4ad7-95d9-f95bdf_D2,d01714eb-22bf-4ad7-95d9-f95bdf_D7_1,,d01714eb-22bf-4ad7-95d9-f95bdf_D6,,ccd93955-378a-48ae-8ed2-07ee76_D1_1,62,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T2,N1a,2,Not Performed,1,,MX,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
11BR006,BRCA,11BR006-T,,,,0.0,,3208e021-1dae-42fd-bd36-0f3c3d,4798bb9d-7100-43aa-b615-85897d_D7_1,,4798bb9d-7100-43aa-b615-85897d_D6_1,,f2cf56e9-6d6d-4e29-8222-212720_D1_1,54,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,4,Not Applicable,0,,M0,,,,,,,No,,,,,,No,,,,405.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,405.0,0.0,
14BR005,BRCA,14BR005-T,,,,0.0,,2386c36d-8d5d-4fd4-bbfa-39cc8d_D2,2386c36d-8d5d-4fd4-bbfa-39cc8d_D7_1,,2386c36d-8d5d-4fd4-bbfa-39cc8d_D6_1,,c28e911d-87c7-4998-b36a-f4cee1_D1_1,78,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0(i-),4,0,0,,MX,,,,,,,No,,,,,,No,,,,517.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,517.0,0.0,
11BR044,BRCA,11BR044-T,,,,0.0,,d92a2942-dba6-4fff-b0d0-0566fb_D2,75adceb5-eea5-4cb1-864e-876a8f_D7_1,,d92a2942-dba6-4fff-b0d0-0566fb_D6_1,,fd55a60e-fa4f-4e4e-a2b8-6273b9_D1_1,48,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N2a,10,Not Reported/ Unknown,7,,M0,,,,,,,No,,,,,,No,,,,382.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,382.0,0.0,
11BR016,BRCA,11BR016-T,,,,0.0,,a7d58d61-5049-488f-9d0a-0a4411_D2,a7d58d61-5049-488f-9d0a-0a4411_D7_1,,a7d58d61-5049-488f-9d0a-0a4411_D6_1,,97a6122a-7d33-49bb-96fb-4ab468_D1_1,30,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,388.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,388.0,0.0,
11BR055,BRCA,11BR055-T,,,,0.0,,4533a2d6-e850-43f3-9c44-621c07_D2,4533a2d6-e850-43f3-9c44-621c07_D7_1,,4533a2d6-e850-43f3-9c44-621c07_D6_1,,284b7f89-0dfe-4333-b05e-988a60_D1_1,56,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,13.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,13.0,0.0,
06BR005,BRCA,06BR005-T,,,,0.0,,25db2586-55b0-4456-9bba-c24e06_D2,25db2586-55b0-4456-9bba-c24e06_D7,,25db2586-55b0-4456-9bba-c24e06_D6,,8d94b162-fa3a-4856-8c84-078f65_D1,58,Female,Unknown,Hispanic or Latino,Ad_Mixed_American,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T1c,N1a,12,Not Performed,3,,MX,,,,,,,No,,,,,,No,,,,320.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,320.0,0.0,
11BR042,BRCA,11BR042-T,,,,0.0,,a176fcc2-97b5-45c3-a0f3-3b2e41_D2,a176fcc2-97b5-45c3-a0f3-3b2e41_D7_1,,a176fcc2-97b5-45c3-a0f3-3b2e41_D6_1,,6e370163-4c31-4b23-be51-8d5c66_D1_1,71,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,374.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,374.0,0.0,
11BR018,BRCA,11BR018-T,,,,0.0,,855256a7-e41e-4158-b02f-ba61a9_D2,855256a7-e41e-4158-b02f-ba61a9_D7,,855256a7-e41e-4158-b02f-ba61a9_D6_1,,ba088f32-97f7-446a-9b7b-a804d2_D1_1,54,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N2a,10,Not Reported/ Unknown,7,,M0,,,,,,,No,,,,,,No,,,,377.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,377.0,0.0,
05BR009,BRCA,05BR009-T,,,,0.0,,48d1b543-dbf6-4594-b34a-d0e30a_D2,48d1b543-dbf6-4594-b34a-d0e30a_D7,,48d1b543-dbf6-4594-b34a-d0e30a_D6,,a1e9c072-ec07-4215-bfc3-5a65eb_D1,64,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T3,N3a,31,0,15,,MX,,,,,,,No,,,,,,No,,,,323.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,323.0,0.0,
01BR025,BRCA,01BR025-T,,,,0.0,,d6d42051-ad8e-4fb2-8cfc-829353_D2,d6d42051-ad8e-4fb2-8cfc-829353_D7,,d6d42051-ad8e-4fb2-8cfc-829353_D6,,110009db-7606-406d-a9f8-1aa86c_D1,62,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Positive (+),,T3,N1a,15,Not Applicable,1,,M0,,,,,,,No,,,,,,No,,,,601.0,,,,,Yes,Yes,,,,No,,,,,,,,,,,,,,,0.0,601.0,0.0,
11BR015,BRCA,11BR015-T,,,,0.0,,6c660b6b-bfda-47b0-9499-160d49,cab796c6-0129-43cf-bd27-7da395_D7_1,,cab796c6-0129-43cf-bd27-7da395_D6_1,,4a92b6da-eff2-46b8-b17e-97a19c_D1,60,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N2a,10,Not Reported/ Unknown,5,,M0,,,,,,,No,,,,,,No,,,,386.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,386.0,0.0,
11BR040,BRCA,11BR040-T,,,,0.0,,d7b05dce-4362-4e8f-a77a-07dd74_D2,d7b05dce-4362-4e8f-a77a-07dd74_D7_1,,d7b05dce-4362-4e8f-a77a-07dd74_D6_1,,4c5dd3bd-ff23-4f6e-9f10-82a33b_D1_1,67,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N2,12,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,377.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,377.0,0.0,
11BR004,BRCA,11BR004-T,,,,0.0,,48de7e82-4cba-423c-9e39-89ac6b_D2,f33d08f0-f15c-4f34-90ba-7cbe75_D7_1,,48de7e82-4cba-423c-9e39-89ac6b_D6_1,,0be767d3-9827-4d4f-9f76-208353_D1_1,54,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,8,Not Applicable,0,,M0,,,,,,,No,,,,,,No,,,,405.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,405.0,0.0,
11BR057,BRCA,11BR057-T,,1.0,"No proteomics, partial genomics",0.0,,8886aaca-adcf-4416-920a-794bf0_D2,,,,,,51,Female,Asian,Not Hispanic or Latino,,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,8,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,371.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,371.0,0.0,
01BR043,BRCA,01BR043-T,,,,0.0,,c4015b28-269b-4dc4-8b2e-1b83f7_D2,c4015b28-269b-4dc4-8b2e-1b83f7_D7_1,,c4015b28-269b-4dc4-8b2e-1b83f7_D6,,99a3ae40-47ba-43af-a290-19619b_D1_1,59,Female,White,Not Hispanic or Latino,European,,No,,,,,Other (specify),"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,TX,N1,,,,,M0,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
05BR003,BRCA,05BR003-T,,,,0.0,,ffc76bfb-61f6-4492-a782-c23321_D2,ffc76bfb-61f6-4492-a782-c23321_D7,,ffc76bfb-61f6-4492-a782-c23321_D6,,e18f4e63-342f-4b53-9236-e1b4e3_D1,37,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T3,N0(i-),3,0,0,,MX,,,,,,,No,,,,,,No,,,,406.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,406.0,0.0,
05BR029,BRCA,05BR029-T,,,,0.0,,7ac27de9-0932-4ff5-aab8-29c527,1dbc76a2-76bf-44fb-8663-923093_D7_1,,d0ce3c06-9c4c-41bd-b583-9254b0_D6_1,,de477850-d854-4df8-8a84-67224c_D1_1,61,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,4,0,0,,MX,,,,,,,No,,,,,,No,,,,342.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,342.0,0.0,
05BR043,BRCA,05BR043-T,,,,0.0,,6eaf19bf-dd93-4b0b-93c5-e2bca3_D2,6eaf19bf-dd93-4b0b-93c5-e2bca3_D7,,6eaf19bf-dd93-4b0b-93c5-e2bca3_D6,,fab8a1c5-c592-47cd-9d32-54bf14_D1_1,50,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T2,N1a,3,Not Performed,1,,MX,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
05BR026,BRCA,05BR026-T,,,,0.0,,d1e36453-8d78-4247-8c3c-3b2a6f_D2,d1e36453-8d78-4247-8c3c-3b2a6f_D7_1,,d1e36453-8d78-4247-8c3c-3b2a6f_D6_1,,a361c808-b55e-451f-be99-1fb391_D1_1,71,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0(i-),2,0,0,,MX,,,,,,,No,,,,,,No,,,,377.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,377.0,0.0,
11BR056,BRCA,11BR056-T,,,,0.0,,e45c73a8-da96-4269-a039-d43942_D2,e45c73a8-da96-4269-a039-d43942_D7_1,,e45c73a8-da96-4269-a039-d43942_D6_1,,0c693667-415a-4f86-b2fc-c16973_D1_1,52,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N1,9,Not Reported/ Unknown,1,,M0,,,,,,,No,,,,,,No,,,,367.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,367.0,0.0,
11BR038,BRCA,11BR038-T,,,,0.0,,4e766d9f-ede3-4311-bf09-b1f9ba_D2,4e766d9f-ede3-4311-bf09-b1f9ba_D7,,4e766d9f-ede3-4311-bf09-b1f9ba_D6_1,,6386a31e-1ecc-4229-9f0d-e09e01_D1_1,47,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,7,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,385.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,385.0,0.0,
11BR036,BRCA,11BR036-T,,,,0.0,,45b99ac4-0859-4a3d-8b1e-ce5590_D2,45b99ac4-0859-4a3d-8b1e-ce5590_D11_1,,45b99ac4-0859-4a3d-8b1e-ce5590_D6_1,,1069702b-d6f0-40db-837f-b006fe_D1_1,51,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,9,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,368.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,368.0,0.0,
18BR009,BRCA,18BR009-T,,,,0.0,,5c9ee07a-ca8f-49bf-9c03-2dc513_D2,5c9ee07a-ca8f-49bf-9c03-2dc513_D7_1,,5c9ee07a-ca8f-49bf-9c03-2dc513_D6_1,,a4e97f71-27e2-44ed-9f3a-76a987_D1_1,63,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,417.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,417.0,0.0,
18BR006,BRCA,18BR006-T,,,,0.0,,bebb15ad-03f1-4773-b3d4-2f78e3_D2,bebb15ad-03f1-4773-b3d4-2f78e3_D7,,bebb15ad-03f1-4773-b3d4-2f78e3_D6_1,,a2e6e27a-79d3-47dd-b9b5-a16ee0_D1_1,62,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,419.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,419.0,0.0,
22BR006,BRCA,22BR006-T,,,,0.0,,a2637649-1fa1-4c20-a19d-5d5f11_D2,cdcc4b54-fcf8-4667-a686-9abda4_D7_1,,cdcc4b54-fcf8-4667-a686-9abda4_D6_1,,4d08772f-7a24-4de1-b997-60dd02_D1_1,55,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T3,N1,17,0,2,,M0,,,,,,,No,,,,,,No,,,,,282.0,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,282.0,1.0,
11BR072,BRCA,11BR072-T,,,,0.0,,59318d66-8b88-45b2-9b97-90e9a7_D2,59318d66-8b88-45b2-9b97-90e9a7_D7_1,,59318d66-8b88-45b2-9b97-90e9a7_D6_1,,faa5e826-30db-411b-8f90-240c1f_D1_1,70,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N3a,10,Not Reported/ Unknown,10,,M0,,,,,,,No,,,,,,No,,,,369.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,369.0,0.0,
11BR027,BRCA,11BR027-T,,,,0.0,,413d7d87-7b86-4b76-af93-8e8136_D2,413d7d87-7b86-4b76-af93-8e8136_D7_1,,413d7d87-7b86-4b76-af93-8e8136_D6,,288bd0e2-6850-4950-a89c-a2a8ab_D1_1,76,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,385.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,385.0,0.0,
01BR040,BRCA,01BR040-T,,,,0.0,,4a25e3da-2226-4e23-a595-c11709_D2,4a25e3da-2226-4e23-a595-c11709_D7_1,,4a25e3da-2226-4e23-a595-c11709_D6_1,,079a67ab-c81a-4fcb-a976-2d2fb6_D1_1,40,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T2,N1,,,,,Not Reported/ Unknown,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
11BR059,BRCA,11BR059-T,,,,0.0,,fc0aa1e4-c1d8-43ed-a5cd-038f61_D2,fc0aa1e4-c1d8-43ed-a5cd-038f61_D7_1,,fc0aa1e4-c1d8-43ed-a5cd-038f61_D6_1,,b8534837-c177-4fcd-9778-dd7844_D1_1,45,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,7,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,382.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,382.0,0.0,
11BR051,BRCA,11BR051-T,,,,0.0,,56b488cf-a189-47a8-b4e2-d976eb_D2,d5187303-080a-4cec-b069-e06b6b_D7_1,,56b488cf-a189-47a8-b4e2-d976eb_D6_1,,6b0937e4-0b78-4c0b-90ba-32fcf5_D1_1,65,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T2,N2a,10,Not Reported/ Unknown,9,,M0,,,,,,,No,,,,,,No,,,,379.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,379.0,0.0,
05BR038,BRCA,05BR038-T,,,,0.0,,942e63bd-84d6-4227-b3de-03e182_D2,b27211b5-7ee1-4e3a-af73-e227b1_D7,,942e63bd-84d6-4227-b3de-03e182_D6,,532b795c-c9cf-463e-85c5-32dfbe_D1,52,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,Not Applicable,,T1c,N0,1,0,0,,M0,,,,,,,No,,,,,,No,,,,195.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,195.0,0.0,
11BR060,BRCA,11BR060-T,,,,0.0,,97cc4d46-cf80-41f1-b99c-bc4829_D2,97cc4d46-cf80-41f1-b99c-bc4829_D7_1,,97cc4d46-cf80-41f1-b99c-bc4829_D6_1,,23d5da6f-7593-4652-8db6-07372e_D1_1,52,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N1,11,Not Reported/ Unknown,1,,M0,,,,,,,No,,,,,,No,,,,385.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,385.0,0.0,
09BR004,BRCA,09BR004-T,,,,0.0,,cfc121b5-9562-4a6d-b792-3cd6d5_D2,cfc121b5-9562-4a6d-b792-3cd6d5_D7_1,,cfc121b5-9562-4a6d-b792-3cd6d5_D6_1,,f111f400-5751-40ea-82b5-3ca0c8_D1_1,75,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0(i-),11,0,0,,MX,,,,,,,No,,,,,,No,,,,,,,,,Not Reported/ Unknown,Not Reported/ Unknown,,,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,357.0,,
11BR075,BRCA,11BR075-T,,,,0.0,,5504c643-4a9c-4ec4-ab07-bebdaf_D2,5504c643-4a9c-4ec4-ab07-bebdaf_D7,,5504c643-4a9c-4ec4-ab07-bebdaf_D6,,b6af20fa-c744-44ac-ab44-e3b62c_D1,79,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T3,N2,10,Not Reported/ Unknown,5,,M0,,,,,,,No,,,,,,No,,,,362.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,362.0,0.0,
03BR002,BRCA,03BR002-T,,,,0.0,,ca576d30-be91-4bf5-a31d-80f7eb_D2,ca576d30-be91-4bf5-a31d-80f7eb_D7,,ca576d30-be91-4bf5-a31d-80f7eb_D6,,14cb26cf-0eec-4140-8db2-b18ce6_D1,60,Female,White,Not Hispanic or Latino,Ad_Mixed_American,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T3,N1a,17,2,1,,MX,,,,,,,No,,,,,,No,,,,365.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,365.0,0.0,
11BR078,BRCA,11BR078-T,,1.0,"No proteomics, partial genomics",0.0,,8c9232b9-bd06-4474-8236-70dd8a_D2,,,,,,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
16BR012,BRCA,16BR012-T,,,,0.0,,7557b796-f11c-4077-a1af-b249c8_D2,7557b796-f11c-4077-a1af-b249c8_D7_1,,7557b796-f11c-4077-a1af-b249c8_D6_1,,c7c982b6-8d9a-474d-82ba-81e59d_D1_1,47,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Negative (-),,T2,N3c,11,Not Performed,7,,M0,,,,,,,No,,,,,,No,,,,478.0,,,,,Yes,Yes,,,,No,,,,,,,,,,,,,,,0.0,478.0,0.0,
06BR014,BRCA,06BR014-T,,,,0.0,,b2d62dca-3741-4d59-92b8-bdcfed_D2,b2d62dca-3741-4d59-92b8-bdcfed_D7_1,,b2d62dca-3741-4d59-92b8-bdcfed_D6,,865b5360-f603-4418-9c9f-c182e9_D1_1,51,Female,Unknown,Hispanic or Latino,African,,No,,,,,Other (specify),"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N1a,3,0,1,,MX,,,,,,,No,,,,,,No,,,,357.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,357.0,0.0,
11BR076,BRCA,11BR076-T,,1.0,"No proteomics, partial genomics",0.0,,5a9e89e9-4ac6-4c2f-b05e-c956ba_D2,,,,,,52,Female,White,Not Hispanic or Latino,,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,378.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,378.0,0.0,
18BR016,BRCA,18BR016-T,,,,0.0,,3bbf4310-6a83-4d3b-8772-a5dbb6_D2,3bbf4310-6a83-4d3b-8772-a5dbb6_D7_1,,3bbf4310-6a83-4d3b-8772-a5dbb6_D6_1,,4720de03-4a0e-4574-99c2-7fd6dc_D1_1,73,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,Not Applicable,,T1,N0,17,0,0,,M0,,,,,,,No,,,,,,No,,,,449.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,449.0,0.0,
05BR005,BRCA,05BR005-T,,,,0.0,,6838157f-361d-4e95-b933-35bd46_D2,c6e0280a-f739-474e-9bcd-821221_D7,,6838157f-361d-4e95-b933-35bd46_D6,,e7e44e0d-7412-4d26-814b-ff0d45_D1,50,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,Not Applicable,,T1c,N0,4,0,0,,M0,,,,,,,No,,,,,,No,,,,528.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,528.0,0.0,
13BR009,BRCA,13BR009-T,,,,0.0,,878c2524-208e-40b2-8089-ceb820_D2,878c2524-208e-40b2-8089-ceb820_D7_1,,878c2524-208e-40b2-8089-ceb820_D6,,d6aff277-c3bf-4977-bb41-64debf_D1_1,75,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1a,23,3,Not Reported/ Unknown,,M0,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
11BR080,BRCA,11BR080-T,,,,0.0,,e2c7113f-957f-4088-b57d-55d2f2_D2,2ddefa4f-77aa-416f-93f3-904e07_D7,,2ddefa4f-77aa-416f-93f3-904e07_D6,,7cfd025a-e4e5-48ac-b44b-56a114_D1,68,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N1,10,Not Reported/ Unknown,2,,M0,,,,,,,No,,,,,,No,,,,377.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,377.0,0.0,
01BR042,BRCA,01BR042-T,,,,0.0,,4df35993-eab6-4289-822c-d77da9_D2,4df35993-eab6-4289-822c-d77da9_D7_1,,4df35993-eab6-4289-822c-d77da9_D6_1,,6be03918-b249-48b1-a447-a1a64b_D1_1,58,Female,Black or African American,Unknown,African,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T2,NX,,,,,MX,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
15BR003,BRCA,15BR003-T,,,,0.0,,433c2eb6-560f-4387-93af-6c2e1a_D2,433c2eb6-560f-4387-93af-6c2e1a_D7,,433c2eb6-560f-4387-93af-6c2e1a_D6_1,,3de9a97b-ec2d-4778-b7cd-f52fb2_D1_1,74,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T1c,N1a,4,0,1,,M0,,,,,,,No,,,,,,No,,,,344.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,344.0,0.0,
14BR014,BRCA,14BR014-T,,,,0.0,,d1034660-11ce-4e38-9ad0-8b9b72_D2,d1034660-11ce-4e38-9ad0-8b9b72_D8_1,,d1034660-11ce-4e38-9ad0-8b9b72_D6,,15f928a5-e824-477a-9882-0f1029_D1_1,59,Female,White,Unknown,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0(i+),3,0,0,,MX,,,,,,,No,,,,,,No,,,,448.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,448.0,0.0,
11BR058,BRCA,11BR058-T,,,,0.0,,80a970f7-7b36-4450-aff8-0b55dc_D2,80a970f7-7b36-4450-aff8-0b55dc_D7_1,,80a970f7-7b36-4450-aff8-0b55dc_D6_1,,425542b5-a675-4283-8480-ff386a_D1_1,65,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,8,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,378.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,378.0,0.0,
11BR012,BRCA,11BR012-T,,,,0.0,,98225215-ff21-4893-8b6d-d9b7e7_D2,98225215-ff21-4893-8b6d-d9b7e7_D7_1,,98225215-ff21-4893-8b6d-d9b7e7_D6_1,,5e62d006-cf7f-45e4-8b14-fcb7a0_D1_1,77,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T2,N0,10,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,42.0,,,,,,,,,,,,,,,,,,,,,,,,,0.0,42.0,0.0,
01BR009,BRCA,01BR009-T,,,,0.0,,0ecabbfa-8095-4875-acdb-051582_D1,,,,,,64,Female,Black or African American,Not Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
01BR008,BRCA,01BR008-T,,,,0.0,,cfa2809f-5468-4457-870c-467c39_D1,,,,,,48,Female,Black or African American,Not Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
21BR001,BRCA,21BR001-T,,,,0.0,,1fb9fca2-cf63-41f2-9381-d9108c,,,,,,86,Female,White,Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
21BR002,BRCA,21BR002-T,,,,0.0,,32944ee6-428e-44fc-97d6-22665e,,,,,,86,Female,White,Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
01BR026,BRCA,01BR026-T,,,,0.0,,884659ef-cce7-4b4a-b28b-0e1f49,,,,,,48,Female,White,Not Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
05BR004,BRCA,05BR004-T,,,,0.0,,71e07184-b085-4d3d-aabf-6e1420_D1,,,,,,46,Female,White,Not Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
03BR006,BRCA,03BR006-T,,,,0.0,,071be0fb-b7fd-4165-b3c5-348352,,,,,,42,Female,White,Not Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
01BR023,BRCA,01BR023-T,,,,0.0,,c875a9a4-035f-425a-9348-26129c_D1,,,,,,52,Female,White,Not Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
01BR020,BRCA,01BR020-T,,,,0.0,,3fd68501-514a-4a30-9ce1-2fca26_D1,,,,,,45,Female,Black or African American,Not Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
20BR006,BRCA,20BR006-T,,,,0.0,,3f52e236-1daa-4aa0-9a77-e3d043_D2,3f52e236-1daa-4aa0-9a77-e3d043_D7_1,,3f52e236-1daa-4aa0-9a77-e3d043_D6_1,,ac6a7d2b-c376-49ca-8fc6-4b1e94_D1_1,65,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Negative (-),,T2,N1a,7,Not Reported/ Unknown,1,,MX,,,,,,,No,,,,,,No,,,,327.0,,,,,Yes,Yes,,,,No,,,,,,,,,,,,,,,0.0,327.0,0.0,
09BR001,BRCA,09BR001-T,,,,0.0,,20506075-36a7-4754-8e5e-628918,,,,,,61,Female,Black or African American,Not Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
03BR011,BRCA,03BR011-T,,,,0.0,,60c8c914-f53d-4f72-a1ce-5fb803,,,,,,71,Female,White,Not Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,"Yes, History of Other Cancer Greater Than One Year",,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
01BR010,BRCA,01BR010-T,,,,0.0,,26ecef2d-fcf3-4b85-9647-5e5d29_D1,,,,,,65,Female,Black or African American,Not Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
604,BRCA,,,,,0.0,,,CPT000814-0008,,CPT000814-0010,,CPT000820-0002,41,Female,Black or African American,Unknown,African,,No,,,,,Triple Negative,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,2,0,1,0,0,,0,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
1488,BRCA,,,1.0,"No proteomics, partial genomics",0.0,,,CPT000815-0008,,CPT000815-0010,,CPT000821-0002,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
100002921,BRCA,,,1.0,"No proteomics, partial genomics",0.0,,,CPT000816-0008,,CPT000816-0010,,CPT000822-0002,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
100003304,BRCA,,,1.0,"No proteomics, partial genomics",0.0,,,CPT000817-0008,,CPT000817-0010,,CPT000823-0002,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
100004012,BRCA,,,1.0,"No proteomics, partial genomics",0.0,,,CPT000818-0008,,CPT000818-0012,,CPT000824-0002,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
100004028,BRCA,,,1.0,"No proteomics, partial genomics",0.0,,,CPT000819-0008,,CPT000819-0010,,CPT000825-0002,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
01BR044,BRCA,,,,,0.0,,,CPT001846-0009,,CPT001846-0011,,CPT001849-0002,84,Female,White,unknown,European,,No,,,,,"other, specify","GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T4b , N0 ,17,0,0,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
03BR012,BRCA,,,1.0,"No proteomics, partial genomics",0.0,,,2d8514b6-c01a-4166-a0c1-bc7012_D7,,2d8514b6-c01a-4166-a0c1-bc7012_D6_1,,52a53fb4-2433-4e65-a5c6-169abe_D1_1,46,Female,White,Not Hispanic or Latino,Ad_Mixed_American,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T3,N1a,6,0,3,,MX,,,,,,,No,,,,,,No,,,,390.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,390.0,0.0,
05BR031,BRCA,,,1.0,"No proteomics, partial genomics",0.0,,,4cab24a5-70d4-4364-a2be-da0d99_D7,,4cab24a5-70d4-4364-a2be-da0d99_D6_1,,0b9c8570-2765-42db-9ad7-696943_D1_1,46,Female,White,Not Hispanic or Latino,European,,No,,,,,Inflitrating Ductal Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,Not Applicable,,T3a,N1a,1,0,1,,M0,,,,,,,No,,,,,,No,,,,319.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,319.0,0.0,
05BR051,BRCA,,,1.0,"No proteomics, partial genomics",0.0,,,CPT000415-0013,,CPT000415-0015,,CPT000409-0002,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
05BR052,BRCA,,,1.0,"No proteomics, partial genomics",0.0,,,CPT000424-0009,,CPT000424-0011,,CPT000419-0002,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
05BR055,BRCA,,,1.0,"No proteomics, partial genomics",0.0,,,CPT000400-0009,,CPT000400-0013,,CPT000404-0002,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
05BR058,BRCA,,,1.0,"No proteomics, partial genomics",0.0,,,CPT000432-0009,,CPT000432-0011,,CPT000428-0002,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
11BR069,BRCA,,,1.0,"No proteomics, partial genomics",0.0,,,07c4bb93-a373-4748-a2c7-5806cb_D7_1,,07c4bb93-a373-4748-a2c7-5806cb_D6_1,,ea97a4cf-4acb-47f5-b19f-1e8d4a_D1,65,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Inflitrating Lobular Carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,Not Applicable,,T2,N0,5,Not Reported/ Unknown,0,,M0,,,,,,,No,,,,,,No,,,,387.0,,,,,Not Applicable,Not Applicable,,,,Not Applicable,,,,,,,,,,,,,,,0.0,387.0,0.0,
18BR008,BRCA,,,1.0,"No proteomics, partial genomics",0.0,,,88ad3f0f-96ac-4a60-a687-d55adf_D7_1,,not run,,not run,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3L-01287,ccRCC,C3L-01287-T,C3L-01287-N,,,0.0,CPT0079430001,CPT0079410003,"['CPT0079420009', 'CPT0079410006', 'CPT007940 0003', 'CPT0079400009', 'CPT007942 0003']",CPT0079430006,CPT0079410009,CPT0079430009,CPT0080130002,60,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,10.5,Clear cell renal cell carcinoma,G4 Undifferentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,cM1,pM1,Left Lung Nodule ,R0:No residual tumor,,178.0,80.0,25.31,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Duloxetine|Atorvastatin,Medical Record|Medical Record,No,630.0,633.0,Main malignancy,,633.0,Yes,Yes,Yes,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,633.0,1.0,0.0
C3L-00561,ccRCC,C3L-00561-T,C3L-00561-N,,,0.0,CPT0023360001,CPT0023350003,['CPT0023350009'],CPT0023360006,CPT0023350006,CPT0023360009,CPT0024550002,50,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,10.0,Clear cell renal cell carcinoma,G4 Undifferentiated,Stage III,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3b,pN0,29,IHC staining not done,0,cM0,Staging Incomplete,Not applicable,RX:Presence of residual tumor cannot be assessed,,185.0,94.0,27.47,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Lispinopril|Lopressor|Tambocor,Medical Record|Medical Record|Medical Record,No,1796.0,,,1796.0,,No,No,No,Not Applicable,Persistent Disease,Yes,368.0,Distant Metastasis,Lung,,,,No,,No,Yes,No,,,368.0,1.0,1796.0,0.0,0.0
C3L-01603,ccRCC,C3L-01603-T,C3L-01603-N,,,0.0,CPT0087050003,CPT0087040003,"['CPT0087030006', 'CPT0087020006', 'CPT0087040006']",CPT0087050006,CPT0087040009,CPT0087050009,CPT0087460001,63,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,4.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,173.0,128.0,42.77,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",36.0,Exposure to secondhand smoke history not available,,,,,No,1765.0,,,1771.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1765.0,0.0,6.0
C3N-01524,ccRCC,C3N-01524-T,C3N-01524-N,,,0.0,CPT0077320001,CPT0077310003,"['CPT0077300006', 'CPT0077310006', 'CPT0077290006']",CPT0077320006,CPT0077310009,CPT0077320009,CPT0077410002,61,Male,Unknown,Unknown,European,Ukraine,No,,Left Kidney,Unifocal,8.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No.,R0:No residual tumor,,182.0,94.0,28.38,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,694.0,,,700.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,694.0,0.0,6.0
C3L-00359,ccRCC,C3L-00359-T,,,,0.0,,CPT0002270011,['CPT0002270005'],,CPT0002270008,,CPT0004370002,73,Female,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,3.0,non-Clear Cell renal cell carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not applicable ,R0:No residual tumor,,165.0,117.0,42.92,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,64.5,Exposure to secondhand smoke history not available,,,Metoprolol Succinate-XL|Duloxetine|Pregabalin|Albuterol|Methylphenidate ER|Lisinopril|Hydrocodone-acetaminophen|Calcium Carb-Cholecalciferol|Loratadine|Melatonin|Docusate Sodium|Naproxen|Alprazolam|Midrin|Allopurinol|Levothyroxine|Magnesium,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1779.0,1779.0,Main malignancy,,1779.0,No,No,No,Not Applicable,Persistent Disease,Yes,1402.0,,,,,No,No,,No,Yes,No,,,1402.0,1.0,1779.0,1.0,0.0
C3N-00834,ccRCC,C3N-00834-T,C3N-00834-N,,,0.0,CPT0078840001,CPT0078830003,['CPT0078830006'],CPT0078840006,CPT0078830009,CPT0078840009,CPT0078870002,65,Male,Unknown,Unknown,European,Poland,No,,Right Kidney,Unifocal,5.0,Clear cell renal cell carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,173.0,90.0,30.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",20.0,Exposure to secondhand smoke history not available,,,Tritace (ramiprilum)|Bisocard (bisoprololi)|IPP (pantoprazolum)|Diuver (torasemidum)|Amlozek (amlodipinum)|Atoris (atorvastatinum)|clexane (enoxaparinum),Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self-reported and Medical Record,No,1755.0,,,1769.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1755.0,0.0,14.0
C3N-01214,ccRCC,C3N-01214-T,C3N-01214-N,,,0.0,CPT0075570001,CPT0075560003,"['CPT0075560009', 'CPT0075550005', 'CPT0075540016']",CPT0075570006,CPT0075560006,CPT0075570009,CPT0075620002,60,Male,Unknown,Unknown,European,Ukraine,No,,Left Kidney,Unifocal,8.4,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,5,IHC staining not done,0,cM0,Staging Incomplete,No.,R0:No residual tumor,,191.0,78.0,21.38,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,41.0,Exposure to secondhand smoke history not available,,,,,No,653.0,,,659.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,653.0,0.0,6.0
C3N-01261,ccRCC,C3N-01261-T,C3N-01261-N,,,0.0,CPT0077500001,CPT0077490003,"['CPT0077490006', 'CPT0077480006', 'CPT0077470006']",CPT0077500006,CPT0077490009,CPT0077500009,CPT0077590002,67,Male,Unknown,Unknown,European,Ukraine,No,,Right Kidney,Unifocal,5.2,Clear cell renal cell carcinoma,G1 Well differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No.,R0:No residual tumor,,167.0,67.0,24.02,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,680.0,,,683.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,680.0,0.0,3.0
C3L-00917,ccRCC,C3L-00917-T,C3L-00917-N,,,0.0,CPT0023710001,CPT0023690003,['CPT0023690009'],CPT0023710006,CPT0023690006,CPT0023710009,CPT0024600002,37,Male,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,Left Kidney,Unifocal,3.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,,185.0,156.0,45.37,No,Lifelong non-drinker,Smoking history not available,,Exposure to secondhand smoke history not available,,,Humira,Medical Record,No,1783.0,,,1783.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1783.0,0.0,0.0
C3L-00607,ccRCC,C3L-00607-T,C3L-00607-N,,,0.0,CPT0025060001,CPT0025050003,['CPT0025050006'],CPT0025060006,CPT0025050009,['CPT0025060009'],CPT0029400002,66,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Multifocal,7.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,171.0,112.0,37.96,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Novolog Flexpen (Insulin)|Lasix,Medical Record|Medical Record,No,781.0,781.0,Main malignancy,,781.0,No,No,No,Complete Remission,,Yes,377.0,,,,,No,Yes,,No,Yes,No,,377.0,377.0,1.0,781.0,1.0,0.0
C3L-01861,ccRCC,C3L-01861-T,C3L-01861-N,,,0.0,CPT0092310003,CPT0092290003,"['CPT0092280006', 'CPT0092300006', 'CPT0092290005']",CPT0092310006,CPT0092290008,CPT0092310009,CPT0093770002,57,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,3.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:No residual tumor,,173.0,86.0,28.63,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",0.5,Exposure to secondhand smoke history not available,Basal cell carcinoma of skin,Unknown,Lipitor|Freestyle Lite strip|Novolog Flexpen|Toujeo Solostar|Hyzaar|glucophage|prilosec|BD Ultra fine |Revatio,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1761.0,,,1761.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1761.0,0.0,0.0
C3N-00194,ccRCC,C3N-00194-T,C3N-00194-N,,,0.0,CPT0014130001,CPT0014160003,"['CPT0014180018', 'CPT0014160009', 'CPT0014150013']",CPT0014130006,CPT0014160006,CPT0014130009,CPT0015040002,51,Female,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,12.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,165.0,73.0,26.96,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,17.5,Exposure to secondhand smoke history not available,,,NORCO|ibprofen,Medical Record|Medical Record,No,208.0,,,209.0,,No,Yes,Unknown,Persistent Disease,,Yes,115.0,,,,,No,No,,No,Yes,No,,,115.0,1.0,208.0,0.0,1.0
C3L-00010,ccRCC,C3L-00010-T,C3L-00010-N,,,0.0,CPT0001230001,CPT0001220008,CPT0001220164,CPT0001230006,CPT0001220165,"['CPT0001230014', 'CPT0001230009']",CPT0000060163,30,Male,White,Not Hispanic or Latino,Ad_Mixed_American,United States,No,,Left Kidney,Unifocal,6.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,2,0,0,cM0,Staging Incomplete,Not Applicable ,R0:No residual tumor,,177.0,107.0,34.15,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,10.0,Exposure to secondhand smoke history not available,,,Tramadol|Esomeprazole |Rivaroxaban,Medical Record|Medical Record|Medical Record,No,896.0,,,896.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,896.0,0.0,0.0
C3L-01352,ccRCC,C3L-01352-T,,,,0.0,,CPT0071150004,['CPT0071150007'],,CPT0071150010,,CPT0071980002,76,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,Right Kidney,Unifocal,3.4,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,163.0,71.0,26.95,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Acetaminophen|Calcitrate/Vita D|Cholecalciferol Vitamin D3|Hydrochlorothiazide|Hydroxychloroquine Sulfate|Latanoprost|Losartan|Multivitamins w/ minerals and iron|Omeprzaole|Refresh Ophthalmic Solution|Sertraline HCL|Simvastatin|Sulfasalazine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,233.0,,,233.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,233.0,0.0,0.0
C3N-01646,ccRCC,C3N-01646-T,C3N-01646-N,,,0.0,CPT0088500001,CPT0088480003,['CPT0088480006'],CPT0088500006,CPT0088480009,"['CPT0088500014', 'CPT0088500009']",CPT0088540001,69,Male,Unknown,Unknown,European,Poland,No,,Right Kidney,Unifocal,10.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,170.0,75.0,25.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,9.6,No or minimal exposure to secondhand smoke,,,trazodone|pregabalin|fluvoxamini|torasemidum|fenofibratum|Rosuvastatinum|Humulin N|Humalog|clexane (enoxaparinum),Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self-reported and Medical Record,No,1470.0,,,1478.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1470.0,0.0,8.0
C3N-00495,ccRCC,C3N-00495-T,C3N-00495-N,,,0.0,CPT0078530001,CPT0078510003,['CPT0078510006'],CPT0078530006,CPT0078510009,CPT0078530009,CPT0078570002,67,Male,Unknown,Unknown,European,Poland,No,,Left Kidney,Unifocal,4.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,170.0,48.0,16.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",1.5,Exposure to secondhand smoke history not available,,,Diuresin (indapamidum)|lokren (betaxololi)|Axtil (ramiprilum)|penester (finasteridum)|Apo-Doxan (doxazosini),Self Report|Self Report|Self Report|Self Report|Self Report,No,1779.0,,,1786.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1779.0,0.0,7.0
C3L-01281,ccRCC,C3L-01281-T,C3L-01281-N,,,0.0,CPT0079510001,CPT0079480003,['CPT0079480006'],CPT0079510006,CPT0079480009,CPT0079510009,CPT0080150002,66,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Multifocal,11.5,Clear cell renal cell carcinoma,G4 Undifferentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,cM1,pM1,Right 8th Rib,R0:No residual tumor,,168.0,98.0,34.76,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,,Exposure to secondhand smoke history not available,,,Budesonide-Formoterol Fumarate|Albuterol|Hydrocodone-acetaminophen,Medical Record|Medical Record|Medical Record,No,1779.0,,,1779.0,,No,No,Yes,Unknown,Persistent Disease,Yes,876.0,,,,,No,No,,Unknown,Unknown,Unknown,,,876.0,1.0,1779.0,0.0,0.0
C3N-00831,ccRCC,C3N-00831-T,C3N-00831-N,,,0.0,CPT0089040001,CPT0089020003,['CPT0089020006'],CPT0089040006,CPT0089020009,CPT0089040009,CPT0089080002,52,Male,Unknown,Unknown,European,Poland,No,,Right Kidney,Unifocal,8.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pNX,0,IHC staining not done,0,cM1,Staging Incomplete,lungs,RX:Presence of residual tumor cannot be assessed,,186.0,107.0,30.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Glucophage (metformini),Self Report,No,374.0,452.0,Main malignancy,,463.0,No,Yes,No,Persistent Disease,,Yes,35.0,,,,,No,No,,No,Yes,No,,,35.0,1.0,452.0,1.0,11.0
C3L-00791,ccRCC,C3L-00791-T,C3L-00791-N,,,0.0,CPT0026420001,CPT0026410003,['CPT0026410006'],,CPT0026410009,,CPT0029500002,76,Male,White,Unknown,European,United States,No,,Right Kidney,Unifocal,6.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN1,1,1,1,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,173.0,88.0,29.49,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Multivutamins,Medical Record,No,708.0,,,708.0,,Unknown,Unknown,Unknown,Unknown,,No,,,,,,,,,,,,,,,0.0,708.0,0.0,0.0
C3L-00369,ccRCC,C3L-00369-T,C3L-00369-N,,,0.0,CPT0006530001,CPT0006440003,"['CPT0006470008', 'CPT0006440006', 'CPT0006520006']",CPT0006530006,CPT0006440009,"['CPT0006530009', 'CPT0006530014']",CPT0002660002,89,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,12.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,175.0,84.0,27.35,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Tramadol|Psyllium|Levothyroxine|Hydrochlorothiazide|Lactulose|Polyethylene glycol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,91.0,91.0,Main malignancy,,91.0,No,No,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,91.0,1.0,0.0
C3L-00183,ccRCC,C3L-00183-T,C3L-00183-N,,,0.0,CPT0066430001,CPT0066470004,CPT0066470007,,CPT0066470010,,CPT0070990002,33,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,Right Kidney,Unifocal,6.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,none,R0:No residual tumor,,157.0,90.0,36.39,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,0.8,Exposure to secondhand smoke history not available,,,albuteral,Medical Record,No,227.0,,,227.0,,No,No,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,227.0,0.0,0.0
C3N-01180,ccRCC,C3N-01180-T,,,,0.0,,CPT0088970003,['CPT0088970006'],,CPT0088970009,,CPT0089010002,51,Male,Unknown,Unknown,European,Poland,No,,Left Kidney,Unifocal,5.0,non-Clear Cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,180.0,80.0,24.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,19.0,Exposure to secondhand smoke history not available,,,,,No,1815.0,,,1824.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1815.0,0.0,9.0
C3N-00168,ccRCC,C3N-00168-T,C3N-00168-N,,,0.0,CPT0020020001,CPT0019990003,"['CPT0019990006', 'CPT0019980006', 'CPT0020000006', 'CPT0020010006']",CPT0020020006,CPT0019990009,CPT0020020009,CPT0020920002,47,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Left Kidney,Unifocal,4.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,0,IHC staining not done,0,cM0,Staging Incomplete,Unknown,R0:No residual tumor,,168.0,53.0,18.78,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,5.0,No or minimal exposure to secondhand smoke,,,,,No,826.0,,,828.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,826.0,0.0,2.0
C3L-00097,ccRCC,C3L-00097-T,C3L-00097-N,,,0.0,CPT0000790001,CPT0000780007,CPT0000780008,CPT0000790006,CPT0000780005,['CPT0000790009'],CPT0003920002,59,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Multifocal,3.7,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,Not Applicable ,R0:No residual tumor,,175.0,113.0,36.81,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",22.0,Exposure to secondhand smoke history not available,,,Ciprofloxacin|Metronidazole,Medical Record|Medical Record,No,1735.0,,,1735.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1735.0,0.0,0.0
C3L-00004,ccRCC,C3L-00004-T,C3L-00004-N,,,0.0,CPT0001550001,CPT0001540009,CPT0001540164,CPT0001550006,CPT0001540165,"['CPT0001550009', 'CPT0001550013']",CPT0000140163,72,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,12.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,Not applicable,R1:Microscopic residual tumor,,170.0,66.0,22.8,No,Lifelong non-drinker,Current reformed smoker within past 15 years,44.0,Exposure to secondhand smoke history not available,,,zocor|colace|glycolax|rivaroxaban|tylenol|Aspirin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,384.0,,,384.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,384.0,0.0,0.0
C3N-00953,ccRCC,C3N-00953-T,C3N-00953-N,,,0.0,CPT0065450001,CPT0065430003,"['CPT0065440006', 'CPT0065430006', 'CPT0065220006']",,CPT0065430009,,CPT0070680002,41,Male,Asian,Not Hispanic or Latino,South_Asian,United States,No,,Left Kidney,Unifocal,8.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,185.0,77.0,22.43,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,1785.0,,,1785.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1785.0,0.0,0.0
C3N-00150,ccRCC,C3N-00150-T,C3N-00150-N,,,0.0,CPT0066520001,CPT0066480003,"['CPT0066510012', 'CPT0066480006', 'CPT0066490006', 'CPT0066500006']",CPT0066520006,CPT0066480009,CPT0066520009,CPT0071650002,55,Female,Unknown,Unknown,European,Ukraine,No,,Left Kidney,Unifocal,12.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,5,IHC staining not done,0,cM1,Staging Incomplete,Brain,R0:No residual tumor,,168.0,52.0,18.42,No,Lifelong non-drinker,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,-7.0,,,0.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,0.0,0.0,7.0
C3L-00583,ccRCC,C3L-00583-T,C3L-00583-N,,,0.0,CPT0019160001,CPT0019130003,"['CPT0019130009', 'CPT0019140006', 'CPT0019150006']",CPT0019160006,CPT0019130006,['CPT0019160009'],CPT0019900002,55,Male,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,Right Kidney,Multifocal,4.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,,162.0,99.0,37.72,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Albuterol sulfate|Ferrous Sulfate|Protonix|Qvar|Sulfasalazine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,301.0,,,301.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,301.0,0.0,0.0
C3N-00244,ccRCC,C3N-00244-T,C3N-00244-N,,,0.0,CPT0014350001,CPT0014370004,['CPT0014370010'],CPT0014350006,CPT0014370007,CPT0014350009,CPT0015060002,46,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,2.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,175.0,136.0,44.3,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,acetaminophen|gabapentin|silodosin,Medical Record|Medical Record|Medical Record,No,728.0,,,675.0,,No,No,No,Not Applicable,,Yes,525.0,,,,,No,No,,Unknown,Unknown,Unknown,,,525.0,1.0,728.0,0.0,-53.0
C3N-01178,ccRCC,C3N-01178-T,C3N-01178-N,,,0.0,CPT0079000001,CPT0078990003,['CPT0078990006'],CPT0079000006,CPT0078990009,CPT0079000009,CPT0079040002,58,Female,Unknown,Unknown,European,Poland,No,,Right Kidney,Unifocal,7.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,173.0,75.0,25.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,5.0,Exposure to secondhand smoke history not available,,,,,No,1703.0,,,1716.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1703.0,0.0,13.0
C3L-00088,ccRCC,C3L-00088-T,C3L-00088-N,,,0.0,CPT0000890001,CPT0000870016,CPT0000870008,CPT0000890006,CPT0000870012,"['CPT0000890009', 'CPT0000890014']",CPT0003890002,72,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,4.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,Not applicable,R1:Microscopic residual tumor,,178.0,104.0,32.82,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",52.0,Exposure to secondhand smoke history not available,,,Apixaban|Asa 81mg|Carvedilol|Digoxin|Anasteride|Lantus Solostar|Lisinopril|Melatonin|Quetlapine|Simvastatin|Tamsulosin|Victoza,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,687.0,694.0,Unknown,,694.0,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,694.0,1.0,0.0
C3L-00814,ccRCC,C3L-00814-T,C3L-00814-N,,,0.0,CPT0065820001,CPT0065810003,['CPT0065810006'],CPT0065820006,CPT0065810009,CPT0065820009,CPT0067690002,83,Male,Unknown,Unknown,European,United States,No,,Left Kidney,Unifocal,3.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a,pNX,0,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,178.0,97.0,30.56,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,lisinopril-hydrochlorothiazide ,Medical Record,No,15.0,,,15.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,15.0,0.0,0.0
C3L-00908,ccRCC,C3L-00908-T,C3L-00908-N,,,0.0,CPT0086370003,CPT0086360003,"['CPT0086360006', 'CPT0086350009']",CPT0086370006,"['CPT0086360009', 'CPT0086350006']",CPT0086370009,CPT0087380001,60,Female,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,10.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pNX,0,0,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,163.0,74.0,27.85,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",3.0,Exposure to secondhand smoke history not available,,,tylenol|albuterol|glucosamine-chondroit|multiple vitamins,Medical Record|Medical Record|Medical Record|Medical Record,No,1785.0,,,1795.0,,No,No,No,Not Applicable,Persistent Disease,Yes,1105.0,Distant Metastasis,Other,Lumbar spine ,,,Yes,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,,1517.0,1105.0,1.0,1785.0,0.0,10.0
C3L-01885,ccRCC,C3L-01885-T,C3L-01885-N,,,0.0,CPT0092800003,CPT0092790003,CPT0092790006,CPT0092800006,CPT0092790009,"['CPT0092800009', 'CPT0092800013']",CPT0093830002,67,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,3.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,,175.0,108.0,35.27,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",37.5,Exposure to secondhand smoke history not available,Renal Cancer|Prostate Cancer,Surgery|Surgery,Uloric |paroxetine|simvastatin|METOPROLOL & DIET MANAGE PROD PO|Toprol XL ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,342.0,,,342.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,342.0,0.0,0.0
C3L-00026,ccRCC,C3L-00026-T,C3L-00026-N,,,0.0,CPT0001510001,CPT0001500009,CPT0001500164,CPT0001510006,CPT0001500005,"['CPT0001510009', 'CPT0001510014']",CPT0000130163,65,Female,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,2.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,Not Applicable,RX:Presence of residual tumor cannot be assessed,,163.0,75.0,28.23,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Citracal|Cyproheptadine HCL|Levothyroxine Sodium|Omeprazole|Valacyclovir|Zomig,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1769.0,,,1769.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1769.0,0.0,0.0
C3L-00447,ccRCC,C3L-00447-T,C3L-00447-N,,,0.0,CPT0006950001,CPT0006900003,"['CPT0006900006', 'CPT0006910006', 'CPT0006860006']",CPT0006950006,CPT0006900009,"['CPT0006950014', 'CPT0006950009']",CPT0002760002,35,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,5.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,,180.0,118.0,36.57,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,15.0,Exposure to secondhand smoke history not available,,,,,No,671.0,,,671.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,671.0,0.0,0.0
C3L-00416,ccRCC,C3L-00416-T,C3L-00416-N,,,0.0,CPT0010120001,CPT0010110003,['CPT0010110009'],CPT0010120006,CPT0010110006,CPT0010120009,CPT0019870002,62,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,6.0,Clear cell renal cell carcinoma,G4 Undifferentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3b,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,175.0,98.0,32.0,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,96.0,Exposure to secondhand smoke history not available,,,norvasc|asa|coreg|lasix|celexa|lopid|catapres|imdur|praxachol|Lantus solotar|trazodone|ferrous sulfate |humalog,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,608.0,,,608.0,,No,No,No,Not Applicable,,Unknown,,,,,,,,,,,,,,,0.0,608.0,0.0,0.0
C3N-00246,ccRCC,C3N-00246-T,C3N-00246-N,,,0.0,CPT0025610001,CPT0025580004,['CPT0025580007'],,CPT0025580010,,CPT0028450002,44,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,3.1,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,175.0,141.0,45.77,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Valium,Medical Record,No,2006.0,,,1982.0,,No,No,No,Complete Remission,Persistent Disease,Yes,1890.0,Distant Metastasis,Other,Retroperitoneum,,,Yes,RX: Presence of Residual Tumor cannot be assessed,No,No,No,,1956.0,1890.0,1.0,2006.0,0.0,-24.0
C3N-00148,ccRCC,C3N-00148-T,C3N-00148-N,,,0.0,CPT0081620001,CPT0081600003,"['CPT0081600009', 'CPT008159 0004', 'CPT0081590006', 'CPT008160 0004', 'CPT008161 0004', 'CPT008158 0004', 'CPT0081610006', 'CPT0081580006']",CPT0081620006,CPT0081600006,CPT0081620009,CPT0081700002,52,Male,Unknown,Unknown,European,Ukraine,No,,Right Kidney,Unifocal,4.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,0,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,178.0,90.0,28.41,No,Lifelong non-drinker,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,-9.0,,,0.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,0.0,0.0,9.0
C3L-00096,ccRCC,C3L-00096-T,C3L-00096-N,,,0.0,CPT0001190001,CPT0001180009,CPT0001180164,CPT0001190006,CPT0001180005,"['CPT0001190015', 'CPT0001190009']",CPT0000050163,52,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Multifocal,12.3,Clear cell renal cell carcinoma,G4 Undifferentiated,Stage IV,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3a,pN0,1,IHC staining not done,0,cM1,pM1,"Pelvic bone, liver, lung, brain",R0:No residual tumor,,185.0,94.0,27.44,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Lisinopril|Glimepiride|Metformin|cyclobenzaprine|Atorvastatin|Asa 81mg,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,68.0,71.0,Unknown,,71.0,Yes,Yes,No,Unknown,,No,,,,,,,,,,,,,,,0.0,71.0,1.0,0.0
C3N-00646,ccRCC,C3N-00646-T,C3N-00646-N,,,0.0,CPT0082010001,CPT0081990003,"['CPT0082000006', 'CPT0081980005', 'CPT0081970006', 'CPT0081990009']",CPT0082010006,CPT0081990006,CPT0082010009,CPT0082030002,57,Female,Unknown,Unknown,European,Ukraine,No,,Right Kidney,Unifocal,3.2,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,None specified,R0:No residual tumor,,172.0,82.0,27.72,No,Lifelong non-drinker,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,-6.0,,,0.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,0.0,0.0,6.0
C3L-00765,ccRCC,C3L-00765-T,,,,0.0,,CPT0015910003,['CPT0015910008'],,CPT0015910006,,CPT0018310001,61,Female,White,Unknown,European,United States,No,,Right Kidney,Unifocal,5.6,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,160.0,56.0,21.96,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,10.0,Exposure to secondhand smoke history not available,,,Omeprazole,Medical Record,No,1414.0,,,1414.0,,No,No,No,Complete Remission,Not Applicable,No,,,,,,,,,,,,,,,0.0,1414.0,0.0,0.0
C3L-01836,ccRCC,C3L-01836-T,C3L-01836-N,,,0.0,CPT0086890003,CPT0086870003,"['CPT0086860006', 'CPT0086870006', 'CPT0086880006']",CPT0086890006,CPT0086870009,CPT0086890009,CPT0087440002,47,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,4.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,0,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,172.0,87.0,29.41,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,,Exposure to secondhand smoke history not available,,,aspirin|fenofibrate|inderal|protonix,Medical Record|Medical Record|Medical Record|Medical Record,No,1122.0,,,1128.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1122.0,0.0,6.0
C3L-00902,ccRCC,C3L-00902-T,C3L-00902-N,,,0.0,CPT0063330001,CPT0063320003,['CPT0063320005'],CPT0063330006,['CPT0063320009'],CPT0063330009,CPT0065240002,69,Female,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,5.0,Clear cell renal cell carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:No residual tumor,,170.0,57.0,19.72,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",3.8,Exposure to secondhand smoke history not available,Left Breast Cancer|Left Breast Cancer,"Radiation,Surgery,Chemotherapy|Radiation,Surgery,Chemotherapy",Alendronate|Gabapentin|Hydroxychloroquine|Leflunomide|Risedronate|Calcium Citrate-Vitamin D|Cholecalciferol|Multi Vitamin|Amlodipine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1791.0,,,1791.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1791.0,0.0,0.0
C3N-01175,ccRCC,C3N-01175-T,C3N-01175-N,,,0.0,CPT0078670001,CPT0078660003,['CPT0078660006'],CPT0078670006,CPT0078660009,CPT0078670009,CPT0078700002,60,Female,Unknown,Unknown,European,Poland,No,,Left Kidney,Unifocal,3.0,non-Clear Cell renal cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,164.0,39.0,14.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Yes,,,bisoprolol,Self-reported and Medical Record,No,1714.0,,,1730.0,,No,No,No,Not Applicable,Not Applicable,No,,,,,,,,,,,,,,,0.0,1714.0,0.0,16.0
C3L-00011,ccRCC,C3L-00011-T,C3L-00011-N,,,0.0,CPT0001350001,CPT0001340003,CPT0001340164,CPT0001350006,CPT0001340005,"['CPT0001350009', 'CPT0001350014']",CPT0000090163,63,Female,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,12.0,Clear cell renal cell carcinoma,G4 Undifferentiated,Stage IV,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,cM1,pM1,Right Patella ,R1:Microscopic residual tumor,,180.0,89.0,27.47,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,Metastatic Renal Cell Carcinoma to Rt Patella,Surgery,Aspirin|Calcium Carb-Cholecalciferol|Diphenhydramine-APAP|Escitalopram Oxalate|Ibandronate Sodium|Levothyroxine Sodium|Multi Vitamin|Naproxen Sodium,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,229.0,241.0,Main malignancy,,241.0,No,Yes,Yes,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,241.0,1.0,0.0
C3N-00177,ccRCC,C3N-00177-T,C3N-00177-N,,,0.0,CPT0020130001,CPT0020120003,"['CPT0020110006', 'CPT0020120006', 'CPT0020100006']",CPT0020130006,CPT0020120009,CPT0020130009,CPT0020940002,52,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Left Kidney,Unifocal,7.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,0,IHC staining not done,0,cM0,Staging Incomplete,Not known,R0:No residual tumor,,173.0,72.0,24.06,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,841.0,,,843.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,841.0,0.0,2.0
C3N-01200,ccRCC,C3N-01200-T,C3N-01200-N,,,0.0,CPT0075170001,CPT0075130003,"['CPT0075130006', 'CPT0075150009', 'CPT0075120009', 'CPT0075160009', 'CPT0075140009']",CPT0075170006,CPT0075130009,CPT0075170009,CPT0075240001,56,Female,Unknown,Unknown,European,Ukraine,No,,Left Kidney,Unifocal,16.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4,pN0,8,IHC staining not done,0,cM1,Staging Incomplete,"Liver, lung.",R0:No residual tumor,,172.0,78.0,26.37,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,47.0,47.0,Main malignancy,,56.0,Yes,Yes,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,47.0,1.0,9.0
C3N-01176,ccRCC,C3N-01176-T,C3N-01176-N,,,0.0,CPT0078940001,CPT0078930003,['CPT0078930006'],CPT0078940006,CPT0078930009,CPT0078940009,CPT0078970002,71,Male,Unknown,Unknown,European,Poland,No,,Right Kidney,Multifocal,6.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,cM1,Staging Incomplete,lungs,RX:Presence of residual tumor cannot be assessed,,175.0,91.0,29.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Symlosin SR (tamsulosini)|Tezeo (telmisartanum)|Amlopin (amlodipinum)|Ipres long (indapamidum)|Zocor (simvastatinum)|betaloc (metorpolol),Self Report|Self Report|Self Report|Self Report|Self Report|Self Report,No,1710.0,,,1724.0,,No,No,No,Persistent Disease,Persistent Disease,No,,,,,,,,,,,,,,,0.0,1710.0,0.0,14.0
C3N-01808,ccRCC,C3N-01808-T,C3N-01808-N,,,0.0,CPT0089480003,CPT0089460004,CPT0089460006,CPT0089480006,CPT0089460009,"['CPT0089480009', 'CPT0089480013']",CPT0091340002,47,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,5.8,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,183.0,96.0,28.75,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,778.0,,,778.0,,Unknown,Unknown,Unknown,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,778.0,0.0,0.0
C3L-00103,ccRCC,C3L-00103-T,C3L-00103-N,,,0.0,CPT0000660001,CPT0000640003,"['CPT0000630009', 'CPT0000640005', 'CPT0000650008']",CPT0000660006,CPT0000640008,"['CPT0000660009', 'CPT0000660014']",CPT0003850002,56,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,11.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3b,pN0,6,IHC staining not done,0,cM0,Staging Incomplete,Not Applicable ,R0:No residual tumor,,180.0,93.0,28.7,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,17.5,Exposure to secondhand smoke history not available,,,Lisinopril ,Medical Report,No,1659.0,1659.0,Main malignancy,,1659.0,No,No,No,Not Applicable,Patient Deceased,Yes,833.0,,,,,No,No,,No,Yes,No,,,833.0,1.0,1659.0,1.0,0.0
C3N-01649,ccRCC,C3N-01649-T,C3N-01649-N,,,0.0,CPT0088640003,CPT0088630003,CPT0088630006,CPT0088640006,CPT0088630009,CPT0088640009,CPT0088680009,51,Male,Unknown,Unknown,European,Poland,No,,Right Kidney,Unifocal,8.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,cM1,No pathologic evidence of distant metastasis,liver,R0:No residual tumor,,173.0,105.0,35.0,No,"Consumed alcohol in the past, but currently a non-drinker",Current reformed smoker within past 15 years,46.5,Exposure to secondhand smoke history not available,,,Methyldopum|nitrendypinum|torasemidum|metoprolol|candesartan,Self Report|Self Report|Self Report|Self Report|Self Report,No,1421.0,,,1430.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1421.0,0.0,9.0
C3N-00149,ccRCC,C3N-00149-T,C3N-00149-N,,,0.0,CPT0084590001,CPT0084560003,"['CPT008458 0004', 'CPT0084560009', 'CPT008457 0004', 'CPT008456 0004', 'CPT0084580006', 'CPT0084570006']",CPT0084590006,CPT0084560006,CPT0084590009,CPT0085310002,68,Female,Unknown,Unknown,European,Ukraine,No,,Left Kidney,Unifocal,12.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4,pN0,0,IHC staining not done,0,cM0,Staging Incomplete,None known,R0:No residual tumor,,162.0,71.0,27.05,No,Lifelong non-drinker,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,-8.0,,,0.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,0.0,0.0,8.0
C3L-00581,ccRCC,C3L-00581-T,C3L-00581-N,,,0.0,CPT0007470001,CPT0007320003,"['CPT0007410006', 'CPT0007320006', 'CPT0007330006']",CPT0007470006,CPT0007320009,['CPT0007470009'],CPT0002780002,52,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,13.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,,168.0,95.0,33.66,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,1230.0,1230.0,Main malignancy,,1230.0,No,No,No,Not Applicable,,Yes,389.0,Distant Metastasis,"Lung, Bone",,,No,Yes,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,,411.0,389.0,1.0,1230.0,1.0,0.0
C3L-00817,ccRCC,C3L-00817-T,,,,0.0,,CPT0065870003,['CPT0065870006'],,CPT0065870009,,CPT0067710002,80,Male,White,Unknown,European,United States,No,,Right Kidney,Unifocal,1.2,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,175.0,104.0,33.96,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,amLODIPine (NORVASC|carvedilol (COREG|glimepiride (AMARYL|hydrochlorothiazide (MICROZIDE|isosorbide mononitrate (IMDUR) ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1365.0,,,1365.0,,No,No,No,Complete Remission,Not Applicable,No,,,,,,,,,,,,,,,0.0,1365.0,0.0,0.0
C3L-01313,ccRCC,C3L-01313-T,C3L-01313-N,,,0.0,CPT0086830003,CPT0086820003,CPT0086820006,CPT0086830006,CPT0086820009,CPT0086830009,CPT0087430002,63,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,9.0,Clear cell renal cell carcinoma,G4 Undifferentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,0,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,165.0,80.0,29.38,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",19.0,Exposure to secondhand smoke history not available,,,Blood Glucose test|lancets|metformin HCI|omeprazole|metoprolol |zofran|norco|baby aspirin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1229.0,1229.0,Main malignancy,,1234.0,No,No,No,Not Applicable,Patient Deceased,Yes,456.0,Distant Metastasis,Other,thoracic and lumbar spine,,No,Yes,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,,469.0,456.0,1.0,1229.0,1.0,5.0
C3N-00573,ccRCC,C3N-00573-T,C3N-00573-N,,,0.0,CPT0069010001,CPT0069000003,"['CPT0068970006', 'CPT0068990006', 'CPT0068980006', 'CPT0069000009']",CPT0069010006,CPT0069000006,CPT0069010009,CPT0069090002,61,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Left Kidney,Unifocal,11.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,0,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,165.0,60.0,22.04,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,6.0,,,7.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,6.0,0.0,1.0
C3L-00360,ccRCC,C3L-00360-T,C3L-00360-N,,,0.0,CPT0002370001,CPT0002350011,['CPT0002350005'],CPT0002370006,CPT0002350008,"['CPT0002370009', 'CPT0002370014']",CPT0004380002,72,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,3.7,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,Not Applicable ,R0:No residual tumor,,177.0,122.0,38.94,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,40.0,Exposure to secondhand smoke history not available,,,Amlodipine|Aspirin|Calcium + D PO|Centrum Silver Adult |Docqlace |Hydrocodone-acetaminophen|Ferrous Gluconate (Iron)|Lisinopril |Metformin|Naproxen DR|Niacin ER|Omeprazole |Atorvastatin ,Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report,No,1780.0,,,1780.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1780.0,0.0,0.0
C3L-01302,ccRCC,C3L-01302-T,C3L-01302-N,,,0.0,CPT0063640001,CPT0063630003,['CPT0063630008'],CPT0063640006,CPT0063630006,['CPT0063640009'],CPT0065290002,71,Female,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,8.5,Clear cell renal cell carcinoma,G4 Undifferentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pN0,22,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,,165.0,98.0,36.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Imodium A-D|methotrexate|folic acid|xarelto|prilosec|Calan|Zyrtec|mobic,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,53.0,55.0,Unknown,,55.0,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,55.0,1.0,0.0
C3N-01361,ccRCC,C3N-01361-T,C3N-01361-N,,,0.0,CPT0088780001,CPT0088760003,['CPT0088760006'],CPT0088780006,CPT0088760009,CPT0088780009,CPT0088820002,48,Male,Unknown,Unknown,European,Poland,No,,Left Kidney,Unifocal,2.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,180.0,128.0,39.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Tolura (telmisartanum)|Dilzem (diltiazemi)|Tertensif SR (indapamidum),Self Report|Self Report|Self Report,No,1811.0,,,1819.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1811.0,0.0,8.0
C3N-01651,ccRCC,C3N-01651-T,C3N-01651-N,,,0.0,CPT0088710001,CPT0088690003,['CPT0088690006'],CPT0088710006,CPT0088690009,CPT0088710009,CPT0088750002,58,Male,Unknown,Unknown,European,Poland,No,,Left Kidney,Multifocal,10.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,172.0,75.0,25.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,fraxiparine,Medical Record,No,1420.0,,,1428.0,,No,No,No,Complete Remission,Persistent Disease,Yes,354.0,,,,,No,No,,No,No,No,,,354.0,1.0,1420.0,0.0,8.0
C3L-00907,ccRCC,C3L-00907-T,C3L-00907-N,,,0.0,CPT0064400001,CPT0064370003,"['CPT0064390006', 'CPT0064370009', 'CPT0064380006']",CPT0064400006,CPT0064370006,CPT0064400009,CPT0065420002,55,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,4.8,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,178.0,150.0,47.25,Yes,Lifelong non-drinker,Current reformed smoker within past 15 years,27.0,Exposure to secondhand smoke history not available,melanoma,Surgery,protonix|metformin|cozaar|amaryl|lipitor|coreg|norco|aspirin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1791.0,,,1795.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1791.0,0.0,4.0
C3L-00448,ccRCC,C3L-00448-T,C3L-00448-N,,,0.0,CPT0010170001,CPT0010160003,['CPT0010160009'],CPT0010170006,CPT0010160006,CPT0010170009,CPT0019880002,66,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,1.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,Not Applicable,R0:No residual tumor,,185.0,90.0,26.18,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",30.0,Exposure to secondhand smoke history not available,,,Apixaban|Metoprolol Succinate|Atorvastatin|Carbamazepine|Primidone|Lisinopril|Fluticasone|Aspirin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1758.0,,,1758.0,,No,No,No,Not Applicable,Complete Remission,Yes,779.0,New Primary Tumor,Other,Prostate,,,,,No,No,No,,,779.0,1.0,1758.0,0.0,0.0
C3L-01286,ccRCC,C3L-01286-T,C3L-01286-N,,,0.0,CPT0086970003,CPT0086950003,"['CPT0086950006', 'CPT0086960006', 'CPT0086940006']",CPT0086970006,CPT0086950009,CPT0086970009,CPT0087450002,58,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,6.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,,185.0,158.0,46.17,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,apresoline|Diovan|kenalog 0.1%|Insulin pen needle |novolog|tresiba Flextouch|Norvasc|Lasix |Silvadene 1% cream|lipitor|coreg,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1028.0,1028.0,Main malignancy,,1028.0,No,No,No,Not Applicable,,Yes,594.0,,,,,No,No,,No,No,Yes,,,594.0,1.0,1028.0,1.0,0.0
C3L-01607,ccRCC,C3L-01607-T,C3L-01607-N,,,0.0,CPT0092190003,CPT0092160003,"['CPT0092160006', 'CPT0092170006', 'CPT0092180013']",CPT0092190006,CPT0092160009,"['CPT0092190013', 'CPT0092190009']",CPT0093750002,83,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,6.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,178.0,87.0,27.52,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,1794.0,,,1794.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1794.0,0.0,0.0
C3N-01179,ccRCC,C3N-01179-T,C3N-01179-N,,,0.0,CPT0088920001,CPT0088900003,['CPT0088900006'],CPT0088920006,CPT0088900009,CPT0088920009,CPT0088960002,72,Male,Unknown,Unknown,European,Poland,No,,Right Kidney,Multifocal,2.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,164.0,72.0,26.0,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,70.5,Exposure to secondhand smoke history not available,,,Co-Prestarium (amlodipinum + perindoprilum)|Noliprel (indapamidum + perindoprilum)|Acard (Acidum acetylsalicylicum)|Zahron (rosuvastatinum)|clexane (enoxaparinum),Self Report|Self Report|Self Report|Self Report|Self-reported and Medical Record,No,1816.0,,,1824.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1816.0,0.0,8.0
C3L-00606,ccRCC,C3L-00606-T,C3L-00606-N,,,0.0,CPT0079300001,CPT0079270003,"['CPT0079290006', 'CPT0079270006', 'CPT007927 0004', 'CPT0079280006', 'CPT007928 0004', 'CPT007929 0004']",CPT0079300006,CPT0079270009,['CPT0079300009'],CPT0080110002,75,Female,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,7.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pN0,5,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,,158.0,105.0,42.33,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",15.0,Exposure to secondhand smoke history not available,,,Amlodipine-benazepril|Atenolol|Furosemide|Simvastatin|Tramadol|Aspirin|Cranberry PO|Cholecalciferol|Potassium,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1045.0,1045.0,Main malignancy,,1045.0,No,No,No,Not Applicable,,Yes,780.0,Distant Metastasis,Bone,,,No,No,,No,No,Yes,,,780.0,1.0,1045.0,1.0,0.0
C3N-01648,ccRCC,C3N-01648-T,C3N-01648-N,,,0.0,CPT0088570001,CPT0088550004,['CPT0088550007'],CPT0088570006,CPT0088550010,CPT0088570009,CPT0088610002,69,Male,Unknown,Unknown,European,Poland,No,,Left Kidney,Multifocal,7.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,176.0,87.0,28.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,29.3,Exposure to secondhand smoke history not available,,,Ramipril|Bisoprolol,Self-reported and Medical Record|Self-reported and Medical Record,No,1417.0,,,1431.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1417.0,0.0,14.0
C3N-00242,ccRCC,C3N-00242-T,C3N-00242-N,,,0.0,CPT0014470001,CPT0014450004,['CPT0014450010'],CPT0014470006,['CPT0014450007'],CPT0014470009,CPT0015070002,69,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,3.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,193.0,146.0,39.2,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",30.0,Exposure to secondhand smoke history not available,,,atorvastatin|diltiazem HCI|glimeperide|metfomin|metoprolol|nitroglycerin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1793.0,,,1793.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1793.0,0.0,0.0
C3L-00418,ccRCC,C3L-00418-T,C3L-00418-N,,,0.0,CPT0006730001,CPT0006630003,"['CPT0006630006', 'CPT0006670006', 'CPT0006640006']",CPT0006730006,CPT0006630009,"['CPT0006730014', 'CPT0006730009']",CPT0002730002,56,Female,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,8.7,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,Not applicable,R1:Microscopic residual tumor,,168.0,169.0,59.88,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,,Exposure to secondhand smoke history not available,,,Norco|Iron|multvitamin|Nifedical|vitamin C,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1714.0,,,1714.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1714.0,0.0,0.0
C3N-00577,ccRCC,C3N-00577-T,C3N-00577-N,,,0.0,CPT0069190001,CPT0069160003,"['CPT0069180006', 'CPT0069170006', 'CPT0069150006', 'CPT0069160009']",CPT0069190006,CPT0069160006,CPT0069190009,CPT0069270002,72,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Left Kidney,Unifocal,14.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage IV,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,4,IHC staining not done,4,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,163.0,58.0,21.83,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,397.0,,,397.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,397.0,0.0,0.0
C3L-01882,ccRCC,C3L-01882-T,C3L-01882-N,,,0.0,CPT0092740003,CPT0092730003,CPT0092730006,CPT0092740006,CPT0092730009,"['CPT0092740013', 'CPT0092740009']",CPT0093820002,48,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,2.2,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,1,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:No residual tumor,,170.0,141.0,48.79,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,35.0,Exposure to secondhand smoke history not available,,,Aspirin|Atorvastatin|Carvedilol|NovolognFlex Pen|Insulin Detemir|Rivaroxaban|Nitroglycerin|lisinopril |Pepcid complete oral tablet |Ester-C500 oral tablet,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,350.0,,,350.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,350.0,0.0,0.0
C3N-00733,ccRCC,C3N-00733-T,C3N-00733-N,,,0.0,CPT0025920001,CPT0025880003,"['CPT0025880006', 'CPT0025900006', 'CPT0025890009']",CPT0025920006,CPT0025880009,CPT0025920009,CPT0028480002,56,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,8.6,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,177.0,87.0,27.77,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,calcium|multiple vitamin|omeprazole,Medical Record|Medical Record|Medical Record,No,1464.0,,,1464.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1464.0,0.0,0.0
C3L-00910,ccRCC,C3L-00910-T,C3L-00910-N,,,0.0,CPT0007870001,CPT0007860003,['CPT0007860006'],CPT0007870006,CPT0007860009,CPT0007870009,CPT0002930002,75,Female,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,5.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,,152.0,84.0,36.36,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",25.0,Exposure to secondhand smoke history not available,,,Microzide|Lopressor|Advair Diskus|valtrex,Medical Record|Medical Record|Medical Record|Medical Record,No,1797.0,,,1797.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1797.0,0.0,0.0
C3L-00079,ccRCC,C3L-00079-T,C3L-00079-N,,,0.0,CPT0001270001,CPT0001260009,CPT0001260164,CPT0001270006,CPT0001260005,"['CPT0001270009', 'CPT0001270014']",CPT0000070163,49,Male,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,14.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pN1,1,IHC staining not done,1,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,,175.0,116.0,37.88,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Yes,,,miralax|Norco|ibuprofen,Medical Record|Medical Record|Medical Record,No,245.0,274.0,Main malignancy,,274.0,Yes,Yes,Yes,Patient Deceased,,Unknown,,,,,,,,,,,,,,,0.0,274.0,1.0,0.0
C3N-01522,ccRCC,C3N-01522-T,C3N-01522-N,,,0.0,CPT0077140001,CPT0077110003,"['CPT0077130006', 'CPT0077120006', 'CPT0077110006']",CPT0077140006,['CPT0077110009'],CPT0077140009,CPT0077230002,80,Male,Unknown,Unknown,European,Ukraine,No,,Right Kidney,Unifocal,5.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,10,IHC staining not done,0,cM0,Staging Incomplete,No,R0:No residual tumor,,171.0,90.0,30.78,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,692.0,,,697.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,692.0,0.0,5.0
C3N-01220,ccRCC,C3N-01220-T,C3N-01220-N,,,0.0,CPT0076350001,CPT0076330003,"['CPT0076320014', 'CPT0076340009', 'CPT0076330008']",CPT0076350006,CPT0076330006,CPT0076350009,CPT0076400002,51,Male,Unknown,Unknown,European,Ukraine,No,,Left Kidney,Unifocal,6.8,Clear cell renal cell carcinoma,G4 Undifferentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,cM1,Staging Incomplete,No,R0:No residual tumor,,183.0,80.0,23.89,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,31.0,Exposure to secondhand smoke history not available,,,,,No,633.0,633.0,Main malignancy,,642.0,No,Yes,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,633.0,1.0,9.0
C3L-01283,ccRCC,C3L-01283-T,,,,0.0,,CPT0079380003,['CPT0079380006'],,CPT0079380009,,CPT0080120001,37,Male,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,Left Kidney,Unifocal,2.4,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,,180.0,100.0,30.86,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,norco|Aleve|colace|Metaxalone|Mult. vitamins,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,735.0,,,735.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,735.0,0.0,0.0
C3L-00813,ccRCC,C3L-00813-T,,,,0.0,,CPT0015810003,CPT0015810009,,CPT0015810013,,CPT0018370002,61,Male,White,Unknown,European,United States,No,,Left Kidney,Unifocal,4.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Cannot be assessed,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,175.0,60.0,19.49,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,5.0,,,5.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,5.0,0.0,0.0
C3L-01560,ccRCC,C3L-01560-T,,,,0.0,,CPT0086030003,CPT0086030006,,CPT0086030009,,CPT0086720001,54,Female,White,Unknown,European,United States,No,,Left Kidney,Unifocal,1.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,160.0,98.0,38.08,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,amLODIPine (NORVASC) |carvedilol (COREG) |losartan-hydrochlorothiazide (HYZAAR) ,Medical Record|Medical Record|Medical Record,No,250.0,,,250.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,250.0,0.0,0.0
C3L-01557,ccRCC,C3L-01557-T,,,,0.0,,CPT0085670003,CPT0085670006,,CPT0085670009,,CPT0086610002,51,Male,Black or African American,Unknown,African,United States,No,,Right Kidney,Unifocal,9.6,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pN0,3,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,"positive for pankeratin, PAX8, CA-9, CD10, Renal Cell Carcinoma Antigen, and Vimentin and negative for CK7 PERSONALIZED CANCER MUTATION PANEL (PCMP);VHL mutation POSITIVE (p.?[splice], c.341-2A>G",157.0,120.0,48.46,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,329.0,,,329.0,,No,No,Unknown,Complete Remission,,No,,,,,,,,,,,,,,,0.0,329.0,0.0,0.0
C3L-00799,ccRCC,C3L-00799-T,,,,0.0,,CPT0025230003,['CPT0025230006'],,CPT0025230009,,CPT0029440002,41,Male,White,Not Hispanic or Latino,European,United States,No,,Left Kidney,Unifocal,2.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,177.0,111.0,35.66,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,495.0,,,495.0,,No,No,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,495.0,0.0,0.0
C3L-00796,ccRCC,C3L-00796-T,,,,0.0,,CPT0065750003,CPT0065750006,,CPT0065750009,,CPT0067670002,67,Male,White,Unknown,European,United States,No,,Right Kidney,Unifocal,5.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,188.0,109.0,30.81,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,47.0,Exposure to secondhand smoke history not available,,,hydrochlorothiazide-lisinopril ,Medical Record,No,333.0,,,333.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,333.0,0.0,0.0
C3L-00792,ccRCC,C3L-00792-T,,,,0.0,,CPT0015730003,['CPT0015730009'],,CPT0015730006,,CPT0018270002,>=90,Female,White,Unknown,European,United States,No,,Right Kidney,Unifocal,8.7,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Cannot be assessed,Seventh Edition (2010),pT2a,pNX,0,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,170.0,86.0,29.6,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Simvastatin|Metoprolol|Insulin (Novolog) ,Medical Record|Medical Record|Medical Record,No,1419.0,,,1419.0,,No,No,No,Complete Remission,Not Applicable,No,,,,,,,,,,,,,,,0.0,1419.0,0.0,0.0
C3N-00832,ccRCC,C3N-00832-T,,,,0.0,,CPT0078800003,['CPT0078800006'],,CPT0078800009,,CPT0078820002,79,Male,Unknown,Unknown,European,Poland,No,,Left Kidney,Unifocal,4.5,non-Clear Cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,164.0,63.0,23.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Apo-tamis (tamsulosini)|Apo-Fina (finasteridum),Self Report|Self Report,No,1770.0,,,1778.0,,No,No,No,Complete Remission,Complete Remission,Yes,299.0,New Primary Tumor,Other,Prostate,,,,,Yes,No,No,,,299.0,1.0,1770.0,0.0,8.0
C3L-01288,ccRCC,C3L-01288-T,,,,0.0,,CPT0079230003,['CPT0079230006'],,CPT0079230009,,CPT0080100002,70,Female,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,2.8,Clear cell renal cell carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,,160.0,101.0,39.45,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,52.0,Exposure to secondhand smoke history not available,,,"Prednisone|Flexeril|Zantac|Lidoderm|Amlactin|Norco|Neurontin|Desyrel|Mult Vitamin for women 50+|Vitamin B 12|OS-CAL calcium carbonate|Imodium|Macrodantin|Lantus Solostar |Atarax|Prinzide zestoretic|Nystatin Topical Powder|Lasix|Effexor|K-Dru, Klorcon|glucose blood VI test strips |Vitamin D",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1800.0,,,1800.0,,No,No,No,Not Applicable,Persistent Disease,Yes,1416.0,Locoregional Recurrence,Other,lesion in the anterior right renal cortex ,,No,,,No,No,No,,,1416.0,1.0,1800.0,0.0,0.0
C3L-00766,ccRCC,C3L-00766-T,,,,0.0,,CPT0025170003,['CPT0025170006'],,CPT0025170009,,CPT0029430002,57,Female,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,2.8,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,156.0,167.0,68.59,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Albuterol|Fenofibrate|Omeprazole,Medical Record|Medical Record|Medical Record,No,266.0,,,266.0,,No,No,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,266.0,0.0,0.0
C3L-00610,ccRCC,C3L-00610-T,,,,0.0,,CPT0025110003,['CPT0025110006'],,CPT0025110009,,CPT0029410002,57,Female,White,Not Hispanic or Latino,European,United States,No,,Right Kidney,Unifocal,6.5,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,160.0,104.0,40.74,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Metoprolol|Atorvastatin,Medical Record|Medical Record,No,1472.0,,,1472.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1472.0,0.0,0.0
C3L-00800,ccRCC,C3L-00800-T,,,,0.0,,CPT0025290003,['CPT0025290006'],,CPT0025290009,,CPT0029460002,41,Male,White,Unknown,European,United States,No,,Right Kidney,Unifocal,4.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,180.0,94.0,29.01,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,344.0,,,344.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,344.0,0.0,0.0
C3N-00154,ccRCC,C3N-00154-T,,,,0.0,,CPT0081880003,['CPT0081880009'],,CPT0081880006,,CPT0085300002,68,Male,Unknown,Unknown,European,Ukraine,No,,Right Kidney,Unifocal,8.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,12,IHC staining not done,0,cM0,Staging Incomplete,,R0:No residual tumor,,182.0,93.0,28.08,No,Lifelong non-drinker,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,-7.0,,,0.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,0.0,0.0,7.0
C3N-01213,ccRCC,C3N-01213-T,,,,0.0,,CPT0075720003,['CPT0075720006'],,CPT0075720009,,CPT0075800002,68,Male,Unknown,Unknown,European,Ukraine,No,,Right Kidney,Unifocal,8.3,Clear cell renal cell carcinoma,G1 Well differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No,R0:No residual tumor,,168.0,64.0,22.68,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,654.0,,,658.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,654.0,0.0,4.0
C3L-01553,ccRCC,C3L-01553-T,,,,0.0,,CPT0065930003,['CPT0065930006'],,CPT0065930009,,CPT0067730002,59,Male,White,Unknown,European,United States,No,,Right Kidney,Unifocal,1.9,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,185.0,159.0,46.17,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Levothyroxine (SYNTHROID)|Metformin (GLUCOPHAGE)|losartan-hydrochlorothiazide (HYZAAR) ,Medical Record|Medical Record|Medical Record,No,384.0,,,384.0,,No,No,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,384.0,0.0,0.0
C3L-00812,ccRCC,C3L-00812-T,,,,0.0,,CPT0025350003,['CPT0025350006'],,CPT0025350009,,CPT0029480002,74,Male,White,Unknown,European,United States,No,,Left Kidney,Unifocal,2.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,164.0,73.0,27.04,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Amlodipine,Medical Record,No,8.0,,,8.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,8.0,0.0,0.0
C3L-00790,ccRCC,C3L-00790-T,,,,0.0,,CPT0065690003,['CPT0065690006'],,CPT0065690009,,CPT0067650002,44,Male,White,Unknown,European,United States,No,,Right Kidney,Unifocal,7.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:No residual tumor,,170.0,113.0,38.99,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,amLODIPine-benazepril (LOTREL|hydroCHLOROthiazide (HYDRODIURIL|sitaGLIPtin (JANUVIA|XIGDUO XR |Metformin (GLUCOPHAGE),Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,441.0,,,441.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,441.0,0.0,0.0
C3N-00313,ccRCC,C3N-00313-T,,,,0.0,,CPT0011410003,['CPT0011410006'],,CPT0011410009,,CPT0012040002,31,Female,Unknown,Unknown,European,Poland,No,,Left Kidney,Unifocal,4.5,non-Clear Cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,158.0,56.0,22.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,clexane,Self-reported and Medical Record,Yes,1869.0,,,1888.0,,No,No,No,Complete Remission,Complete Remission,Yes,1803.0,New Primary Tumor,Other,right breast,,,,,No,No,No,,,1803.0,1.0,1869.0,0.0,19.0
C3N-00852,ccRCC,C3N-00852-T,C3N-00852-N,,,0.0,CPT0024680001,CPT0024670003,"['CPT0024650009', 'CPT0024670006', 'CPT0024660009']",CPT0024680013,CPT0024670009,CPT0024680009,CPT0024740002,62,Male,Unknown,Unknown,European,Ukraine,No,,Right Kidney,Unifocal,13.6,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No,R0:No residual tumor,,179.0,92.0,28.71,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,620.0,,,628.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,620.0,0.0,8.0
C3N-00437,ccRCC,C3N-00437-T,C3N-00437-N,,,0.0,CPT0012570003,CPT0012550003,"['CPT0012550006', 'CPT0012560008', 'CPT0012540009']",,CPT0012550008,CPT0012570009,CPT0012620002,69,Female,Unknown,Unknown,European,Poland,No,,Right Kidney,Unifocal,6.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,156.0,92.0,37.0,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,0.3,Exposure to secondhand smoke history not available,Clear Cell Renal Carcinoma,Surgery,letrox|Theovent (teofilin)|Zafiron|Gensulin M50|Tritace|Nebilenin|Poltram Combo|Prazol|Atrox|clexane,Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self-reported and Medical Record,Yes,1637.0,1637.0,Unknown,,1644.0,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1637.0,1.0,7.0
C3N-00320,ccRCC,C3N-00320-T,C3N-00320-N,,,0.0,CPT0013790003,CPT0012370003,"['CPT0012390006', 'CPT0012380006', 'CPT0012370006', 'CPT0012360006']",,CPT0012370009,['CPT0013790009'],CPT0012530002,67,Male,Unknown,Unknown,European,Poland,No,,Right Kidney,Unifocal,4.0,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,170.0,94.0,32.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,40.0,Exposure to secondhand smoke history not available,,,Bisocard|Gisartan (Hydrochlorothiazide + Telmisartan)|Polocard|clexane|Tulip (atorvastatin)|Amlopin|Milurit|Euthyrox,Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report,Yes,1849.0,,,1856.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1849.0,0.0,7.0
C3N-00492,ccRCC,C3N-00492-T,C3N-00492-N,,,0.0,CPT0012770003,CPT0079180003,['CPT0079180006'],,CPT0079180009,CPT0012770009,CPT0012820002,49,Female,Unknown,Unknown,European,Poland,No,,Right Kidney,Unifocal,11.0,non-Clear Cell renal cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,170.0,76.0,26.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Yes,,,Euthyrox (levothyroxine)|Fostex (beclomethasone + formoterolum),Self Report|Self Report,Yes,1792.0,,,1801.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1792.0,0.0,9.0
C3N-00305,ccRCC,C3N-00305-T,,,,0.0,,CPT0011240003,CPT0011240005,,CPT0011240009,,CPT0011270002,60,Female,Unknown,Unknown,European,Poland,No,,Left Kidney,Multifocal,1.0,Clear cell renal cell carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pNX,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,164.0,52.0,19.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,38.0,Exposure to secondhand smoke history not available,,,acard|Bisoprolol|pantoprazole,Self Report|Self Report|Self Report,Yes,1913.0,,,1920.0,,No,No,No,Complete Remission,Complete Remission,Yes,199.0,,,,,Yes,No,,Yes,Yes,No,213.0,,199.0,1.0,1913.0,0.0,7.0
C3N-00491,ccRCC,C3N-00491-T,C3N-00491-N,,,0.0,CPT0012640003,CPT0012670003,CPT0012670009,CPT0012640006,CPT0012670006,CPT0012640009,CPT0012730002,54,Male,Unknown,Unknown,European,Poland,No,,Right Kidney,Unifocal,6.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,cM1,Staging Incomplete,left femur,RX:Presence of residual tumor cannot be assessed,,176.0,95.0,30.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Vivace (ramipril)|tulip  (atorvastatin)|betaloc (metorpolol),Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,77.0,99.0,Unknown,,112.0,No,No,No,Persistent Disease,,Unknown,,,,,,,,,,,,,,,0.0,99.0,1.0,13.0
C3N-00314,ccRCC,C3N-00314-T,C3N-00314-N,,,0.0,CPT0012090003,CPT0012080003,"['CPT0012070016', 'CPT0012080006', 'CPT0012060009', 'CPT0012050005']",CPT0012090013,"['CPT0012070011', 'CPT0012080009']",['CPT0012090009'],CPT0012150002,78,Male,Unknown,Unknown,European,Poland,No,,Right Kidney,Unifocal,4.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,175.0,96.0,31.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,50.0,No or minimal exposure to secondhand smoke,,,clexane|Tulip (atorvastatin)|Tolura (telmisartan)|Bisoprolol,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,62.0,126.0,Unknown,,140.0,No,Yes,No,Persistent Disease,,Yes,1.0,,,,,No,Unknown,,No,No,No,,,1.0,1.0,126.0,1.0,14.0
C3N-00435,ccRCC,C3N-00435-T,C3N-00435-N,,,0.0,CPT0018250001,CPT0017850003,['CPT0017850006'],CPT0018250006,CPT0017850009,CPT0018250009,CPT0022960002,72,Male,Unknown,Unknown,European,Ukraine,No,,Right Kidney,Unifocal,10.5,non-Clear Cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,12,IHC staining not done,12,cM0,Staging Incomplete,No,R0:No residual tumor,,170.0,78.0,26.99,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,7.0,,,14.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,7.0,0.0,7.0
C3N-00317,ccRCC,C3N-00317-T,C3N-00317-N,,,0.0,CPT0012290003,CPT0012280003,"['CPT0012280006', 'CPT0012260009']",,CPT0012280009,CPT0012290009,CPT0012350002,74,Female,Unknown,Unknown,European,Poland,No,,Left Kidney,Unifocal,5.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,168.0,65.0,23.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,clexane|insulin|perindopril|metoprolol,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,Yes,1133.0,,,1143.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1133.0,0.0,10.0
C3N-00315,ccRCC,C3N-00315-T,,,,0.0,,CPT0012180003,['CPT0012180006'],,CPT0012180009,,CPT0012240002,68,Male,Unknown,Unknown,European,Poland,No,,Left Kidney,Unifocal,7.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,164.0,77.0,28.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Apo_tamis (tamsulosin)|Apo_Fina (finastyrid)|clexane,Self Report|Self Report|Self-reported and Medical Record,Yes,1861.0,,,1870.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1861.0,0.0,9.0
C3N-00380,ccRCC,C3N-00380-T,,,,0.0,,CPT0021240003,['CPT0021240006'],,CPT0021240009,,CPT0021300002,57,Female,Unknown,Unknown,European,Ukraine,No,,Left Kidney,Unifocal,4.1,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No,R0:No residual tumor,,172.0,138.0,46.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,662.0,,,670.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,662.0,0.0,8.0
C3N-00310,ccRCC,C3N-00310-T,C3N-00310-N,,,0.0,CPT0009020003,CPT0009000003,"['CPT0009000009', 'CPT0008980013', 'CPT0009010006', 'CPT0008990006']",CPT0009020006,CPT0009000006,CPT0009020009,CPT0009030002,84,Male,Unknown,Unknown,European,Poland,No,,Right Kidney,Unifocal,5.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,172.0,84.0,28.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",1.0,No or minimal exposure to secondhand smoke,,,Hyplafin (finasterid)|TamisPras (tamsulosine)|Axtil (ramipril)|clexane,Self Report|Self Report|Self Report|Self-reported and Medical Record,Yes,1623.0,1623.0,Other reasons,,1637.0,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1623.0,1.0,14.0
C3N-00390,ccRCC,C3N-00390-T,C3N-00390-N,,,0.0,CPT0017450001,CPT0017410003,"['CPT0017410006', 'CPT0017380009', 'CPT0017420009', 'CPT0017440009']",CPT0017450006,CPT0017410009,CPT0017450009,CPT0017650002,58,Male,Unknown,Unknown,European,Ukraine,No,,Left Kidney,Unifocal,14.1,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,cM1,Staging Incomplete,Liver.,R0:No residual tumor,,176.0,90.0,29.05,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,687.0,,,693.0,,No,Yes,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,687.0,0.0,6.0
C3N-00312,ccRCC,C3N-00312-T,C3N-00312-N,,,0.0,CPT0009080003,CPT0009060003,"['CPT0009050006', 'CPT0009040006', 'CPT0009060009', 'CPT0009070006']",,CPT0009060006,CPT0009080009,CPT0009090002,68,Male,Unknown,Unknown,European,Poland,No,,Right Kidney,Unifocal,4.0,Clear cell renal cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,173.0,92.0,30.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,clexane|Sintrom (acenokumarol),Self-reported and Medical Record|Self Report,Yes,1888.0,,,1898.0,,No,No,No,Complete Remission,Complete Remission,Yes,236.0,,,,,Yes,No,,No,No,No,247.0,,236.0,1.0,1888.0,0.0,10.0
C3N-00494,ccRCC,C3N-00494-T,C3N-00494-N,,,0.0,CPT0012920003,CPT0012900004,"['CPT0012910009', 'CPT0012900007', 'CPT0012880009']",CPT0012920013,CPT0012900010,['CPT0012920009'],CPT0012980002,66,Male,Unknown,Unknown,European,Poland,No,,Left Kidney,Unifocal,5.5,Clear cell renal cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,165.0,94.0,34.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,84.0,Exposure to secondhand smoke history not available,,,Carvedilol|Insulin|Allopurinol|Ramipril|Doxazosin|Rosuvastatin|Clopidogrel|clexane,Self Report|Self-reported and Medical Record|Self Report|Self Report|Self Report|Self Report|Self Report|Self-reported and Medical Record,Yes,1786.0,,,1793.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1786.0,0.0,7.0
11CO037,COAD,11CO037-T,11CO037-N,,,0.0,853ecf90-71e6-4156-a56f-a34b65_D2,1563ef63-d2e6-406f-adc1-255949_D3,1563ef63-d2e6-406f-adc1-255949_D7_1,,1563ef63-d2e6-406f-adc1-255949_D6,,38fe94db-051d-408f-abe8-7e87c2_D1_1,52,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1b,10,999,2,,M0,,R0,,155.0,40.0,,No,,,,,,No,,,,368.0,,,,,No,Not Reported/ Unknown,,,,No,,,,,,,,,,,,,,,0.0,368.0,0.0,
11CO051,COAD,11CO051-T,11CO051-N,,,0.0,b3696374-c6c0-49dd-833e-596e26_D2,f6b1079b-9d67-4c63-b3d0-d562b5_D2,f2a13f8d-b129-4567-beae-049b15_D7_1,,f2a13f8d-b129-4567-beae-049b15_D6_1,,07245471-6673-4b5c-a88e-ee5904_D1_1,61,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,5,Not Reported/ Unknown,0,,M0,,R0,,164.0,80.0,,No,,,,,,No,,,,417.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,417.0,0.0,
01CO008,COAD,01CO008-T,01CO008-N,,,0.0,5347d2ce-df0c-4d81-a3e2-22db11_D2,8cc7e656-0152-4359-8566-0581c3,9452572f-e3ec-4063-a82e-43ac90_D7,,9452572f-e3ec-4063-a82e-43ac90_D6,,0c1f2419-4b8a-42f7-a369-a5b438_D1,54,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,21,0,0,,M0,,R0,,175.0,88.4,,No,,,,,,No,,,,369.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,369.0,0.0,
22CO006,COAD,22CO006-T,22CO006-N,,,0.0,1c070992-647b-4173-a481-904c4d_D2,e1cd3d70-132b-452f-ba10-026721_D2,4d86cf19-8d5b-46b5-ab4c-ace0b2_D7_1,,4d86cf19-8d5b-46b5-ab4c-ace0b2_D6,,3487b5c2-1dce-4e1c-bb84-30e8f2_D1_1,57,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N2b,25,0,24,,M0,,R0,,178.0,68.0,,No,,,,,,No,,,,334.0,,,,,Not Reported/ Unknown,Yes,,,,Yes,,Both Locoregional and Distant Metastasis,Liver,,,No,,,Not Applicable,Yes,,,,,1.0,334.0,0.0,
05CO002,COAD,05CO002-T,05CO002-N,,,0.0,cc271b3d-ed33-481f-9d23-15f2f6_D2,f635496c-0046-4ecd-89bc-7a4f33_D2,159c49fd-40ff-4616-b6b6-be21a6_D7,,159c49fd-40ff-4616-b6b6-be21a6_D6,,d271597e-f19c-4c55-b9dd-1a251a_D1,,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T2,N1a,17,0,1,,MX,,R0,,167.0,82.73,,No,,,,,,No,,,,350.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,350.0,0.0,
11CO036,COAD,11CO036-T,11CO036-N,,,0.0,41a04113-2061-4923-bca5-da586c_D2,21cab01c-e968-42cc-9651-1e53c0_D3,21cab01c-e968-42cc-9651-1e53c0_D7_1,,21cab01c-e968-42cc-9651-1e53c0_D6_1,,8ffc3824-36ef-464a-a1e4-9e0e50_D1_1,36,Male,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1a,9,Not Reported/ Unknown,1,,M0,,R0,,166.0,55.0,,No,,,,,,No,,,,367.0,,,,,No,Not Reported/ Unknown,,,,No,,,,,,,,,,,,,,,0.0,367.0,0.0,
20CO006,COAD,20CO006-T,20CO006-N,1.0,Exclusion by working group,0.0,9a6879b1-4f78-4ac6-9fca-dad049_D2,bd67de01-ad7d-431a-9ad6-4dd5a1,,,,,,58,Male,White,Not Hispanic or Latino,,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage IV,,,,T3,N1a,38,Not Performed,1,,M1,,R0,,188.0,123.0,,No,,,,,,No,,,,309.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,309.0,0.0,
01CO019,COAD,01CO019-T,01CO019-N,,,0.0,7784e2e5-c0e1-4b85-8cc1-7faac8_D2,573048dd-2502-40e0-8e8c-c41bb8_D3,573048dd-2502-40e0-8e8c-c41bb8_D7_1,,573048dd-2502-40e0-8e8c-c41bb8_D6,,6e1e0cf0-0af1-4561-b8f4-056fcb_D1_1,63,Female,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T4a,N2a,12,0,4,,MX,,R0,,165.0,83.97,,No,,,,,,No,,,,357.0,,,,,No,Yes,,,,Yes,,Distant Metastasis,Liver,,,No,,,No,Yes,,,,,1.0,357.0,0.0,
09CO005,COAD,09CO005-T,09CO005-N,,,0.0,e3c012aa-51c2-42b0-a478-bd620f_D2,ec9afcc4-ccf7-4226-b0e8-d6897d_D3,ec9afcc4-ccf7-4226-b0e8-d6897d_D7,,ec9afcc4-ccf7-4226-b0e8-d6897d_D6,,04a00ed3-7f0c-4ddf-9de5-ec7916_D1,69,Female,White,Not Hispanic or Latino,African,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1a,19,1,Not Reported/ Unknown,,M0,,R0,,157.0,63.2,,No,,,,,,No,,,,293.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,293.0,0.0,
05CO035,COAD,05CO035-T,05CO035-N,,,0.0,e070ff10-058b-4733-93ab-bdd702_D2,dfdf03a6-c324-4d8c-a909-ea7345_D2,1312a0e0-5025-433e-9670-0595bb_D7_1,,1312a0e0-5025-433e-9670-0595bb_D6,,c69ba610-1bdb-41b6-8369-a83016_D1_1,64,Female,Black or African American,Hispanic or Latino,Ad_Mixed_American,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,28,0,0,,MX,,R0,,157.0,154.4,,No,,,,,,No,,,,360.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,360.0,0.0,
05CO053,COAD,05CO053-T,05CO053-N,,,0.0,cd3a9d59-bf13-48f3-ae97-bdbca4_D2,66b829db-1cdd-460d-b2f3-0e9ca9_D3,66b829db-1cdd-460d-b2f3-0e9ca9_D7_1,,66b829db-1cdd-460d-b2f3-0e9ca9_D6_1,,acefec8a-32a0-4686-a421-6d12d5_D1_1,51,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N1b,48,0,2,,MX,,R0,,178.0,118.0,,No,,,,,,No,,,,363.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,363.0,0.0,
20CO001,COAD,20CO001-T,20CO001-N,,,0.0,5c70e654-583c-4dd3-ad42-0d9b39_D2,b2400046-1d25-429d-a821-6040a6,d8345fa1-f692-4025-bc82-bfaec6_D7,,d8345fa1-f692-4025-bc82-bfaec6_D6,,04143d60-42b0-477d-9e44-6ab225_D1,53,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1a,16,Not Performed,2,,MX,,R0,,165.0,46.0,,No,,,,,,No,,,,353.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,353.0,0.0,
05CO045,COAD,05CO045-T,05CO045-N,,,0.0,bda3787a-1397-4716-bb17-4992a8_D2,92c1ebb5-ac1d-4bf5-a14f-516e1d_D3,92c1ebb5-ac1d-4bf5-a14f-516e1d_D7_1,,92c1ebb5-ac1d-4bf5-a14f-516e1d_D6_1,,8d0e2230-208e-43d7-8048-73d6d6_D1_1,75,Female,White,Unknown,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1b,29,0,2,,MX,,R0,,150.0,80.0,,No,,,,,,No,,,,354.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,354.0,0.0,
15CO001,COAD,15CO001-T,15CO001-N,,,0.0,a243b765-61ab-4aa6-88e1-226896_D2,cd89ffbb-574a-4052-bd9a-00c890_D2,c2db7236-990c-42b6-9ffb-2ad150_D7_1,,c2db7236-990c-42b6-9ffb-2ad150_D6,,7e71d580-cbc5-4ced-938a-a2d9b9_D1_1,57,Female,Asian,Hispanic or Latino,East_Asian,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1a,16,999,1,,MX,,RX,,139.0,39.0,,No,,,,,,No,,,,353.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,353.0,0.0,
05CO044,COAD,05CO044-T,05CO044-N,,,0.0,d8805fa4-30f9-4417-907e-fdc50c_D2,8af80ae9-2088-4124-91fb-8d6c17_D3,8af80ae9-2088-4124-91fb-8d6c17_D7,,8af80ae9-2088-4124-91fb-8d6c17_D6_1,,eb4fbb4e-3f5f-4f33-a7ac-be0306_D1_1,70,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T4a,N0,15,0,0,,MX,,R0,,157.0,72.0,,"Yes, History of Other Cancer Greater Than One Year Ago",,,,,,No,,,,365.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,365.0,0.0,
11CO053,COAD,11CO053-T,11CO053-N,,,0.0,d80408d6-598d-4411-ab34-eb2545_D2,092c5a37-325b-4181-b230-2d8fff_D2,ecf1ca92-c8b7-470f-baf4-81cf73_D7_1,,ecf1ca92-c8b7-470f-baf4-81cf73_D6_1,,5bf39865-182c-4c82-90e4-a7ea59_D1_1,63,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,5,Not Reported/ Unknown,0,,M0,,R0,,155.0,90.0,,No,,,,,,No,,,,411.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,411.0,0.0,
11CO019,COAD,11CO019-T,11CO019-N,,,0.0,325b5314-6f3c-4d79-9b36-4e7ded_D2,722378ea-d1a7-4cfc-aca5-ba45f9_D8,722378ea-d1a7-4cfc-aca5-ba45f9_D7_1,,722378ea-d1a7-4cfc-aca5-ba45f9_D6,,7303fb7b-e7a6-4753-be4d-1e3d29_D1_1,74,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1b,5,Not Reported/ Unknown,3,,M0,,R0,,163.0,62.0,,No,,,,,,No,,,,373.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,373.0,0.0,
20CO007,COAD,20CO007-T,20CO007-N,,,0.0,5de06adb-e00d-4114-8d76-04bd30_D2,0065bfd9-e1b9-43a8-9379-9658ba_D3,0065bfd9-e1b9-43a8-9379-9658ba_D7_1,,0065bfd9-e1b9-43a8-9379-9658ba_D6_1,,46c880d8-2352-43b5-84cc-acc87c_D1_1,54,Male,Black or African American,Not Hispanic or Latino,African,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,61,Not Performed,0,,MX,,R0,,170.0,108.0,,No,,,,,,No,,,,279.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,279.0,0.0,
05CO041,COAD,05CO041-T,05CO041-N,,,0.0,3a17283c-a0f4-4514-956b-080d11_D2,b4dd4a04-5eda-43dd-8298-215b07_D3,b4dd4a04-5eda-43dd-8298-215b07_D7_1,,b4dd4a04-5eda-43dd-8298-215b07_D6_1,,693ff8e7-2929-4caa-bbcf-6b0016_D1_1,78,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,24,0,0,,MX,,R0,,162.0,66.5,,No,,,,,,No,,,,362.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,362.0,0.0,
11CO042,COAD,11CO042-T,11CO042-N,,,0.0,43bc845e-d22e-4c10-b3e8-bc54e6_D2,2167c594-c33f-4795-b95b-69bd07_D2,4b68d71e-48b4-45ba-a041-9d6aa0_D7_1,,4b68d71e-48b4-45ba-a041-9d6aa0_D6,,163f4ce9-bec0-48bc-9899-033cb7_D1_1,70,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,5,Not Reported/ Unknown,0,,M0,,R0,,163.0,65.0,,No,,,,,,No,,,,375.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,375.0,0.0,
05CO033,COAD,05CO033-T,05CO033-N,,,0.0,a5c8bf1d-776c-406f-82a3-2d9ce6_D2,2f8b02e4-1848-4abc-a95e-dd9eb5_D3,2f8b02e4-1848-4abc-a95e-dd9eb5_D7,,2f8b02e4-1848-4abc-a95e-dd9eb5_D6,,2db0e2fa-e434-4751-924f-c55ad3_D1,61,Male,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T2,N2a,19,0,4,,MX,,R0,,187.0,86.0,,"Yes, History of Other Cancer Greater Than One Year Ago",,,,,,No,,,,337.0,,,,,No,Yes,,,,Yes,,Distant Metastasis,Liver,,,Yes,,R0,No,No,,,,,1.0,337.0,0.0,
11CO008,COAD,11CO008-T,11CO008-N,,,0.0,e74089a9-f78c-4ffe-8174-aef71b_D2,98742d96-cc2f-43f0-9de2-bc7afe_D3,98742d96-cc2f-43f0-9de2-bc7afe_D7_1,,de439530-464e-481b-91ab-0685b9_D6,,012baf0d-2c53-4409-91ec-2c7998_D1_1,67,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1,4,Not Reported/ Unknown,2,,M0,,R0,,152.0,40.0,,No,,,,,,No,,,,384.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,384.0,0.0,
09CO008,COAD,09CO008-T,09CO008-N,,,0.0,154115ac-2ec2-439d-b55e-0464ee_D2,aa0f5b40-3290-4255-8f4d-f45d4e_D3,aa0f5b40-3290-4255-8f4d-f45d4e_D7,,aa0f5b40-3290-4255-8f4d-f45d4e_D6,,02345909-96ed-4f40-a623-7b95be_D1,53,Male,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1a,19,1,Not Reported/ Unknown,,MX,,RX,,160.0,64.41,,No,,,,,,No,,,,343.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,343.0,0.0,
11CO033,COAD,11CO033-T,11CO033-N,,,0.0,348f6009-e1be-44d2-a093-9ca844_D2,8960a27e-69d8-4ec8-a795-c6cf8a_D3,8960a27e-69d8-4ec8-a795-c6cf8a_D7_1,,8960a27e-69d8-4ec8-a795-c6cf8a_D6,,d14ecda4-00aa-463e-b6a9-a8a255_D1_1,54,Male,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,10,Not Reported/ Unknown,0,,M0,,R0,,167.0,46.0,,No,,,,,,No,,,,385.0,,,,,No,Not Reported/ Unknown,,,,No,,,,,,,,,,,,,,,0.0,385.0,0.0,
05CO039,COAD,05CO039-T,05CO039-N,,,0.0,694e8df1-d9ee-473b-bec1-4f9237_D2,66b57abc-0d49-46bb-a390-0e11a9_D2,c952715e-35ca-4e18-ad6f-dd4e39_D7_1,,c952715e-35ca-4e18-ad6f-dd4e39_D6_1,,38dbebd9-e1ba-475d-bc18-1e3506_D1_1,73,Male,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T4a,N0,20,0,0,,MX,,R0,,180.0,135.0,,No,,,,,,No,,,,,214.0,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,214.0,1.0,
11CO020,COAD,11CO020-T,11CO020-N,,,0.0,377cdd37-d1bd-4042-997e-478a0f_D2,321fb3b2-ebb6-4ea5-b737-081264_D2,52d61ab1-5781-4b47-8e88-37c2ea_D7_1,,52d61ab1-5781-4b47-8e88-37c2ea_D6,,0318bcea-2ea7-471a-9f42-5f5ccd_D1_1,55,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1b,5,Not Reported/ Unknown,3,,M0,,R0,,183.0,100.0,,No,,,,,,No,,,,370.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,370.0,0.0,
21CO007,COAD,21CO007-T,21CO007-N,,,0.0,efee6bb9-69dd-46c2-85b3-b55962_D2,a467b905-fc0b-427b-8753-6d38dd_D3,a467b905-fc0b-427b-8753-6d38dd_D7_1,,a467b905-fc0b-427b-8753-6d38dd_D6,,8f5bf7df-cd1f-4300-a6c2-1aa47c_D1_1,50,Male,White,Not Hispanic or Latino,Ad_Mixed_American,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage IV,,,,T4a,N2a,31,999,5,,M1,,Not Reported/ Unknown,,175.0,94.8,,No,,,,,,No,,,,279.0,,,,,Not Reported/ Unknown,Not Reported/ Unknown,,,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,279.0,0.0,
05CO034,COAD,05CO034-T,05CO034-N,,,0.0,f5ed5ebc-881d-456a-80d7-42c9e7_D2,42216d99-e8ff-43c9-b6db-28c3a6_D3,42216d99-e8ff-43c9-b6db-28c3a6_D7_1,,42216d99-e8ff-43c9-b6db-28c3a6_D6,,e2ef6cb4-e7d6-45e1-ac92-947fb5_D1_1,54,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1a,29,0,1,,MX,,R0,,160.0,75.7,,No,,,,,,No,,,,373.0,,,,,Yes,Yes,,,,No,,,,,,,,,,,,,,,0.0,373.0,0.0,
05CO007,COAD,,05CO007-N,1.0,No proteomics,0.0,963fc8db-f412-4427-a198-23f660_D2,,9899e1ad-62e1-4cc2-91fc-49b85c_D7,,9899e1ad-62e1-4cc2-91fc-49b85c_D6,,6539f675-8d03-49eb-abc4-65f803_D1,85,Female,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T4a,N2b,31,0,7,,MX,,R0,,152.0,49.0,,No,,,,,,No,,,,363.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,363.0,0.0,
05CO054,COAD,05CO054-T,05CO054-N,,,0.0,da747cee-5026-4923-af63-ad9f81_D2,43192517-085e-450e-9481-0a6713_D3,43192517-085e-450e-9481-0a6713_D7_1,,43192517-085e-450e-9481-0a6713_D6_1,,be329c23-0f98-494d-b489-9047e9_D1_1,86,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,,,T2,N0,20,0,0,,MX,,R0,,168.0,79.0,,No,,,,,,No,,,,355.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,355.0,0.0,
05CO029,COAD,05CO029-T,05CO029-N,,,0.0,e14c2cbe-eca0-4745-97f6-8f27bd_D2,58a92726-4d1f-4e44-8938-52b97d_D3,58a92726-4d1f-4e44-8938-52b97d_D7,,58a92726-4d1f-4e44-8938-52b97d_D6,,848bb071-7372-4b79-abfe-9728da_D1,55,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,27,0,0,,MX,,R0,,168.0,116.0,,No,,,,,,No,,,,358.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,358.0,0.0,
20CO003,COAD,20CO003-T,20CO003-N,,,0.0,3e8019e8-125f-4615-a1fa-a448e9_D2,2d266d2d-4bb3-436c-a3e7-06acb2_D3,2d266d2d-4bb3-436c-a3e7-06acb2_D7_1,,2d266d2d-4bb3-436c-a3e7-06acb2_D6,,9bd71309-d808-414e-8127-75b586_D1,60,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage IV,,,,T4a,N1b,18,Not Performed,3,,M1,,R0,,185.0,91.0,,No,,,,,,No,,,,,318.0,,,,No,No,,,,Not Applicable,,,,,,,,,,,,,,,0.0,318.0,1.0,
01CO006,COAD,01CO006-T,01CO006-N,,,0.0,b6b41ba2-6415-41aa-b5f5-4d47db_D2,f9d6fb1b-988e-4D88-9272-cc672f_D8,f9d6fb1b-988e-4d28-9272-cc672f_D7,,f9d6fb1b-988e-4d28-9272-cc672f_D6,,a354b1e9-7813-4274-957c-5e1768_D1,75,Female,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T4a,N2b,18,0,7,,M0,,RX,,157.0,57.7,,No,,,,,,No,,,,365.0,,,,,No,Yes,,,,Yes,,Distant Metastasis,Ovary,,,Yes,,RX,No,No,,,,,1.0,365.0,0.0,
15CO002,COAD,15CO002-T,15CO002-N,,,0.0,974e136f-7020-4a38-b9c1-094df9_D2,c65afd57-530c-4366-b2c8-463a46_D2,74f7759a-279c-4098-b080-358900_D7_1,,74f7759a-279c-4098-b080-358900_D6_1,,d98655bc-7db0-4301-bffc-a59a1d_D1_1,53,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T4a,N0,15,999,0,,MX,,RX,,163.0,84.8,,No,,,,,,No,,,,321.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,321.0,0.0,
11CO022,COAD,11CO022-T,11CO022-N,,,0.0,88c621d7-7fb3-4825-abbe-82ae4c_D2,2b810478-7956-4a8b-870d-184859_D2,21c6f56a-8881-421b-81fa-c354cb_D7_1,,21c6f56a-8881-421b-81fa-c354cb_D6_1,,71dedc2c-428f-4229-aadb-c149cd_D1_1,72,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage IV,,,,T4b,N0,5,Not Reported/ Unknown,0,,M1,,R0,,174.0,53.0,,No,,,,,,No,,,,382.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,382.0,0.0,
05CO050,COAD,05CO050-T,05CO050-N,,,0.0,87b0e853-43ea-4efb-8a22-dd221f_D2,5271982c-5de1-4d6e-b414-b1f3ef_D2,17cd2121-d347-431c-9cc7-fbab14_D7_1,,17cd2121-d347-431c-9cc7-fbab14_D6_1,,757d441d-5ff7-409b-8578-3ba7b3_D1_1,66,Female,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1b,54,0,3,,MX,,R0,,163.0,127.0,,No,,,,,,No,,,,299.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,299.0,0.0,
09CO019,COAD,09CO019-T,09CO019-N,,,0.0,c9f0f144-47f3-4d64-b29f-bcedfa_D2,79097be1-cd36-4a23-99d1-3d744f_D2,b913f361-c5c2-4e49-91ca-719bd8_D7_1,,b913f361-c5c2-4e49-91ca-719bd8_D6_1,,10c76663-ccb6-4acf-be38-a3264a_D1_1,87,Male,Black or African American,Not Hispanic or Latino,African,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,,,T2,N0,17,Not Reported/ Unknown,0,,MX,,R0,,185.0,92.3,,No,,,,,,No,,,,207.0,,,,,Not Reported/ Unknown,Not Reported/ Unknown,,,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,207.0,0.0,
11CO032,COAD,11CO032-T,11CO032-N,,,0.0,1136008b-97ce-49b0-bf24-abbea6_D2,01d1ffca-4235-4dfe-bf62-56f71d_D3,01d1ffca-4235-4dfe-bf62-56f71d_D7_1,,01d1ffca-4235-4dfe-bf62-56f71d_D6_1,,7a8f4f4f-c503-46f3-8239-e717ba_D1_1,57,Male,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1b,2,Not Reported/ Unknown,2,,M0,,R0,,165.0,57.0,,No,,,,,,No,,,,368.0,,,,,No,Not Reported/ Unknown,,,,No,,,,,,,,,,,,,,,0.0,368.0,0.0,
11CO043,COAD,11CO043-T,11CO043-N,,,0.0,6d9f8b06-f28c-4e9b-823b-33ebb7_D2,591fb460-703a-437d-8d9a-ff2a35_D3,591fb460-703a-437d-8d9a-ff2a35_D7_1,,591fb460-703a-437d-8d9a-ff2a35_D6,,4eb92587-cfca-47b3-8cc9-0d4a64_D1_1,67,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,5,Not Reported/ Unknown,0,,M0,,R0,,165.0,67.0,,No,,,,,,No,,,,375.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,375.0,0.0,
05CO011,COAD,05CO011-T,05CO011-N,,,0.0,02cde0c0-6840-495b-9b11-007d82_D2,c1b66358-d103-493c-b8ec-92c43b_D2,8495cc54-eb88-40ab-b03f-363edf_D7,,8495cc54-eb88-40ab-b03f-363edf_D6,,36897a83-b98f-45af-955e-a75e47_D1,39,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,41,0,0,,MX,,R0,,175.0,100.0,,No,,,,,,No,,,,387.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,387.0,0.0,
11CO021,COAD,11CO021-T,11CO021-N,,,0.0,65867ab1-5eab-44a8-b2bb-d27263_D2,642fc6c3-8d4a-4e3d-ad0a-cc088a_D2,cf795cd2-317b-4897-a35e-390001_D7_1,,cf795cd2-317b-4897-a35e-390001_D6_1,,fa74656d-803c-4984-bbcd-8f3179_D1_1,74,Female,White,Not Hispanic or Latino,Ad_Mixed_American,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage IV,,,,T3,N2a,5,Not Reported/ Unknown,5,,M1,,R0,,168.0,75.0,,No,,,,,,No,,,,,95.0,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,95.0,1.0,
11CO018,COAD,11CO018-T,11CO018-N,,,0.0,059a7065-3a5f-4eea-97e5-85ab01_D2,3d797911-d476-436f-9cce-33e20c_D8,3d797911-d476-436f-9cce-33e20c_D7_1,,3d797911-d476-436f-9cce-33e20c_D6,,7b852609-7cc7-4950-b18a-423b86_D1_1,74,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,5,Not Reported/ Unknown,0,,M0,,R0,,170.0,89.0,,No,,,,,,No,,,,371.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,371.0,0.0,
01CO014,COAD,01CO014-T,01CO014-N,,,0.0,4c9dcc8c-ccdc-4336-8e23-107feb_D2,c9730cb4-b52c-4ca8-9652-4509d0_D2,be2d5946-3452-4003-880a-e0372e_D7_1,,be2d5946-3452-4003-880a-e0372e_D6_1,,323ea2fc-46f2-4d43-9b5d-ca5164_D1_1,77,Female,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N2a,19,0,5,,M0,,R0,,158.0,75.7,,No,,,,,,No,,,,371.0,,,,,No,Yes,,,,Yes,,Both Locoregional and Distant Metastasis,Omentum,,,Not Performed,,,No,No,,,,,1.0,371.0,0.0,
11CO077,COAD,11CO077-T,11CO077-N,,,0.0,211cbcef-cb1f-4c80-a1c8-a76d3c_D2,5557e478-3e6f-475b-8acc-1b4159_D8,5557e478-3e6f-475b-8acc-1b4159_D7_1,,5557e478-3e6f-475b-8acc-1b4159_D6,,dee0705e-34e8-467b-a5f6-b3678c_D1_1,67,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,5,Not Reported/ Unknown,0,,M0,,R0,,180.0,80.0,,No,,,,,,No,,,,383.0,,,,,No,Yes,,,,Yes,,Distant Metastasis,Lung,,,No,,,Not Reported/ Unknown,Yes,,,,,1.0,383.0,0.0,
22CO004,COAD,22CO004-T,22CO004-N,,,0.0,9a48cf57-e1f0-4ea1-9804-d563f2_D2,a2f03d85-5f1a-4b3e-9dbf-74e67e_D3,a2f03d85-5f1a-4b3e-9dbf-74e67e_D7_1,,a2f03d85-5f1a-4b3e-9dbf-74e67e_D6_1,,263fea68-40db-4402-9b99-c93b0c_D1_1,51,Male,White,Hispanic or Latino,Ad_Mixed_American,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,13,0,0,,M0,,R0,,178.0,86.0,,No,,,,,,No,,,,346.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,346.0,0.0,
09CO014,COAD,09CO014-T,09CO014-N,,,0.0,6e0d04fc-e6a8-41ed-b6f3-45537d_D2,8b9e4266-7754-4f2c-ac9e-329905_D2,1ea1d7ee-e382-4a68-8e7c-74e833_D7_1,,1ea1d7ee-e382-4a68-8e7c-74e833_D6_1,,d97af421-cedf-4cc6-b1e5-3b1ad2_D1_1,66,Male,White,Not Hispanic or Latino,African,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,22,Not Reported/ Unknown,0,,MX,,RX,,185.0,125.6,,No,,,,,,No,,,,323.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,323.0,0.0,
09CO006,COAD,09CO006-T,09CO006-N,,,0.0,a27cf22d-836e-49a7-802f-47c1db_D2,c2c53076-b5db-4b7d-983c-a35740_D3,c2c53076-b5db-4b7d-983c-a35740_D7,,c2c53076-b5db-4b7d-983c-a35740_D6,,bcf6d821-c2f1-4d84-81e0-f41b45_D1,86,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Reported/ Unknown,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,,,T2,N0,14,0,Not Reported/ Unknown,,MX,,RX,,180.0,74.5,,No,,,,,,No,,,,39.0,,,,,Not Reported/ Unknown,Not Reported/ Unknown,,,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,39.0,0.0,
16CO011,COAD,16CO011-T,16CO011-N,,,0.0,c307b7b0-534a-45fa-a420-35f773_D2,a90eb718-6a8f-4cbf-89c1-f9e9bd_D2,7782134d-02db-44ee-adfa-fc1372_D7_1,,7782134d-02db-44ee-adfa-fc1372_D6,,894e68d6-bf00-47b5-913c-f1c50f_D1_1,59,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1,4,Not Performed,2,,M0,,R0,,168.0,72.0,,No,,,,,,No,,,,420.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,420.0,0.0,
27CO004,COAD,27CO004-T,27CO004-N,,,0.0,71b2c1cc-0a31-4ca8-8beb-251e17_D2,d0511ea6-43c3-4c61-b08e-cf49b7_D3,d0511ea6-43c3-4c61-b08e-cf49b7_D7_1,,d0511ea6-43c3-4c61-b08e-cf49b7_D6_1,,445994d9-9fa5-478c-91b7-abc726_D1_1,50,Female,White,Hispanic or Latino,Ad_Mixed_American,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N2a,24,5,5,,MX,,R0,,147.0,122.72,,No,,,,,,No,,,,435.0,,,,,Not Applicable,Not Applicable,,,,No,,,,,,,,,,,,,,,0.0,435.0,0.0,
09CO015,COAD,09CO015-T,09CO015-N,,,0.0,7fd2eea8-bf99-4f97-8b9e-fb703f_D2,1ab06c24-ffc0-4323-a0cc-e9f5c5_D2,d068de5f-8394-46bc-b03a-c6dc9c_D7_1,,d068de5f-8394-46bc-b03a-c6dc9c_D6_1,,2056d495-4d6d-4d84-a29a-80373d_D1_1,68,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1b,32,Not Reported/ Unknown,2,,MX,,R0,,165.0,94.9,,No,,,,,,No,,,,362.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,362.0,0.0,
11CO070,COAD,11CO070-T,11CO070-N,,,0.0,7fd386f0-e7f6-4ee1-9cd7-b3318a_D2,c8694e31-2c8f-4eb6-a7ef-a137d9_D3,c8694e31-2c8f-4eb6-a7ef-a137d9_D7_1,,c8694e31-2c8f-4eb6-a7ef-a137d9_D6_1,,e465b51d-3c58-4d02-8552-7f5cd3_D1_1,35,Male,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1b,5,Not Reported/ Unknown,3,,M0,,R0,,163.0,61.0,,No,,,,,,No,,,,372.0,,,,,No,Not Reported/ Unknown,,,,No,,,,,,,,,,,,,,,0.0,372.0,0.0,
09CO018,COAD,09CO018-T,09CO018-N,,,0.0,515040a4-bbfb-4a15-9e53-e7b6e6_D2,372c900a-fced-4eef-9dc4-7282ec_D2,743c74e4-cd76-4f38-8cb4-3c9107_D7_1,,743c74e4-cd76-4f38-8cb4-3c9107_D6_1,,74c4f1df-e3a5-423f-983d-3a0f94_D1_1,52,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T2,N1a,25,Not Reported/ Unknown,1,,MX,,R0,,168.0,82.2,,No,,,,,,No,,,,273.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,273.0,0.0,
01CO001,COAD,,01CO001-N,1.0,No proteomics,0.0,5a3aa99d-ca10-45f6-939f-12392a_D2,,760f15d2-444c-4deb-b133-62f3ca_D7,,760f15d2-444c-4deb-b133-62f3ca_D6,,32a96c14-8234-45e7-b15b-085a13_D1,60,Male,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T4a,N2b,29,0,23,,M0,,R0,,180.0,108.9,,No,,,,,,No,,,,390.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,390.0,0.0,
14CO002,COAD,,14CO002-N,1.0,Exclusion by working group,0.0,903d5fe0-970a-47be-a97f-3cc914_D2,,5a85e6e7-35ab-4ca9-ab62-707e77_D7_1,,5a85e6e7-35ab-4ca9-ab62-707e77_D6_1,,f089ce8f-3dd1-4cd5-8183-a9a0c4_D1_1,62,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,22,0,0,,MX,,RX,,174.0,91.8,,No,,,,,,No,,,,12.0,,,,,No,No,,,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,12.0,0.0,
11CO054,COAD,11CO054-T,11CO054-N,,,0.0,b871c0c1-a97b-4ac1-887c-0317b6_D2,9bf309bc-0fb6-4060-aba2-888eb3_D2,f6a7f764-2495-4a1d-89a2-e12f51_D7_1,,f6a7f764-2495-4a1d-89a2-e12f51_D6_1,,7de55254-1dfe-43e0-8ee9-6e26e8_D1_1,65,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,5,Not Reported/ Unknown,0,,M0,,R0,,160.0,70.0,,No,,,,,,No,,,,404.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,404.0,0.0,
09CO011,COAD,09CO011-T,09CO011-N,,,0.0,46dfc1e4-0110-4d9f-888e-6a29ab_D2,1425a1a1-c835-47a2-a9b9-4db5d0_D8,1425a1a1-c835-47a2-a9b9-4db5d0_D7_1,,1425a1a1-c835-47a2-a9b9-4db5d0_D6,,42f03c67-93e0-4c61-adeb-a0c82c_D1_1,75,Female,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,,,T2,N0,14,0,0,,MX,,R0,,168.0,80.6,,No,,,,,,No,,,,243.0,,,,,Not Reported/ Unknown,Not Reported/ Unknown,,,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,243.0,0.0,
16CO006,COAD,16CO006-T,16CO006-N,,,0.0,62627b73-1763-48bc-8eea-e5bd76_D2,4bb08fad-fa5e-471e-978b-6b09ab_D2,97423edb-6f19-4b41-a7cb-af1635_D7_1,,97423edb-6f19-4b41-a7cb-af1635_D6_1,,c90a8f99-71b8-41bf-b60d-9be49c_D1_1,64,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage IV,,,,T3,N0,7,Not Performed,0,,M1,,R2,,172.0,80.0,,No,,,,,,No,,,,177.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,177.0,0.0,
20CO004,COAD,20CO004-T,20CO004-N,,,0.0,233ec093-9a30-4ef4-a12c-91757e_D2,e196a0b4-2a05-43de-bb30-ceb761_D2,f0bb6ff4-7cb8-427f-84bf-7f51d7_D7_1,,f0bb6ff4-7cb8-427f-84bf-7f51d7_D6_1,,21d715d5-1958-42d0-b14a-efb87f_D1_1,55,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T4a,N2b,42,Not Performed,7,,MX,,R0,,173.0,200.5,,No,,,,,,No,,,,347.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,347.0,0.0,
05CO003,COAD,05CO003-T,05CO003-N,,,0.0,8fab37a4-cdf9-4ce8-9081-7b9148_D2,7cc7f69f-99f5-4b23-a9e0-ba0dc8_D8,7cc7f69f-99f5-4b23-a9e0-ba0dc8_D7,,7cc7f69f-99f5-4b23-a9e0-ba0dc8_D6,,4ecabbd2-ce60-46d1-a451-b8d106_D1,,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,33,0,0,,MX,,R0,,180.0,84.0,,No,,,,,,No,,,,321.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,321.0,0.0,
05CO032,COAD,05CO032-T,05CO032-N,,,0.0,a313f6ef-5994-4d49-9e66-c26911_D2,695b0b00-a86b-43c0-a6c8-50a840_D3,695b0b00-a86b-43c0-a6c8-50a840_D7,,695b0b00-a86b-43c0-a6c8-50a840_D6,,ccdcd5e5-685c-4cc7-b357-35a272_D1,79,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1a,16,0,1,,MX,,R0,,193.0,110.0,,No,,,,,,No,,,,338.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,338.0,0.0,
11CO052,COAD,11CO052-T,11CO052-N,,,0.0,5cf5e61d-21ff-4678-9126-14e9bb_D2,0630ecb0-b664-4e75-bb3c-fb62ee_D3,0630ecb0-b664-4e75-bb3c-fb62ee_D7_1,,0630ecb0-b664-4e75-bb3c-fb62ee_D6_1,,965f3b09-d548-48b9-8954-2fa73f_D1_1,66,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N2a,5,Not Reported/ Unknown,4,,M0,,R0,,156.0,80.0,,No,,,,,,No,,,,,223.0,,,,No,No,,,,Yes,,Distant Metastasis,Liver,,,No,,,No,Yes,,,,,1.0,223.0,1.0,
05CO020,COAD,05CO020-T,05CO020-N,,,0.0,da95f6f8-be46-4ed8-a493-2c99f0_D2,803736b3-9ca9-4f9f-bdfe-8783e3_D3,803736b3-9ca9-4f9f-bdfe-8783e3_D7,,803736b3-9ca9-4f9f-bdfe-8783e3_D6,,0a573420-cece-4cb1-ba68-00ede0_D1,>=90,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,12,0,0,,MX,,R0,,157.0,74.6,,No,,,,,,No,,,,371.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,371.0,0.0,
05CO049,COAD,05CO049-T,05CO049-N,,,0.0,54565eae-05c5-4dae-bde9-ae4874_D2,d7608884-a0d6-4e9e-aac7-6cd813_D3,d7608884-a0d6-4e9e-aac7-6cd813_D7_1,,d7608884-a0d6-4e9e-aac7-6cd813_D6_1,,68f33ff4-7bd8-4464-b00b-a3106b_D1_1,87,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,31,0,0,,MX,,R0,,168.0,80.0,,No,,,,,,No,,,,328.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,328.0,0.0,
05CO037,COAD,05CO037-T,05CO037-N,,,0.0,067db520-1b1f-4569-9414-e37a6e_D2,e2e83b72-b14b-4b06-9461-1115d6_D2,5a007558-764c-463b-a788-fdbccb_D7_1,,5a007558-764c-463b-a788-fdbccb_D6,,5fd542b5-33a6-4657-943b-2749e0_D1_1,50,Male,American Indian or Alaska Native,Not Hispanic or Latino,East_Asian,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,15,0,0,,MX,,R0,,160.0,83.4,,No,,,,,,No,,,,340.0,,,,,Yes,Yes,,,,No,,,,,,,,,,,,,,,0.0,340.0,0.0,
11CO031,COAD,11CO031-T,11CO031-N,,,0.0,359f5c81-2575-497e-8630-e4866f_D2,c6ae57a7-65a0-438e-bae2-97b1c8_D3,c6ae57a7-65a0-438e-bae2-97b1c8_D7_1,,c6ae57a7-65a0-438e-bae2-97b1c8_D6,,5d22fc4e-2cfa-4dab-a46b-dd44b9_D1_1,53,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,9,Not Reported/ Unknown,0,,M0,,R0,,157.0,55.0,,No,,,,,,No,,,,386.0,,,,,No,Not Reported/ Unknown,,,,No,,,,,,,,,,,,,,,0.0,386.0,0.0,
05CO015,COAD,05CO015-T,05CO015-N,,,0.0,6797a69d-2f74-44b9-8147-cd4fac_D2,0aef1fe8-ca61-4113-81d0-d82ee7_D2,416bb805-e4cd-4ca6-8fdd-1eec2d_D7,,416bb805-e4cd-4ca6-8fdd-1eec2d_D6,,aa1c4fc6-9d37-4816-bf95-3a19dc_D1,73,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,33,0,0,,MX,,R0,,170.0,66.0,,No,,,,,,No,,,,,130.0,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,130.0,1.0,
05CO048,COAD,05CO048-T,05CO048-N,,,0.0,64ed43a2-f083-43cb-9d0d-118495_D2,92f7419c-c57a-4b50-bdc9-4d09ca_D2,4976cbf9-cad4-48ce-b234-622c70_D7_1,,4976cbf9-cad4-48ce-b234-622c70_D6,,4f120ff2-622f-4dfd-876e-46e788_D1_1,78,Female,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T4b,N2a,24,0,6,,MX,,R0,,152.0,49.4,,No,,,,,,No,,,,334.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,334.0,0.0,
05CO026,COAD,05CO026-T,05CO026-N,,,0.0,8980bb9d-65c1-41cb-9f90-dddd5f_D2,41ee934e-f7a3-4ef5-8a83-e2ac56_D2,b2615b47-5ac2-4775-9205-50990d_D7_1,,b2615b47-5ac2-4775-9205-50990d_D6_1,,a9f7cc96-dfaa-4b22-99a7-037ead_D1_1,70,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1a,75,0,1,,MX,,R0,,160.0,58.7,,No,,,,,,No,,,,318.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,318.0,0.0,
11CO007,COAD,11CO007-T,11CO007-N,,,0.0,7478980a-60fb-4f5e-aa1c-2d7941_D2,799893aa-d523-4a08-9ea7-611cca_D3,799893aa-d523-4a08-9ea7-611cca_D7_1,,799893aa-d523-4a08-9ea7-611cca_D6_1,,784ff553-c9a7-4d30-b747-ffcbdf_D1_1,64,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,12,Not Reported/ Unknown,0,,M0,,R0,,152.0,45.0,,No,,,,,,No,,,,378.0,,,,,No,Not Reported/ Unknown,,,,No,,,,,,,,,,,,,,,0.0,378.0,0.0,
11CO048,COAD,11CO048-T,11CO048-N,,,0.0,cbd0e774-c741-4753-9c9e-391a7d_D2,cfb4831f-e9ee-4e11-80fb-958f6f_D2,43e0432b-343d-4e12-817f-21281c_D7_1,,43e0432b-343d-4e12-817f-21281c_D6_1,,474590db-eaf1-4d70-a4f7-81a026_D1_1,64,Male,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,5,Not Reported/ Unknown,0,,M0,,R0,,167.0,72.0,,No,,,,,,No,,,,383.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,383.0,0.0,
11CO045,COAD,11CO045-T,11CO045-N,,,0.0,a84149b1-8453-45f0-8400-d7b12f_D2,f4bccfe4-98d0-466b-a6d7-44341b_D3,f4bccfe4-98d0-466b-a6d7-44341b_D7_1,,f4bccfe4-98d0-466b-a6d7-44341b_D6_1,,6e84e841-28fb-4443-8876-23c6bf_D1_1,71,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1b,3,Not Reported/ Unknown,3,,M0,,R0,,155.0,59.0,,No,,,,,,No,,,,385.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,385.0,0.0,
14CO003,COAD,14CO003-T,,,,0.0,,ea6df59d-5240-4927-b19d-d44590_D2,fd4edc52-09ef-4b01-be7c-f23f05_D7,,fd4edc52-09ef-4b01-be7c-f23f05_D6_1,,79cabe71-f083-48ec-9b50-0c97a3_D1_1,74,Female,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N2b,27,0,2,,M0,,R0,,166.0,84.0,,No,,,,,,No,,,,504.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,504.0,0.0,
21CO006,COAD,21CO006-T,21CO006-N,,,0.0,5e886f1c-8165-4232-9591-d80799_D2,5f823547-ee16-45b7-a6a0-ef25d6_D3,5f823547-ee16-45b7-a6a0-ef25d6_D7_1,,5f823547-ee16-45b7-a6a0-ef25d6_D6_1,,737c4705-afed-4c22-b8ef-91fa00_D1_1,76,Male,White,Hispanic or Latino,Ad_Mixed_American,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,,,T2,N0,18,0,0,,M0,,RX,,165.0,72.6,,"Yes, History of Other Cancer Greater Than One Year Ago",,,,,,No,,,,368.0,,,,,Not Reported/ Unknown,Not Reported/ Unknown,,,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,368.0,0.0,
11CO030,COAD,11CO030-T,11CO030-N,,,0.0,bed27f66-ef3b-4868-b4ad-205018_D2,4cdeecb5-19fb-493c-91f5-eb0efc_D3,4cdeecb5-19fb-493c-91f5-eb0efc_D7_1,,4cdeecb5-19fb-493c-91f5-eb0efc_D6,,7dc8c605-b0a0-4491-a2f2-ef457c_D1_1,54,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,4,Not Reported/ Unknown,0,,M0,,R0,,164.0,67.0,,No,,,,,,No,,,,369.0,,,,,No,Not Reported/ Unknown,,,,No,,,,,,,,,,,,,,,0.0,369.0,0.0,
11CO027,COAD,11CO027-T,11CO027-N,,,0.0,04ded2cd-3b57-4aec-9c11-48f58e_D2,5da00abd-5fa7-4deb-95f1-7982e0_D3,5da00abd-5fa7-4deb-95f1-7982e0_D7_1,,5da00abd-5fa7-4deb-95f1-7982e0_D6_1,,7afb9ddb-f1c1-40ac-9873-a34cc9_D1_1,55,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,6,Not Reported/ Unknown,0,,M0,,R0,,153.0,53.0,,No,,,,,,No,,,,378.0,,,,,No,Not Reported/ Unknown,,,,No,,,,,,,,,,,,,,,0.0,378.0,0.0,
11CO061,COAD,11CO061-T,11CO061-N,,,0.0,47d2a435-b203-4438-ae72-53c424_D2,8c73f3a5-fea8-4942-90c0-966f66_D3,8c73f3a5-fea8-4942-90c0-966f66_D7_1,,8c73f3a5-fea8-4942-90c0-966f66_D6_1,,127d1942-2f41-4487-9c09-702e20_D1_1,47,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,12,Not Reported/ Unknown,0,,M0,,R0,,150.0,56.0,,No,,,,,,No,,,,388.0,,,,,No,Not Reported/ Unknown,,,,No,,,,,,,,,,,,,,,0.0,388.0,0.0,
11CO062,COAD,11CO062-T,11CO062-N,,,0.0,3765c09a-fff7-4b37-bf2b-452b23_D2,e8faa3a7-9fc7-428e-9334-a0afd0_D3,e8faa3a7-9fc7-428e-9334-a0afd0_D7_1,,e8faa3a7-9fc7-428e-9334-a0afd0_D6,,ee8227b3-320c-49ce-9c94-5b0252_D1_1,74,Male,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage IV,,,,T3,N0,15,Not Reported/ Unknown,0,,M1,,R0,,170.0,53.0,,No,,,,,,No,,,,379.0,,,,,No,Not Reported/ Unknown,,,,No,,,,,,,,,,,,,,,0.0,379.0,0.0,
01CO013,COAD,01CO013-T,01CO013-N,,,0.0,1fbb1add-4660-4ec1-b8c2-360f9f_D2,c7aeb685-31b3-445e-8177-a3e729_D3,c7aeb685-31b3-445e-8177-a3e729_D7,,c7aeb685-31b3-445e-8177-a3e729_D6_1,,de434a02-cb27-4b7e-8013-7c289a_D1_1,57,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,,,T2,N0,16,0,0,,M0,,R0,,183.0,119.5,,No,,,,,,No,,,,155.0,,,,,Not Performed,Not Performed,,,,No,,,,,,,,,,,,,,,0.0,155.0,0.0,
11CO047,COAD,11CO047-T,11CO047-N,,,0.0,23e938d0-92b8-4aea-90c1-4385df_D2,cd6a4013-2958-44b9-a4f1-45c9e4_D2,3ca0ab23-70ae-4083-bd7d-9f71d8_D7_1,,3ca0ab23-70ae-4083-bd7d-9f71d8_D6_1,,9eb5c82b-8609-47ac-bf8b-87782a_D1_1,65,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,5,Not Reported/ Unknown,0,,M0,,R0,,174.0,80.0,,No,,,,,,No,,,,384.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,384.0,0.0,
11CO072,COAD,11CO072-T,11CO072-N,,,0.0,16ac8458-5200-4302-9ad0-b311df_D2,0f238226-864c-4de0-8c61-01e729_D2,64b606d7-d40f-41ae-b220-a66324_D7_1,,64b606d7-d40f-41ae-b220-a66324_D6_1,,0a628b4d-6b65-4105-812b-698836_D1_1,64,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1b,5,Not Reported/ Unknown,3,,M0,,R0,,156.0,73.0,,No,,,,,,No,,,,133.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,133.0,0.0,
14CO005,COAD,14CO005-T,14CO005-N,,,0.0,51590333-cfe5-4ce5-b8ff-58fa3c_D2,db3f5ad9-d14d-4126-a3e7-d80faa_D3,db3f5ad9-d14d-4126-a3e7-d80faa_D7_1,,db3f5ad9-d14d-4126-a3e7-d80faa_D6_1,,2007507a-455c-4a72-bf89-9ee8c2_D1_1,75,Female,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,19,0,0,,MX,,R0,,157.0,63.8,,No,,,,,,No,,,,466.0,,,,,No,No,,,,No,,,Not Applicable,,,,,,,,,,,,0.0,466.0,0.0,
01CO015,COAD,01CO015-T,01CO015-N,,,0.0,b2978e90-cd2a-4665-b1bf-508a99_D2,6e20c8e9-ab75-4996-9296-445b00_D2,b873f54a-5a86-4dca-90f9-715820_D7_1,,b873f54a-5a86-4dca-90f9-715820_D6,,3ac1f563-df29-48cd-ac47-86cd34_D1,88,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,,,T2,N0,,,,,MX,,R0,,193.0,77.11,,No,,,,,,No,,,,374.0,,,,,Not Performed,Not Performed,,,,No,,,,,,,,,,,,,,,0.0,374.0,0.0,
11CO044,COAD,11CO044-T,11CO044-N,,,0.0,2cc46aec-6142-4fb9-aca5-c442b9_D2,b605fafc-f7dd-44cc-9c86-da04e3_D2,7e3d5ae0-3dcc-4207-8dd2-59ab4b_D7_1,,7e3d5ae0-3dcc-4207-8dd2-59ab4b_D6_1,,1b7c35d8-3f4b-4d7c-acfe-049847_D1_1,69,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage IV,,,,T3,N1a,5,Not Reported/ Unknown,1,,M1,,R0,,156.0,75.0,,No,,,,,,No,,,,,235.0,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,235.0,1.0,
09CO022,COAD,09CO022-T,09CO022-N,,,0.0,76498650-fdbf-4f5d-a19a-cce9a2_D2,f69deaeb-6b6f-4c61-8900-fd0f26_D3,f69deaeb-6b6f-4c61-8900-fd0f26_D7_1,,f69deaeb-6b6f-4c61-8900-fd0f26_D6_1,,60805d52-8ca1-46d4-8101-0ad055_D1_1,71,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T4a,N0,23,Not Reported/ Unknown,0,,MX,,R0,,170.0,101.2,,No,,,,,,No,,,,315.0,,,,,Not Reported/ Unknown,Not Reported/ Unknown,,,,No,,,,,,,,,,,,,,,0.0,315.0,0.0,
01CO005,COAD,01CO005-T,01CO005-N,,,0.0,0784c7b3-e6a4-42a8-9288-eb4ba0_D2,05a33362-82bb-48ac-8feb-ad2ea1_D2,59891744-2db3-4541-a86a-7f911f_D7,,59891744-2db3-4541-a86a-7f911f_D6,,26fc0181-e1ed-4853-9c67-535552_D1,69,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,14,0,0,,M0,,R0,,162.0,84.1,,No,,,,,,No,,,,,531.0,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,531.0,1.0,
05CO028,COAD,05CO028-T,05CO028-N,,,0.0,2666323d-522f-4f0a-823c-ff8866_D2,e0068ac5-f557-443a-bd4b-bdfcef_D3,e0068ac5-f557-443a-bd4b-bdfcef_D7,,e0068ac5-f557-443a-bd4b-bdfcef_D6,,71116934-bfd8-4ecc-a6c1-ed0bff_D1,61,Female,White,Not Hispanic or Latino,Ad_Mixed_American,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,,,T2,N0,48,0,0,,M0,,R0,,157.0,67.0,,No,,,,,,No,,,,326.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,326.0,0.0,
11CO079,COAD,11CO079-T,11CO079-N,,,0.0,7bdfa5c9-d11f-4600-9c44-a87996_D2,f6afe41c-111d-4818-8485-fe95e0_D2,77c493b1-34ba-4efc-8def-987116_D7_1,,77c493b1-34ba-4efc-8def-987116_D6_1,,a266a66e-f9fb-4056-96a5-0f6c55_D1_1,75,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1,3,Not Reported/ Unknown,1,,M0,,R0,,165.0,68.0,,No,,,,,,No,,,,377.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,377.0,0.0,
11CO057,COAD,11CO057-T,11CO057-N,,,0.0,26acb513-3ffe-49ad-8581-9dfc97_D2,e515eb5c-8005-416a-9b42-59de9d_D8,e515eb5c-8005-416a-9b42-59de9d_D7_1,,e515eb5c-8005-416a-9b42-59de9d_D6_1,,428d09b8-eca7-432f-8af9-6b5697_D1_1,73,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1,5,Not Reported/ Unknown,3,,M0,,R0,,178.0,90.0,,No,,,,,,No,,,,399.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,399.0,0.0,
05CO047,COAD,05CO047-T,05CO047-N,,,0.0,1f79fed9-f0d4-4c45-acd2-ea1441_D2,f6173181-0993-4a5f-a4cd-5f30b1_D2,01bf1906-9bdc-41c3-89a0-b89ef6_D7_1,,506131e8-6460-472f-9e25-71f8b1_D6_1,,f01e8a3e-9003-45dd-9f3e-5ad6a6_D1_1,56,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,,,T2,N0,19,0,0,,MX,,R0,,183.0,111.0,,No,,,,,,No,,,,344.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,344.0,0.0,
11CO010,COAD,11CO010-T,11CO010-N,,,0.0,206f3bd9-f62c-4663-8fdb-5b731b_D2,0f757044-9bc8-4ed4-90f3-e0a49a_D3,0f757044-9bc8-4ed4-90f3-e0a49a_D7_1,,0f757044-9bc8-4ed4-90f3-e0a49a_D6_1,,6a61fdfd-3d84-425d-8c72-ce8302_D1_1,59,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,10,Not Reported/ Unknown,0,,M0,,R0,,156.0,50.0,,No,,,,,,No,,,,375.0,,,,,No,Not Reported/ Unknown,,,,No,,,,,,,,,,,,,,,0.0,375.0,0.0,
01CO022,COAD,01CO022-T,01CO022-N,,,0.0,0d5554d1-1653-4589-a44f-43113e_D2,b4e91300-405e-4239-b8da-5e1a42_D2,7a0266b4-b07c-41dc-8ddd-350e1b_D7_1,,7a0266b4-b07c-41dc-8ddd-350e1b_D6,,863521b3-62a8-462c-9f1f-7fa758_D1_1,76,Female,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,,,T2,N0,23,0,0,,MX,,R0,,162.0,95.88,,No,,,,,,No,,,,376.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,376.0,0.0,
11CO005,COAD,11CO005-T,11CO005-N,,,0.0,176d1b96-8c6e-44fe-8a32-e15194_D2,bc574f73-89ba-44d7-992e-82622c_D3,bc574f73-89ba-44d7-992e-82622c_D7_1,,bc574f73-89ba-44d7-992e-82622c_D6_1,,6dde8e08-dd45-40f2-91ef-224298_D1_1,66,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1,3,999,1,,M0,,R0,,160.0,50.0,,No,,,,,,No,,,,384.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,384.0,0.0,
11CO039,COAD,11CO039-T,11CO039-N,,,0.0,411d9597-c785-4de5-b449-29a80d_D2,d6584b4a-ca99-4a2a-8b4e-c8b22e_D2,e295a7d1-a0d0-4b0b-bdc2-729a0d_D7_1,,d6584b4a-ca99-4a2a-8b4e-c8b22e_D6_1,,b400a501-7308-4808-8d50-40213d_D1_1,67,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,5,Not Reported/ Unknown,0,,M0,,R0,,154.0,52.0,,No,,,,,,No,,,,386.0,,,,,No,Not Reported/ Unknown,,,,No,,,,,,,,,,,,,,,0.0,386.0,0.0,
06CO002,COAD,06CO002-T,06CO002-N,,,0.0,82157a70-12f1-4913-b548-d98881_D2,4b263734-430f-41dc-a296-8691f0_D3,4b263734-430f-41dc-a296-8691f0_D7,,4b263734-430f-41dc-a296-8691f0_D6,,0cf1768a-8df5-4648-ba22-00f0fb_D1,73,Female,Unknown,Hispanic or Latino,Ad_Mixed_American,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N2a,18,Not Performed,4,,MX,,R0,,160.0,64.0,,No,,,,,,No,,,,322.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,322.0,0.0,
11CO060,COAD,,11CO060-N,1.0,No proteomics,0.0,0c330883-ab58-4a5a-bff7-07d283_D2,,fe4b3b1c-9f7f-4109-8a76-ca1d6f_D7_1,,fe4b3b1c-9f7f-4109-8a76-ca1d6f_D6_1,,04373565-6aca-4d46-a6f3-abb811_D1_1,71,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,5,Not Reported/ Unknown,0,,M0,,R0,,160.0,65.0,,No,,,,,,No,,,,398.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,398.0,0.0,
09CO013,COAD,09CO013-T,09CO013-N,,,0.0,63c1f7ac-b1ae-4c28-95aa-ce21e5_D2,dffcac99-9eac-4717-aeb6-f4a2e7_D8,dffcac99-9eac-4717-aeb6-f4a2e7_D7_1,,dffcac99-9eac-4717-aeb6-f4a2e7_D6,,71972f70-36ac-4508-adc4-766715_D1_1,50,Male,White,Not Hispanic or Latino,European,,No,,,,,Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1b,34,0,2,,M0,,R0,,178.0,130.0,,No,,,,,,No,,,,183.0,,,,,Not Reported/ Unknown,Not Reported/ Unknown,,,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,183.0,0.0,
16CO002,COAD,16CO002-T,16CO002-N,,,0.0,6b0a3188-d8ca-4d50-a377-a8fe4c_D2,820a3f08-5bb1-44b3-a133-ee167e_D2,6f5853a3-1d47-4a54-94dc-970c1c_D7_1,,6f5853a3-1d47-4a54-94dc-970c1c_D6_1,,f96ed690-876c-4dc1-a919-025154_D1_1,67,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1,6,Not Performed,1,,M0,,RX,,172.0,83.0,,No,,,,,,No,,,,420.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,420.0,0.0,
11CO058,COAD,11CO058-T,11CO058-N,,,0.0,019cd0c0-733d-4b25-90e3-d54ce0_D2,d3078fa8-0692-411f-8441-0c7c48_D8,d3078fa8-0692-411f-8441-0c7c48_D7_1,,d3078fa8-0692-411f-8441-0c7c48_D6_1,,b2642bf8-c902-49cd-a765-59c718_D1_1,56,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,5,Not Reported/ Unknown,0,,M0,,R0,,164.0,72.0,,No,,,,,,No,,,,399.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,399.0,0.0,
05CO006,COAD,05CO006-T,05CO006-N,,,0.0,df479b07-bbf6-472d-a580-c3fd0c_D2,37219a7c-6fe2-4684-a494-d0be08_D2,a8955d38-7a72-4f9d-9c70-5c0f08_D7,,a8955d38-7a72-4f9d-9c70-5c0f08_D6,,0a182bf2-b58f-4152-b9b2-459e08_D1,83,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1b,23,0,3,,MX,,R0,,157.0,75.0,,No,,,,,,No,,,,328.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,328.0,0.0,
06CO001,COAD,06CO001-T,06CO001-N,,,0.0,1bf00d93-240f-47e8-8055-f546b0_D2,87408d9e-4029-4e8f-b14c-8efc04_D3,87408d9e-4029-4e8f-b14c-8efc04_D7,,87408d9e-4029-4e8f-b14c-8efc04_D6,,a5ceba47-6596-47ff-8fab-e835d3_D1,75,Male,Unknown,Hispanic or Latino,Ad_Mixed_American,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1b,12,Not Performed,3,,MX,,R0,,175.0,73.0,,No,,,,,,No,,,,84.0,,,,,No,Not Reported/ Unknown,,,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,84.0,0.0,
16CO003,COAD,16CO003-T,16CO003-N,,,0.0,fc9b09af-23b8-4ffe-b6c6-41236d_D2,526c3664-5b9b-4a2b-a00e-a14623_D2,47b9deba-dea0-4e0c-8b0a-4864c3_D7_1,,47b9deba-dea0-4e0c-8b0a-4864c3_D6,,b078ea81-4c88-4864-9de5-7c25a3_D1_1,63,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,4,Not Performed,0,,M0,,R0,,169.0,59.0,,No,,,,,,No,,,,376.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,376.0,0.0,
05CO004,COAD,,,1.0,Only clinical data available,0.0,,,9fb0c084-16fd-4d54-ab60-d94303_D7,,9fb0c084-16fd-4d54-ab60-d94303_D6,,ae22357c-a8a3-46d0-a1b1-657420_D1,40,Female,White,Hispanic or Latino,,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1b,39,0,3,,M0,,R0,,157.0,107.0,,No,,,,,,No,,,,,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,,0.0,
05CO005,COAD,,,1.0,No proteomics,0.0,,,"['a23ef085-a2a1-4ffc-9d1a-56c0f0_D7', '21880d70-69eb-4f09-bea9-8de3e6_D7_1']",,"['a23ef085-a2a1-4ffc-9d1a-56c0f0_D6', '21880d70-69eb-4f09-bea9-8de3e6_D6_1']",,"['c8b34c3b-89de-4f3d-a1af-c06f5a_D1', 'c8b34c3b-89de-4f3d-a1af-c06f5a_D1']",62,Male,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,,,T2,N0,14,0,0,,M0,,R0,,177.0,92.0,,No,,,,,,No,,,,,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,,0.0,
05CO014,COAD,,,1.0,QC Fail. Excluded by GDC; No proteomics,0.0,,,6968a80f-fd06-4669-b4bd-9a5cb5_D7,,6968a80f-fd06-4669-b4bd-9a5cb5_D6,,acf5eda7-4858-4a52-8ebd-54326f_D1,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
05CO055,COAD,,,1.0,No proteomics,0.0,,,ccaab7e8-e841-4397-80aa-370b58_D7_1,,ccaab7e8-e841-4397-80aa-370b58_D6_1,,16c0626f-d1a6-4e24-b371-552643_D1_1,53,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T4a,N2b,37,0,8,,MX,,R0,,173.0,141.0,,No,,,,,,No,,,,365.0,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,365.0,0.0,
11CO059,COAD,,,1.0,No proteomics,0.0,,,d4afb9cf-2f90-44b9-bd60-d03069_D11,,d4afb9cf-2f90-44b9-bd60-d03069_D10,,4c4918cc-e239-4894-9deb-535e21_D1,83,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,T3,N0,5,Not Reported/ Unknown,0,,M0,,R0,,150.0,59.0,,No,,,,,,No,,,,398.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,398.0,0.0,
16CO012,COAD,,,1.0,Exclusion by working group,0.0,,,6a9a1d66-d666-44df-a68e-ddc58d_D7_1,,6a9a1d66-d666-44df-a68e-ddc58d_D6_1,,dd8edec7-4c65-4a5a-b670-777661_D1_1,74,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,,,,T2,N0,5,Not Performed,0,,M0,,R0,,162.0,70.0,,No,,,,,,No,,,,310.0,,,,,No,No,,,,No,,,,,,,,,,,,,,,0.0,310.0,0.0,
24CO005,COAD,,,1.0,Exclusion by working group,0.0,,,b75e68fd-cfa1-4e9e-b4c1-a57ad8_D7_1,,b75e68fd-cfa1-4e9e-b4c1-a57ad8_D6,,3888c00c-99c7-44da-9234-5959f8_D1_1,41,Female,White,Not Hispanic or Latino,European,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T2,N1b,49,0,2,,MX,,RX,,165.0,94.3,,No,,,,,,No,,,,,,,,,No,Yes,,,,No,,,,,,,,,,,,,,,0.0,,0.0,
13CO001,COAD,,,1.0,Only clinical data available,,,,,,,,,70,Male,Asian,Not Hispanic or Latino,,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,T3,N1a,24,,,,MX,,,,167.0,49.0,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
14CO001,COAD,,,1.0,Only clinical data available,,,,,,,,,49,Female,Unknown,Hispanic or Latino,,,No,,,,,Not Mucinous,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,T3,N1a,25,,1,,M0,,R0,,155.0,65.0,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
PT-NPJ7,GBM,,,1.0,GTEx normals not included in study,1.0,,,,,,,,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PT-P44H,GBM,,,1.0,GTEx normals not included in study,1.0,,,,,,,,,Male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PT-Q2AG,GBM,,,1.0,GTEx normals not included in study,1.0,,,,,,,,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PT-QVJO,GBM,,,1.0,GTEx normals not included in study,1.0,,,,,,,,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PT-R55F,GBM,,,1.0,GTEx normals not included in study,1.0,,,,,,,,,Male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PT-RN5K,GBM,,,1.0,GTEx normals not included in study,1.0,,,,,,,,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PT-RU72,GBM,,,1.0,GTEx normals not included in study,1.0,,,,,,,,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PT-UTHO,GBM,,,1.0,GTEx normals not included in study,1.0,,,,,,,,,Male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PT-WVLH,GBM,,,1.0,GTEx normals not included in study,1.0,,,,,,,,,Male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
PT-Y8DK,GBM,,,1.0,GTEx normals not included in study,1.0,,,,,,,,,Male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3L-03747,GBM,,,1.0,Exclusion by working group,0.0,,,CPT0217000010,,CPT0217000007,,CPT0217980002,62,Male,White,Not Hispanic or Latino,,United States,No,,Right,,4.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,180.0,91.0,27.89,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Acetominophen|Dexamethasone|Famotidine|Levetiracetam|Atorvastatin|Lisinopril,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,705.0,705.0,Main malignancy,,711.0,Yes,Yes,No,Persistent Disease,,Yes,231.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,231.0,1.0,705.0,1.0,6.0
C3N-03183,GBM,C3N-03183-T,,,,0.0,,CPT0206670004,CPT0206670013,,CPT0206670007,,CPT0206720002,53,Male,Unknown,Unknown,East_Asian,China,No,Temporal Lobe and Basal ganglia and thalamus Hemisphere and Temporal Lobe and Basal ganglia and thalamus,Left,,7.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"GFAP（+），Olig-2（+），ATRX（about 90%），P53（occasionally positive），Ki-67（about 50%），Syn（+），BRAFV600E（-），CD34（vessel positive），CK（occasionally positive），Vimentin（+） TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",175.0,80.0,26.12,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,315.0,315.0,Main malignancy,,321.0,Yes,Yes,No,Persistent Disease,,Unknown,,,,,,,,,,,,,,,0.0,315.0,1.0,6.0
C3N-01505,GBM,C3N-01505-T,,,,0.0,,CPT0089150003,CPT0089150006,,CPT0089150009,,CPT0091300002,74,Male,White,Not Hispanic or Latino,European,United States,No,,Right,,1.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,175.0,80.0,25.99,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,acetaminphen|alprazolam|Vitamin D|dexamethasone|omeprazole|polyethylene glycol|simvastatin|tamsulosin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,192.0,192.0,Main malignancy,,192.0,Yes,Yes,No,Patient Deceased,,Yes,189.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,189.0,1.0,192.0,1.0,0.0
C3N-03188,GBM,C3N-03188-T,,,,0.0,,CPT0207030003,CPT0207030013,,CPT0207030009,,CPT0207080002,54,Male,Unknown,Unknown,East_Asian,China,No,Frontal Lobe Left Hemisphere and Right Hemisphere and Frontal Lobe,Bilateral,,8.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"MMP9(±), EGFR(+++), P53(-), Ki-67(about20%), ATRX(++-+++) TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: no",175.0,88.0,28.73,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,1022.0,1022.0,Main malignancy,,1028.0,Yes,Yes,No,Persistent Disease,Patient Deceased,Yes,452.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,452.0,1.0,1022.0,1.0,6.0
C3L-02984,GBM,C3L-02984-T,,,,0.0,,CPT0190240004,CPT0190240010,,CPT0190240007,,CPT0191140002,34,Male,Asian,Not Hispanic or Latino,East_Asian,United States,No,,Left,,3.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,173.0,98.0,32.69,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Yes,,,cyanocoblamin|levetiracetam|levocetirizine,Medical Record|Medical Record|Medical Record,No,1469.0,,,1488.0,,Yes,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1469.0,0.0,19.0
C3L-02542,GBM,C3L-02542-T,,,,0.0,,CPT0161730003,CPT0161730009,,CPT0161730006,,CPT0162540002,58,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,Right,,4.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,CD34 Negative for ganglion cells FISH negative for 1p36 deletion and Negative for 19q13 deletion,160.0,67.0,26.21,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,,Exposure to secondhand smoke history not available,Breast Cancer,Surgery,Boswellia Serrata|Motrin|Probiotic|Turmeric|dexamethasone|ativan,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,154.0,180.0,Main malignancy,,180.0,No,No,Yes,Persistent Disease,,Unknown,,,,,,,,,,,,,,,0.0,180.0,1.0,0.0
C3L-01142,GBM,C3L-01142-T,,,,0.0,,CPT0218330004,CPT0218330010,,CPT0218330007,,CPT0220250002,42,Female,Unknown,Unknown,European,Russia,No,,Left,,3.3,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,165.0,63.0,23.14,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,omeprazole|Levetiracetam|Lornoxicam|Dexamethasone|enalapril,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,0.0,,,8.0,,Unknown,Unknown,Unknown,Not Applicable,,Unknown,,,,,,,,,,,,,,,0.0,0.0,0.0,8.0
C3L-01834,GBM,C3L-01834-T,,,,0.0,,CPT0104220003,CPT0104220005,,['CPT0104220010'],,CPT0105090002,68,Female,White,Not Hispanic or Latino,European,United States,No,,Right,,5.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,175.0,69.0,22.56,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Venlafaxine|Multi Vitamin|Vitamin B Complex|Vitamin D3|OsteoMatrix|Synthroid,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,482.0,497.0,Main malignancy,,497.0,Yes,Yes,No,Persistent Disease,,Yes,449.0,Progression,,,,,,,,,,,,449.0,1.0,497.0,1.0,0.0
C3N-02256,GBM,C3N-02256-T,,,,0.0,,CPT0182580003,CPT0182580009,,CPT0182580006,,CPT0182600002,65,Male,Unknown,Unknown,European,Poland,No,,Right,,2.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,181.0,112.0,34.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,normodypine|losacor,Self-reported|Self-reported,No,188.0,263.0,Main malignancy,,263.0,Yes,Yes,No,Unknown,,Yes,160.0,Recurrence,Site : left temporal,,,No,,,No,No,No,,,160.0,1.0,263.0,1.0,0.0
C3N-01814,GBM,C3N-01814-T,,,,0.0,,CPT0167860004,CPT0167860010,,CPT0167860007,,CPT0167920004,48,Female,Unknown,Unknown,East_Asian,China,No,"Temporal, Parietal Lobe, and lateral  ventricle Temporal parietal Lobe, and lateral  ventricle",Left,,7.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,153.0,52.0,22.21,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,383.0,,,386.0,,Unknown,Unknown,Unknown,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,383.0,0.0,3.0
C3N-02770,GBM,C3N-02770-T,,,,0.0,,CPT0205670004,CPT0205670010,,CPT0205670007,,CPT0205730002,70,Male,Unknown,Unknown,East_Asian,China,No,,Left,,5.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"MMP-9（+），EGFR（+++），P53（±），Ki-67（25%），ATRX（-） TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",170.0,75.0,25.95,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,10.0,No or minimal exposure to secondhand smoke,,,Insulin,Self Report,No,779.0,779.0,Main malignancy,,785.0,Yes,Yes,No,Complete Remission,,Yes,550.0,New Primary Tumor,,,,,,,Yes,No,No,,,550.0,1.0,779.0,1.0,6.0
C3N-01364,GBM,C3N-01364-T,,,,0.0,,CPT0093450003,CPT0093450006,,CPT0093450009,,CPT0093490002,34,Female,Unknown,Unknown,European,Poland,No,,Left,,4.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,158.0,58.0,23.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,720.0,,,720.0,,No,No,No,Persistent Disease,,Yes,480.0,Recurrence,Site : Brain ,,,Yes,,RX: Presence of Residual Tumor cannot be assessed,Yes,Unknown,Unknown,499.0,,480.0,1.0,720.0,0.0,0.0
C3L-00365,GBM,C3L-00365-T,,,,0.0,,CPT0002410011,['CPT0002410013'],,CPT0002410008,,CPT0004390002,59,Female,White,Not Hispanic or Latino,European,United States,No,,Left,,1.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,162.0,54.0,20.61,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,30.0,Exposure to secondhand smoke history not available,,,,,No,280.0,322.0,Main malignancy,,322.0,Yes,Yes,No,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,322.0,1.0,0.0
C3L-03266,GBM,C3L-03266-T,,,,0.0,,CPT0189460003,CPT0189460009,,CPT0189460006,,CPT0190220002,61,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,Right,,2.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,163.0,66.0,24.89,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,2.2,Yes,,,Amlodipine|Dexamethasone|Levetiracetam|Vitamin D|Vitamin C|Omeprazole|Levothyroxine|Atenolol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,223.0,281.0,Main malignancy,,281.0,Yes,Yes,Unknown,Persistent Disease,,Yes,28.0,Progression,,,,,,,,,,,,28.0,1.0,281.0,1.0,0.0
C3N-01798,GBM,C3N-01798-T,,,,0.0,,CPT0167750004,CPT0167750010,,CPT0167750007,,CPT0167810002,44,Male,Unknown,Unknown,East_Asian,China,No,,Left,,5.0,Small cell  glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,170.0,70.0,24.22,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,590.0,590.0,Main malignancy,,591.0,Yes,Yes,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,590.0,1.0,1.0
C3L-01146,GBM,C3L-01146-T,,,,0.0,,CPT0218690004,CPT0218690010,,CPT0218690007,,CPT0220330002,59,Male,Unknown,Unknown,European,Russia,No,,Right,,6.4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,175.0,96.0,31.35,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Omeprazole|Dexamethasone|Amlodipine|Bisoprolol|Aminolevulinic acid|Cefazolin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,508.0,509.0,Main malignancy,,518.0,Yes,Yes,No,Persistent Disease,,Yes,336.0,Progression,,,,,,,,,,,,336.0,1.0,509.0,1.0,9.0
C3L-03748,GBM,C3L-03748-T,,,,0.0,,CPT0217060003,CPT0217060009,,CPT0217060006,,CPT0218000002,64,Female,White,Not Hispanic or Latino,European,United States,No,,Left,,6.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,165.0,68.0,24.79,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,"Acetaminophen|Ascorbic acid, vitamin C|Potassium & Magnesium Aspartate",Medical Record|Medical Record|Medical Record,No,397.0,401.0,Main malignancy,,406.0,Yes,Yes,No,Persistent Disease,,Yes,162.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,162.0,1.0,401.0,1.0,5.0
C3N-02783,GBM,C3N-02783-T,,,,0.0,,CPT0205890003,CPT0205890006,,CPT0205890009,,CPT0205950002,24,Female,Unknown,Unknown,East_Asian,China,No,"Parietal, Occipital and Temporal Lobe Parietal Lobe and Occipital Lobe and Temporal Lobe",Left,,8.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,153.0,43.0,18.37,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,977.0,,,986.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,977.0,0.0,9.0
C3L-02708,GBM,C3L-02708-T,,,,0.0,,CPT0189570004,CPT0189570010,,CPT0189570007,,CPT0190620002,43,Male,White,Not Hispanic or Latino,European,United States,No,,Right,,4.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,188.0,166.0,46.97,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Acetaminophen|Bupropion XL|Docusate|Ergocalciferol|Escitalopram|Levetiracetam|Multivitamin capsule|Ondansetron|Oxycodone-acetaminophen|Polyethylene glycol|Propanolol|Sennosides|Temozolomide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,738.0,738.0,Main malignancy,,738.0,Yes,Yes,Yes,Unknown,,Yes,525.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,525.0,1.0,738.0,1.0,0.0
C3N-02782,GBM,C3N-02782-T,,,,0.0,,CPT0205780003,CPT0205780006,,CPT0205780009,,CPT0205800002,47,Female,Unknown,Unknown,East_Asian,China,No,,Right,,6.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,164.0,56.0,20.82,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,985.0,,,988.0,,Yes,Yes,No,Persistent Disease,,Yes,606.0,Recurrence,,,,,,,No,Yes,No,,,606.0,1.0,985.0,0.0,3.0
C3N-02186,GBM,C3N-02186-T,,,,0.0,,CPT0168720003,CPT0168720009,,CPT0168720006,,CPT0168760004,53,Male,Unknown,Unknown,East_Asian,China,No,,Right,,6.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,," Ki-67(70%), P53(15%), ATRX(+) TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",175.0,67.0,21.88,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,264.0,,,265.0,,Yes,Yes,No,Complete Remission,,Yes,99.0,Recurrence,Site : Brain ,,,Unknown,,,Unknown,Unknown,Unknown,,,99.0,1.0,264.0,0.0,1.0
C3N-01367,GBM,C3N-01367-T,,,,0.0,,CPT0093550003,CPT0093550006,,CPT0093550012,,CPT0093570002,74,Male,Unknown,Unknown,European,Poland,No,,Left,,3.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,185.0,78.0,22.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3L-01048,GBM,C3L-01048-T,,,,0.0,,CPT0217190003,CPT0217190009,,CPT0217190006,,CPT0220100002,60,Male,Unknown,Unknown,European,Russia,No,,Left,,4.4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,168.0,69.0,24.45,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Dexamethasone  |Omeprazole                    |Cefazolin,Medical Record|Medical Record|Medical Record,No,806.0,,,814.0,,Yes,Yes,No,Persistent Disease,Persistent Disease,Yes,216.0,Progression,,,,,,,,,,,,216.0,1.0,806.0,0.0,8.0
C3L-01149,GBM,C3L-01149-T,,,,0.0,,CPT0218770003,CPT0218770009,,CPT0218770006,,CPT0220350002,48,Male,Unknown,Unknown,European,Russia,No,Parietal and Temporal Lobe Parietal and temporal lobe,Left,,6.3,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,173.0,91.0,30.41,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Omeprazole|Dexamethasone|Aminolevulinic acid,Medical Record|Medical Record|Medical Record,No,666.0,,,677.0,,Yes,Yes,No,Persistent Disease,Persistent Disease,Yes,584.0,Progression,,,,,,,Yes,Yes,No,,,584.0,1.0,666.0,0.0,11.0
C3L-03260,GBM,C3L-03260-T,,,,0.0,,CPT0189250003,CPT0189250009,,CPT0189250006,,CPT0190200002,75,Female,White,Not Hispanic or Latino,European,United States,No,,Right,,1.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,168.0,86.0,30.66,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,Januvia|Pepcid|Lorazepam|Acetylcysteine|Humalog Solution|Lantus Solution|Dexamethasone|Lisinopril|Metformin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,42.0,43.0,Main malignancy,,43.0,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,43.0,1.0,0.0
C3N-01192,GBM,C3N-01192-T,,,,0.0,,CPT0087950003,CPT0087950006,,CPT0087950009,,CPT0087980002,60,Female,Unknown,Unknown,European,Poland,No,,Left,,4.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,165.0,85.0,31.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,1209.0,1209.0,Unknown,,1215.0,Yes,Yes,No,Complete Remission,Patient Deceased,Yes,498.0,Progression,,,,,,,,,,,,498.0,1.0,1209.0,1.0,6.0
C3L-03407,GBM,C3L-03407-T,,,,0.0,,CPT0190360004,CPT0190360010,,CPT0190360007,,CPT0191160002,57,Female,Unknown,Hispanic or Latino,Ad_Mixed_American,United States,No,,Left,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,155.0,75.0,31.17,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,,Yes,,,aspirin|atorvastatin|enalapril maleate|metformin|prednisone,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,176.0,238.0,Main malignancy,,243.0,Yes,Yes,No,Persistent Disease,,Yes,209.0,Progression,,,,,,,,,,,,209.0,1.0,238.0,1.0,5.0
C3L-03387,GBM,C3L-03387-T,,,,0.0,,CPT0224330003,CPT0224330006,,CPT0224330009,,CPT0226180002,70,Male,Unknown,Unknown,European,Russia,No,,Right,,9.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,171.0,76.0,25.99,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,403.0,403.0,Main malignancy,,403.0,Yes,Yes,Unknown,Complete Remission,,Yes,293.0,Progression,,,,,,,,,,,,293.0,1.0,403.0,1.0,0.0
C3L-02970,GBM,C3L-02970-T,,,,0.0,,CPT0217880003,CPT0217880013,,CPT0217880006,,CPT0219880002,58,Male,White,Not Hispanic or Latino,European,United States,No,,Right,,3.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,173.0,94.0,31.47,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,30.0,Exposure to secondhand smoke history not available,,,Vitamin D |Coenzyme Q10|dexamethasone|Diltiazem|Lofibra |efudex 5% cream |Flonase|Levetiracetam |magnesium |mirlax|zanaflex|Keppra|Hyzaar|Toprol-XL|Mulivitamin men +50|Omega-3 acids,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,381.0,381.0,Main malignancy,,381.0,Yes,Yes,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,381.0,1.0,0.0
C3L-01043,GBM,C3L-01043-T,,,,0.0,,CPT0127420003,CPT0127420009,,CPT0127420006,,CPT0128550002,59,Male,Unknown,Unknown,European,Russia,No,,Left,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,170.0,70.0,24.22,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,61.5,Yes,,,Dexamethasone|Omeprazole|Lornoxicam|Sterofundin|Cefazolin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1.0,79.0,Main malignancy,,76.0,No,No,No,Patient Deceased,,Unknown,,,,,,,,,,,,,,,0.0,79.0,1.0,-3.0
C3L-01156,GBM,C3L-01156-T,,,,0.0,,CPT0218960004,CPT0218960010,,CPT0218960006,,CPT0220410002,57,Male,Unknown,Unknown,European,Russia,No,,Right,,5.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,171.0,73.0,24.96,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Omeprazole|Dexamethasone|Lornoxicam| Enalapril|Cefazolin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,182.0,291.0,Main malignancy,,302.0,Yes,Yes,No,Persistent Disease,,Yes,178.0,Progression,,,,,,,,,,,,178.0,1.0,291.0,1.0,11.0
C3N-02183,GBM,C3N-02183-T,,,,0.0,,CPT0168480003,CPT0168480009,,CPT0168480006,,CPT0168540004,63,Female,Unknown,Unknown,East_Asian,China,No,,Right,,6.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,157.0,50.0,20.28,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Amlodipine|Nimodipine|Captopril,Self Report|Self Report|Self Report,No,340.0,340.0,Main malignancy,,343.0,No,No,No,Persistent Disease,,Yes,248.0,Recurrence,,,,,,,Unknown,Unknown,Unknown,,,248.0,1.0,340.0,1.0,3.0
C3L-03681,GBM,C3L-03681-T,,,,0.0,,CPT0221180003,CPT0221180009,,CPT0221180005,,CPT0220510002,62,Female,White,Not Hispanic or Latino,European,United States,No,,Left,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"Positive for GFAP, Vimentin, PTEN, P53 with High MIB-1. Negative for AE1/AE3 and CAM5.2 PDGFRA amplification (not detected), 19q13 Deletion (not detected), MET amplification (not detected), MYCN amplification (not detected), positive PD-L1 expression in 60% of tumor (IHC)",157.0,76.0,30.72,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Yes,,,Vitamin B12|Calcium Supplement|Fish Oil,Medical Record|Medical Record|Medical Record,No,7.0,7.0,Unknown,,12.0,No,No,No,Patient Deceased,,Unknown,,,,,,,,,,,,,,,0.0,7.0,1.0,5.0
C3L-01154,GBM,C3L-01154-T,,,,0.0,,CPT0218830004,CPT0218830010,,CPT0218830007,,CPT0220370002,51,Female,Unknown,Unknown,European,Russia,No,"Parietal, Occipital, Temporal Lobe Parietal, Occipital, temporal lobe",Right,,3.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,165.0,74.0,27.18,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Omeprazole |Dexamethasone|Paracetamol |Ketoprofen|Ondansetron|Cefazolin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,496.0,496.0,Main malignancy,,505.0,Yes,Yes,No,Persistent Disease,,Yes,230.0,Progression,,,,,,,,,,,,230.0,1.0,496.0,1.0,9.0
C3L-03728,GBM,C3L-03728-T,,,,0.0,,CPT0225760003,CPT0225760009,,CPT0225760006,,CPT0226080002,80,Female,White,Not Hispanic or Latino,European,United States,No,,Left,,5.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,152.0,64.0,27.56,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,127.0,127.0,Main malignancy,,127.0,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,127.0,1.0,0.0
C3N-01818,GBM,C3N-01818-T,,,,0.0,,CPT0168270003,CPT0168270009,,CPT0168270006,,CPT0168320002,60,Male,Unknown,Unknown,East_Asian,China,No,,Left,,6.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,170.0,65.0,22.49,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,80.0,No or minimal exposure to secondhand smoke,,,,,No,221.0,270.0,Unknown,,271.0,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,270.0,1.0,1.0
C3L-00674,GBM,C3L-00674-T,,,,0.0,,CPT0064650003,CPT0064650006,,CPT0064650009,,CPT0066670002,45,Male,White,Not Hispanic or Latino,European,United States,No,,Right,,4.9,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,193.0,102.0,27.44,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Decadron,Medical Record,No,385.0,478.0,Main malignancy,,478.0,Yes,Yes,Unknown,Persistent Disease,,Yes,194.0,Recurrence,Site : Head,,,Yes,,RX: Presence of Residual Tumor cannot be assessed,Unknown,Unknown,Unknown,279.0,,194.0,1.0,478.0,1.0,0.0
C3N-03186,GBM,C3N-03186-T,,,,0.0,,CPT0206880003,CPT0206880006,,CPT0206880009,,CPT0206940002,54,Female,Unknown,Unknown,East_Asian,China,No,Occipital and Temporal Lobe Right Hemisphere and Occipital Lobe and Temporal Lobe,Right,,8.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"MMP-9（vessel positive）, EGFR（+++）, P53（-）, Ki-67（about 25%）, ATRX（about 60% TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",158.0,54.0,21.63,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,646.0,646.0,Main malignancy,,651.0,Yes,Yes,No,Complete Remission,,Yes,459.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,459.0,1.0,646.0,1.0,5.0
C3N-02181,GBM,C3N-02181-T,,,,0.0,,CPT0168380003,CPT0168380009,,CPT0168380006,,CPT0168430002,53,Female,Unknown,Unknown,East_Asian,China,No,,Left,,4.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,160.0,70.0,27.34,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,388.0,,,389.0,,Yes,Yes,No,Complete Remission,,Yes,143.0,Progression,,,,,,,,,,,,143.0,1.0,388.0,0.0,1.0
C3N-02784,GBM,C3N-02784-T,,,,0.0,,CPT0206000004,CPT0206000010,,CPT0206000007,,CPT0206060002,37,Male,Unknown,Unknown,East_Asian,China,No,Frontal and Temporal Lobe Left Hemisphere and Frontal Lobe and Temporal Lobe,Left,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,175.0,90.0,29.39,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,20.0,No or minimal exposure to secondhand smoke,,,,,No,391.0,391.0,Main malignancy,,396.0,Yes,Yes,No,Complete Remission,,Yes,555.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,555.0,1.0,391.0,1.0,5.0
C3N-01517,GBM,C3N-01517-T,,,,0.0,,CPT0167530003,CPT0167530009,,CPT0167530006,,CPT0167590002,49,Male,Unknown,Unknown,East_Asian,China,No,,Right,,4.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"GFAP(+), Olig-2(+), IDH1(-), Ki-67(+++), P53(±), ATRX(+) TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: yes",172.0,78.0,26.37,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,1023.0,,,1025.0,,Yes,Yes,No,Complete Remission,,Yes,894.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,894.0,1.0,1023.0,0.0,2.0
C3L-02707,GBM,C3L-02707-T,,,,0.0,,CPT0189850004,CPT0189850010,,CPT0189850007,,CPT0190680002,58,Male,White,Not Hispanic or Latino,European,United States,No,,Left,,2.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,178.0,68.0,21.52,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Acetaminophen|Dexamethasone|Docusate|Famitodine|Fluoxetine|Levetiracetam|Losartan|Mirtazapine|Multivitamin-minerals-lutein|Oxycodone|Polyethylene glycol|Sulfamethoxazole-trimethoprim|Temozolomide|Tolterodine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,91.0,,,91.0,,Yes,Yes,No,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,91.0,0.0,0.0
C3L-02955,GBM,C3L-02955-T,,,,0.0,,CPT0196850003,CPT0196850006,,CPT0196850009,,CPT0197750002,76,Female,White,Not Hispanic or Latino,European,United States,No,,Right,,3.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,163.0,87.0,32.95,No,Lifelong non-drinker,Smoking history not available,,Exposure to secondhand smoke history not available,,,FUROsemide|Metoprolol tartrate|dexamethasone|famotidine|levetiracetam|Oxycodone|levothyroxine |mulivitamin |Omega-3 acids,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,350.0,378.0,Main malignancy,,378.0,Yes,Yes,Yes,Persistent Disease,,Yes,146.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,146.0,1.0,378.0,1.0,0.0
C3N-03182,GBM,C3N-03182-T,,,,0.0,,CPT0206560003,CPT0206560006,,CPT0206560009,,CPT0206610002,47,Male,Unknown,Unknown,East_Asian,China,No,Basal Ganglia Right Basal Ganglia,Right,,4.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,170.0,73.0,25.26,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,763.0,763.0,Main malignancy,,764.0,Unknown,Yes,No,Complete Remission,,Yes,502.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,502.0,1.0,763.0,1.0,1.0
C3L-03392,GBM,C3L-03392-T,,,,0.0,,CPT0219080004,CPT0219080010,,CPT0219080007,,CPT0220450002,50,Female,Unknown,Unknown,European,Russia,No,,Right,,5.1,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,159.0,71.0,28.08,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Omeprazole|Dexamethasone|Acetazolamide|Lornoxicam|Sterofundin|Etamsylate,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,-9.0,147.0,Main malignancy,,156.0,No,Yes,No,Patient Deceased,,Unknown,,,,,,,,,,,,,,,0.0,147.0,1.0,9.0
C3L-03405,GBM,C3L-03405-T,,,,0.0,,CPT0224600003,CPT0224600006,,CPT0224600009,,CPT0226240002,59,Male,Unknown,Unknown,European,Russia,No,Frontal and Temporal Lobe Frontal Lobe / Temporal Lobe,Left,,5.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,168.0,76.0,26.93,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,87.0,87.0,Unknown,,87.0,No,No,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,87.0,1.0,0.0
C3L-02465,GBM,C3L-02465-T,,,,0.0,,CPT0125570003,CPT0125570006,,CPT0125570009,,CPT0124250002,50,Male,Unknown,Hispanic or Latino,Ad_Mixed_American,United States,No,,Right,,4.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,180.0,125.0,38.34,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Acetaminophen|albuterol|Clonidine|Dulcolax|Effervescent potassium/chloride|Famotidine|Fentanyl|Hydralazine|Labetalol|Magnesium Sulfate|Miralax|Morphine|Narcan|Ocean Nasal Spray|Oxycodone|Phenergan|Senokot|Simethicone|Sodium Chloride|Tears Naturale|Versed|Zofran,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,550.0,591.0,Main malignancy,,591.0,Yes,Yes,Unknown,Persistent Disease,,Yes,102.0,Progression,,,,,,,,,,,,102.0,1.0,591.0,1.0,0.0
C3N-03473,GBM,C3N-03473-T,,,,0.0,,CPT0207090003,CPT0207090013,,CPT0207090009,,CPT0207150002,30,Female,Unknown,Unknown,East_Asian,China,No,"Frontal, Parietal and Temporal Lobe Right Hemisphere and Frontal Lobe and Parietal Lobe and Temporal Lobe",Right,,7.8,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"ATRX（about 90%）, P53（about 80%）, Ki-67（about 50%）, EGFR（-）, MMP-9（++） TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: no",175.0,62.0,20.24,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,297.0,297.0,Main malignancy,,301.0,Yes,Yes,Unknown,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,297.0,1.0,4.0
C3L-01049,GBM,C3L-01049-T,,,,0.0,,CPT0217430008,CPT0217430014,,CPT0217430011,,CPT0220120002,46,Male,Unknown,Unknown,European,Russia,No,,Left,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,172.0,86.0,29.07,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,, Dexamethasone|Omeprazole|Metformin and Sulfonamides|Cyanocobalamin|Sterofundin|Sodiym valproate,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,69.0,191.0,Main malignancy,,201.0,Yes,Yes,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,191.0,1.0,10.0
C3N-02185,GBM,C3N-02185-T,,,,0.0,,CPT0168590003,CPT0168590009,,CPT0168590006,,CPT0168650002,61,Female,Unknown,Unknown,East_Asian,China,No,,Right,,8.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"MMP-9(±)GFAP(+),Ki-67(30%), P53(++), IDH1(-), ATRX(+), EGFR(+++) TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",158.0,50.0,20.03,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,386.0,,,387.0,,Yes,Yes,No,Complete Remission,,Yes,279.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,279.0,1.0,386.0,0.0,1.0
C3N-01851,GBM,C3N-01851-T,,,,0.0,,CPT0186100003,CPT0186100009,,CPT0186100006,,CPT0186120002,47,Male,Unknown,Unknown,European,Poland,No,Thalamus thalamus,Left,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,184.0,103.0,30.42,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,66.0,No or minimal exposure to secondhand smoke,,,,,No,363.0,363.0,Main malignancy,,377.0,No,Yes,No,Persistent Disease,,Yes,220.0,Progression,,,,,,,No,Yes,No,,,220.0,1.0,363.0,1.0,14.0
C3N-01816,GBM,C3N-01816-T,,,,0.0,,CPT0168080003,CPT0168080009,,CPT0168080006,,CPT0168120002,53,Female,Unknown,Unknown,East_Asian,China,No,,Left,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,156.0,65.0,26.71,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Phenobarbital Sodium|Phenobarbital and Sodium Bromide Tablets,Self Report|Self Report,No,841.0,841.0,Main malignancy,,842.0,Yes,Yes,No,Complete Remission,,Yes,445.0,Recurrence,,,,,,,No,No,No,,,445.0,1.0,841.0,1.0,1.0
C3N-01369,GBM,C3N-01369-T,,,,0.0,,CPT0162020003,CPT0162020009,,CPT0162020006,,CPT0162040002,57,Female,Unknown,Unknown,European,Poland,No,,Left,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,166.0,56.0,20.0,Unknown,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3L-02642,GBM,C3L-02642-T,,,,0.0,,CPT0201710003,CPT0201710009,,CPT0201710006,,CPT0201790002,77,Male,Unknown,Unknown,European,Bulgaria,No,,Right,,6.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,172.0,70.0,23.66,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Ampodipine|Telmisartan|Indipam,Medical Record|Medical Record|Medical Record,No,828.0,828.0,Main malignancy,,834.0,Yes,Yes,No,Persistent Disease,,Unknown,,,,,,,,,,,,,,,0.0,828.0,1.0,6.0
C3L-03390,GBM,C3L-03390-T,,,,0.0,,CPT0224390004,CPT0224390007,,CPT0224390011,,CPT0226190002,44,Female,Unknown,Unknown,European,Russia,No,Parietal and Occipital Lobe Parietal and Occipital Lobe,Right,,4.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,163.0,79.0,29.73,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,815.0,,,816.0,,Yes,Yes,No,Persistent Disease,,Yes,649.0,Progression,,,,,,,No,Yes,No,,,649.0,1.0,815.0,0.0,1.0
C3N-03088,GBM,C3N-03088-T,,,,0.0,,CPT0209440003,CPT0209440008,,CPT0209440005,,CPT0209480002,31,Female,Unknown,Unknown,East_Asian,China,No,,Right,,3.8,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,153.0,46.0,19.65,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,ibuprofen,Medical Record,No,27.0,142.0,Unknown,,148.0,Yes,Yes,No,Unknown,,No,,,,,,,,,,,,,,,0.0,142.0,1.0,6.0
C3L-01155,GBM,C3L-01155-T,,,,0.0,,CPT0218890004,CPT0218890010,,CPT0218890007,,CPT0220390002,66,Male,Unknown,Unknown,European,Russia,No,,Right,,3.6,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,183.0,91.0,27.17,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,362.0,,,373.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,362.0,0.0,11.0
C3N-03070,GBM,C3N-03070-T,,,,0.0,,CPT0208980003,CPT0208980009,,CPT0208980006,,CPT0209010002,65,Female,Unknown,Unknown,East_Asian,China,No,,Right,,4.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,165.0,65.0,23.88,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available, astrocytoma,Surgery,,,No,332.0,,,336.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,332.0,0.0,4.0
C3L-01045,GBM,C3L-01045-T,,,,0.0,,CPT0123530003,CPT0123530006,,CPT0123530009,,CPT0124830002,73,Female,Unknown,Unknown,European,Russia,No,,Left,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,165.0,60.0,22.04,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Yes,,,Dexamethasone|Acetazolamide|Omeprazole|Sterofundin,Medical Record|Medical Record|Medical Record|Medical Record,No,0.0,66.0,Unknown,,66.0,Yes,No,No,Patient Deceased,,Unknown,,,,,,,,,,,,,,,0.0,66.0,1.0,0.0
C3L-00677,GBM,C3L-00677-T,,,,0.0,,CPT0071100003,['CPT0071100009'],,CPT0071100006,,CPT0071960002,69,Female,White,Not Hispanic or Latino,European,United States,No,,Left,,4.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,164.0,52.0,19.32,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,29.0,Exposure to secondhand smoke history not available,,,Atenolol|Dexamethasone|Famotidine|NaCl|Myrbetriq,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,155.0,155.0,Main malignancy,,155.0,Yes,Yes,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,155.0,1.0,0.0
C3N-02255,GBM,C3N-02255-T,,,,0.0,,CPT0182550003,CPT0182550009,,CPT0182550006,,CPT0182570002,88,Male,Unknown,Unknown,European,Poland,No,,Bilateral,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,172.0,70.0,23.66,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,,No or minimal exposure to secondhand smoke,,,,,No,226.0,265.0,Main malignancy,,283.0,No,No,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,265.0,1.0,18.0
C3L-01061,GBM,C3L-01061-T,,,,0.0,,CPT0217710008,CPT0217710014,,CPT0217710011,,CPT0220160002,66,Male,Unknown,Unknown,European,Russia,No,,Right,,3.8,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,172.0,76.0,25.69,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Dexamethasone|Cefazolin|Lornixicam|Ondansetron|Bromdihydrochlorphenylbenzodiazepine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,840.0,,,851.0,,Yes,Yes,No,Persistent Disease,Persistent Disease,Yes,343.0,Progression,,,,,,,No,Yes,No,,,343.0,1.0,840.0,0.0,11.0
C3L-02041,GBM,C3L-02041-T,,,,0.0,,CPT0125510003,CPT0125510006,,CPT0125510009,,CPT0124240002,51,Female,White,Not Hispanic or Latino,European,United States,No,,Left,,0.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,170.0,56.0,19.46,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Clonidine|Keppra|Pepcid|Dexamethasone|Oxycodone|Simethicone,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1030.0,,,1030.0,,No,No,No,Persistent Disease,,Yes,235.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,235.0,1.0,1030.0,0.0,0.0
C3L-01046,GBM,C3L-01046-T,,,,0.0,,CPT0127480003,CPT0127480010,,CPT0127480007,,CPT0128570002,50,Male,Unknown,Unknown,European,Russia,No,,Left,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,185.0,110.0,32.14,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",26.3,Yes,,,Dexamethasone|Omeprazole|Acetazolamide|Sterofundin,Medical Record|Medical Record|Medical Record|Medical Record,No,195.0,349.0,Main malignancy,,349.0,No,No,No,Patient Deceased,,Yes,195.0,Progression,,,,,,,,,,,,195.0,1.0,349.0,1.0,0.0
C3N-01518,GBM,C3N-01518-T,,,,0.0,,CPT0167640003,CPT0167640009,,CPT0167640006,,CPT0167700002,72,Female,Unknown,Unknown,East_Asian,China,No,,Right,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"MMP-9(+, vessels+), EGFR(+++), P53(+++), Ki-67(about30%-60%), ATRX(+++), GFAP(+), Olig-2(+) TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: no",164.0,70.0,26.03,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,Breast adenoma,Surgery,,,No,805.0,805.0,Main malignancy,,806.0,No,No,No,Complete Remission,,Yes,538.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,538.0,1.0,805.0,1.0,1.0
C3N-00662,GBM,C3N-00662-T,,,,0.0,,CPT0087680003,CPT0087680006,,CPT0087680009,,CPT0087720002,77,Female,Unknown,Unknown,European,Poland,No,,Right,,3.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,153.0,61.0,26.0,Yes,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,57.0,No or minimal exposure to secondhand smoke,Uterine leiomyomas,Surgery,indapamide|lisinopril|simvastatin,Medical Record|Medical Record|Medical Record,No,116.0,116.0,Other reasons,,126.0,Yes,No,No,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,116.0,1.0,10.0
C3L-03400,GBM,C3L-03400-T,,,,0.0,,CPT0224540004,CPT0224540007,,CPT0224540010,,CPT0226220002,38,Female,Unknown,Unknown,European,Russia,No,,Left,,6.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,167.0,82.0,29.4,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Omeprazole|Dexamethasone|Acetazolamide|Lornoxicam|Sterofundin|Etamsylate,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,786.0,,,804.0,,Yes,Yes,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,786.0,0.0,18.0
C3N-01815,GBM,C3N-01815-T,,,,0.0,,CPT0167970003,CPT0167970009,,CPT0167970006,,CPT0168030004,71,Female,Unknown,Unknown,East_Asian,China,No,hemisphere hemisphere,Left,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"MMP-9(-), EGFR(++), P53(+++), ki-67(15%), ATRX(+ TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: no",158.0,58.0,23.23,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,Esophageal cancer,Unknown,Metoprolol|Valsartan|Nifedipine,Self Report|Self Report|Self Report,No,96.0,121.0,Unknown,,122.0,No,No,No,Patient Deceased,,Unknown,,,,,,,,,,,,,,,0.0,121.0,1.0,1.0
C3N-01856,GBM,C3N-01856-T,,,,0.0,,CPT0162100003,CPT0162100009,,CPT0162100006,,CPT0162120002,66,Male,Unknown,Unknown,European,Poland,No,,Right,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,178.0,80.0,25.0,Unknown,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,B12,Self Report,No,382.0,382.0,Main malignancy,,403.0,Yes,Yes,No,Complete Remission,,Yes,281.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,281.0,1.0,382.0,1.0,21.0
C3L-02704,GBM,C3L-02704-T,,,,0.0,,CPT0189750004,CPT0189750010,,CPT0189750007,,CPT0190660002,54,Male,White,Not Hispanic or Latino,European,United States,No,,Right,,1.7,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,180.0,98.0,29.98,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,,Exposure to secondhand smoke history not available,,,Enalapril|Glyburide|Levetiracetam|Metformin|Omeprazole|Rosuvastatin|Temozolomide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,186.0,,,186.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,186.0,0.0,0.0
C3L-01887,GBM,C3L-01887-T,,,,0.0,,CPT0104330003,CPT0104330006,,CPT0104330009,,CPT0105110002,48,Male,White,Not Hispanic or Latino,European,United States,No,,Left,,3.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,178.0,95.0,30.11,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Ativan |Ambien,Medical Record|Medical Record,No,1622.0,1703.0,Main malignancy,,1704.0,Yes,Yes,No,Complete Remission,Patient Deceased,Yes,1468.0,New Primary Tumor,Site : Left temporal tumor ,,,Yes,,R1: Microscopic Residual Tumor,No,Yes,Yes,1468.0,,1468.0,1.0,1703.0,1.0,1.0
C3N-01857,GBM,C3N-01857-T,,,,0.0,,CPT0162140003,CPT0162140010,,CPT0162140007,,CPT0162170002,69,Female,Unknown,Unknown,European,Poland,No,,Right,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,164.0,60.0,22.0,Unknown,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Levothyroxine,Self Report,No,651.0,651.0,Main malignancy,,672.0,Yes,Yes,No,Unknown,,Yes,406.0,Recurrence,,,,,,,No,Yes,No,,,406.0,1.0,651.0,1.0,21.0
C3N-01196,GBM,C3N-01196-T,,,,0.0,,CPT0078580003,['CPT0078580013'],,CPT0078580006,,CPT0078600002,67,Male,Unknown,Unknown,European,Poland,No,,Right,,1.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,172.0,90.0,30.42,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,230.0,653.0,Main malignancy,,656.0,Yes,Unknown,No,Persistent Disease,,Yes,194.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,194.0,1.0,653.0,1.0,3.0
C3N-01366,GBM,C3N-01366-T,,,,0.0,,CPT0093510003,CPT0093510006,,CPT0093510009,,CPT0093540002,63,Male,Unknown,Unknown,European,Poland,No,,Right,,3.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,182.0,97.0,29.28,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,6.0,6.0,Main malignancy,,6.0,No,No,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,6.0,1.0,0.0
C3N-00661,GBM,C3N-00661-T,,,,0.0,,CPT0087570003,CPT0087570006,,CPT0087570009,,CPT0087650002,49,Male,Unknown,Unknown,European,Poland,No,,Right,,7.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,176.0,105.0,33.0,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",2.3,No or minimal exposure to secondhand smoke,,,telmisartan,Medical Record,No,1107.0,,,1119.0,,Yes,Yes,No,Complete Remission,,Yes,339.0,Recurrence,Site : null,,,,,,Yes,No,No,,,339.0,1.0,1107.0,0.0,12.0
C3L-03744,GBM,C3L-03744-T,,,,0.0,,CPT0216920008,CPT0216920018,,CPT0216920011,,CPT0217940002,75,Male,White,Not Hispanic or Latino,European,United States,No,,Right,,2.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,180.0,79.0,24.27,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Acetaminophen|Celecoxib|Cetirizine|Docusate|Finasteride|Hydrochlorothiazide|Ondansetron|Polyethylene glycol|Prednisone|Senna|Simvastatin|Temozolomide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1040.0,,,1043.0,,Yes,Yes,Yes,Persistent Disease,Complete Remission,No,,,,,,,,,,,,,,,0.0,1040.0,0.0,3.0
C3L-03968,GBM,C3L-03968-T,,,,0.0,,CPT0228220003,CPT0228220009,,CPT0228220006,,CPT0228320002,60,Female,Unknown,Unknown,European,Bulgaria,No,Frontal and Parietal Lobe Frontal-parietal lobe,Right,,3.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,160.0,60.0,23.44,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,986.0,,,992.0,,Yes,Yes,No,Unknown,Unknown,Unknown,,,,,,,,,,,,,,,0.0,986.0,0.0,6.0
C3L-02504,GBM,C3L-02504-T,,,,0.0,,CPT0175060003,CPT0175060009,,CPT0175060006,,CPT0175520002,71,Male,White,Not Hispanic or Latino,European,United States,No,,Left,,1.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,168.0,70.0,25.07,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,45.0,Exposure to secondhand smoke history not available,,,Levothyroxine|Gabapentin|Finasteride|Doxazosin|Aspirin|Dexamethasone|Combigan/Latanoprost Ophthalmic Solution,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,866.0,873.0,Main malignancy,,873.0,Yes,Yes,Unknown,Unknown,Patient Deceased,Yes,454.0,New Primary Tumor,Site : left occipital lobe,,,Yes,,RX: Presence of Residual Tumor cannot be assessed,Unknown,Unknown,Unknown,454.0,,454.0,1.0,873.0,1.0,0.0
C3N-02788,GBM,C3N-02788-T,,,,0.0,,CPT0206330003,"['CPT0206350006', 'CPT0206330009']",,"['CPT0206330006', 'CPT0206350009']",,CPT0206390002,64,Male,Unknown,Unknown,East_Asian,China,No,,Left,,6.6,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"MMP-9（-）, EGFR（+++）, P53（++）, Ki-67（15%）,ATRX（±）,GFAP（+） TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",170.0,68.0,23.53,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,45.0,No or minimal exposure to secondhand smoke,,,Amlodipine besylate|EnalaprilMaleate,Self Report|Self Report,No,845.0,845.0,Main malignancy,,850.0,Yes,Yes,No,Complete Remission,,Yes,450.0,Recurrence,,,,,,,No,Yes,No,,,450.0,1.0,845.0,1.0,5.0
C3L-04084,GBM,C3L-04084-T,,,,0.0,,CPT0217100003,CPT0217100013,,CPT0217100006,,CPT0218020002,63,Female,White,Not Hispanic or Latino,European,United States,No,,Left,,5.4,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,152.0,55.0,23.82,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Clopidogrel|Gabapentin|Levetiracetam|Ondansetron|Oxycodone|Tapentadol|Temozolomide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,206.0,274.0,Main malignancy,,276.0,Yes,Yes,No,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,274.0,1.0,2.0
C3L-01157,GBM,C3L-01157-T,,,,0.0,,CPT0199770003,CPT0199770009,,CPT0199770006,,CPT0200400002,66,Female,Unknown,Unknown,European,Russia,No,,Right,,4.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,162.0,75.0,28.58,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,984.0,984.0,Main malignancy,,984.0,Yes,No,No,Complete Remission,Patient Deceased,No,,,,,,,,,,,,,,,0.0,984.0,1.0,0.0
C3L-02705,GBM,C3L-02705-T,,,,0.0,,CPT0189650004,CPT0189650010,,CPT0189650007,,CPT0190640002,60,Male,White,Not Hispanic or Latino,European,United States,No,,Right,,4.1,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,196.0,98.0,25.61,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,Basal cell carcinoma in situ of skin|Squamous cell carcinoma in situ,Unknown|Unknown,Acetaminophen|Albuterol|Bisacodyl|Dexamethasone|Enoxaparin|Glycopyrrolate|Guaifenesin|Lorazepam|Melatonin|Mirtazapine|Morphine|Scopolamine|Tramadol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,104.0,111.0,Main malignancy,,111.0,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,111.0,1.0,0.0
C3N-01334,GBM,C3N-01334-T,,,,0.0,,CPT0125220003,CPT0125220009,,CPT0125220006,,CPT0125250002,64,Female,Unknown,Unknown,European,Poland,No,,Right,,4.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,KI67 30-40 % GFAP +,160.0,65.0,25.0,Unknown,Lifelong non-drinker,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,7.0,7.0,Main malignancy,,15.0,No,No,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,7.0,1.0,8.0
C3N-03180,GBM,C3N-03180-T,,,,0.0,,CPT0206450003,CPT0206450006,,CPT0206450009,,CPT0206500002,53,Male,Unknown,Unknown,East_Asian,China,No,Temporal Lobe Right Hemisphere and Temporal Lobe,Right,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"MMP-9（±）, EGFR（+++）, P53（±）, Ki-67（25%）, ATRX（+++） TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",165.0,85.0,31.22,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,30.0,No or minimal exposure to secondhand smoke,,,Aspirin,Self Report,No,511.0,511.0,Main malignancy,,515.0,Yes,Yes,Unknown,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,511.0,1.0,4.0
C3N-01852,GBM,C3N-01852-T,,,,0.0,,CPT0182500003,CPT0182500009,,CPT0182500006,,CPT0182540002,59,Male,Unknown,Unknown,European,Poland,No,,Left,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,184.0,82.0,24.22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,3.0,,,8.0,,Unknown,Unknown,Unknown,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,3.0,0.0,5.0
C3L-03727,GBM,C3L-03727-T,,,,0.0,,CPT0225730003,CPT0225730009,,CPT0225730006,,CPT0226070002,71,Female,White,Not Hispanic or Latino,European,United States,No,,Left,,5.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,150.0,77.0,34.41,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Aspirin|Centrum Silver|Clonazepam|Diphenhydramine|Famotidine|Loperamide|sumatriptan|treximet|Vitamin C|Vitamin D3,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,613.0,721.0,Main malignancy,,721.0,Yes,Yes,Unknown,Persistent Disease,,Yes,457.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,457.0,1.0,721.0,1.0,0.0
C3N-01368,GBM,C3N-01368-T,,,,0.0,,CPT0093590003,CPT0093590006,,CPT0093590009,,CPT0093620002,65,Male,Unknown,Unknown,European,Poland,No,,Right,,3.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,180.0,90.0,27.78,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Bisoprolol|Metformax,Medical Record|Medical Record,No,245.0,245.0,Unknown,,267.0,No,No,No,Persistent Disease,,Yes,63.0,Recurrence,Site : Brain,,,Yes,,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,76.0,,63.0,1.0,245.0,1.0,22.0
C3N-00665,GBM,C3N-00665-T,,,,0.0,,CPT0093360003,CPT0093360006,,CPT0093360009,,CPT0093440002,65,Female,Unknown,Unknown,European,Poland,No,,Right,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,164.0,58.0,21.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Yes,,,Acetylsalicylic acid|Vitamin D3|Metformin hydrochloride|Levothyroxine sodium|Bisoprolol fumarate|Telmisartan|Simvastatin,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,No,1585.0,,,1590.0,,Yes,Yes,No,Complete Remission,Persistent Disease,Yes,1291.0,New Primary Tumor,Site : right frontal lobe,,,Yes,,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,1297.0,,1291.0,1.0,1585.0,0.0,5.0
C3N-03184,GBM,C3N-03184-T,,,,0.0,,CPT0206780003,CPT0206780006,,CPT0206780009,,CPT0206830002,35,Male,Unknown,Unknown,East_Asian,China,No,Parietal Lobe Left Hemisphere and Parietal Lobe,Left,,3.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"MMP-9（-）, EGFR（+++）, P53（-）, Ki-67（about 50%）, ATRX（±） TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",185.0,90.0,26.3,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,15.0,No or minimal exposure to secondhand smoke,,,,,No,390.0,,,395.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,390.0,0.0,5.0
C3L-02900,GBM,C3L-02900-T,,,,0.0,,CPT0218670003,CPT0218670009,,CPT0218670006,,CPT0219910002,52,Male,White,Not Hispanic or Latino,European,United States,No,,Right,,2.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,173.0,66.0,22.2,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,tylenol 500 |pepcid |neurontin |mulivitamin |Flomax|restoril ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1053.0,1053.0,Main malignancy,,1053.0,Yes,Yes,No,Persistent Disease,Patient Deceased,No,,,,,,,,,,,,,,,0.0,1053.0,1.0,0.0
C3N-00663,GBM,C3N-00663-T,,,,0.0,,CPT0087730003,CPT0087730006,,CPT0087730009,,CPT0087810002,39,Male,Unknown,Unknown,European,Poland,No,,Bilateral,,7.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,182.0,100.0,30.19,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,1.0,1.0,Main malignancy,,11.0,No,No,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,1.0,1.0,10.0
C3L-01327,GBM,C3L-01327-T,,,,0.0,,CPT0064890003,['CPT0064890006'],,CPT0064890009,,CPT0066690002,74,Male,White,Not Hispanic or Latino,European,United States,No,,Left,,2.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,175.0,77.0,25.07,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,,Exposure to secondhand smoke history not available,,,ASA 325 |Dexamethasone|Acetaminophen|Albuterol|Clonidin|Dulcolax|Famotidine|Hydrolazine|KCL|Labetol|Magnesium Sulfate|Miralax|Morphine|Narcan|Oxycodone|Phenergan|Senokot|Zofran|Simethicone,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,2.0,646.0,Main malignancy,,646.0,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,646.0,1.0,0.0
C3N-02786,GBM,C3N-02786-T,,,,0.0,,CPT0206230003,CPT0206230009,,CPT0206230006,,CPT0206280002,39,Female,Unknown,Unknown,East_Asian,China,No,Frontal Lobe Hemisphere and Frontal Lobe,Left,,6.8,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,166.0,67.0,24.31,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,1047.0,,,1077.0,,Yes,Yes,No,Persistent Disease,Persistent Disease,No,,,,,,,,,,,,,,,0.0,1047.0,0.0,30.0
C3L-01040,GBM,C3L-01040-T,,,,0.0,,CPT0171580008,CPT0171580014,,CPT0171580011,,CPT0171540002,77,Male,Unknown,Unknown,European,Russia,No,,Left,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,170.0,70.0,24.22,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,608.0,,,607.0,,Yes,Yes,No,Persistent Disease,,Yes,559.0,Progression,,,,,,,,,,,,559.0,1.0,608.0,0.0,-1.0
C3N-02188,GBM,C3N-02188-T,,,,0.0,,CPT0168830003,CPT0168830009,,CPT0168830006,,CPT0168870002,59,Male,Unknown,Unknown,East_Asian,China,No,,Right,,5.2,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,180.0,70.0,21.6,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,411.0,411.0,Main malignancy,,414.0,Yes,Yes,No,Complete Remission,,Yes,260.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,260.0,1.0,411.0,1.0,3.0
C3N-01515,GBM,C3N-01515-T,,,,0.0,,CPT0079790003,CPT0079790006,,CPT0079790009,,['CPT0080730002'],73,Female,White,Not Hispanic or Latino,European,United States,No,,Right,,1.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,160.0,71.0,27.73,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,"Current reformed smoker, more than 15 years",1.0,Exposure to secondhand smoke history not available,,,lactulose|metoprolol,Medical Record|Medical Record,No,19.0,19.0,Main malignancy,,19.0,No,No,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,19.0,1.0,0.0
C3L-00104,GBM,C3L-00104-T,,,,0.0,,CPT0092440003,CPT0092440006,,CPT0092440009,,CPT0093800002,58,Male,White,Not Hispanic or Latino,European,United States,No,,Left,,1.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,188.0,115.0,32.54,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,35.0,Exposure to secondhand smoke history not available,,,lyrica|norco|aspirin|celebrex|plavix|viatmin B12|gabapentin|glipizide|metformin|metoprolol|omeprazole|actos|ramipril|rosuvastatin|valtrex,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,128.0,129.0,Unknown,,129.0,Yes,Yes,No,Persistent Disease,,Yes,101.0,Progression,,,,,,,,,,,,101.0,1.0,129.0,1.0,0.0
C3N-02769,GBM,C3N-02769-T,,,,0.0,,CPT0205570003,CPT0205570006,,CPT0205570009,,CPT0205620002,53,Male,Unknown,Unknown,East_Asian,China,No,,Left,,5.3,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,170.0,65.0,22.49,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,1115.0,1115.0,Main malignancy,,1121.0,Yes,Yes,No,Complete Remission,Patient Deceased,Yes,667.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,667.0,1.0,1115.0,1.0,6.0
C3N-02785,GBM,C3N-02785-T,,,,0.0,,CPT0206110003,CPT0206110006,,CPT0206110009,,CPT0206170002,69,Male,Unknown,Unknown,East_Asian,China,No,Temporal Lobe Left Hemisphere and Temporal Lobe,Left,,5.0,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"MMP-9（±），EGFR（+++），P53（±），Ki-67（30%），ATRX（+++） TERT Promoter C228T Mutation: no, TERT Promoter C250T Mutation: no",178.0,75.0,23.67,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,20.0,No or minimal exposure to secondhand smoke,,,,,No,546.0,546.0,Main malignancy,,552.0,Yes,Yes,No,Complete Remission,,Yes,466.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,466.0,1.0,546.0,1.0,6.0
C3N-02190,GBM,C3N-02190-T,,,,0.0,,CPT0205450004,CPT0205450010,,CPT0205450007,,CPT0205510002,53,Male,Unknown,Unknown,East_Asian,China,No,,Left,,5.5,Glioblastoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,"EGFR (+++), P53 (20%), ATRX (90%), Ki -67 (50%), MMP 9 (-), H3K27M(-) TERT Promoter C228T Mutation: yes, TERT Promoter C250T Mutation: no",182.0,75.0,22.64,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Metoprolol Tartrate|Levoamlodipine Maleate,Self Report|Self Report,No,311.0,311.0,Main malignancy,,317.0,Yes,Yes,No,Complete Remission,,Yes,261.0,Recurrence,Site : Brain,,,Unknown,,,Unknown,Unknown,Unknown,,,261.0,1.0,311.0,1.0,6.0
C3N-01643,HNSCC,,,,,0.0,,,CPT0162890009,,CPT0162890006,,CPT0162920002,68,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,2.6,"Squamous cell carcinoma, keratinizing",G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,6,IHC staining not done,0,cM0,pM0,,RX: Presence of residual tumor cannot be assessed,,172.0,84.0,28.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",54.0,No or minimal exposure to secondhand smoke,,,"bisoprolol 1,25 mg|acetylsalicylic acid 75 mg once a day",Self Report|Self-reported,No,1460.0,,,1474.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1460.0,0.0,14.0
C3L-00997,HNSCC,C3L-00997-T,C3L-00997-N,,,0.0,CPT0123190003,CPT0123180003,CPT0123180006,CPT0123190009,CPT0123180009,CPT0123190006,CPT0124760002,47,Male,Unknown,Unknown,European,Ukraine,No,,Unknown,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,13,IHC staining not done,1,cM0,Staging Incomplete,Not documented,R0: No residual tumor,,163.0,58.0,21.83,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",15.0,Yes,,,,,No,442.0,,,445.0,,Yes,No,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,442.0,0.0,3.0
C3N-03849,HNSCC,C3N-03849-T,C3N-03849-N,,,0.0,CPT0237150003,CPT0237130004,CPT0237130010,CPT0237150006,CPT0237130007,CPT0237150009,CPT0237190002,55,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,7.0,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN2b,25,IHC staining not done,3,cM0,pM0,no,R0: No residual tumor,,160.0,55.0,21.48,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,335.0,,,341.0,,No,No,No,Not Applicable,,Yes,265.0,,Larynx,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,265.0,1.0,335.0,0.0,6.0
C3N-01858,HNSCC,C3N-01858-T,C3N-01858-N,,,0.0,CPT0163860003,CPT0163840003,CPT0163840009,,CPT0163840006,,CPT0163900002,62,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,3.2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN3b,15,IHC staining not done,1,cM0,pMx,,RX: Presence of residual tumor cannot be assessed,,176.0,78.0,25.0,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current reformed smoker within past 15 years,61.5,Exposure to secondhand smoke history not available,,,"Xarelto 15 1x |Bisocard 2.5 1x |Prestarium 5 1/2 1x |clexane 0,4 x2|digoxin 0,1",Self Report|Self Report|Self Report|Medical Record|Self Report,No,598.0,,,617.0,,Yes,Yes,No,Persistent Disease,,Yes,200.0,,Larynx,,Biopsy with Histologic Confirmation,Unknown,,,Unknown,Unknown,Unknown,,,200.0,1.0,598.0,0.0,19.0
C3N-03487,HNSCC,C3N-03487-T,,,,0.0,,CPT0194960003,CPT0194960013,CPT0194980006,CPT0194960009,CPT0194980009,CPT0195070002,53,Female,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Present,Cannot be assessed,Seventh Edition (2010),pT4a,pN0,5,IHC staining not done,0,cM0,Staging Incomplete,No,RX: Presence of residual tumor cannot be assessed,,164.0,132.0,49.08,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,728.0,,,714.0,,No,Yes,No,Complete Remission,,Yes,390.0,,Oral Cavity,,Biopsy with Histologic Confirmation,Yes,,,No,Yes,No,391.0,,390.0,1.0,728.0,0.0,-14.0
C3L-04791,HNSCC,C3L-04791-T,,,,0.0,,CPT0250310003,CPT0250310009,CPT0250330006,CPT0250310006,,CPT0250450002,81,Male,Unknown,Unknown,European,Bulgaria,No,,Midline,Unifocal,3.0,Keratinizing Squamous Cell Carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1,pNX,10,IHC staining not done,0,cMX,pMX,,R0: No residual tumor,,180.0,75.0,23.15,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Amiodarone Hydrochloride,Self Report,No,273.0,,,281.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,273.0,0.0,8.0
C3N-04273,HNSCC,C3N-04273-T,,,,0.0,,CPT0245230004,CPT0245230007,,CPT0245230010,,CPT0245290002,73,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,2.0,Basaloid squamous cell carcinoma,G2 Moderately differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2b,22,IHC staining not done,8,cM0,pMx,,R0: No residual tumor,,172.0,75.0,25.0,No,"Consumed alcohol in the past, but currently a non-drinker",Current reformed smoker within past 15 years,38.0,No or minimal exposure to secondhand smoke,,,,,No,377.0,425.0,Main malignancy,,431.0,No,No,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,425.0,1.0,6.0
C3N-03664,HNSCC,C3N-03664-T,,,,0.0,,CPT0196210003,CPT0196210006,,CPT0196210009,,CPT0196330002,58,Male,Unknown,Unknown,European,Ukraine,No,,Midline,Unifocal,3.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN2c,9,IHC staining not done,3,cM0,Staging Incomplete,No,RX: Presence of residual tumor cannot be assessed,,176.0,72.0,23.24,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,733.0,,,720.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,733.0,0.0,-13.0
C3N-01859,HNSCC,C3N-01859-T,C3N-01859-N,,,0.0,C3N-01859-04,CPT0163910003,CPT0163910009,,CPT0163910006,,CPT0163950002,67,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,3.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN2c,24,IHC staining not done,9,cM0,pMx,,RX: Presence of residual tumor cannot be assessed,,160.0,63.0,24.0,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,40.0,Yes,ca planoepitheliale,Surgery,enalapryl,Self Report,No,1039.0,1039.0,Unknown,,1057.0,Yes,No,No,Persistent Disease,Patient Deceased,Unknown,,,,,,,,,,,,,,,0.0,1039.0,1.0,18.0
C3N-03781,HNSCC,C3N-03781-T,C3N-03781-N,,,0.0,CPT0245560003,CPT0245550003,CPT0245550009,,CPT0245550006,,CPT0245590002,68,Male,Unknown,Unknown,European,Poland,No,,Midline,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN0,3,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,170.0,88.0,30.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",22.0,No or minimal exposure to secondhand smoke,,,Primacor,Self Report,No,1235.0,1235.0,Unknown,,1239.0,Yes,No,No,Complete Remission,Patient Deceased,No,,,,,,,,,,,,,,,0.0,1235.0,1.0,4.0
C3N-03933,HNSCC,C3N-03933-T,C3N-03933-N,,,0.0,CPT0220620003,CPT0220610003,CPT0220610009,CPT0220620009,CPT0220610006,CPT0220620006,CPT0220710002,70,Female,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,3.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,7,IHC staining not done,1,cM0,Staging Incomplete,no,R0: No residual tumor,,160.0,65.0,25.39,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,749.0,,,722.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,749.0,0.0,-27.0
C3L-00999,HNSCC,C3L-00999-T,C3L-00999-N,,,0.0,CPT0123280003,CPT0123260003,CPT0123260006,CPT0123280009,CPT0123260009,CPT0123280006,CPT0124780002,56,Male,Unknown,Unknown,European,Russia,No,,Midline,Unifocal,2.2,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,17,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not documented,R0: No residual tumor,,176.0,82.0,26.47,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,36.0,Yes,,,,,No,1137.0,,,1098.0,,No,No,No,Complete Remission,Persistent Disease,Yes,232.0,,Cervical Lymph Node,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,232.0,1.0,1137.0,0.0,-39.0
C3N-03009,HNSCC,C3N-03009-T,,,,0.0,,CPT0245060004,CPT0245060007,,CPT0245060010,,CPT0245120002,58,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,2.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1,pN0,14,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,170.0,52.0,17.0,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,31.5,Yes,,,Beto ZK 25|Tritace|Agen|Torsemed|Acard,Self Report|Self Report|Self Report|Self Report|Self Report,No,636.0,655.0,Unknown,,657.0,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,655.0,1.0,2.0
C3N-03015,HNSCC,C3N-03015-T,C3N-03015-N,,,0.0,CPT0245190003,CPT0245180003,CPT0245180006,CPT0245190006,CPT0245180009,CPT0245190009,CPT0245220002,61,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,1.0,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN2b,24,IHC staining not done,7,cM0,pMx,,R0: No residual tumor,,164.0,85.0,31.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,"Bisocard 2,5|Vivace|Acard|Atrox",Self Report|Self Report|Self Report|Self Report,No,1493.0,,,1499.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1493.0,0.0,6.0
C3N-01948,HNSCC,C3N-01948-T,,,,0.0,,CPT0163650003,CPT0163650009,CPT0163670006,CPT0163650006,,CPT0163710002,55,Female,Unknown,Unknown,European,Poland,No,,Right,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN2b,26,IHC staining not done,4,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,168.0,55.0,19.0,Unknown,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Bisocard 2.5 mg 1/2 1x,Self Report,No,422.0,,,435.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,422.0,0.0,13.0
C3N-03490,HNSCC,C3N-03490-T,C3N-03490-N,,,0.0,CPT0195700003,CPT0195680003,CPT0195680006,CPT0195700006,CPT0195680009,CPT0195700009,CPT0195790002,64,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,4.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,8,IHC staining not done,0,cM0,Staging Incomplete,No,R0: No residual tumor,,175.0,85.0,27.76,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,634.0,,,634.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,634.0,0.0,0.0
C3N-03012,HNSCC,C3N-03012-T,C3N-03012-N,,,0.0,CPT0226350003,CPT0226340003,CPT0226340009,,CPT0226340006,,CPT0226380002,71,Male,Unknown,Unknown,European,Poland,No,,Midline,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pTIVA,pN0,7,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,168.0,78.0,27.0,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, years unknown",,No or minimal exposure to secondhand smoke,ca planoepitheliale - larynx,Surgery,,,No,1333.0,1333.0,Unknown,,1333.0,Yes,No,No,Complete Remission,Patient Deceased,No,,,,,,,,,,,,,,,0.0,1333.0,1.0,0.0
C3N-01620,HNSCC,C3N-01620-T,C3N-01620-N,,,0.0,C3N-01620-05,CPT0095040003,CPT0095040006,,CPT0095040008,,CPT0095090002,56,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,4.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,5,0,0,cM0,No pathologic evidence of distant metastasis,no,R0: No residual tumor,,190.0,113.0,31.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,1202.0,,,1213.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1202.0,0.0,11.0
C3N-02730,HNSCC,C3N-02730-T,,,,0.0,,CPT0207870004,CPT0207870010,,CPT0207870007,,CPT0207930002,40,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,2.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1,pN1,19,IHC staining not done,1,cM0,pM0,no,R0: No residual tumor,,172.0,70.0,23.66,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,amlodipine|diformin tablet,Medical Record|Medical Record,No,365.0,,,371.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,365.0,0.0,6.0
C3N-01758,HNSCC,C3N-01758-T,C3N-01758-N,,,0.0,C3N-01758-04,CPT0163340003,CPT0163340009,,CPT0163340006,,CPT0163400002,59,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN1,6,IHC staining not done,1,cM0,pM0,,RX: Presence of residual tumor cannot be assessed,,165.0,65.0,23.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,30.0,No or minimal exposure to secondhand smoke,,,,,No,702.0,712.0,Main malignancy,,730.0,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,712.0,1.0,18.0
C3N-04277,HNSCC,C3N-04277-T,C3N-04277-N,,,0.0,CPT0245410003,CPT0245400003,CPT0245400009,CPT0245410006,CPT0245400006,,CPT0245440002,72,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,1.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pNx,5,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,165.0,71.0,26.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,23.5,No or minimal exposure to secondhand smoke,,,Bisocard 2.5,Self Report,No,1162.0,,,1162.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1162.0,0.0,0.0
C3N-03045,HNSCC,C3N-03045-T,C3N-03045-N,,,0.0,CPT0235920003,CPT0235910003,CPT0235910009,CPT0235920006,CPT0235910006,,CPT0235970002,77,Male,Unknown,Hispanic or Latino,Ad_Mixed_American,United States,No,,Left,Unifocal,2.2,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),T2,N1,33,IHC staining not done,1,m0,Not identified,,RX: Presence of residual tumor cannot be assessed,,,,,,,,,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3N-02275,HNSCC,C3N-02275-T,,,,0.0,,CPT0163740003,CPT0163740013,CPT0163720006,CPT0163740007,,CPT0163780002,69,Male,Unknown,Unknown,European,Poland,No,,Midline,Unifocal,3.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN0,5,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,R0: No residual tumor,,170.0,91.0,31.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Insulin according to glucose lovel|acard 75 mg,Self Report|Self Report,No,1358.0,,,1372.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1358.0,0.0,14.0
C3N-01339,HNSCC,C3N-01339-T,,,,0.0,,CPT0094490004,CPT0094490007,,CPT0094490010,,CPT0094550002,68,Female,Unknown,Unknown,European,Poland,No,,Left,Unifocal,3.4,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Stage IV,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4,pN1,2,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,169.0,64.0,22.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,203.0,211.0,Main malignancy,,231.0,Yes,Yes,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,211.0,1.0,20.0
C3N-01337,HNSCC,C3N-01337-T,C3N-01337-N,,,0.0,CPT0088010003,CPT0087990003,CPT0087990006,CPT0088010009,CPT0087990009,CPT0088010006,CPT0088050002,52,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,5.0,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage IV,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4,pN2b,10,IHC staining not done,4,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,164.0,55.0,20.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,13.2,Yes,,,,,No,616.0,,,629.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,616.0,0.0,13.0
C3N-03226,HNSCC,C3N-03226-T,,,,0.0,,CPT0194420003,CPT0194420013,CPT0194440006,CPT0194420009,CPT0194440009,CPT0194530002,54,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,3.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN2b,6,IHC staining not done,3,cM0,Staging Incomplete,No,R0: No residual tumor,,174.0,74.0,24.44,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,35.0,Exposure to secondhand smoke history not available,,,,,No,730.0,,,708.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,730.0,0.0,-22.0
C3N-02713,HNSCC,C3N-02713-T,C3N-02713-N,,,0.0,CPT0190860003,CPT0190850003,CPT0190850009,CPT0190860006,CPT0190850006,CPT0190860009,CPT0190950002,64,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,3.3,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN2,1,IHC staining not done,1,cM0,Staging Incomplete,No,RX: Presence of residual tumor cannot be assessed,,180.0,67.0,20.68,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,45.0,Exposure to secondhand smoke history not available,,,,,No,744.0,,,720.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,744.0,0.0,-24.0
C3N-03619,HNSCC,C3N-03619-T,C3N-03619-N,,,0.0,CPT0195880003,CPT0195860003,CPT0195860006,CPT0195880006,CPT0195860009,CPT0195880008,CPT0195970002,59,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,3.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,4,IHC staining not done,0,cM0,Staging Incomplete,No,R0: No residual tumor,,172.0,70.0,23.66,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,35.0,Exposure to secondhand smoke history not available,,,,,No,97.0,,,97.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,97.0,0.0,0.0
C3N-00871,HNSCC,C3N-00871-T,,,,0.0,,CPT0094420004,CPT0094420007,,CPT0094420010,,CPT0094480008,58,Male,Unknown,Unknown,European,Poland,No,,Midline,Unifocal,5.2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN2b,7,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,no distant metastasis,R0: No residual tumor,,176.0,57.0,18.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,344.0,400.0,Main malignancy,,414.0,Yes,Yes,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,400.0,1.0,14.0
C3N-02693,HNSCC,,C3N-02693-N,,,0.0,C3N-02693-06,,CPT0226130009,,CPT0226130006,,CPT0226170002,42,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,4.1,"Squamous cell carcinoma, non-keratinizing",G2 Moderately differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,11,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,195.0,102.0,26.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,1349.0,,,1349.0,,Yes,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1349.0,0.0,0.0
C3L-04844,HNSCC,C3L-04844-T,C3L-04844-N,,,0.0,CPT0248350003,CPT0248330003,CPT0248330009,,CPT0248330006,,CPT0248360002,61,Female,Unknown,Unknown,European,Other: TSS did not collect,No,,Right,Unifocal,6.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN3,79,IHC staining not done,5,cM0,pM0,Not applicable,R0: No residual tumor,,167.0,58.0,20.73,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,50.0,Exposure to secondhand smoke history not available,,,zopiclone|Rosuvastatin|Pantoprazole|Symbicort|benzydamine|amitriptyline|oxyneo,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1096.0,,,1057.0,,Yes,Yes,No,Complete Remission,Complete Remission,Yes,702.0,,Oral Cavity,,Biopsy with Histologic Confirmation,Yes,,R0: No Residual Tumor,No,No,No,702.0,,702.0,1.0,1096.0,0.0,-39.0
C3N-03458,HNSCC,C3N-03458-T,,,,0.0,,CPT0246670003,CPT0246670009,,CPT0246670006,,CPT0246710002,70,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,2.0,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage II,Not identified,Cannot be assessed,Eighth Edition (2017),pT2,pN0,3,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,174.0,75.0,24.0,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,56.3,Yes,,,,,No,1393.0,,,1399.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1393.0,0.0,6.0
C3N-01338,HNSCC,C3N-01338-T,C3N-01338-N,,,0.0,CPT0088080003,CPT0088060004,CPT0088060007,CPT0088080009,CPT0088060010,CPT0088080006,CPT0088120002,50,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,3.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,13,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,175.0,75.0,24.0,Unknown,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,574.0,585.0,Unknown,,620.0,Yes,No,No,Complete Remission,Patient Deceased,Yes,492.0,,Locoregional Recurrence,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,492.0,1.0,585.0,1.0,35.0
C3N-01947,HNSCC,C3N-01947-T,C3N-01947-N,,,0.0,CPT0226090003,CPT0226030003,CPT0226030009,CPT0226090009,CPT0226030006,CPT0226090006,CPT0226120002,49,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,5.5,"Squamous cell carcinoma, keratinizing",G2 Moderately differentiated,Stage IV,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN2b,8,IHC staining not done,2,cM0,pMx,,R0: No residual tumor,,166.0,61.0,22.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Nebilet,Medical Record,No,1191.0,,,1204.0,,Yes,Yes,No,Complete Remission,Unknown,Unknown,,,,,,,,,,,,,,,0.0,1191.0,0.0,13.0
C3N-01645,HNSCC,C3N-01645-T,C3N-01645-N,,,0.0,CPT0088430003,CPT0088410003,CPT0088410006,CPT0088430006,CPT0088410009,,CPT0088470002,71,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,3.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,9,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,172.0,84.0,28.0,Unknown,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,584.0,,,612.0,,No,No,No,Complete Remission,,Yes,374.0,,"Locoregional Recurrence, Cervical Lymph Node",,Convincing Image (i.e. CT/PET/MRI),Unknown,,,Unknown,Unknown,Unknown,,,374.0,1.0,584.0,0.0,28.0
C3N-04611,HNSCC,C3N-04611-T,,,,0.0,,CPT0261520003,CPT0261520009,CPT0261550009,CPT0261520006,CPT0261550006,CPT0261640002,55,Male,Unknown,Unknown,European,Ukraine,No,,Right,Unifocal,6.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No,RX: Presence of residual tumor cannot be assessed,,175.0,75.0,24.49,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,Aspirin Cardio,Medical Record,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3N-03011,HNSCC,C3N-03011-T,C3N-03011-N,,,0.0,CPT0226270003,CPT0226250004,CPT0226250010,,CPT0226250007,,CPT0226330002,62,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,2.0,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2b,31,IHC staining not done,3,cM0,pMx,,R0: No residual tumor,,182.0,79.0,23.85,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,38.0,No or minimal exposure to secondhand smoke,colon adenocarcinoma,"Radiation, Surgery, Chemotherapy",,,No,598.0,598.0,Unknown,,598.0,Yes,Yes,No,Persistent Disease,,Yes,396.0,,"Hypopharynx, Distant Metastasis (specify)",vertebrae,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,396.0,1.0,598.0,1.0,0.0
C3L-01237,HNSCC,C3L-01237-T,C3L-01237-N,,,0.0,CPT0199830003,CPT0199820003,CPT0199820009,CPT0199830009,CPT0199820006,CPT0199830006,CPT0200410002,57,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN2,9,IHC staining not done,5,cM0,Staging Incomplete,Not documented,R0: No residual tumor,,176.0,54.0,17.43,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",6.0,Exposure to secondhand smoke history not available,,,,,No,20.0,,,0.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,20.0,0.0,-20.0
C3N-01946,HNSCC,C3N-01946-T,C3N-01946-N,,,0.0,CPT0163610003,CPT0163600003,CPT0163600009,CPT0163610006,CPT0163600006,,CPT0163640002,64,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,1.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,1,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,R0: No residual tumor,,176.0,83.0,26.79,No,Lifelong non-drinker,"Current reformed smoker, years unknown",,Exposure to secondhand smoke history not available,,,,,No,1335.0,,,1346.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1335.0,0.0,11.0
C3N-01756,HNSCC,C3N-01756-T,C3N-01756-N,,,0.0,CPT0163170003,CPT0163160003,CPT0163160009,CPT0163170009,CPT0163160006,CPT0163170006,CPT0163200002,62,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,4.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN2c,9,IHC staining not done,1,cM0,pM0,,RX: Presence of residual tumor cannot be assessed,,164.0,57.0,21.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,22.5,No or minimal exposure to secondhand smoke,,,,,No,1547.0,,,1563.0,,Yes,No,No,Persistent Disease,Complete Remission,No,,,,,,,,,,,,,,,0.0,1547.0,0.0,16.0
C3N-01945,HNSCC,C3N-01945-T,,,,0.0,,CPT0163530003,CPT0163530009,,CPT0163530006,,CPT0163590002,61,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,5,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,no distant metastasis,R0: No residual tumor,,179.0,52.0,16.0,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,,,No,1115.0,1115.0,Unknown,,1128.0,Unknown,Unknown,Unknown,Unknown,Patient Deceased,Unknown,,,,,,,,,,,,,,,0.0,1115.0,1.0,13.0
C3L-04354,HNSCC,C3L-04354-T,C3L-04354-N,,,0.0,CPT0243140004,CPT0243090003,CPT0243090009,CPT0243140007,CPT0243090006,CPT0243140010,CPT0243240002,60,Male,Unknown,Unknown,European,Bulgaria,No,,Midline,Unifocal,2.0,Non-Keratinized Squamous Cell Carcinoma,G3 Poorly differentiated,Stage II,Present,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT2 ,pNX,-1,IHC staining not done,0,cMX,pMX,,R0: No residual tumor,,180.0,85.0,26.23,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,9.0,Exposure to secondhand smoke history not available,,,Gliclazide|Bisoprolol fumarate,Self Report|Self Report,No,1017.0,,,1024.0,,Yes,No,No,Persistent Disease,Complete Remission,No,,,,,,,,,,,,,,,0.0,1017.0,0.0,7.0
C3L-00987,HNSCC,C3L-00987-T,,,,0.0,,CPT0127050003,CPT0127050009,,CPT0127050006,,CPT0128500002,61,Male,Unknown,Unknown,European,Ukraine,No,,Unknown,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,7,IHC staining not done,1,cM0,Staging Incomplete,Not documented,R0: No residual tumor,,182.0,80.0,24.15,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,43.0,Yes,,,,,No,429.0,,,433.0,,Yes,No,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,429.0,0.0,4.0
C3L-04025,HNSCC,C3L-04025-T,,,,0.0,,CPT0256560003,CPT0256560009,CPT0256590010,CPT0256560006,CPT0256590007,CPT0256700002,69,Male,Unknown,Unknown,European,Bulgaria,No,,Right,Unifocal,1.5,Squamous cell verrucous carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pNX,-1,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX: Presence of residual tumor cannot be assessed,,182.0,80.0,24.15,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,470.0,,,479.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,470.0,0.0,9.0
C3L-02621,HNSCC,C3L-02621-T,C3L-02621-N,,,0.0,CPT0201860004,CPT0201830004,CPT0201830010,CPT0201860010,CPT0201830007,CPT0201860007,CPT0201970002,68,Male,Unknown,Unknown,European,Bulgaria,No,,Unknown,Multifocal,0.6,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1,pNX,0,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0: No residual tumor,,178.0,80.0,25.25,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,45.0,Yes,,,Amlodipine|Valsartan|Hydrochlorothiazide|Amiodarone,Self Report|Self Report|Self Report|Self Report,No,314.0,,,327.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,314.0,0.0,13.0
C3N-02925,HNSCC,C3N-02925-T,,,,0.0,,CPT0184530003,CPT0184530009,CPT0184550009,CPT0184530006,CPT0184550006,CPT0184590002,68,Female,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,4.2,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN2b,29,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,no,R0: No residual tumor,,160.0,53.0,20.7,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,1022.0,,,1028.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,1022.0,0.0,6.0
C3N-03612,HNSCC,C3N-03612-T,,,,0.0,,CPT0194790003,CPT0194790013,CPT0194800006,CPT0194790009,CPT0194800009,CPT0194890002,51,Male,Unknown,Unknown,European,Ukraine,No,,Right,Unifocal,2.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,0,R0: No residual tumor,,174.0,91.0,30.06,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,697.0,,,669.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,697.0,0.0,-28.0
C3N-01752,HNSCC,C3N-01752-T,,,,0.0,,CPT0162940003,CPT0162940009,,CPT0162940006,,CPT0162970002,73,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,5.6,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN0,26,IHC staining not done,4,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,168.0,55.0,19.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Bisocard 2.5 mg 1/2 x 1,Self Report,No,998.0,998.0,Main malignancy,,1009.0,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,998.0,1.0,11.0
C3N-03837,HNSCC,C3N-03837-T,C3N-03837-N,,,0.0,CPT0236640003,CPT0236620003,CPT0236620009,CPT0236640006,CPT0236620006,,CPT0236680002,54,Male,Unknown,Unknown,East_Asian,China,No,,Midline,Unifocal,4.5,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,19,IHC staining not done,0,cM0,pM0,no,R0: No residual tumor,,165.0,65.0,23.88,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Metformin,Medical Record,No,706.0,,,706.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,706.0,0.0,0.0
C3N-03027,HNSCC,C3N-03027-T,C3N-03027-N,,,0.0,CPT0226400003,CPT0226390003,CPT0226390009,CPT0226400009,CPT0226390006,CPT0226400006,CPT0226430002,65,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,1.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,0,IHC staining not done,0,cM0,pM0,,R0: No residual tumor,,174.0,62.0,20.0,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,48.0,No or minimal exposure to secondhand smoke,,,,,No,211.0,211.0,Other reasons,,221.0,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,211.0,1.0,10.0
C3N-01943,HNSCC,C3N-01943-T,C3N-01943-N,,,0.0,CPT0163430003,CPT0163410003,CPT0163410009,CPT0163430009,CPT0163410006,CPT0163430006,CPT0163470002,63,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,5.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT4a,pN3a,39,IHC staining not done,17,cM0,pMx,no distant metastasis,R1: Microscopic residual tumor,,175.0,95.0,31.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,840.0,852.0,Main malignancy,,852.0,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,852.0,1.0,0.0
C3N-04278,HNSCC,C3N-04278-T,C3N-04278-N,,,0.0,CPT0245460003,CPT0245450003,CPT0245450009,CPT0245460006,CPT0245450006,CPT0245460009,CPT0245490002,71,Male,Unknown,Unknown,European,Poland,No,,Midline,Unifocal,4.0,Basaloid squamous cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pNx,0,0,0,cM0,pMx,,R0: No residual tumor,,163.0,80.0,30.0,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,28.5,No or minimal exposure to secondhand smoke,ca planoepitheliale (lungs),"Surgery,Chemotherapy",Bataloc ZOK 50|Tritace 5|Atrox 20|Polocard,Self Report|Self Report|Self Report|Medical Record,No,576.0,,,582.0,,No,No,No,Complete Remission,,Yes,455.0,,Hypopharynx,,Convincing Image (i.e. CT/PET/MRI),Unknown,,,Unknown,Unknown,Unknown,,,455.0,1.0,576.0,0.0,6.0
C3N-03785,HNSCC,C3N-03785-T,,,,0.0,,CPT0245680003,CPT0245680009,,CPT0245680006,,CPT0245720002,66,Male,Unknown,Unknown,European,Poland,No,,Right,Multifocal,1.2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1,pNx,0,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,172.0,95.0,32.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,9.2,Yes,,,Co-prestarium,Medical Record,No,658.0,1152.0,Unknown,,1158.0,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1152.0,1.0,6.0
C3N-03620,HNSCC,C3N-03620-T,C3N-03620-N,,,0.0,CPT0196060003,CPT0196040003,CPT0196040006,CPT0196060009,CPT0196040009,CPT0196060006,CPT0196150002,61,Male,Unknown,Unknown,European,Ukraine,No,,Right,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No,RX: Presence of residual tumor cannot be assessed,,168.0,90.0,31.89,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,728.0,,,724.0,,No,Yes,No,Complete Remission,,Yes,149.0,,"Oral Cavity, Cervical Lymph Node",,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,149.0,1.0,728.0,0.0,-4.0
C3N-02695,HNSCC,C3N-02695-T,,,,0.0,,CPT0244940004,CPT0244940007,,CPT0244940010,,CPT0245000002,45,Male,Unknown,Unknown,European,Poland,No,,Left,Multifocal,3.7,"Squamous cell carcinoma, non-keratinizing",G1 Well differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,17,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,168.0,73.0,25.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,16.8,No or minimal exposure to secondhand smoke,,,"Bespres 160 |Cardilopin 2,5",Self Report|Self Report,No,604.0,632.0,Main malignancy,,636.0,Yes,No,No,Complete Remission,Not Applicable,No,,,,,,,,,,,,,,,0.0,632.0,1.0,4.0
C3L-00995,HNSCC,C3L-00995-T,C3L-00995-N,,,0.0,CPT0169920003,CPT0169890003,CPT0169890009,CPT0169920009,CPT0169890006,CPT0169920006,CPT0167190002,56,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,4.0,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,6,IHC staining not done,1,cM0,Staging Incomplete,Not evaluated,R0: No residual tumor,,170.0,60.0,20.76,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current reformed smoker within past 15 years,31.0,Exposure to secondhand smoke history not available,,,,,No,-10.0,-9.0,Other reasons,,1.0,No,No,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,0.0,1.0,10.0
C3L-02651,HNSCC,C3L-02651-T,C3L-02651-N,,,0.0,CPT0242000004,CPT0241980004,CPT0241980010,CPT0242000010,CPT0241980007,CPT0242000007,CPT0242110002,81,Male,Unknown,Unknown,European,Bulgaria,No,,Unknown,Unifocal,2.5,Keratinizing Squamous Cell Carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2 ,pNX,-1,IHC staining not done,0,cMX,pMX,,RX: Presence of residual tumor cannot be assessed,,183.0,70.0,20.9,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,78.0,Exposure to secondhand smoke history not available,,,,,No,291.0,,,301.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,291.0,0.0,10.0
C3L-02617,HNSCC,C3L-02617-T,C3L-02617-N,,,0.0,CPT0229190003,CPT0229190003,"['CPT0229190013', 'CPT0229210013']",CPT0229230009,"['CPT0229190006', 'CPT0229210006']",CPT0229230006,CPT0229330002,64,Male,Unknown,Unknown,European,Bulgaria,No,,Unknown,Unifocal,6.0,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pNX,-1,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0: No residual tumor,,178.0,73.0,23.04,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,66.0,Yes,,,BISOPROLOL|Perindopril arginine,Self Report|Self Report,No,967.0,,,981.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,967.0,0.0,14.0
C3N-02716,HNSCC,C3N-02716-T,,,,0.0,,CPT0177390003,CPT0177390009,,CPT0177390006,,CPT0177460002,76,Male,Unknown,Unknown,European,Ukraine,No,,Unknown,Unifocal,1.2,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No,R0: No residual tumor,,185.0,120.0,35.06,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,,,No,258.0,,,267.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,258.0,0.0,9.0
C3N-00825,HNSCC,C3N-00825-T,,,,0.0,,CPT0094280004,CPT0094280007,,CPT0094280010,,CPT0094340002,53,Male,Unknown,Unknown,European,Poland,No,,Left,Multifocal,2.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,26,0,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,175.0,77.0,25.0,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,25.3,Exposure to secondhand smoke history not available,,,,,No,1730.0,,,1758.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1730.0,0.0,28.0
C3N-04280,HNSCC,C3N-04280-T,,,,0.0,,CPT0245600003,CPT0245600009,,CPT0245600006,,CPT0245620002,65,Male,Unknown,Unknown,European,Poland,No,,Midline,Unifocal,4.0,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,15,IHC staining not done,0,cM0,cMx,,R0: No residual tumor,,176.0,102.0,32.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,10.0,No or minimal exposure to secondhand smoke,,,Siofor|Co-Prestarium,Self Report|Self Report,No,1058.0,,,1087.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1058.0,0.0,29.0
C3N-03042,HNSCC,C3N-03042-T,C3N-03042-N,,,0.0,CPT0235470002,CPT0235460003,CPT0235460009,,CPT0235460006,,CPT0235610002,67,Female,Unknown,Hispanic or Latino,Ad_Mixed_American,United States,No,,Right,Unifocal,5.2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),T4a,N3b,41,IHC staining not done,4,M0,Not identified,Not identified,RX: Presence of residual tumor cannot be assessed,,,,,,,,,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3N-04279,HNSCC,C3N-04279-T,C3N-04279-N,,,0.0,C3N-04279-05,CPT0245500003,CPT0245500009,,CPT0245500006,,CPT0245540002,65,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,3.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,6,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,182.0,76.0,22.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,33.8,No or minimal exposure to secondhand smoke,,,,,No,1139.0,,,1139.0,,Yes,No,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,1139.0,0.0,0.0
C3N-02279,HNSCC,C3N-02279-T,C3N-02279-N,,,0.0,CPT0163800003,CPT0163790003,CPT0163790009,CPT0163800009,CPT0163790006,CPT0163800006,CPT0163830002,59,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,4,IHC staining not done,0,cM0,pM0,,RX: Presence of residual tumor cannot be assessed,,167.0,48.0,17.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,39.0,Yes,,,,,No,414.0,,,423.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,414.0,0.0,9.0
C3N-02714,HNSCC,C3N-02714-T,C3N-02714-N,,,0.0,CPT0177220003,CPT0177200003,CPT0177200009,CPT0177220009,CPT0177200006,CPT0177220006,CPT0177310002,23,Male,Unknown,Unknown,European,Ukraine,No,,Right,Unifocal,2.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No,R0: No residual tumor,,182.0,89.0,26.87,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,907.0,,,720.0,,Yes,Yes,No,Complete Remission,,Yes,301.0,,"Locoregional Recurrence, Cervical Lymph Node",,Convincing Image (i.e. CT/PET/MRI),Yes,,,No,No,No,313.0,,301.0,1.0,907.0,0.0,-187.0
C3N-01755,HNSCC,C3N-01755-T,,,,0.0,,CPT0163090003,CPT0163090009,,CPT0163090006,,CPT0163150002,68,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,5.0,"Squamous cell carcinoma, keratinizing",G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,PN1,3,IHC staining not done,1,cM0,pM0,,RX: Presence of residual tumor cannot be assessed,,176.0,77.0,24.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, years unknown",,Yes,,,,,No,1701.0,,,1709.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1701.0,0.0,8.0
C3N-00857,HNSCC,C3N-00857-T,C3N-00857-N,,,0.0,C3N-00857-05,CPT0094350004,CPT0094350007,,CPT0094350010,,CPT0094410002,64,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,3.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4a,pN1,14,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,172.0,64.0,21.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,636.0,636.0,Unknown,,636.0,Yes,No,No,Complete Remission,Patient Deceased,No,,,,,,,,,,,,,,,0.0,636.0,1.0,0.0
C3N-03456,HNSCC,C3N-03456-T,,,,0.0,,CPT0246590003,CPT0246590009,,CPT0246590006,,CPT0246610002,64,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,7.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN0,22,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,186.0,88.0,25.0,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,41.0,Yes,,,Clexane|Diuver,Medical Record|Medical Record,No,1426.0,,,1429.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1426.0,0.0,3.0
C3N-03841,HNSCC,C3N-03841-T,C3N-03841-N,,,0.0,CPT0236870003,CPT0236850004,CPT0236850010,CPT0236870006,CPT0236850007,CPT0236870009,CPT0236910002,59,Male,Unknown,Unknown,East_Asian,China,No,,Midline,Unifocal,3.0,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,26,IHC staining not done,2,cM0,pM0,,R0: No residual tumor,,168.0,56.0,19.84,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,34.0,Exposure to secondhand smoke history not available,,,,,No,331.0,753.0,Unknown,,765.0,No,No,No,Complete Remission,,Yes,105.0,,"New Primary Tumor, Specify",Liver,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,105.0,1.0,753.0,1.0,12.0
C3N-01757,HNSCC,C3N-01757-T,C3N-01757-N,,,0.0,CPT0163250003,CPT0163240003,CPT0163240009,,CPT0163240006,,CPT0163310002,64,Male,Unknown,Unknown,European,Poland,No,,Midline,Unifocal,2.7,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pNx,2,IHC staining not done,0,cM0,pMx,no distant metastasis,R0: No residual tumor,,176.0,72.0,23.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,"Vivace 2,5 1 x 1/2",Self Report,No,1337.0,,,1344.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1337.0,0.0,7.0
C3N-03013,HNSCC,C3N-03013-T,C3N-03013-N,,,0.0,CPT0245140003,CPT0245130003,CPT0245130006,,CPT0245130009,,CPT0245170002,59,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,3.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT2,pNx,0,IHC staining not done,0,cMx,pMx,,R0: No residual tumor,,175.0,90.0,29.0,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,ca planoepitheliale (tonsil),"Radiation,Chemotherapy",Prenessa|Bisocard 5|Atrox 20|Acard|cavinton,Self Report|Self Report|Self Report|Self Report|Self Report,No,1389.0,,,1393.0,,Yes,No,No,Complete Remission,Unknown,No,,,,,,,,,,,,,,,0.0,1389.0,0.0,4.0
C3N-02700,HNSCC,C3N-02700-T,,,,0.0,,CPT0177010003,CPT0177010009,,CPT0177010006,,CPT0177130002,80,Female,Unknown,Unknown,European,Ukraine,No,,Unknown,Unifocal,3.5,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No,R0: No residual tumor,,165.0,68.0,24.98,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,5.0,,,8.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,5.0,0.0,3.0
C3N-03878,HNSCC,C3N-03878-T,C3N-03878-N,,,0.0,CPT0237640003,CPT0237620004,CPT0237620007,CPT0237640009,CPT0237620010,CPT0237640006,CPT0237680002,52,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,2.0,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,77,IHC staining not done,3,cM0,pM0,,R0: No residual tumor,,170.0,55.0,19.03,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,10.0,Exposure to secondhand smoke history not available,,,,,No,650.0,,,649.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,650.0,0.0,-1.0
C3N-01340,HNSCC,C3N-01340-T,C3N-01340-N,,,0.0,CPT0094580003,CPT0094560004,CPT0094560010,CPT0094580006,CPT0094560007,,CPT0094620002,72,Male,Unknown,Unknown,European,Poland,No,,Midline,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4a,pN0,4,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,R1: Microscopic residual tumor,,175.0,77.0,25.0,Yes,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,ca plano laryngeal,Surgery,Cardilopin 10mg 1X,Self Report,No,1264.0,1388.0,Main malignancy,,1399.0,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,1388.0,1.0,11.0
C3N-01754,HNSCC,C3N-01754-T,C3N-01754-N,,,0.0,CPT0163020003,CPT0162990004,CPT0162990010,CPT0163020009,CPT0162990007,CPT0163020006,CPT0163080002,64,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,4.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,5,IHC staining not done,0,cM0,pMx,,RX: Presence of residual tumor cannot be assessed,,185.0,77.0,22.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,41.0,Yes,,,,,No,1535.0,,,1549.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1535.0,0.0,14.0
C3N-02727,HNSCC,C3N-02727-T,,,,0.0,,CPT0177710003,"['CPT0177700009', 'CPT0177710009']",CPT0177730009,"['CPT0177700006', 'CPT0177710006']",CPT0177730006,CPT0177820002,49,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,3.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No,RX: Presence of residual tumor cannot be assessed,,168.0,73.0,25.86,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,,,No,693.0,,,673.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,693.0,0.0,-20.0
C3N-02333,HNSCC,C3N-02333-T,,,,0.0,,CPT0176770003,CPT0176770009,CPT0176790009,CPT0176770006,CPT0176790006,CPT0176950002,61,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No,R0: No residual tumor,,168.0,59.0,20.9,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,,Exposure to secondhand smoke history not available,,,,,No,735.0,,,735.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,735.0,0.0,0.0
C3N-04276,HNSCC,C3N-04276-T,C3N-04276-N,,,0.0,C3N-04276-06,CPT0245350003,CPT0245350009,,CPT0245350012,,CPT0245390002,68,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,5.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Cannot be assessed,Eighth Edition (2017),pT4a,pN0,23,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,175.0,90.0,29.0,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,36.8,No or minimal exposure to secondhand smoke,laryngeal cancer (ca planoepitheliale),Surgery,"Bisocard 2,5",Self Report,No,1165.0,,,1165.0,,Yes,Yes,No,Complete Remission,Complete Remission,Yes,1106.0,,"New Primary Tumor, Specify",Lung tumor,"Biopsy with Histologic Confirmation, Convincing Image (i.e. CT/PET/MRI)",Unknown,,,Unknown,Unknown,Unknown,,,1106.0,1.0,1165.0,0.0,0.0
C3N-03928,HNSCC,C3N-03928-T,C3N-03928-N,,,0.0,CPT0223460003,CPT0223450003,CPT0223450009,CPT0223460009,CPT0223450006,CPT0223460006,CPT0223550002,60,Female,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,3.0,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,13,IHC staining not done,1,cM0,Staging Incomplete,no,R0: No residual tumor,,163.0,103.0,38.77,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,702.0,,,694.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,702.0,0.0,-8.0
C3N-03888,HNSCC,C3N-03888-T,C3N-03888-N,,,0.0,CPT0222200003,CPT0222180003,CPT0222180009,CPT0222200009,CPT0222180006,CPT0222200006,CPT0222290002,58,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,2.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,no,R0: No residual tumor,,176.0,116.0,37.45,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,40.0,Exposure to secondhand smoke history not available,,,,,No,675.0,,,675.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,675.0,0.0,0.0
C3N-03433,HNSCC,C3N-03433-T,,,,0.0,,CPT0246540003,CPT0246540009,,CPT0246540006,,CPT0246580002,76,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,2.4,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Not identified,Cannot be assessed,Eighth Edition (2017),pT2,pN0,7,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,168.0,82.0,29.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,40.5,No or minimal exposure to secondhand smoke,,,Bisocard 5|Polpril 5 mg|Siofor 1000|Insulin|Clexane,Self Report|Self Report|Self Report|Medical Record|Medical Record,No,960.0,960.0,Unknown,,964.0,No,No,No,Persistent Disease,Patient Deceased,No,,,,,,,,,,,,,,,0.0,960.0,1.0,4.0
C3N-03783,HNSCC,C3N-03783-T,,,,0.0,,CPT0245730003,CPT0245730009,,CPT0245730006,,CPT0245770002,67,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,2.0,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2b,7,IHC staining not done,2,cM0,pMx,,R0: No residual tumor,,176.0,100.0,32.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,50.0,Yes,,,Axtil|Amlopin 5,Self Report|Self Report,No,952.0,952.0,Main malignancy,,954.0,Yes,Yes,No,Complete Remission,Persistent Disease,Yes,721.0,,Oral Cavity,,Biopsy with Histologic Confirmation,No,,,No,No,No,,,721.0,1.0,952.0,1.0,2.0
C3N-03457,HNSCC,C3N-03457-T,,,,0.0,,CPT0246620003,CPT0246620009,,CPT0246620006,,CPT0246660002,71,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,2.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,17,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,165.0,70.0,25.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,36.8,No or minimal exposure to secondhand smoke,,,"Con Cor Cor 1,25",Self Report,No,1395.0,,,1400.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1395.0,0.0,5.0
C3L-04849,HNSCC,C3L-04849-T,,,,0.0,,CPT0248520003,CPT0248520009,,CPT0248520006,,CPT0248540002,63,Male,Unknown,Unknown,European,Other: TSS did not collect,No,,Left,Unifocal,4.7,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN3,45,IHC staining not done,8,cM0,No pathologic evidence of distant metastasis,Not applicable,R1: Microscopic residual tumor,,174.0,95.0,31.63,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,31.5,Exposure to secondhand smoke history not available,,,Ibuprofen,Medical Record,No,356.0,,,315.0,,Yes,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,356.0,0.0,-41.0
C3L-01138,HNSCC,C3L-01138-T,,,,0.0,,CPT0199700003,CPT0199700009,CPT0199710009,CPT0199700006,CPT0199710006,CPT0200380002,62,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,6.0,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN1,12,IHC staining not done,1,cM0,Staging Incomplete,Not documented,R0: No residual tumor,,182.0,70.0,21.13,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,54.0,Exposure to secondhand smoke history not available,,,,,No,367.0,,,361.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,367.0,0.0,-6.0
C3N-03488,HNSCC,C3N-03488-T,C3N-03488-N,,,0.0,CPT0194260003,CPT0194250003,CPT0194250013,CPT0194260006,CPT0194250009,CPT0194260009,CPT0194350002,64,Male,Unknown,Unknown,European,Ukraine,No,,Right,Unifocal,5.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No,R0: No residual tumor,,171.0,51.0,17.44,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,45.0,Exposure to secondhand smoke history not available,,,,,No,706.0,,,673.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,706.0,0.0,-33.0
C3N-03876,HNSCC,C3N-03876-T,C3N-03876-N,,,0.0,CPT0237500003,CPT0237480004,CPT0237480010,CPT0237500006,CPT0237480007,,CPT0237540002,65,Male,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,2.5,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN2b,27,IHC staining not done,5,cM0,pM0,no,R0: No residual tumor,,172.0,57.0,19.27,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,"Current reformed smoker, more than 15 years",22.0,Exposure to secondhand smoke history not available,,,,,No,422.0,465.0,Unknown,,470.0,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,465.0,1.0,5.0
C3N-03782,HNSCC,C3N-03782-T,,,,0.0,,CPT0245630003,CPT0245630009,,CPT0245630006,,CPT0245670002,50,Female,Unknown,Unknown,European,Poland,No,,Right,Unifocal,3.0,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pTIVA,pN0,12,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,165.0,61.0,22.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,30.0,Yes,,,"Bisocard 2,5",Self Report,No,1088.0,,,1092.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1088.0,0.0,4.0
C3N-02694,HNSCC,C3N-02694-T,,,,0.0,,CPT0244890004,CPT0244890007,,CPT0244890010,,CPT0244930002,57,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,2.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT2,pN2b,13,IHC staining not done,2,cM0,pMx,,R0: No residual tumor,,180.0,93.0,28.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, years unknown",,No or minimal exposure to secondhand smoke,,,,,No,617.0,617.0,Main malignancy,,622.0,Yes,Yes,No,Complete Remission,Patient Deceased,No,,,,,,,,,,,,,,,0.0,617.0,1.0,5.0
C3N-04275,HNSCC,C3N-04275-T,C3N-04275-N,,,0.0,C3N-04275-05,CPT0245300003,CPT0245300009,,CPT0245300006,,CPT0245340002,61,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,2.0,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,7,IHC staining not done,0,cM0,pMx,,R0: No residual tumor,,175.0,73.0,23.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,41.0,Yes,,,,,No,1135.0,,,1137.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1135.0,0.0,2.0
C3N-00204,HNSCC,C3N-00204-T,C3N-00204-N,,,0.0,CPT0084650004,CPT0084630009,CPT0084630015,CPT0084650007,CPT0084630012,,CPT0085320002,63,Female,Unknown,Unknown,European,Bulgaria,No,,Left,Unifocal,3.2,Adenosquamous carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,1,IHC staining not done,1,cM0,Staging Incomplete,Not specified,R0: No residual tumor,,153.0,45.0,19.22,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Bisor|Amlovasik|Skorpyl plus,Self-reported|Medical Record|Medical Record,No,145.0,175.0,Main malignancy,,175.0,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,175.0,1.0,0.0
C3L-00994,HNSCC,C3L-00994-T,C3L-00994-N,,,0.0,CPT0169740004,CPT0169730003,CPT0169730009,CPT0169750009,CPT0169730006,CPT0169750006,CPT0167170002,50,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,3.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,5,IHC staining not done,0,cM0,Staging Incomplete,Not evaluated,R0: No residual tumor,,182.0,72.0,21.74,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current reformed smoker within past 15 years,10.2,Exposure to secondhand smoke history not available,,,,,No,133.0,202.0,Main malignancy,,176.0,Yes,No,No,Complete Remission,,Yes,133.0,,"Oral Cavity, Locoregional Recurrence",,Biopsy with Histologic Confirmation,No,,,No,No,No,,,133.0,1.0,202.0,1.0,-26.0
C3L-00977,HNSCC,C3L-00977-T,,,,0.0,,CPT0169640003,CPT0169640009,CPT0169650008,CPT0169640006,CPT0169650006,CPT0167150002,56,Male,Unknown,Unknown,European,Russia,No,,Midline,Unifocal,1.2,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1,pN1,11,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,No documented,R0: No residual tumor,,182.0,110.0,33.21,No,Lifelong non-drinker,"Current reformed smoker, years unknown",,Yes,,,Metformin|Isosorbide dinitrate|Famotidin|Atorvastatin,Medical Record|Self Report|Medical Record|Self Report,No,1537.0,1537.0,Main malignancy,,1504.0,No,No,No,Complete Remission,Patient Deceased,Yes,853.0,,Distant Metastasis (specify),Lung,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,853.0,1.0,1537.0,1.0,-33.0
C3N-04152,HNSCC,C3N-04152-T,,,,0.0,,CPT0223970003,CPT0223970009,CPT0224000009,CPT0223970006,CPT0224000006,CPT0224090002,54,Male,Unknown,Unknown,European,Other: Armenia,No,,Left,Unifocal,4.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN2b,18,IHC staining not done,3,cM0,Staging Incomplete,no,R0: No residual tumor,,177.0,72.0,22.98,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,671.0,,,639.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,671.0,0.0,-32.0
C3N-03889,HNSCC,C3N-03889-T,,,,0.0,,CPT0222360003,CPT0222360009,CPT0222380009,CPT0222360006,CPT0222380006,CPT0222470002,53,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN0,-1,IHC staining not done,0,cM0,Staging Incomplete,no,R0: No residual tumor,,182.0,108.0,32.6,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,30.0,Exposure to secondhand smoke history not available,,,,,No,694.0,,,681.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,694.0,0.0,-13.0
C3L-03378,HNSCC,C3L-03378-T,C3L-03378-N,,,0.0,CPT0199890003,CPT0199880003,CPT0199880009,CPT0199890009,CPT0199880006,CPT0199890006,CPT0200430002,54,Male,Unknown,Unknown,European,Russia,No,,Midline,Unifocal,1.8,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4a,pN2c,16,IHC staining not done,6,cM0,Staging Incomplete,Not documented,R0: No residual tumor,,174.0,67.0,22.13,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,34.0,Yes,,,Metformin|Gliclazide|Bisoprolol|Ketonal,Medical Record|Medical Record|Medical Record|Medical Record,No,1175.0,,,1175.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1175.0,0.0,0.0
C3N-03028,HNSCC,C3N-03028-T,C3N-03028-N,,,0.0,CPT0226450003,CPT0226440003,CPT0226440009,CPT0226450009,CPT0226440006,CPT0226450006,CPT0226480002,59,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,3.0,"Squamous cell carcinoma, keratinizing",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2b,21,IHC staining not done,7,cM0,pMx,,R0: No residual tumor,,180.0,70.0,21.0,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,39.0,No or minimal exposure to secondhand smoke,,,Acard|Atoris|Bisocard|Valzek|Amlopin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1010.0,,,1015.0,,Yes,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1010.0,0.0,5.0
C3N-03008,HNSCC,C3N-03008-T,C3N-03008-N,,,0.0,CPT0245020003,CPT0245010003,CPT0245010006,,CPT0245010009,,CPT0245050002,65,Female,Unknown,Unknown,European,Poland,No,,Midline,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4a,pN2c,38,IHC staining not done,7,cM0,pMx,,R0: No residual tumor,,168.0,61.0,21.0,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,22.5,No or minimal exposure to secondhand smoke,,,Bisocard,Self Report,No,146.0,158.0,Main malignancy,,167.0,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,158.0,1.0,9.0
C3N-01944,HNSCC,C3N-01944-T,C3N-01944-N,,,0.0,CPT0163490003,CPT0163480003,CPT0163480009,CPT0163490009,CPT0163480006,CPT0163490006,CPT0163520002,65,Male,Unknown,Unknown,European,Poland,No,,Midline,Unifocal,3.5,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Stage IV,Present,Cannot be assessed,Eighth Edition (2017),pT4a,pN1,6,IHC staining not done,1,cM0,pM0,,RX: Presence of residual tumor cannot be assessed,,167.0,73.0,26.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,45.0,No or minimal exposure to secondhand smoke,,,indapamidum|atorvastatin,Self Report|Self Report,No,610.0,,,618.0,,Yes,Yes,No,Complete Remission,,Yes,558.0,,Oral Cavity,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,558.0,1.0,610.0,0.0,8.0
C3N-00822,HNSCC,C3N-00822-T,,,,0.0,,CPT0087820003,CPT0087820006,,CPT0087820009,,CPT0087880002,53,Female,Unknown,Unknown,European,Poland,No,,Left,Unifocal,2.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,12,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,186.0,90.0,26.0,Unknown,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,978.0,978.0,Unknown,,983.0,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,978.0,1.0,5.0
C3N-00519,HNSCC,C3N-00519-T,C3N-00519-N,,,0.0,CPT0013460003,CPT0013430003,['CPT0013430006'],CPT0013460006,CPT0013430009,CPT0013460009,CPT0013520002,67,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,3.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,23,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,173.0,70.0,23.39,No,"Consumed alcohol in the past, but currently a non-drinker",Current reformed smoker within past 15 years,40.0,Exposure to secondhand smoke history not available,,,,,Yes,258.0,258.0,Unknown,,261.0,Yes,No,No,Persistent Disease,Patient Deceased,No,,,,,,,,,,,,,,,0.0,258.0,1.0,3.0
C3N-00829,HNSCC,C3N-00829-T,C3N-00829-N,,,0.0,CPT0013250003,CPT0013210004,CPT0013210007,,CPT0013210010,,CPT0013310002,53,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,2.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage IV,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2,pN2b,4,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,174.0,75.0,24.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,Yes,952.0,958.0,Main malignancy,,965.0,Yes,Yes,No,Complete Remission,,Yes,442.0,,Locoregional Recurrence,,Convincing Image (i.e. CT/PET/MRI),No,,,Yes,No,No,,,442.0,1.0,958.0,1.0,7.0
C3N-00295,HNSCC,C3N-00295-T,C3N-00295-N,,,0.0,C3N-00295-05,CPT0008520008,['CPT0008520013'],,CPT0008520010,,CPT0008550002,53,Female,Unknown,Unknown,European,Poland,No,,Right,Unifocal,2.2,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pNX,0,0,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,R0: No residual tumor,,155.0,56.0,23.31,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,Yes,1679.0,,,1708.0,,Yes,No,No,Complete Remission,Patient Deceased,No,,,,,,,,,,,,,,,0.0,1679.0,0.0,29.0
C3N-00828,HNSCC,C3N-00828-T,,,,0.0,,CPT0013130003,['CPT0013130006'],,CPT0013130009,,CPT0013200002,67,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,4.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pNX,0,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,R1: Microscopic residual tumor,,169.0,80.0,28.01,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,50.0,Exposure to secondhand smoke history not available,,,"spironol, nebilet, furosemid, amlodypina, roswera, nasen, vitacon",Self Report,Yes,948.0,948.0,Unknown,,949.0,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,948.0,1.0,1.0
C3N-00297,HNSCC,C3N-00297-T,,,,0.0,,CPT0011130005,['CPT0011130008'],,CPT0011130011,,CPT0011220002,69,Male,Unknown,Unknown,European,Poland,No,,Unknown,Unifocal,3.5,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,2,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,172.0,50.0,16.9,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,Yes,1734.0,,,1744.0,,Unknown,Unknown,Unknown,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1734.0,0.0,10.0
C3N-00306,HNSCC,C3N-00306-T,C3N-00306-N,,,0.0,CPT0011320003,CPT0011290003,['CPT0011290005'],CPT0011320006,CPT0011290008,CPT0011320009,CPT0011380006,50,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,3.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,16,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,176.0,91.0,29.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,Yes,645.0,,,658.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,645.0,0.0,13.0
C3N-00846,HNSCC,C3N-00846-T,,,,0.0,,CPT0024810003,['CPT0024810006'],,CPT0024810009,,CPT0024890002,67,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,2.0,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No.,R0:No residual tumor,,177.0,79.0,25.22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,15.0,Exposure to secondhand smoke history not available,,,,,Yes,644.0,,,629.0,,Yes,No,No,Complete Remission,,Yes,615.0,,Cervical Lymph Node,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,615.0,1.0,644.0,0.0,-15.0
C3N-00498,HNSCC,C3N-00498-T,C3N-00498-N,,,0.0,CPT0013030003,CPT0013000004,['CPT0013000007'],CPT0013030010,CPT0013000010,,CPT0013090002,63,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,3.0,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,12,IHC staining not done,4,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,176.0,84.0,27.12,Unknown,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,polocard,Self Report,Yes,1704.0,,,1715.0,,No,No,No,Persistent Disease,Complete Remission,No,,,,,,,,,,,,,,,0.0,1704.0,0.0,11.0
C3N-00307,HNSCC,C3N-00307-T,C3N-00307-N,,,0.0,CPT0008960003,CPT0008930003,['CPT0008930009'],CPT0008960005,CPT0008930006,CPT0008960008,CPT0008970002,70,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,3.0,"Squamous cell carcinoma, conventional",G3 Poorly differentiated,Stage IV,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4a,pNX,0,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,173.0,100.0,33.41,Yes,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,squamous cell carcinoma,Surgery,"Bisocard 5|Amlopin 10|Clexane 0,6",Self Report|Medical Record|Self-reported and Medical Record,Yes,270.0,270.0,Unknown,,282.0,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,270.0,1.0,12.0
C3N-00299,HNSCC,C3N-00299-T,,,,0.0,,CPT0008630003,['CPT0008630009'],,CPT0008630006,,CPT0008670002,54,Male,Unknown,Unknown,European,Poland,No,,Unknown,Unifocal,3.1,"Squamous cell carcinoma, conventional",G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,8,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no distant metastasis,RX: Presence of residual tumor cannot be assessed,,176.0,64.0,20.0,Unknown,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,Yes,-20.0,231.0,Unknown,,251.0,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,231.0,1.0,20.0
C3L-05257,HNSCC,,C3L-05257-N,1.0,"No Tumor sample, no proteomics data ",0.0,CPT0281470002,,,,,,,56,Female,Unknown,Unknown,,Other: Montenegro,No,,Right,Unifocal,4.5,"Squamous cell carcinoma, conventional",G1 Well differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,14,IHC staining not done,0,staging incomplete,staging incomplete,,RX: Presence of residual tumor cannot be assessed,,178.0,83.0,26.2,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Yes,,,,,No,1001.0,,,1017.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1001.0,0.0,16.0
C3L-02665,LSCC,C3L-02665-T,C3L-02665-N,,,0.0,CPT0192590004,CPT0192540004,CPT0192540010,CPT0192590007,CPT0192540007,CPT0192590010,CPT0192700002,51,Male,Unknown,Unknown,European,Bulgaria,No,,Right,Multifocal,6.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Cannot be assessed,Seventh Edition (2010),pT3,pNX,-1,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,178.0,80.0,25.25,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,29.0,Exposure to secondhand smoke history not available,,,,,No,3.0,,,3.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,3.0,0.0,0.0
C3L-01663,LSCC,C3L-01663-T,C3L-01663-N,,,0.0,CPT0091620003,CPT0091610003,CPT0091610006,CPT0091620009,CPT0091610009,CPT0091620006,CPT0093630002,73,Female,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,1.6,Squamous cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN2,18,IHC staining not done,3,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:No residual tumor,"p40: Stongly Positive, TTF-1: Negative PD-L1: Negative, TPS: 0%",165.0,57.0,20.94,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,alendronate (FOSAMAX) |Ascorbic Acid (VITAMIN C)|aspirin| Calcium|clopidogrel (PLAVIX)| Omega-3 Fatty Acids (FISH OIL),Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1723.0,1729.0,Main malignancy,,1729.0,Yes,Yes,No,Complete Remission,Patient Deceased,Yes,1204.0,Distant Metastasis,Liver,,Biopsy with Histologic Confirmation,,No,,Yes,Yes,Yes,,,1204.0,1.0,1729.0,1.0,0.0
C3N-02575,LSCC,C3N-02575-T,C3N-02575-N,,,0.0,CPT0147700003,CPT0147680004,CPT0147680007,CPT0147700009,CPT0147680010,CPT0147700006,CPT0147710002,69,Male,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,2.5,Squamous cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,12,IHC staining not done,0,cM0,Staging Incomplete,no,R0:No residual tumor,"HER2（-）, TTF1（-）, EGFR（+），CK7（-），Ki-67（+,80％），β-Cat（membranous +）, P63（+）, ERCC1（-）, RRM1（-）, Syn（-），P40(+),  Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（-），NapsinA（-），CK20（-），CK5/6（+）",175.0,72.0,23.51,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,100.0,Exposure to secondhand smoke history not available,,,,,No,491.0,540.0,Unknown,,547.0,No,No,No,Not Applicable,,Yes,359.0,Distant Metastasis,Other,kidney,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,No,No,,,359.0,1.0,540.0,1.0,7.0
C3L-02546,LSCC,C3L-02546-T,C3L-02546-N,,,0.0,CPT0112660003,CPT0112650003,CPT0112650006,CPT0112660009,CPT0112650009,CPT0112660006,CPT0115180002,74,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,4.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,2,IHC staining not done,0,cM1,No pathologic evidence of distant metastasis,Possible tiny bone metastases to the anterior fourth rib,RX:Presence of residual tumor cannot be assessed,,182.0,82.0,24.7,Yes,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",40.0,Exposure to secondhand smoke history not available,Squamous Cell Laryngeal Cancer,"Radiation,Surgery,Chemotherapy",Albuterol|Aspirin|Atorvastatin|Nystatin|Omeprazole,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1432.0,,,1432.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1432.0,0.0,0.0
C3L-00965,LSCC,C3L-00965-T,,,,0.0,,CPT0101130003,CPT0101130006,,CPT0101130009,,CPT0100930002,63,Male,Unknown,Unknown,European,Russia,No,,Right,Unifocal,4.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,18,IHC staining not done,2,cM0,Staging Incomplete,Not documented,R0:No residual tumor,,161.0,61.0,23.53,No,Lifelong non-drinker,Current reformed smoker within past 15 years,42.0,Yes,,,Amlodipine |Famotidine,Medical Record|Medical Record,No,1857.0,,,1826.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1857.0,0.0,-31.0
C3L-02963,LSCC,C3L-02963-T,C3L-02963-N,,,0.0,CPT0197100003,CPT0197090003,CPT0197090006,CPT0197100006,CPT0197090009,CPT0197100009,CPT0197830002,71,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,3.2,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2a,pN0,16,IHC staining not done,0,unknown,No pathologic evidence of distant metastasis,,R0:No residual tumor,,178.0,66.0,20.95,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,56.0,Exposure to secondhand smoke history not available,,,"Albuterol inhaler|Acetaminophen|Norvasc|Lipitor|Lasix|Lutein|colace|K-Dur,Klor-con|Protonix|pericolace|Flomax|Ultram|diovan",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1435.0,,,1435.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1435.0,0.0,0.0
C3N-04162,LSCC,C3N-04162-T,C3N-04162-N,,,0.0,CPT0222740003,CPT0222730003,CPT0222730009,CPT0222740006,CPT0222730006,,CPT0222830002,46,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,6.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,-1,IHC staining not done,0,cM0,Staging Incomplete,no,R0:No residual tumor,,172.0,67.0,22.65,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,349.0,,,358.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,349.0,0.0,9.0
C3L-02646,LSCC,C3L-02646-T,C3L-02646-N,,,0.0,CPT0202580004,CPT0202530004,CPT0202530010,,CPT0202530007,,CPT0202660002,74,Male,Unknown,Unknown,European,Bulgaria,No,,Left,Unifocal,5.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage III,Present,Cannot be assessed,Seventh Edition (2010),pT3,pNX,-1,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,178.0,95.0,29.98,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,5.0,Exposure to secondhand smoke history not available,,,,,No,1027.0,1027.0,Main malignancy,,1034.0,Yes,Yes,No,Persistent Disease,Patient Deceased,No,,,,,,,,,,,,,,,0.0,1027.0,1.0,7.0
C3N-02285,LSCC,C3N-02285-T,C3N-02285-N,,,0.0,CPT0126760003,CPT0126740003,CPT0126740009,CPT0126760009,CPT0126740006,CPT0126760006,CPT0126800002,72,Female,Unknown,Unknown,European,Poland,No,,Left,Unifocal,5.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),3,0,37,IHC staining not done,0,0,0,,R0:No residual tumor,,157.0,65.0,26.37,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,35.3,Exposure to secondhand smoke history not available,,,,,No,1527.0,,,1527.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1527.0,0.0,0.0
C3N-03875,LSCC,C3N-03875-T,C3N-03875-N,,,0.0,CPT0237430003,CPT0237410004,CPT0237410010,CPT0237430006,CPT0237410007,CPT0237430009,CPT0237470002,68,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,4.8,Squamous cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN0,19,IHC staining not done,0,cM0,pM0,no,R0:No residual tumor,,158.0,61.0,24.44,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current reformed smoker within past 15 years,,Exposure to secondhand smoke history not available,,,digoxin |tongxinluo,Medical Record|Medical Record,No,1017.0,,,1017.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1017.0,0.0,0.0
C3N-03424,LSCC,C3N-03424-T,C3N-03424-N,,,0.0,CPT0245790003,CPT0245780003,CPT0245780009,CPT0245790009,CPT0245780006,CPT0245790006,CPT0245820002,74,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,1.2,Non-keratinizing squamous cell carcinoma,G3 Poorly differentiated,Stage I,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,23,0,0,cM0,No pathologic evidence of distant metastasis,No,R0:No residual tumor,,169.0,72.0,25.21,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,,,No,1330.0,,,1339.0,,No,No,No,Complete Remission,Unknown,No,,,,,,,,,,,,,,,0.0,1330.0,0.0,9.0
C3N-01017,LSCC,C3N-01017-T,C3N-01017-N,,,0.0,CPT0069900003,CPT0069890003,['CPT0069890009'],CPT0069900006,CPT0069890006,CPT0069900009,CPT0069980002,56,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Nearby of hilar,Left,Unifocal,3.5,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,8,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,170.0,58.0,20.07,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,5.0,No or minimal exposure to secondhand smoke,,,,,No,459.0,,,453.0,,No,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,459.0,0.0,-6.0
C3L-00081,LSCC,C3L-00081-T,C3L-00081-N,,,0.0,CPT0001030003,CPT0001020003,CPT0001020164,CPT0001030009,CPT0001020005,CPT0001030006,CPT0000010163,61,Female,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,5.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,22,IHC staining not done,3,cM0,Staging Incomplete,Not applicable,R1:Microscopic residual tumor,,157.0,80.0,32.29,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,xanax|bupropion|ProAir HFA 90|vitamin D3 2000|ibuprofen|Probiotic Formula oral capsule,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,472.0,473.0,Main malignancy,,473.0,No,Yes,No,Unknown,,Yes,188.0,Distant Metastasis,Brain,,Convincing Image (i.e. CT/PET/MRI),209,Yes,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,209.0,209.0,188.0,1.0,473.0,1.0,0.0
C3L-02649,LSCC,C3L-02649-T,C3L-02649-N,,,0.0,CPT0204820003,CPT0204800003,CPT0204800009,CPT0204820009,CPT0204800006,CPT0204820006,CPT0204930002,62,Male,Unknown,Unknown,European,Bulgaria,No,,Left,Unifocal,8.8,Squamous cell carcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3A,pN2,16,IHC staining not done,2,cMx,,,RX:Presence of residual tumor cannot be assessed,,200.0,93.0,23.25,No,Lifelong non-drinker,Current reformed smoker within past 15 years,,Yes,,,Doxazosin,Self-reported and Medical Record,No,1019.0,1072.0,Main malignancy,,1072.0,No,Yes,No,Persistent Disease,Patient Deceased,Yes,235.0,Distant Metastasis,"Lung, Liver",,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,,,235.0,1.0,1072.0,1.0,0.0
C3L-01838,LSCC,C3L-01838-T,,,,0.0,,CPT0091820003,CPT0091820006,,CPT0091820009,,CPT0093670002,70,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,4.0,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,0,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,,170.0,81.0,28.03,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",33.0,Exposure to secondhand smoke history not available,,,Aspirin 81mg|Voltaren|nexium|Glucosamine-chondroit|lisinopril-hydrochlorothiazide|Zocor|Mens one daily ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1707.0,,,1707.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1707.0,0.0,0.0
C3N-02252,LSCC,C3N-02252-T,C3N-02252-N,,,0.0,CPT0128900003,CPT0128890003,CPT0128890009,CPT0128900009,CPT0128890006,CPT0128900006,CPT0130770002,68,Female,White,Not Hispanic or Latino,European,United States,No,,,,,Squamous cell carcinoma,G3 Poorly differentiated,Staging is not applicable or unknown,,,,,,,,,,,,,,,,,,,,,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3L-03963,LSCC,C3L-03963-T,C3L-03963-N,,,0.0,CPT0227420003,CPT0227400003,CPT0227400009,CPT0227420009,CPT0227400006,CPT0227420006,CPT0227530002,73,Male,Unknown,Unknown,European,Bulgaria,No,,Left,Unifocal,6.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,8,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,170.0,85.0,29.41,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,60.0,Yes,,,Nebivolol|Fosinopril Sodium,Self Report|Self Report,No,993.0,,,1000.0,,No,No,No,Unknown,Complete Remission,No,,,,,,,,,,,,,,,0.0,993.0,0.0,7.0
C3N-03072,LSCC,C3N-03072-T,C3N-03072-N,,,0.0,CPT0209040003,CPT0209020004,CPT0209020010,,CPT0209020007,,CPT0209080002,62,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,3.2,Squamous cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2a,pN2,24,IHC staining not done,4,cM0,pM0,no,R0:No residual tumor,,175.0,95.0,31.02,No,Lifelong non-drinker,Current reformed smoker within past 15 years,,Exposure to secondhand smoke history not available,,,azithromycin,Medical Record,No,323.0,,,323.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,323.0,0.0,0.0
C3L-02969,LSCC,C3L-02969-T,C3L-02969-N,,,0.0,CPT0217490003,CPT0217420003,CPT0217420009,CPT0217490009,CPT0217420006,CPT0217490006,CPT0219800002,76,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,3.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1c,pN0,26,IHC staining not done,0,unknown,unknown ,,R0:No residual tumor,,173.0,102.0,34.21,No,Lifelong non-drinker,Current reformed smoker within past 15 years,45.0,Exposure to secondhand smoke history not available,,,aspirin 325|Lipitor|Plavix|Dulaglutide |Glucosamine 1500 complex|Toujeo Solostar |Lisinopril |Lyrica |Lopressor|Omega-3 acids,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1427.0,,,1427.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1427.0,0.0,0.0
C3N-03662,LSCC,C3N-03662-T,C3N-03662-N,,,0.0,CPT0219390003,CPT0219360003,CPT0219360009,,CPT0219360006,,CPT0219480002,64,Male,Unknown,Unknown,European,Ukraine,No,,Right,Unifocal,4.0,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,11,IHC staining not done,3,cM0,Staging Incomplete,no,R0:No residual tumor,,180.0,85.0,26.23,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,6.0,,,12.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,6.0,0.0,6.0
C3N-03051,LSCC,C3N-03051-T,C3N-03051-N,,,0.0,CPT0208780003,CPT0208770003,CPT0208770009,CPT0208780009,CPT0208770006,CPT0208780006,CPT0208820002,65,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,5.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN2,53,IHC staining not done,1,cM0,pM0,no,R0:No residual tumor,,168.0,72.0,25.51,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,40.0,Exposure to secondhand smoke history not available,,,,,No,735.0,,,735.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,735.0,0.0,0.0
C3N-02434,LSCC,C3N-02434-T,C3N-02434-N,,,0.0,CPT0115860003,CPT0115830003,CPT0115830006,CPT0115860009,CPT0115830009,CPT0115860006,CPT0116430002,74,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,4.5,Squamous cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,6,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,157.0,101.0,40.6,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,40.0,Exposure to secondhand smoke history not available,,,amlodipine|aspirin|chlorthalidone|enalapril|metformin|metaprolol|triamcinolone acetonide 55,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1421.0,,,1396.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1421.0,0.0,-25.0
C3L-02127,LSCC,C3L-02127-T,C3L-02127-N,,,0.0,CPT0130310003,CPT0130270003,CPT0130270006,CPT0130310009,CPT0130270009,CPT0130310006,CPT0130390002,66,Male,Unknown,Unknown,European,Bulgaria,No,,Left,Unifocal,4.0,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,13,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,178.0,80.0,25.25,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,78.0,Yes,,,Enalapril/Hydrochlothiazide,Self Report,No,1447.0,,,1446.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1447.0,0.0,-1.0
C3N-02339,LSCC,C3N-02339-T,C3N-02339-N,,,0.0,CPT0136660003,CPT0136640003,CPT0136640013,CPT0136660009,CPT0136640009,CPT0136660006,CPT0136750002,78,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,7.0,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,21,IHC staining not done,0,cM0,Staging Incomplete,No,R0:No residual tumor,,172.0,92.0,31.1,Unknown,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,170.0,,,176.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,170.0,0.0,6.0
C3L-03961,LSCC,C3L-03961-T,C3L-03961-N,,,0.0,CPT0232690003,CPT0232670003,"['CPT0232640009', 'CPT0232670009']",CPT0232690009,"['CPT0232640006', 'CPT0232670006']",CPT0232690006,CPT0232790002,48,Female,Unknown,Unknown,European,Bulgaria,No,,Left,Unifocal,3.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,10,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,164.0,78.0,29.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,43.5,Yes,,,,,No,5.0,,,14.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,5.0,0.0,9.0
C3L-04391,LSCC,C3L-04391-T,C3L-04391-N,,,0.0,CPT0234580003,CPT0234560003,CPT0234560009,CPT0234580009,CPT0234560006,CPT0234580006,CPT0235180002,70,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,3.8,Squamous cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2a,pN0,10,IHC staining not done,0,unknown,,,R0:No residual tumor,,175.0,71.0,23.03,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,"Current reformed smoker, more than 15 years",10.0,Exposure to secondhand smoke history not available,,,amiodarone |Ascorbic Acid |B complex vitimins|Chelated Zinc|Vitamin B-12|Mag Aspart-potassium aspart|Melatonin |glucosamine chondroitin msm |Potassium chloride SA |selenuim |St. Johns wort |Bactrim-Septra|Vitamin E|Omega-3 acids|Thera M plus,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1155.0,,,1155.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1155.0,0.0,0.0
C3L-02619,LSCC,C3L-02619-T,C3L-02619-N,,,0.0,CPT0191930003,CPT0191860003,CPT0191860009,CPT0191930006,CPT0191860006,CPT0191930009,CPT0192020002,70,Male,Unknown,Unknown,European,Bulgaria,No,,Right,Unifocal,8.5,Squamous cell carcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4,pN1,13,IHC staining not done,1,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,182.0,120.0,36.23,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,72.0,Exposure to secondhand smoke history not available,,,Lercanidipine hydrochloride|Propafenone hydrochloride|Allopurinol,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,No,505.0,,,514.0,,Yes,No,No,Unknown,,No,,,,,,,,,,,,,,,0.0,505.0,0.0,9.0
C3N-02494,LSCC,C3N-02494-T,C3N-02494-N,,,0.0,CPT0234820003,CPT0234790003,CPT0234790009,CPT0234820006,CPT0234790006,CPT0234820009,CPT0234910002,66,Female,Black or African American,Not Hispanic or Latino,African,United States,No,,Right,Unifocal,3.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,16,0,0,cM0,No pathologic evidence of distant metastasis,No metastasis,RX:Presence of residual tumor cannot be assessed,,,,,,,,,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3N-03880,LSCC,C3N-03880-T,C3N-03880-N,,,0.0,CPT0237710003,CPT0237690004,CPT0237690010,CPT0237710009,CPT0237690007,CPT0237710006,CPT0237750002,76,Male,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,2.2,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1c,pN1,24,IHC staining not done,1,cM0,pM0,no,R0:No residual tumor,,170.0,85.0,29.41,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,108.0,Exposure to secondhand smoke history not available,,,,,No,736.0,,,736.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,736.0,0.0,0.0
C3N-03092,LSCC,C3N-03092-T,C3N-03092-N,,,0.0,CPT0197520003,CPT0197480003,CPT0197480009,CPT0197520009,CPT0197480006,CPT0197520006,CPT0197660002,61,Male,Unknown,Unknown,European,Ukraine,No,,,,,Squamous cell carcinoma,G2 Moderately differentiated,Staging is not applicable or unknown,,,,,,,,,,,,,,,,,,,,,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3L-02669,LSCC,C3L-02669-T,C3L-02669-N,,,0.0,CPT0202400004,CPT0202350004,CPT0202350010,CPT0202400010,CPT0202350007,CPT0202400007,CPT0202510002,73,Male,Unknown,Unknown,European,Bulgaria,No,,Right,Unifocal,4.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,11,IHC staining not done,-1,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,170.0,60.0,20.76,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,96.3,Yes,,,Rosuvastatin|Trimetazidine dihydrochloride|Zofenopril calcium|Clopidogrel|Torasemide|Famotidine|Lercanidipine hydrochloride,Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report,No,637.0,796.0,Main malignancy,,796.0,Unknown,Unknown,Unknown,Persistent Disease,Patient Deceased,No,,,,,,,,,,,,,,,0.0,796.0,1.0,0.0
C3N-03877,LSCC,C3N-03877-T,C3N-03877-N,,,0.0,CPT0237570003,CPT0237550004,CPT0237550007,CPT0237570009,CPT0237550010,CPT0237570006,CPT0237610002,53,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,7.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,35,IHC staining not done,25,cM0,pM0,no,R0:No residual tumor,,183.0,88.0,26.28,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,irbesartan,Medical Record,No,682.0,,,682.0,,Yes,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,682.0,0.0,0.0
C3N-01846,LSCC,C3N-01846-T,C3N-01846-N,,,0.0,CPT0098800003,CPT0098770003,CPT0098770013,CPT0098800006,CPT0098770009,CPT0098800009,CPT0098810002,70,Male,Unknown,Unknown,European,Ukraine,No,,Right,Unifocal,4.0,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,No,R0:No residual tumor,,168.0,72.0,25.51,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,533.0,533.0,Main malignancy,,472.0,No,No,No,Complete Remission,,Yes,123.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,,,123.0,1.0,533.0,1.0,-61.0
C3L-02964,LSCC,C3L-02964-T,C3L-02964-N,,,0.0,CPT0197380003,CPT0197210003,CPT0197210009,CPT0197380006,CPT0197210006,CPT0197380009,CPT0199140002,58,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,4.5,Non-keratinizing squamous cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN0,14,IHC staining not done,0,unknown,No pathologic evidence of distant metastasis,,R0:No residual tumor,,170.0,75.0,26.0,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,42.0,Exposure to secondhand smoke history not available,,,Lipitor|Wellbutrin|cozaar,Medical Record|Medical Record|Medical Record,No,766.0,766.0,Main malignancy,,766.0,No,No,No,Not Applicable,Patient Deceased,Yes,402.0,Distant Metastasis,Other,"mediastinal lymphadenopathy, neck, hila",Biopsy with Histologic Confirmation,,No,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,,,402.0,1.0,766.0,1.0,0.0
C3N-00247,LSCC,C3N-00247-T,,,,0.0,,CPT0089880003,CPT0089880006,,CPT0089880009,,CPT0091400002,77,Female,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,2.2,Adenosquamous Carcinoma; at least 66% squamous component,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN1,17,0,3,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,165.0,75.0,27.45,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",2.5,Exposure to secondhand smoke history not available,,,acetaminophen|Vitamin D|ibprofen|metaprolol|multiple vitamin|ranibizumab,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1580.0,,,1523.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1580.0,0.0,-57.0
C3N-01018,LSCC,C3N-01018-T,C3N-01018-N,1.0,Deemed as adenocarcinoma - excluded by WG,0.0,CPT0104950003,CPT0104930003,CPT0104930006,CPT0104950006,CPT0104930009,CPT0104950009,CPT0107500002,64,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Right,Unifocal,4.0,Solid adenocarcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,7,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,170.0,48.0,16.61,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,419.0,,,412.0,,Yes,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,419.0,0.0,-7.0
C3N-02288,LSCC,C3N-02288-T,C3N-02288-N,,,0.0,CPT0186140003,CPT0186130003,CPT0186130009,CPT0186140006,CPT0186130006,CPT0186140009,CPT0186170002,58,Female,Unknown,Unknown,European,Poland,No,,Left,Unifocal,8.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,18,0,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,154.0,60.0,25.3,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",40.0,No or minimal exposure to secondhand smoke,,,,,No,1462.0,,,1462.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1462.0,0.0,0.0
C3L-01606,LSCC,C3L-01606-T,C3L-01606-N,,,0.0,CPT0086270003,CPT0086260003,CPT0086260006,CPT0086270009,CPT0086260009,CPT0086270006,CPT0087360002,66,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,2.2,Squamous cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,86,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,,175.0,96.0,31.35,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,35.0,Exposure to secondhand smoke history not available,,,Albuterol|Arava|Leucovorin|levothyroxine|Prenisone|methotrexate|testosterone cypionate,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1782.0,,,1782.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1782.0,0.0,0.0
C3L-02164,LSCC,C3L-02164-T,C3L-02164-N,,,0.0,CPT0175270003,CPT0175260003,CPT0175260013,CPT0175270009,CPT0175260006,CPT0175270006,CPT0175340002,58,Male,Unknown,Unknown,European,Bulgaria,No,,Left,Unifocal,2.5,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,31,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,172.0,78.0,26.37,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, years unknown",,Yes,,,Levofloxacin|Probiotic|Salbutamol|Lidocaine|Sodium chloride,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,370.0,,,360.0,,Yes,Yes,No,Persistent Disease,,Yes,54.0,Distant Metastasis,Brain,,Convincing Image (i.e. CT/PET/MRI),67,Yes,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,67.0,67.0,54.0,1.0,370.0,0.0,-10.0
C3N-02374,LSCC,C3N-02374-T,C3N-02374-N,,,0.0,CPT0146400003,CPT0146380004,CPT0146380007,CPT0146400009,CPT0146380010,CPT0146400006,CPT0146410002,67,Male,Unknown,Unknown,East_Asian,China,No,Other Middle and lower lobe,Right,Unifocal,9.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,32,IHC staining not done,1,cM0,Staging Incomplete,no,R0:No residual tumor,,162.0,59.0,22.48,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,42.0,Exposure to secondhand smoke history not available,,,,,No,1061.0,,,1067.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,1061.0,0.0,6.0
C3N-02675,LSCC,C3N-02675-T,C3N-02675-N,,,0.0,CPT0187380003,CPT0187370003,CPT0187370009,CPT0187380006,CPT0187370006,CPT0187380009,CPT0187410002,69,Male,Unknown,Unknown,European,Poland,No,,Right,Multifocal,1.7,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Cannot be assessed,Seventh Edition (2010),pT3,pN2,-1,1,1,Staging Incomplete,Staging Incomplete,,R2:Macroscopic residual tumor,,176.0,84.0,27.0,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",20.0,No or minimal exposure to secondhand smoke,,,,,No,1338.0,1338.0,Main malignancy,,1337.0,Yes,No,No,Unknown,Patient Deceased,Yes,750.0,Both Locoregional and Distant Metastasis,Lung,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,,,750.0,1.0,1338.0,1.0,-1.0
C3N-02523,LSCC,C3N-02523-T,C3N-02523-N,,,0.0,CPT0234950004,CPT0234930004,CPT0234930010,CPT0234950007,CPT0234930007,CPT0234950010,CPT0235050002,61,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,2.0,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),T1b,N0,19,IHC staining not done,0,m0,Not identified,No metastasis,RX:Presence of residual tumor cannot be assessed,,,,,,,,,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3L-02130,LSCC,C3L-02130-T,C3L-02130-N,,,0.0,CPT0130070003,CPT0130030003,CPT0130030006,CPT0130070009,CPT0130030009,CPT0130070006,CPT0130150002,70,Male,Unknown,Unknown,European,Bulgaria,No,,Left,Unifocal,3.3,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage I,Present,Cannot be assessed,Seventh Edition (2010),pT2a,pN0,11,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,175.0,85.0,27.76,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,24.0,Yes,,,,,No,1386.0,1407.0,Unknown,,1403.0,No,Yes,No,Complete Remission,Patient Deceased,No,,,,,,,,,,,,,,,0.0,1407.0,1.0,-4.0
C3N-02426,LSCC,C3N-02426-T,C3N-02426-N,,,0.0,CPT0147200003,CPT0147180004,CPT0147180007,CPT0147200006,CPT0147180010,CPT0147200009,CPT0147220004,69,Female,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,2.0,adenosquamous carcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,22,IHC staining not done,0,cM0,Staging Incomplete,no,R0:No residual tumor,,158.0,60.0,24.03,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,338.0,442.0,Unknown,,442.0,No,No,No,Not Applicable,,Yes,274.0,New Primary Tumor,Other,teratoma,Convincing Image (i.e. CT/PET/MRI),,,R0: No Residual Tumor,No,No,No,,,274.0,1.0,442.0,1.0,0.0
C3N-02284,LSCC,C3N-02284-T,,,,0.0,,CPT0126670003,CPT0126670009,,CPT0126670006,,CPT0126730002,69,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,5.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),3,0,17,0,0,0,0,0,R0:No residual tumor,,165.0,70.0,25.71,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,,,No,1512.0,,,1531.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1512.0,0.0,19.0
C3L-00923,LSCC,C3L-00923-T,C3L-00923-N,,,0.0,CPT0063440003,CPT0063430003,['CPT0063430006'],CPT0063440009,CPT0063430009,CPT0063440006,CPT0065260002,71,Female,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,3.5,Squamous cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,32,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,,149.0,82.0,36.76,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,67.5,Exposure to secondhand smoke history not available,,,Atenolol|Levothyroxine|Probiotic |Multi Vitamin|Omeprazole,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1792.0,,,1792.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1792.0,0.0,0.0
C3N-03486,LSCC,C3N-03486-T,C3N-03486-N,,,0.0,CPT0195520003,CPT0195510003,CPT0195510006,CPT0195520006,CPT0195510009,CPT0195520009,CPT0195610002,65,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,3.0,Basaloid squamous cell carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,20,IHC staining not done,0,cM0,Staging Incomplete,No,R0:No residual tumor,,173.0,70.0,23.39,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,315.0,,,321.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,315.0,0.0,6.0
C3N-04127,LSCC,C3N-04127-T,C3N-04127-N,,,0.0,CPT0238130003,CPT0238110004,CPT0238110007,CPT0238130009,CPT0238110010,CPT0238130006,CPT0238170002,63,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,5.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN2,33,IHC staining not done,1,cM0,pM0,no,R0:No residual tumor,,167.0,59.0,21.16,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,58.5,Exposure to secondhand smoke history not available,,,,,No,765.0,,,765.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,765.0,0.0,0.0
C3L-02951,LSCC,C3L-02951-T,C3L-02951-N,,,0.0,CPT0197170003,CPT0197150003,CPT0197150006,CPT0197170006,CPT0197150009,CPT0197170009,CPT0197840002,61,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,4.8,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN0,11,IHC staining not done,0,unknown,No pathologic evidence of distant metastasis,,R0:No residual tumor,,155.0,59.0,24.56,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,20.0,Exposure to secondhand smoke history not available,,,Albuterol inhaler|Symbicort inhaler|Hydrocodone-acetaminophen ,Medical Record|Medical Record|Medical Record,No,1420.0,,,1420.0,,No,No,No,Not Applicable,Persistent Disease,Yes,853.0,Locoregional Recurrence,Lung,,Biopsy with Histologic Confirmation,Yes,,R0: No Residual Tumor,No,No,No,957.0,,853.0,1.0,1420.0,0.0,0.0
C3L-02629,LSCC,C3L-02629-T,C3L-02629-N,,,0.0,CPT0202220004,CPT0202170003,CPT0202170009,CPT0202220010,CPT0202170006,CPT0202220007,CPT0202330002,57,Male,Unknown,Unknown,European,Bulgaria,No,,Right,Unifocal,8.0,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,22,IHC staining not done,0,cM0,Staging Incomplete,0,RX:Presence of residual tumor cannot be assessed,,176.0,98.0,31.64,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,Insulin|Metformin hydrochloride,Self-reported and Medical Record|Self-reported and Medical Record,No,40.0,,,40.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,40.0,0.0,0.0
C3L-04013,LSCC,C3L-04013-T,C3L-04013-N,,,0.0,CPT0233330003,CPT0233320003,CPT0233320009,CPT0233330009,CPT0233320006,CPT0233330006,CPT0233440002,61,Male,Unknown,Unknown,European,Bulgaria,No,Other Left lung,Left,Unifocal,8.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,9,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,165.0,72.0,26.45,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,48.8,Yes,,,Bisoprolol fumarate,Self Report,No,5.0,,,13.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,5.0,0.0,8.0
C3N-00221,LSCC,C3N-00221-T,C3N-00221-N,,,0.0,CPT0111000004,CPT0111150004,CPT0111150007,CPT0111000007,CPT0111150015,,CPT0111280005,78,Male,Unknown,Not Hispanic or Latino,African,United States,No,,Right,Unifocal,4.7,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage III,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,10,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,188.0,93.0,26.43,Yes,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",36.0,Yes,Prostate,Surgery,Symbicort|Verelan PM|Ferrous Sulfate|Potassium PO|Vitamin E PO|Asorbic Acid,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,548.0,,,549.0,,Yes,No,No,Unknown,,No,,,,,,,,,,,,,,,0.0,548.0,0.0,1.0
C3L-00568,LSCC,C3L-00568-T,C3L-00568-N,,,0.0,CPT0023500003,CPT0023470003,['CPT0023470008'],CPT0023500009,CPT0023470005,CPT0023500006,CPT0024570002,74,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,Right,Unifocal,4.7,Squamous cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,6,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,160.0,73.0,28.52,No,Lifelong non-drinker,Current reformed smoker within past 15 years,39.0,Exposure to secondhand smoke history not available,,,combivent|aspirin|symbicort|lisinopril|Multi Vitamins ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,93.0,,,93.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,93.0,0.0,0.0
C3N-04155,LSCC,C3N-04155-T,C3N-04155-N,,,0.0,CPT0223820003,CPT0223790003,CPT0223790009,,CPT0223790006,CPT0223820006,CPT0223910002,76,Male,Unknown,Unknown,European,Ukraine,No,,Right,Unifocal,2.5,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,5,IHC staining not done,0,cM0,Staging Incomplete,No,R0:No residual tumor,,163.0,84.0,31.62,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,46.0,,,11.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,46.0,0.0,-35.0
C3N-01025,LSCC,C3N-01025-T,C3N-01025-N,,,0.0,CPT0083990003,CPT0083980003,['CPT0083980009'],CPT0083990009,CPT0083980006,CPT0083990006,CPT0084010002,52,Male,Unknown,Unknown,East_Asian,Vietnam,No,"Other Right lung, not otherwise specified",Right,Unifocal,10.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,15,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,168.0,63.0,22.32,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,1.5,No or minimal exposure to secondhand smoke,,,,,No,7.0,,,0.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,7.0,0.0,-7.0
C3L-02552,LSCC,C3L-02552-T,C3L-02552-N,,,0.0,CPT0112600003,CPT0112580003,CPT0112580009,CPT0112600009,CPT0112580006,CPT0112600006,CPT0115170002,68,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,3.7,Adenosquamous carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,22,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:No residual tumor,,195.0,121.0,31.82,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,79.5,Exposure to secondhand smoke history not available,,,Glucophage|Lisinopril |Glipizide|Lipitor|Toprol-XL |Mult. vitamin|Triple Omega 3-6-9|Desyrel|Vitamin B-12|Aspirin 81 mg,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1387.0,1387.0,Other reasons,,1387.0,No,No,No,Not Applicable,Patient Deceased,No,,,,,,,,,,,,,,,0.0,1387.0,1.0,0.0
C3N-02375,LSCC,C3N-02375-T,C3N-02375-N,,,0.0,CPT0146500003,CPT0146480004,CPT0146480007,CPT0146500009,CPT0146480010,CPT0146500006,CPT0146510002,59,Male,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,3.5,Squamous cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,29,IHC staining not done,0,cM0,Staging Incomplete,no,R0:No residual tumor,"HER2(+), TTF1(focal +), EGFR(+)，CK7(focal+)，Ki-67(+, 60％)，β-Cat(membranous +), P63(+), ERCC1(+), RRM1(focal+), Syn(focal+) Immunohistochemistry:P40(+), GATA3(-), CDX2(-)，SPA(-)，NapsinA(-)，CK20(-)，CK5/6(+)",172.0,67.0,22.65,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,29.0,Exposure to secondhand smoke history not available,,,,,No,1179.0,,,1183.0,,No,No,No,Not Applicable,Not Applicable,No,,,,,,,,,,,,,,,0.0,1179.0,0.0,4.0
C3L-02660,LSCC,C3L-02660-T,C3L-02660-N,,,0.0,CPT0202740003,CPT0202720003,CPT0202720009,CPT0202740009,CPT0202720006,CPT0202740006,CPT0202840002,72,Male,Unknown,Unknown,European,Bulgaria,No,Other Right lung,Right,Unifocal,3.0,Keratinizing squamous cell carcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,23,IHC staining not done,15,cM0,Staging Incomplete,0,RX:Presence of residual tumor cannot be assessed,,172.0,72.0,24.34,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,,Yes,,,,,No,1.0,355.0,Main malignancy,,363.0,Yes,No,No,Persistent Disease,,Unknown,,,,,,,,,,,,,,,0.0,355.0,1.0,8.0
C3L-01884,LSCC,C3L-01884-T,C3L-01884-N,,,0.0,CPT0104380003,CPT0104360003,CPT0104360006,CPT0104380009,CPT0104360011,CPT0104380006,CPT0105120002,74,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,3.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,17,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,,170.0,82.0,28.31,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,Acetaminophen|Aggrenox|Albuterol|Amoxicillin-clavulanate|Benazepril|Diphenhydramine|Finasteride|Fluticasone|Fluticasone-Salmeterol|Lovastatin|Multi Vitamins|Ranitidine|Tamsulosin|Tiotropium Bromide Monohydrate|Viagra,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1483.0,1653.0,Other reasons,,1653.0,No,No,No,Not Applicable,Complete Remission,Yes,173.0,Distant Metastasis,Other,Vocal cord ,Biopsy with Histologic Confirmation,173,Yes,RX: Presence of Residual Tumor cannot be assessed,Yes,No,No,173.0,173.0,173.0,1.0,1653.0,1.0,0.0
C3N-02300,LSCC,C3N-02300-T,C3N-02300-N,,,0.0,CPT0126830003,CPT0126810003,CPT0126810009,CPT0126830006,CPT0126810006,,CPT0126870002,69,Female,Unknown,Unknown,European,Poland,No,,Left,Unifocal,5.6,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),3,0,11,IHC staining not done,0,0,0,,R0:No residual tumor,TTF1 - CK7 + p40 + p63 + CK5/6 + pT3 pN0 (IIB),159.0,77.0,30.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,1479.0,,,1506.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1479.0,0.0,27.0
C3L-01285,LSCC,C3L-01285-T,C3L-01285-N,,,0.0,CPT0087210003,CPT0087190003,CPT0087190006,CPT0087210009,['CPT0087190009'],CPT0087210006,CPT0087480002,54,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,5.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,7,IHC staining not done,1,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,177.0,67.0,21.39,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,celexa|albuterol|wellbutrin|meloxicam|prilosec|zanaflex|incruse ellipta|symbicort,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1697.0,,,1703.0,,No,No,No,Unknown,Complete Remission,Yes,610.0,Distant Metastasis,Other,anterior shin left leg,Biopsy with Histologic Confirmation,617,Yes,RX: Presence of Residual Tumor cannot be assessed,No,No,No,617.0,617.0,610.0,1.0,1697.0,0.0,6.0
C3L-02627,LSCC,C3L-02627-T,C3L-02627-N,,,0.0,CPT0202040003,CPT0202020008,CPT0202020014,CPT0202040009,CPT0202020011,CPT0202040006,CPT0202150002,64,Female,Unknown,Unknown,European,Bulgaria,No,,Right,Unifocal,2.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1,pN0,11,IHC staining not done,0,cM0,Staging Incomplete,0,R0:No residual tumor,,160.0,70.0,27.34,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,45.0,Yes,,,,,No,1411.0,,,1417.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1411.0,0.0,6.0
C3L-00993,LSCC,C3L-00993-T,C3L-00993-N,,,0.0,CPT0102840003,CPT0102790003,CPT0102790006,CPT0102840009,CPT0102790009,CPT0102840006,CPT0101090002,75,Male,Unknown,Unknown,European,Ukraine,No,,Right,Unifocal,6.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage III,Present,Cannot be assessed,Seventh Edition (2010),pT2b,pN2,5,IHC staining not done,3,cM0,No pathologic evidence of distant metastasis,Not documented,R0:No residual tumor,,178.0,72.0,22.72,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Yes,,,,,No,-1.0,-1.0,Unknown,,2.0,No,No,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,0.0,1.0,3.0
C3N-02425,LSCC,C3N-02425-T,C3N-02425-N,,,0.0,CPT0183270003,CPT0183250004,CPT0183250010,CPT0183270009,CPT0183250007,CPT0183270006,CPT0183310002,61,Male,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,7.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,36,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no,R0:No residual tumor,"HER2(partly+), TTF1(-), EGFR(+),CK7(-),Ki-67(+,70％),β-Cat(membranous +), P63(+), ERCC1(partly+), RRM1(-), Syn(-),P40(+) Immunohistochemistry:GATA3(-), CDX2(-),SPA(-),NapsinA(-),CK20(-),CK5/6(+)",167.0,60.0,21.51,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,40.0,Exposure to secondhand smoke history not available,,,,,No,1064.0,,,1073.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,1064.0,0.0,9.0
C3L-02170,LSCC,C3L-02170-T,,,,0.0,,CPT0175560003,CPT0175560009,,CPT0175560006,,CPT0175640002,73,Male,Unknown,Unknown,European,Bulgaria,No,,Right,Unifocal,4.5,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,15,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,166.0,93.0,33.75,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,38.0,Yes,,,Indacaterol/Glycopyrronium,Self Report,No,27.0,,,6.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,27.0,0.0,-21.0
C3L-02624,LSCC,C3L-02624-T,C3L-02624-N,1.0,Exclusion by working group,0.0,CPT0227070003,CPT0227020003,CPT0227020009,CPT0227070009,CPT0227020006,CPT0227070006,CPT0227170002,63,Male,Unknown,Unknown,European,Bulgaria,No,,Left,Unifocal,3.5,Squamous cell carcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,10,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,178.0,85.0,26.83,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,40.0,Yes,,,Atorvastaitin/amlodipine,Self Report,No,776.0,832.0,Other reasons,,839.0,No,No,No,Not Applicable,Patient Deceased,Yes,130.0,New Primary Tumor,Liver,,Convincing Image (i.e. CT/PET/MRI),,,RX: Presence of Residual Tumor cannot be assessed,No,No,Yes,,,130.0,1.0,832.0,1.0,7.0
C3N-00555,LSCC,C3N-00555-T,C3N-00555-N,,,0.0,CPT0068320003,CPT0068280003,['CPT0068280009'],CPT0068320006,CPT0068280006,CPT0068320009,CPT0068390002,59,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Right,Unifocal,5.5,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,4,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,170.0,59.0,20.42,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,3.2,No or minimal exposure to secondhand smoke,,,,,No,787.0,,,782.0,,Yes,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,787.0,0.0,-5.0
C3N-01893,LSCC,C3N-01893-T,C3N-01893-N,,,0.0,CPT0126470003,CPT0126450003,CPT0126450009,CPT0126470009,CPT0126450006,CPT0126470006,CPT0126510002,70,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,5.1,Squamous cell carcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),3,1,15,IHC staining not done,1,0,0,,R0:No residual tumor,,162.0,66.0,25.15,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,663.0,663.0,Main malignancy,,671.0,No,Yes,No,Complete Remission,Patient Deceased,No,,,,,,,,,,,,,,,0.0,663.0,1.0,8.0
C3N-03093,LSCC,C3N-03093-T,C3N-03093-N,,,0.0,CPT0197860003,CPT0197740003,CPT0197740009,CPT0197860009,CPT0197740006,CPT0197860006,CPT0198000002,70,Female,Unknown,Unknown,European,Ukraine,No,,,,,Squamous cell carcinoma,G3 Poorly differentiated,Staging is not applicable or unknown,,,,,,,,,,,,,,,,,,,,,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3L-01455,LSCC,C3L-01455-T,C3L-01455-N,,,0.0,CPT0108600003,CPT0108560003,CPT0108560006,CPT0108600009,CPT0108560009,CPT0108600006,CPT0108340002,88,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,5.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,17,IHC staining not done,1,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,183.0,89.0,26.58,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,,,No,16.0,33.0,Unknown,,36.0,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,33.0,1.0,3.0
C3N-03848,LSCC,C3N-03848-T,C3N-03848-N,,,0.0,CPT0237080003,CPT0237060004,CPT0237060010,CPT0237080006,CPT0237060007,CPT0237080009,CPT0237120002,56,Female,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,3.5,Squamous cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2a,pN2,23,IHC staining not done,3,cM0,pM0,no,R0:No residual tumor,,158.0,65.0,26.04,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Euthyrox,Medical Record,No,635.0,,,635.0,,Yes,Yes,No,Complete Remission,,Yes,474.0,Distant Metastasis,Other,pleura,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,No,No,,,474.0,1.0,635.0,0.0,0.0
C3L-02968,LSCC,C3L-02968-T,C3L-02968-N,,,0.0,CPT0196820003,CPT0196810003,CPT0196810006,CPT0196820006,CPT0196810009,CPT0196820009,CPT0197760002,64,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,6.0,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN0,19,IHC staining not done,0,unknown,No pathologic evidence of distant metastasis,,R0:No residual tumor,,168.0,72.0,25.66,Yes,Lifelong non-drinker,Current reformed smoker within past 15 years,,Exposure to secondhand smoke history not available,Prostate ,Surgery,Albuterol inhaler|Acetaminophen|Wellbutrin|Voltaren|methodone|B complex vitimins|Calcium carbonate |mulivitamin |aspirin 81mg,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1375.0,,,1375.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1375.0,0.0,0.0
C3N-03204,LSCC,C3N-03204-T,C3N-03204-N,,,0.0,CPT0209510003,CPT0209490003,CPT0209490009,CPT0209510009,CPT0209490006,CPT0209510006,CPT0209550002,62,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,3.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1c,pN0,43,IHC staining not done,0,cM0,pM0,no,R0:No residual tumor,,173.0,80.0,26.73,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,, aspirin|diltiazem|trimetazidine|isosorbide mononitrate|lipitor,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,835.0,,,835.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,835.0,0.0,0.0
C3L-00445,LSCC,C3L-00445-T,C3L-00445-N,,,0.0,CPT0130440004,CPT0130410003,CPT0130410006,CPT0130440010,CPT0130410009,CPT0130440007,CPT0130530002,74,Male,Unknown,Unknown,European,Bulgaria,No,,Right,Unifocal,5.0,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,25,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,178.0,95.0,29.98,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,40.0,Yes,,,Amiodarone|Bisoprolol|Quinapril|Spironolactone|Chlophazoline|Vildagliptine/Metformin|Vitamin A and E,Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report,No,3.0,3.0,Unknown,,3.0,No,No,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,3.0,1.0,0.0
C3N-02283,LSCC,C3N-02283-T,,,,0.0,,CPT0126530003,CPT0126530009,,CPT0126530006,,CPT0126580002,67,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,4.1,Spindle cell carcinoma with undifferentiated non small carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),2b,1,16,4,4,0,0,0,R0:No residual tumor,,181.0,98.0,29.0,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,90.0,Exposure to secondhand smoke history not available,,,,,No,108.0,,,160.0,,Unknown,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,108.0,0.0,52.0
C3N-02289,LSCC,C3N-02289-T,C3N-02289-N,,,0.0,CPT0186210003,CPT0186180003,CPT0186180009,CPT0186210006,CPT0186180006,CPT0186210009,CPT0186960002,73,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,5.0,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,9,0,0,cM0,No pathologic evidence of distant metastasis,No,R0:No residual tumor,,180.0,75.0,23.15,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,,,No,1407.0,,,1411.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1407.0,0.0,4.0
C3L-03962,LSCC,C3L-03962-T,C3L-03962-N,,,0.0,CPT0233160003,CPT0233120003,CPT0233120013,CPT0233160009,CPT0233120006,CPT0233160006,CPT0233260002,65,Male,Unknown,Unknown,European,Bulgaria,No,,Left,Unifocal,2.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,17,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,178.0,75.0,23.67,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,20.0,Yes,,,Ranitidine,Self Report,No,5.0,,,13.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,5.0,0.0,8.0
C3L-03272,LSCC,C3L-03272-T,C3L-03272-N,,,0.0,CPT0225470003,CPT0225380003,CPT0225380009,CPT0225470009,CPT0225380006,CPT0225470006,CPT0226050002,67,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,7.3,Squamous cell carcinoma,G2 Moderately differentiated,Stage IV,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT4,pN1,22,IHC staining not done,8,staging incomplete,No pathologic  evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,185.0,116.0,33.71,No,"Consumed alcohol in the past, but currently a non-drinker",Current reformed smoker within past 15 years,,Exposure to secondhand smoke history not available,,,Amlodipine|Lexiscan|Cardiolite|Tretrofosmin,Medical Record|Medical Record|Medical Record|Medical Record,No,155.0,,,155.0,,No,Yes,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,155.0,0.0,0.0
C3N-01411,LSCC,C3N-01411-T,C3N-01411-N,,,0.0,CPT0105430003,CPT0105420003,CPT0105420006,CPT0105430009,CPT0105420009,CPT0105430006,CPT0107860002,64,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Right,Unifocal,4.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,7,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,170.0,48.0,16.61,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,445.0,,,442.0,,No,No,No,Persistent Disease,,Yes,424.0,Locoregional Recurrence,Lung,,Convincing Image (i.e. CT/PET/MRI),,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,,,424.0,1.0,445.0,0.0,-3.0
C3L-00415,LSCC,C3L-00415-T,C3L-00415-N,,,0.0,CPT0010060003,CPT0010050003,['CPT0010050009'],CPT0010060009,CPT0010050006,CPT0010060006,CPT0019860002,64,Female,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,6.5,Squamous cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,36,IHC staining not done,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,,158.0,69.0,27.64,No,Lifelong non-drinker,Current reformed smoker within past 15 years,35.0,Exposure to secondhand smoke history not available,,,Albuterol|hydrodiuril|Lisinopril|collagen|B-12 Vitamin|Flaxseed oil|Vitamin D,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1786.0,,,1786.0,,No,Yes,No,Unknown,Persistent Disease,Yes,356.0,New Primary Tumor,Lung,,Convincing Image (i.e. CT/PET/MRI),,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,,,356.0,1.0,1786.0,0.0,0.0
C3N-03882,LSCC,C3N-03882-T,C3N-03882-N,,,0.0,CPT0237780003,CPT0237760003,CPT0237760009,CPT0237780009,CPT0237760006,CPT0237780006,CPT0237820002,68,Male,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,4.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2a,pN1,22,IHC staining not done,5,cM0,pM0,no,R0:No residual tumor,,168.0,70.0,24.8,No,Lifelong non-drinker,Current reformed smoker within past 15 years,,Exposure to secondhand smoke history not available,,,,,No,715.0,,,715.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,715.0,0.0,0.0
C3L-01000,LSCC,C3L-01000-T,C3L-01000-N,,,0.0,CPT0123370003,CPT0123350003,CPT0123350006,CPT0123370009,CPT0123350009,CPT0123370006,CPT0124800002,59,Male,Unknown,Unknown,European,Russia,No,,Right,Unifocal,4.2,Non-keratinizing squamous cell carcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,9,IHC staining not done,0,cM0,Staging Incomplete,Not documented,R0:No residual tumor,,182.0,110.0,33.21,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,84.0,Yes,,,Bisoprolol|Valsartan|Amlodipine,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,No,1376.0,,,1380.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1376.0,0.0,4.0
C3L-02650,LSCC,C3L-02650-T,C3L-02650-N,,,0.0,CPT0205000003,CPT0204990003,CPT0204990009,CPT0205000009,CPT0204990006,CPT0205000006,CPT0205110002,53,Male,Unknown,Unknown,European,Bulgaria,No,Other lung,Right,Multifocal,8.0,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN2,18,IHC staining not done,2,cM0,Staging Incomplete,unknown,R0:No residual tumor,,175.0,95.0,31.02,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,,Yes,,,Insulin,Medical Record,No,1422.0,,,1422.0,,No,Yes,No,Unknown,Complete Remission,No,,,,,,,,,,,,,,,0.0,1422.0,0.0,0.0
C3L-02358,LSCC,C3L-02358-T,C3L-02358-N,,,0.0,CPT0112730003,CPT0112720003,CPT0112720009,CPT0112730009,CPT0112720006,CPT0112730006,CPT0115190002,75,Female,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,4.4,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,17,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,"VVG: Confirmed viscera pleural invasion PD-L1: Negative, TPS: 0%",168.0,87.0,30.82,Yes,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",70.0,Exposure to secondhand smoke history not available,Mature t/NK-cell Lymphomas|Cervical Cancer Stage 3,Unknown|Surgery," atorvastatin (LIPITOR)|clindamycin-benzoyl peroxide (BENZACLIN) gel|clobetasol (TEMOVATE)|lisinopril (PRINIVIL,ZESTRIL)|metoprolol tartrate (LOPRESSOR)|Misc Natural Products (OSTEO BI-FLEX ADV JOINT SHIELD PO)|omeprazole (PRILOSEC OTC)",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1448.0,,,1448.0,,No,Yes,No,Persistent Disease,Persistent Disease,Yes,398.0,Distant Metastasis,Bone,,Biopsy with Histologic Confirmation,,No,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,,,398.0,1.0,1448.0,0.0,0.0
C3L-02168,LSCC,C3L-02168-T,C3L-02168-N,,,0.0,CPT0175410003,CPT0175390003,CPT0175390009,CPT0175410009,CPT0175390006,CPT0175410006,CPT0175480002,66,Male,Unknown,Unknown,European,Bulgaria,No,,Right,Unifocal,3.9,Keratinizing squamous cell carcinoma,G1 Well differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,18,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,177.0,90.0,28.73,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,Prostate carcinoma,Surgery,,,No,1421.0,,,1413.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1421.0,0.0,-8.0
C3L-02625,LSCC,C3L-02625-T,C3L-02625-N,,,0.0,CPT0191750003,CPT0191710003,CPT0191710009,CPT0191750006,CPT0191710006,CPT0191750009,CPT0191850005,66,Male,Unknown,Unknown,European,Bulgaria,No,Other Left lung,Left,Multifocal,3.0,Keratinizing squamous cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,15,IHC staining not done,2,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,173.0,79.0,26.4,No,Lifelong non-drinker,Current reformed smoker within past 15 years,36.0,Exposure to secondhand smoke history not available,,,Metoprolol succinate|Perindopril arginine|Atorvastatin|Ciprofloxacin|Levofloxacin|Rutin|Vitamin C|Dicynone,Self Report|Self Report|Self Report|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,503.0,489.0,Main malignancy,,497.0,Yes,No,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,489.0,1.0,8.0
C3N-01028,LSCC,C3N-01028-T,C3N-01028-N,,,0.0,CPT0091090003,CPT0091050003,CPT0091050006,CPT0091090009,CPT0091050009,CPT0091090006,CPT0091160002,72,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Right,Unifocal,5.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,7,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,170.0,61.0,21.11,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,345.0,345.0,Unknown,,338.0,Unknown,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,345.0,1.0,-7.0
C3N-02435,LSCC,C3N-02435-T,C3N-02435-N,,,0.0,CPT0241210003,CPT0241170003,CPT0241170009,CPT0241210009,CPT0241170006,CPT0241210006,CPT0241820002,64,Female,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,3.2,Squamous cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2a,N1,7,IHC staining not done,2,M0,,,RX:Presence of residual tumor cannot be assessed,,167.0,66.0,23.59,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,52.5,Exposure to secondhand smoke history not available,,,acetaminophen|albuterol|clonazepam|sertaline|sprivia|varenicline,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1086.0,,,1042.0,,No,Yes,No,Complete Remission,Complete Remission,Yes,541.0,New Primary Tumor,"Liver, Other",Left and Right Breast Implant and capsule ,Biopsy with Histologic Confirmation,,,,No,No,Yes,,,541.0,1.0,1086.0,0.0,-44.0
C3N-03441,LSCC,C3N-03441-T,C3N-03441-N,,,0.0,CPT0245890003,CPT0245880003,CPT0245880009,CPT0245890009,CPT0245880006,CPT0245890006,CPT0245920002,67,Male,Unknown,Unknown,European,Poland,No,,Left,Unifocal,3.0,Non-keratinizing squamous cell carcinoma,G3 Poorly differentiated,Stage III,Present,Cannot be assessed,Seventh Edition (2010),pT1b,pN2,4,1,1,cM0,No pathologic evidence of distant metastasis,No,R0:No residual tumor,,164.0,51.0,18.96,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,,,No,1332.0,,,1338.0,,Yes,Yes,No,Unknown,Unknown,Unknown,,,,,,,,,,,,,,,0.0,1332.0,0.0,6.0
C3L-04071,LSCC,C3L-04071-T,C3L-04071-N,,,0.0,CPT0221220003,CPT0221200003,CPT0221200009,CPT0221220009,CPT0221200006,CPT0221220006,CPT0220490002,69,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,2.9,Non-keratinizing squamous cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,6,0,0,cM0,No pathologic evidence of distant metastasis,,R0:No residual tumor,,178.0,79.0,24.96,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current reformed smoker within past 15 years,79.5,No or minimal exposure to secondhand smoke,,,aspirin|coQ10|Fish Oil|Breo Ellipta|ipratropium albuterol|Centrum Ultra Men's multivitamin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1144.0,,,1117.0,,No,No,No,Unknown,Unknown,Yes,271.0,Locoregional Recurrence,Lung,,Biopsy with Histologic Confirmation,,,,Yes,No,Yes,,,271.0,1.0,1144.0,0.0,-27.0
C3N-01020,LSCC,C3N-01020-T,C3N-01020-N,,,0.0,CPT0117770003,CPT0117720003,CPT0117720006,CPT0117770009,CPT0117720009,CPT0117770006,CPT0118970002,65,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Not specified,Left,Unifocal,4.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage I,Present,Cannot be assessed,Seventh Edition (2010),pT2a,pN0,5,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,150.0,43.0,19.11,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,403.0,,,396.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,403.0,0.0,-7.0
C3N-00497,LSCC,C3N-00497-T,C3N-00497-N,,,0.0,CPT0079110003,CPT0079100003,['CPT0079100006'],CPT0079110006,CPT0079100009,CPT0079110009,CPT0079140002,64,Female,Unknown,Unknown,European,Poland,No,,Right,Unifocal,5.0,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN1,10,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,none,R0:No residual tumor,,159.0,53.0,20.96,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,31.0,Exposure to secondhand smoke history not available,,,Diaprel|Anapran |Tulip ,Medical Record|Medical Record|Medical Record,No,1812.0,,,1843.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1812.0,0.0,31.0
C3N-01194,LSCC,C3N-01194-T,C3N-01194-N,,,0.0,CPT0079060003,CPT0079050003,['CPT0079050006'],CPT0079060006,CPT0079050009,CPT0079060009,CPT0079090002,69,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,4.0,Non-keratinizing squamous cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,12,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,none,R0:No residual tumor,,173.0,93.0,31.0,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,45.0,Exposure to secondhand smoke history not available,,,,,No,1741.0,,,1758.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1741.0,0.0,17.0
C3L-02648,LSCC,C3L-02648-T,C3L-02648-N,,,0.0,CPT0204660003,CPT0204600003,CPT0204600007,CPT0204660009,CPT0204600010,CPT0204660006,CPT0204750002,72,Male,Unknown,Unknown,European,Bulgaria,No,Other Left lung,Left,Unifocal,3.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,16,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,186.0,95.0,27.46,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,3.0,No or minimal exposure to secondhand smoke,,,,,No,1.0,261.0,Unknown,,268.0,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,261.0,1.0,7.0
C3L-03678,LSCC,C3L-03678-T,,,,0.0,,CPT0190550003,CPT0190550009,,CPT0190550006,,CPT0191230002,49,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,3.5,Squamous cell carcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,18,IHC staining not done,3,cM0,No pathologic evidence of distant metastasis,,R0:No residual tumor,,173.0,109.0,36.49,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,70.0,Yes,,,alprazolam|varenicline,Medical Record|Medical Record,No,485.0,485.0,Unknown,,492.0,No,Yes,No,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,485.0,1.0,7.0
C3L-02891,LSCC,C3L-02891-T,C3L-02891-N,,,0.0,CPT0218310003,CPT0218280003,CPT0218280009,CPT0218310009,CPT0218280006,CPT0218310006,CPT0219890002,66,Female,White,Not Hispanic or Latino,European,United States,No,Other Base of upper lobe/superior lower lobe ,Left,Unifocal,2.7,Squamous cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT1c,pN1,15,IHC staining not done,5,unknown,unknown ,,RX:Presence of residual tumor cannot be assessed,p40: positive  PD-L1 22C3 FDA Keytruda expressed tumor proportion score: 50% intensity strong ,157.0,57.0,22.86,No,Lifelong non-drinker,Current reformed smoker within past 15 years,,Exposure to secondhand smoke history not available,,,synthroid|prilosec|dyazide |mult vitamin |levoxyl |aspirin 81mg,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1412.0,,,1412.0,,Yes,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1412.0,0.0,0.0
C3L-00927,LSCC,C3L-00927-T,C3L-00927-N,,,0.0,CPT0063500003,CPT0063480003,['CPT0063480006'],CPT0063500009,['CPT0063480009'],CPT0063500006,CPT0065270002,74,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,3.5,Squamous cell carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,17,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,,188.0,93.0,26.31,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,57.0,Exposure to secondhand smoke history not available,,,Hydrocodone-acetaminophen|albuterol|lisinopril|zocor|glucosamine chond complex MSM|motrin|fish oil|Advair Diskus|Chantix |Tricor|Prilosec|multivitamin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1777.0,,,1777.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1777.0,0.0,0.0
C3N-03886,LSCC,C3N-03886-T,C3N-03886-N,,,0.0,CPT0221660003,CPT0221650003,CPT0221650009,,CPT0221650006,CPT0221660006,CPT0221750002,60,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,4.2,Basaloid squamous cell carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,15,IHC staining not done,0,cM0,Staging Incomplete,no,R0:No residual tumor,,188.0,106.0,29.99,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Insulin,Medical Record,No,360.0,,,311.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,360.0,0.0,-49.0
C3L-04014,LSCC,C3L-04014-T,C3L-04014-N,,,0.0,CPT0233640003,CPT0233600003,CPT0233600009,CPT0233640009,CPT0233600006,CPT0233640006,CPT0233750002,57,Male,Unknown,Unknown,European,Bulgaria,No,,Right,Unifocal,2.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1,pN0,9,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,172.0,72.0,24.34,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,43.5,Yes,,,,,No,444.0,,,459.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,444.0,0.0,15.0
C3N-03076,LSCC,C3N-03076-T,C3N-03076-N,,,0.0,CPT0236430003,CPT0236420003,CPT0236420009,CPT0236430006,CPT0236420006,CPT0236430009,CPT0236470002,68,Male,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,4.4,Squamous cell carcinoma,G3 Poorly differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN0,34,IHC staining not done,0,cM0,pM0,no,R0:No residual tumor,,170.0,56.0,19.38,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,,,No,332.0,,,332.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,332.0,0.0,0.0
C3N-03425,LSCC,C3N-03425-T,C3N-03425-N,,,0.0,CPT0245840003,CPT0245830003,CPT0245830009,CPT0245840009,CPT0245830006,CPT0245840006,CPT0245870002,64,Female,Unknown,Unknown,European,Poland,No,,Left,Unifocal,3.0,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,-1,0,0,cM0,No pathologic evidence of distant metastasis,No,R0:No residual tumor,,164.0,57.0,21.19,Yes,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,braest cancer,"Radiation,Surgery,Chemotherapy,Other(hormontherapy)",,,No,1332.0,,,1340.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1332.0,0.0,8.0
C3L-02163,LSCC,C3L-02163-T,C3L-02163-N,,,0.0,CPT0175160003,CPT0175120003,CPT0175120013,CPT0175160009,CPT0175120006,CPT0175160006,CPT0175220002,57,Male,Unknown,Unknown,European,Bulgaria,No,,Left,Unifocal,4.5,Keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,9,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,160.0,74.0,28.91,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,20.0,Exposure to secondhand smoke history not available,,,Perindopril|Lacidipine,Self Report|Self Report,No,727.0,,,724.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,727.0,0.0,-3.0
C3N-04124,LSCC,C3N-04124-T,C3N-04124-N,,,0.0,CPT0237990003,CPT0237970004,CPT0237970007,CPT0237990009,CPT0237970010,CPT0237990006,CPT0238030002,62,Male,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,3.5,Squamous cell carcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2a,pN0,31,IHC staining not done,0,cM0,pM0,no,R0:No residual tumor,,169.0,60.0,21.01,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,19.0,Exposure to secondhand smoke history not available,,,,,No,974.0,,,974.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,974.0,0.0,0.0
C3L-00904,LSCC,C3L-00904-T,C3L-00904-N,,,0.0,CPT0007760003,CPT0007740003,['CPT0007740006'],CPT0007760009,CPT0007740009,CPT0007760006,CPT0002920002,71,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,4.4,Squamous cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,13,IHC staining not done,0,cM0,Staging Incomplete,Not applicable,R1:Microscopic residual tumor,"Neoplastic cells strongly positive for p40 and p63;TTF-1 is negative, supportive of squamous differentiation GMS and Kinyon stains negative for fungal and acid-fast organisms, respectively",165.0,53.0,19.47,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,56.0,Exposure to secondhand smoke history not available,,,tylenol,Medical Record,No,761.0,795.0,Main malignancy,,795.0,No,No,No,Not Applicable,,Yes,546.0,Distant Metastasis,"Lung, Liver, Other",pancreas,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,,,546.0,1.0,795.0,1.0,0.0
C3N-00211,LSCC,C3N-00211-T,,,,0.0,,CPT0090440003,CPT0090440006,,CPT0090440009,,CPT0092490002,40,Male,Unknown,Unknown,European,Bulgaria,No,,Right,Unifocal,4.5,Squamous cell carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,4,IHC staining not done,2,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,176.0,120.0,38.74,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Ibuprofen,Self Report,No,0.0,92.0,Main malignancy,,92.0,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,92.0,1.0,0.0
C3N-01892,LSCC,C3N-01892-T,C3N-01892-N,,,0.0,CPT0126400003,CPT0126390003,CPT0126390009,CPT0126400009,CPT0126390006,CPT0126400006,CPT0126440002,77,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,6.5,Non-keratinizing squamous cell carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),3,0,21,IHC staining not done,0,0,0,,R0:No residual tumor,,165.0,83.0,30.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Euthyrox |Euphylin long ,Self Report|Self Report,No,903.0,903.0,Main malignancy,,926.0,No,No,No,Complete Remission,Patient Deceased,No,,,,,,,,,,,,,,,0.0,903.0,1.0,23.0
C3L-00603,LSCC,C3L-00603-T,C3L-00603-N,,,0.0,CPT0064050003,CPT0064040003,['CPT0064040009'],CPT0064050008,CPT0064040006,CPT0064050006,CPT0065370002,72,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,3.0,Squamous cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,26,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:No residual tumor,,178.0,113.0,35.68,Yes,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",67.5,Exposure to secondhand smoke history not available,Basal cell carcinoma of skin of nose|Colon Caner - Adenocarcinoma,Unknown|Surgery,Metoprolol tartrate|Captopril|Levothyroxine|Glimepiride|Hydralazine|Potassium Chloride|Fenofibrate|Allopurinol|Simvastatin|Hydrochlorothiazide|Omeprazole,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1794.0,,,1794.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1794.0,0.0,0.0
C3L-03965,LSCC,C3L-03965-T,C3L-03965-N,,,0.0,CPT0207250003,CPT0207210003,CPT0207210009,CPT0207250006,CPT0207210006,CPT0207250009,CPT0207360002,54,Male,Unknown,Unknown,European,Bulgaria,No,Other Right lung,Right,Unifocal,4.2,Squamous cell carcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN2,13,IHC staining not done,7,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,170.0,107.0,37.02,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,40.0,Exposure to secondhand smoke history not available,,,Olmesartan medoxomil,Self Report,No,1422.0,,,1429.0,,Yes,Yes,No,Unknown,Complete Remission,No,,,,,,,,,,,,,,,0.0,1422.0,0.0,7.0
C3N-03851,LSCC,C3N-03851-T,C3N-03851-N,,,0.0,CPT0237210003,CPT0237200004,CPT0237200010,CPT0237210006,CPT0237200007,,CPT0237260002,44,Male,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,4.5,Squamous cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2b,pN1,32,IHC staining not done,1,cM0,pM0,no,R0:No residual tumor,,178.0,75.0,23.67,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,25.0,Exposure to secondhand smoke history not available,,,,,No,642.0,,,642.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,642.0,0.0,0.0
C3L-02349,LSCC,C3L-02349-T,C3L-02349-N,,,0.0,CPT0112550003,CPT0112540003,CPT0112540006,CPT0112550009,CPT0112540009,CPT0112550006,CPT0115160002,81,Female,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,1.9,Squamous cell carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,6,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,"p40: Diffusely Positive PD-L1: Positive, Low Expression, TPS: 10%",165.0,50.0,18.37,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,Albuterol|Amlodipine|Calcium Carb-Cholecalciferol|Carvedilol|Ibuprofen|Ipratropium-Albuterol|Simvastatin|SM Nicotine Patch,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1442.0,,,1442.0,,No,No,No,Not Applicable,Persistent Disease,Yes,1016.0,Locoregional Recurrence,Lung,,Biopsy with Histologic Confirmation,,,RX: Presence of Residual Tumor cannot be assessed,Yes,No,No,,,1016.0,1.0,1442.0,0.0,0.0
C3N-01799,LUAD,C3N-01799-T,C3N-01799-N,,,0.0,CPT0089360003,CPT0089340003,CPT0089340006,CPT0089360006,CPT0089340009,CPT0089360009,CPT0091320002,81,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,3.5,Adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,13,IHC staining not done,1,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,173.0,82.0,27.37,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",0.3,Exposure to secondhand smoke history not available,Prostate Cancer,Surgery,aspirin|Calcium-Magnesium |flonase|glucosa-chondr-Na|krill oil|losartan|Restasis 0.05% OPHTH Emulsion|tiotropium ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1545.0,,,1545.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1545.0,0.0,0.0
C3L-01890,LUAD,C3L-01890-T,C3L-01890-N,,,0.0,CPT0092940003,CPT0092930003,CPT0092930006,CPT0092940006,CPT0092930008,CPT0092940009,CPT0093850002,58,Female,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,3.0,Lepidic adenocarcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,15,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,,153.0,53.0,22.6,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,33.0,Exposure to secondhand smoke history not available,,,albuterol|Norvasc|Lotensin|symbicort|zyrtec|norco|spiriva,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,671.0,,,671.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,671.0,0.0,0.0
C3N-00572,LUAD,C3N-00572-T,C3N-00572-N,,,0.0,CPT0015420003,CPT0015410003,['CPT0015410006'],CPT0015420006,CPT0015410009,CPT0015420009,CPT0015440002,48,Female,Unknown,Unknown,East_Asian,Vietnam,No,,Right,Unifocal,2.0,"Adenocarcinoma, mixed subtype",G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,2,IHC staining not done,0,cM0,Staging Incomplete,Not documented,R0:No residual tumor,,156.0,44.0,18.08,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,431.0,,,431.0,,No,No,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,431.0,0.0,0.0
C3N-02423,LUAD,C3N-02423-T,C3N-02423-N,,,0.0,CPT0147000003,CPT0146980004,CPT0146980007,CPT0147000006,CPT0146980010,CPT0147000009,CPT0147010002,70,Male,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,3.0,Adenocarcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,31,IHC staining not done,0,cM0,Staging Incomplete,NO,R0:No residual tumor,,168.0,79.0,27.99,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,100.0,Exposure to secondhand smoke history not available,,,adalat,Self-reported and Medical Record,No,695.0,,,701.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,695.0,0.0,6.0
C3N-02729,LUAD,C3N-02729-T,C3N-02729-N,,,0.0,CPT0148300003,CPT0148280004,CPT0148280007,CPT0148300006,CPT0148280010,CPT0148300009,CPT0148310002,45,Male,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,4.5,Adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,15,IHC staining not done,0,cM0,Staging Incomplete,no,R0:No residual tumor,"HER2（-）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,10％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（-），P40（-） Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（+），NapsinA（+），CK20（-），CK5/6（-）",173.0,60.0,20.05,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,694.0,820.0,Unknown,,832.0,No,Yes,No,Complete Remission,Complete Remission,Yes,640.0,Distant Metastasis,"Lung, Brain",,Convincing Image (i.e. CT/PET/MRI),,No,,No,No,No,,,640.0,1.0,820.0,1.0,12.0
C3L-00263,LUAD,C3L-00263-T,C3L-00263-N,,,0.0,CPT0011750003,CPT0011710004,['CPT0011710010'],CPT0011750005,CPT0011710007,CPT0011750008,CPT0012420002,79,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,6.5,Adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,11,IHC staining not done,0,cM0,Staging Incomplete,None specified,RX:Presence of residual tumor cannot be assessed,,188.0,80.0,22.77,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,27.0,Exposure to secondhand smoke history not available,,,"Chlorhexidine Gluconate|Scrub, Isopropyl|Alcohol, Duraprep|0.25% Marcaine with EPI|1.5g Zinacef IV|Bupivacaine 0.25%|Epinephrine|Hydromorphine|Ondansetron|Lactated Ringers|SEVO|Fentanyl|Rocuronium|Zofran|Propofol/Lido|Versed|Amiodarone|Ascorbic Acid|Aspirin|Cholecalciferol|Digoxin|Docusate|Doxazosin|Enoxaparin|Metoprolol|Multivitamin with Minerals|Nitroglycerin|Omega-3 Polyunsaturated Fatty Acids|Oxycodone|Saw Palmetto|Simvastatin|Warfarin",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,1157.0,,,1157.0,,No,No,No,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,1157.0,0.0,0.0
C3N-01410,LUAD,C3N-01410-T,C3N-01410-N,,,0.0,CPT0118010003,CPT0117970003,CPT0117970006,CPT0118010006,CPT0117970009,CPT0118010009,CPT0119210002,64,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Not specified,Right,Unifocal,5.0,Solid adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Cannot be assessed,Seventh Edition (2010),pT3,pN0,4,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,160.0,48.0,18.75,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,436.0,,,436.0,,No,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,436.0,0.0,0.0
C3N-00578,LUAD,C3N-00578-T,C3N-00578-N,,,0.0,CPT0069370003,CPT0069360003,['CPT0069360009'],CPT0069370006,CPT0069360006,CPT0069370009,CPT0069450002,48,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Not Applicable,Left,Unifocal,4.0,Colloid adenocarcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,15,IHC staining not done,5,cM0,Staging Incomplete,Not known,R0:No residual tumor,,170.0,64.0,22.15,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,6.3,No or minimal exposure to secondhand smoke,,,,,No,24.0,24.0,Unknown,,24.0,Unknown,Yes,No,Not Applicable,,Unknown,,,,,,,,,,,,,,,0.0,24.0,1.0,0.0
C3N-02587,LUAD,C3N-02587-T,C3N-02587-N,,,0.0,CPT0148100003,CPT0148080004,CPT0148080007,CPT0148100006,CPT0148080010,CPT0148100009,CPT0148110002,59,Female,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,2.0,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,10,IHC staining not done,0,cM0,Staging Incomplete,no,R0:No residual tumor,"HER2（-）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,5％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（-），P40（-）  Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（+），NapsinA（+），CK20（-），CK5/6（-）",151.0,50.0,21.93,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Telmisartan|gliclazide,Self-reported and Medical Record|Self-reported and Medical Record,No,1111.0,,,1123.0,,No,No,No,Not Applicable,Not Applicable,No,,,,,,,,,,,,,,,0.0,1111.0,0.0,12.0
C3L-00893,LUAD,C3L-00893-T,C3L-00893-N,,,0.0,CPT0083140003,CPT0083100003,['CPT0083100006'],CPT0083140006,CPT0083100009,CPT0083140009,CPT0081760002,71,Male,Unknown,Hispanic or Latino,Ad_Mixed_American,United States,No,,Right,Unifocal,3.5,Acinar adenocarcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,17,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,173.0,87.0,29.1,No,"Consumed alcohol in the past, but currently a non-drinker","Current reformed smoker, more than 15 years",40.0,Exposure to secondhand smoke history not available,,,Losartan Potassium|Metoprolol Tartrate|Naproxen|Atorvastatin|Flecainide|Savaysa,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,No,23.0,,,23.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,23.0,0.0,0.0
C3N-01488,LUAD,C3N-01488-T,C3N-01488-N,,,0.0,CPT0118180003,CPT0118160003,CPT0118160006,CPT0118180006,CPT0118160009,CPT0118180009,CPT0119390002,54,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Not specified,Right,Unifocal,4.0,Adenocarcinoma,G3 Poorly differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT2a,pN0,8,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,170.0,50.0,17.3,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,5.0,No or minimal exposure to secondhand smoke,,,,,No,409.0,,,409.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,409.0,0.0,0.0
C3N-01413,LUAD,C3N-01413-T,C3N-01413-N,,,0.0,CPT0105550003,CPT0105510003,CPT0105510006,CPT0105550006,CPT0105510009,CPT0105550009,CPT0107980002,62,Female,Unknown,Unknown,East_Asian,Vietnam,No,,Left,Unifocal,4.0,Adenocarcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,1,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,153.0,70.0,29.9,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,444.0,,,444.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,444.0,0.0,0.0
C3N-01030,LUAD,C3N-01030-T,C3N-01030-N,,,0.0,CPT0091260003,CPT0091240003,CPT0091240006,CPT0091260005,CPT0091240009,CPT0091260008,CPT0091500002,56,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Right,Unifocal,4.5,squamous versus adenocarcinoma pending IHC,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,6,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,168.0,65.0,23.03,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,443.0,,,443.0,,Yes,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,443.0,0.0,0.0
C3N-02588,LUAD,C3N-02588-T,C3N-02588-N,,,0.0,CPT0148200003,CPT0148180004,CPT0148180007,CPT0148200006,CPT0148180010,CPT0148200009,CPT0148210002,69,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,4.5,Adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,39,IHC staining not done,0,cM0,pM1b,no,R0:No residual tumor,,180.0,80.0,24.69,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,1106.0,,,1121.0,,No,No,No,Not Applicable,Not Applicable,No,,,,,,,,,,,,,,,0.0,1106.0,0.0,15.0
C3N-00552,LUAD,C3N-00552-T,C3N-00552-N,,,0.0,CPT0068130003,CPT0068100003,['CPT0068100009'],CPT0068130006,CPT0068100006,CPT0068130009,CPT0068210002,49,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other Not otherwise specified,Right,Unifocal,5.0,Solid adenocarcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,4,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,156.0,50.0,20.55,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,396.0,,,396.0,,No,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,396.0,0.0,0.0
C3L-01889,LUAD,C3L-01889-T,C3L-01889-N,,,0.0,CPT0092250003,CPT0092240003,CPT0092240006,CPT0092250006,CPT0092240009,CPT0092250009,CPT0093760002,71,Female,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,2.2,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,12,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,,167.0,98.0,35.03,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",60.0,Exposure to secondhand smoke history not available,,,Alprazolam|Augmented Betamethasone Dipropionate Ointment|B Complex PO|Cholecalciferol|Clobetasol Ointment|Diphenhydramine|Estradiol|Hydroxyzine|Ibuprofen|Levothyroxine|Mometasone|Omega-3 Fatty Acids|Pravastatin|Probiotic Product|Tumeric PO,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1799.0,,,1799.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1799.0,0.0,0.0
C3N-00169,LUAD,C3N-00169-T,C3N-00169-N,,,0.0,CPT0014930003,CPT0014860003,['CPT0014860006'],CPT0014930006,CPT0014860009,CPT0014930009,CPT0016620002,57,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Not otherwise specified,Left,Unifocal,4.0,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,1,IHC staining not done,0,cM0,Staging Incomplete,Not documented,R0:No residual tumor,,170.0,66.0,22.84,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,12.0,No or minimal exposure to secondhand smoke,,,,,No,376.0,,,376.0,,Yes,Yes,No,Unknown,,No,,,,,,,,,,,,,,,0.0,376.0,0.0,0.0
C3L-00422,LUAD,C3L-00422-T,C3L-00422-N,,,0.0,CPT0082890003,CPT0082850004,['CPT0082850007'],CPT0082890006,CPT0082850010,CPT0082890009,CPT0081740002,35,Female,Unknown,Hispanic or Latino,Ad_Mixed_American,United States,No,,Left,Unifocal,3.5,Adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,16,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,160.0,100.0,39.05,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Fentanyl|Cefazolin/D5W|Levofloxacin|Naproxen|Methocarbamol|Cetirizine|Atorvastatin|Ethinyl Estradiol-Norgestimate|Fentanyl|Alamine Lotion|Ortho Tri-Cyclen|Zyrtec,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,1916.0,,,1916.0,,No,No,No,Unknown,Complete Remission,No,,,,,,,,,,,,,,,0.0,1916.0,0.0,0.0
C3L-00083,LUAD,C3L-00083-T,C3L-00083-N,,,0.0,CPT0091870003,CPT0091860003,CPT0091860006,CPT0091870006,CPT0091860013,CPT0091870009,CPT0093680002,71,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,5.0,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,20,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,,177.0,92.0,29.37,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,Lisinopril-hydrochlorothiazide|Lisinopril|Metoprolol Succinate XL|Amoxicillin|Aspirin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1790.0,,,1790.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1790.0,0.0,0.0
C3N-00551,LUAD,C3N-00551-T,C3N-00551-N,,,0.0,CPT0067950003,CPT0067940003,['CPT0067940009'],CPT0067950006,CPT0067940006,CPT0067950009,CPT0068030002,54,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,,Unifocal,5.0,Mixed acinar and micropapillary adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,2,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,170.0,52.0,17.99,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,7.0,No or minimal exposure to secondhand smoke,,,,,No,391.0,,,391.0,,No,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,391.0,0.0,0.0
C3N-01842,LUAD,C3N-01842-T,,,,0.0,,CPT0098130003,CPT0098130006,,CPT0098130009,,CPT0098170002,69,Male,Unknown,Unknown,European,Ukraine,No,,Right,Unifocal,2.0,Adenocarcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,1,IHC staining not done,0,cM0,Staging Incomplete,No,R0:No residual tumor,,173.0,95.0,31.74,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Enalapril|Glibenclamide,Medical Record|Medical Record,No,681.0,,,681.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,681.0,0.0,0.0
C3N-02089,LUAD,C3N-02089-T,C3N-02089-N,,,0.0,CPT0118360003,CPT0118340003,CPT0118340009,CPT0118360006,CPT0118340006,CPT0118360009,CPT0119570002,76,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Not specified,Right,Unifocal,5.5,Acinar adenocarcinoma,G3 Poorly differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT2a,pN0,7,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,167.0,62.0,22.23,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,403.0,,,398.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,403.0,0.0,-5.0
C3L-01682,LUAD,C3L-01682-T,C3L-01682-N,,,0.0,CPT0110890003,CPT0110860004,CPT0110860007,CPT0110890006,CPT0110860010,CPT0110890009,CPT0112370002,78,Female,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,3.5,Acinar adenocarcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,1,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,,R0:No residual tumor,,163.0,64.0,24.2,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",9.0,Yes,,,Evista|Florinef|synthroid |Gabpentin|Cyclobenzaprine,Self Report|Self Report|Self Report|Self Report|Self Report,No,1617.0,,,1555.0,,No,No,No,Not Applicable,Unknown,No,,,,,,,,,,,,,,,0.0,1617.0,0.0,-62.0
C3N-01016,LUAD,C3N-01016-T,C3N-01016-N,,,0.0,CPT0083810003,CPT0083780003,['CPT0083780009'],CPT0083810006,CPT0083780006,CPT0083810009,CPT0083830002,56,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Right,Unifocal,4.0,Acinar adenocarcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,6,IHC staining not done,1,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,160.0,51.0,19.92,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,3.5,No or minimal exposure to secondhand smoke,,,,,No,428.0,,,428.0,,No,Yes,No,Persistent Disease,,Yes,306.0,Locoregional Recurrence,Other,Bilateral cervical lymph nodes,Biopsy with Histologic Confirmation,No,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,,,306.0,1.0,428.0,0.0,0.0
C3N-00580,LUAD,C3N-00580-T,C3N-00580-N,,,0.0,CPT0069720003,CPT0069700003,['CPT0069700009'],CPT0069720006,CPT0069700006,CPT0069720009,CPT0069800002,56,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Left,Unifocal,4.5,Papillary adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,4,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,168.0,54.0,19.13,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,6.3,No or minimal exposure to secondhand smoke,,,,,No,386.0,,,386.0,,No,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,386.0,0.0,0.0
11LU013,LUAD,11LU013-T,,,,0.0,,CPT0053040004,['CPT0053040007'],,CPT0053040010,,CPT0040210002,59,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Left,Unifocal,6.0,not specified,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,7,IHC staining not done,4,cM0,Staging Incomplete,none,R0:No residual tumor,,156.0,52.0,21.37,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,Yes,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3N-02000,LUAD,C3N-02000-T,C3N-02000-N,,,0.0,CPT0109700003,CPT0109680004,CPT0109680007,CPT0109700006,CPT0109680010,CPT0109700009,CPT0139090002,46,Female,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,2.5,Adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN1,14,IHC staining not done,2,cM0,Staging Incomplete,NO,R0:No residual tumor,"HER2（focally +）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+, 10％），β-Cat（membranous +）, P63（-）, ERCC1（-）, RRM1（+）, Syn（-），P40（+） Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（partial +），NapsinA（+），CK20（-），CK5/6（-）",162.0,63.0,24.01,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,azithromycin ,Medical Record,No,1086.0,,,1091.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,1086.0,0.0,5.0
C3N-01489,LUAD,C3N-01489-T,C3N-01489-N,,,0.0,CPT0105980003,CPT0105940003,CPT0105940006,CPT0105980006,CPT0105940009,CPT0105980009,CPT0108270002,65,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Right,Unifocal,3.5,Adenocarcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,14,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,170.0,48.0,16.61,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,434.0,,,427.0,,Yes,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,434.0,0.0,-7.0
C3N-00737,LUAD,C3N-00737-T,C3N-00737-N,,,0.0,CPT0090200003,CPT0090170004,CPT0090170007,CPT0090200006,CPT0090170010,CPT0090200008,CPT0091440002,71,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,2.2,adenocarcinoma with neuroendocrine differentiation,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,10,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,170.0,83.0,28.5,No,Lifelong non-drinker,Current reformed smoker within past 15 years,50.0,Exposure to secondhand smoke history not available,,,,,No,384.0,,,384.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,384.0,0.0,0.0
C3N-01405,LUAD,C3N-01405-T,C3N-01405-N,,,0.0,CPT0105370004,CPT0105330003,CPT0105330006,CPT0105370007,CPT0105330009,CPT0105370010,CPT0107800002,59,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Right,Unifocal,5.0,Solid adenocarcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,4,IHC staining not done,0,cM0,Staging Incomplete,Not Specified,R0:No residual tumor,,167.0,50.0,17.93,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,418.0,,,418.0,,Unknown,Yes,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,418.0,0.0,0.0
C3N-01416,LUAD,C3N-01416-T,C3N-01416-N,,,0.0,CPT0105740003,CPT0105710003,CPT0105710006,CPT0105740006,CPT0105710009,CPT0105740009,CPT0108160002,67,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Left,Unifocal,3.5,Acinar adenocarcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,4,IHC staining not done,1,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,170.0,48.0,16.61,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,434.0,,,434.0,,Yes,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,434.0,0.0,0.0
C3N-02149,LUAD,C3N-02149-T,C3N-02149-N,,,0.0,CPT0118650003,CPT0118620003,CPT0118620009,CPT0118650006,CPT0118620006,CPT0118650009,CPT0119870002,64,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Not specified,Right,Unifocal,6.0,Acinar adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Cannot be assessed,Seventh Edition (2010),pT3,pN0,7,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,160.0,50.0,19.53,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,3.8,No or minimal exposure to secondhand smoke,,,,,No,413.0,,,406.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,413.0,0.0,-7.0
C3N-02424,LUAD,C3N-02424-T,C3N-02424-N,,,0.0,CPT0147100003,CPT0147080004,CPT0147080007,CPT0147100006,CPT0147080010,CPT0147100009,CPT0147110002,64,Male,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,5.0,Adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,8,IHC staining not done,5,cM0,Staging Incomplete,NO,R0:No residual tumor,,164.0,64.0,23.8,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,30.0,Exposure to secondhand smoke history not available,,,,,No,355.0,,,365.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,355.0,0.0,10.0
C3L-00279,LUAD,C3L-00279-T,C3L-00279-N,,,0.0,CPT0082770003,CPT0082740004,['CPT0082740007'],CPT0082770006,CPT0082740010,CPT0082770009,CPT0081730001,72,Female,White,Unknown,European,United States,No,,Left,Unifocal,4.0,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,12,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,165.0,75.0,27.45,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,"NaCl 0.9%|Cyanocobalamin 500 mcg|Calcium Carbonate 1500 mg|Pantoprazole 40 mg EC|Atorvastatin 10mg|Magnesium Oxide|Heparin 5,000|Ascorbic Acid 500 mg|Omega-3 Fish Oil|Oxycodone/Acetaminophen|Acitaminophen 325 mg|Mg Hydrox/ALh/smc|Docusate Sodium|Magnesium sulf/SW|Magnesium Sulf/D5W|Morphine 2 mg/mL|Ondansetron 2 mg/mL|Potassium Cl/SW Premix|Potassium Chloride 10%|Promethazine/NS|Promethazine 12.5 mg Supp|Sotalol 60 mg|Vitamin E 400|Losartan 50 mg|Calcium Carbonate|Vitamin B-12|Heparin 1,000|Diphenhydramine 50 mg/mL|Fentanyl 50 mcg/mL|Flumazenil 0.1 mg/mL|Midazolam 1 mg|Naloxone 0.4 mg/mL|Cholecalciferol|Enoxaparin|Dabigatran|Omeprazole|Spiriva|Advair|Simvastatin|Plavix|Metropolol",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,606.0,,,606.0,,No,No,No,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,606.0,0.0,0.0
C3N-02379,LUAD,C3N-02379-T,C3N-02379-N,,,0.0,CPT0146600003,CPT0146580004,CPT0146580007,CPT0146600006,CPT0146580010,CPT0146600009,CPT0146610002,57,Female,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,4.0,Adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,24,IHC staining not done,4,cM0,Staging Incomplete,no,R0:No residual tumor,"HER2(partial +), TTF1(+), EGFR(+),CK7(+),Ki-67(+, 60％),β-Cat(membranous +), P63(partial+), ERCC1(+), RRM1(+), Syn(-),P40(-) Immunohistochemistry:GATA3(-), ALK(Ventana)(-), ALK-Neg-Tissue(-),CDX2(-),SPA(partial +),NapsinA(partial +),CK20(-),CK5/6(-)",168.0,65.0,23.03,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,429.0,443.0,Unknown,,450.0,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,443.0,1.0,7.0
C3L-00095,LUAD,C3L-00095-T,C3L-00095-N,,,0.0,CPT0001690003,CPT0001660013,['CPT0001660008'],CPT0001690006,CPT0001660005,CPT0001690009,CPT0003910002,62,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,2.4,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,13,IHC staining not done,0,cM0,Staging Incomplete,Not Applicable,R0:No residual tumor,,175.0,106.0,34.61,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,25.0,Exposure to secondhand smoke history not available,,,Insulin Glargine|Trazodone|Albuterol Sulfate|Lisinopril|Glimepiride|Furosemide|Ipratropium|Metformin|Atorvastatin,Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report,No,1794.0,,,1794.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1794.0,0.0,0.0
C3N-02572,LUAD,C3N-02572-T,C3N-02572-N,,,0.0,CPT0147600003,CPT0147580004,CPT0147580007,CPT0147600006,CPT0147580010,CPT0147600009,CPT0147610002,49,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,3.0,Adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,16,IHC staining not done,4,cM0,Staging Incomplete,no,R0:No residual tumor,,169.0,70.0,24.51,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,melbine|acarbose,Medical Record|Medical Record,No,1135.0,,,1141.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1135.0,0.0,6.0
C3N-00559,LUAD,C3N-00559-T,C3N-00559-N,,,0.0,CPT0068650003,CPT0068610003,['CPT0068610006'],CPT0068650006,CPT0068610009,CPT0068650009,CPT0068730002,55,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Left,Unifocal,2.5,Acinar adenocarcinoma and papillary adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,8,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,152.0,48.0,20.78,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,398.0,,,398.0,,No,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,398.0,0.0,0.0
C3N-00545,LUAD,C3N-00545-T,C3N-00545-N,1.0,Failed Pathology review,0.0,CPT0066930003,CPT0066890003,"['CPT0066890009', 'CPT0066910009']",CPT0066930005,"['CPT0066890006', 'CPT0066910006']",CPT0066930008,CPT0067010002,59,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Right,Unifocal,1.2,Acinar adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a,pN2,2,IHC staining not done,0,cM0,Staging Incomplete,not specified,R0:No residual tumor,,165.0,53.0,19.47,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,21.8,No or minimal exposure to secondhand smoke,,,,,No,650.0,,,644.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,650.0,0.0,-6.0
11LU016,LUAD,11LU016-T,,,,0.0,,CPT0052940004,['CPT0052940014'],,CPT0052940010,,CPT0037120002,62,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Right,Unifocal,3.0,not specified,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN2,9,IHC staining not done,4,cM0,Staging Incomplete,none,R0:No residual tumor,,165.0,51.0,18.73,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,Yes,445.0,445.0,Main malignancy,,441.0,No,No,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,445.0,1.0,-4.0
C3L-02345,LUAD,C3L-02345-T,C3L-02345-N,,,0.0,CPT0114010003,CPT0113990003,CPT0113990006,CPT0114010006,CPT0113990009,CPT0114010009,CPT0115310002,61,Female,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,2.8,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,16,IHC staining not done,0,cM1,No pathologic evidence of distant metastasis,Metastatic Adenocarcinoma to Left Adrenal Gland,R0:No residual tumor,"GMS/silver and AFB/Kinyoun are all Negative     PD-L1: Positive, Low Expression, TPS: 2%",172.0,67.0,22.55,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,25.0,Exposure to secondhand smoke history not available,Skin Cancer,Unknown,Estradiol|Crestor|Aspirin|Calcium Carbonate / Vitamin D3|Cholecalciferol|Glucosamine-Chondroitin Complex|Super B Complex-Vitamin C|Flaxseed Oil|Womens Multi-Vitamin|Pristiq,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1376.0,,,1376.0,,No,Yes,Yes,Persistent Disease,Persistent Disease,Yes,351.0,Distant Metastasis,Other,Right adrenal mass ,Convincing Image (i.e. CT/PET/MRI),,Yes,RX: Presence of Residual Tumor cannot be assessed,Unknown,Unknown,Yes,,376.0,351.0,1.0,1376.0,0.0,0.0
C3L-00093,LUAD,C3L-00093-T,C3L-00093-N,,,0.0,CPT0086320003,CPT0086310003,CPT0086310006,CPT0086320006,CPT0086310009,CPT0086320009,CPT0087370002,66,Female,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,3.0,"Adenocarcinoma, acinar predominant ",G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,10,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,,157.0,84.0,34.08,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,Endometrial Carcinoma,Surgery,Tramadol|Meformin-XR|Lisinopril|Amlodipine|Carvedilol|Atorvastatin|Krill Oil PO|Grape Seed Extract|Tumeric|Resveratrol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1698.0,1703.0,Main malignancy,,1703.0,No,No,No,Not Applicable,Persistent Disease,Yes,382.0,Locoregional Recurrence,Lung,,Convincing Image (i.e. CT/PET/MRI),No,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,,,382.0,1.0,1703.0,1.0,0.0
C3L-00510,LUAD,C3L-00510-T,C3L-00510-N,,,0.0,CPT0011930003,CPT0011910004,['CPT0011910014'],CPT0011930006,CPT0011910007,CPT0011930009,CPT0012490002,80,Female,Unknown,Unknown,Ad_Mixed_American,United States,No,,Right,Unifocal,2.8,Adenocarcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,4,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R2:Macroscopic residual tumor,,165.0,85.0,31.35,No,Lifelong non-drinker,Current reformed smoker within past 15 years,,Exposure to secondhand smoke history not available,,,Aleve|Multivitamins|Tetrofosmin|Acetaminophen|Benzonatate|Levaquin|Lasix|Tessalon Perles|Aspirin|Omega-3|Polyunsaturated Fatty Acids,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,38.0,,,40.0,,Unknown,Unknown,Unknown,Unknown,,No,,,,,,,,,,,,,,,0.0,38.0,0.0,2.0
C3L-00913,LUAD,C3L-00913-T,C3L-00913-N,,,0.0,CPT0106100003,CPT0106110003,CPT0106110006,CPT0106100006,CPT0106110009,CPT0106100008,CPT0107080002,66,Male,White,Not Hispanic or Latino,European,United States,No,Other Upper lobe extending into middle lobe,Right,Unifocal,7.5,Adenocarcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,19,IHC staining not done,1,cM1,No pathologic evidence of distant metastasis,Extension into the chest wall at the right posterior 5th and 6th ribs.,R0:No residual tumor,,182.0,56.0,16.91,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,100.0,Exposure to secondhand smoke history not available,,,Senna-docusate|Morphine ER|Hydromorphone,Medical Record|Medical Record|Medical Record,No,73.0,73.0,Main malignancy,,73.0,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,73.0,1.0,0.0
11LU022,LUAD,11LU022-T,,,,0.0,,CPT0052170004,['CPT0052170014'],,CPT0052170010,,CPT0038140002,53,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Left,Unifocal,4.0,not specified,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,2,IHC staining not done,0,cM0,Staging Incomplete,,R0:No residual tumor,,159.0,55.0,21.76,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,Yes,7.0,,,0.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,7.0,0.0,-7.0
C3L-00412,LUAD,C3L-00412-T,C3L-00412-N,,,0.0,CPT0023320003,CPT0023310003,['CPT0023310009'],CPT0023320006,CPT0023310006,CPT0023320009,CPT0024540002,64,Male,American Indian or Alaska Native,Not Hispanic or Latino,European,United States,No,,Right,Multifocal,2.2,Acinar adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN2,32,IHC staining not done,11,Staging Incomplete,Staging Incomplete,,R0:No residual tumor,,183.0,84.0,25.12,No,Lifelong non-drinker,Current reformed smoker within past 15 years,46.0,Exposure to secondhand smoke history not available,,,bactroban|nicoderm|elavil|prilosec|plavix|celexa|toprolol|proventil|flomax|albuterol|neurontin|lipitor|alavert|asa|duoneb|multiple vitamins|vitamin B complex|KEPPRA,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,162.0,162.0,Main malignancy,,162.0,Yes,Yes,No,Persistent Disease,,Yes,72.0,Both Locoregional and Distant Metastasis,"Bone, Other",Anterior left pelvis ,Convincing Image (i.e. CT/PET/MRI),No,No,,Yes,Yes,No,,,72.0,1.0,162.0,1.0,0.0
C3N-01415,LUAD,C3N-01415-T,C3N-01415-N,,,0.0,CPT0105680003,CPT0105630003,CPT0105630006,CPT0105680006,CPT0105630009,CPT0105680009,CPT0108100002,72,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Left,Unifocal,5.0,Adenocarcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,8,IHC staining not done,1,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,170.0,48.0,16.61,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,792.0,,,420.0,,No,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,792.0,0.0,-372.0
C3N-00549,LUAD,C3N-00549-T,C3N-00549-N,,,0.0,CPT0067470004,CPT0067450003,['CPT0067450009'],CPT0067470007,CPT0067450006,CPT0067470010,CPT0067550002,58,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Left,Unifocal,5.0,"Adenocaricnoma, mixed sub-type (solid and acinar)",G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,5,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,168.0,60.0,21.26,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,5.0,No or minimal exposure to secondhand smoke,,,,,No,791.0,,,785.0,,Yes,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,791.0,0.0,-6.0
C3N-02433,LUAD,C3N-02433-T,C3N-02433-N,,,0.0,CPT0147400003,CPT0147380004,CPT0147380007,CPT0147400006,CPT0147380010,CPT0147400009,CPT0147410002,68,Female,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,2.5,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,12,IHC staining not done,0,cM0,Staging Incomplete,no,R0:No residual tumor,"HER2（+）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,8％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（-），P40（-） Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（+），NapsinA（+），CK20（-），CK5/6（-）",165.0,74.0,27.18,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,1137.0,,,1144.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1137.0,0.0,7.0
C3N-01021,LUAD,C3N-01021-T,C3N-01021-N,,,0.0,CPT0105010004,CPT0104970003,CPT0104970006,CPT0105010007,CPT0104970009,CPT0105010010,CPT0107560002,44,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Left,Unifocal,3.5,Acinar adenocarcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,13,IHC staining not done,10,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,158.0,50.0,20.03,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,434.0,,,428.0,,No,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,434.0,0.0,-6.0
C3N-00203,LUAD,C3N-00203-T,C3N-00203-N,,,0.0,CPT0090370003,CPT0090340003,CPT0090340006,CPT0090370006,CPT0090340009,CPT0090370009,CPT0092480002,72,Male,Unknown,Unknown,European,Bulgaria,No,,Left,Unifocal,5.2,Squamous cell carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,6,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,173.0,60.0,20.05,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,49.0,Yes,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3L-01330,LUAD,C3L-01330-T,C3L-01330-N,,,0.0,CPT0083420003,CPT0083390004,CPT0083390010,CPT0083420006,CPT0083390007,CPT0083420009,CPT0081800001,68,Female,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,2.5,Acinar adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,7,0,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,168.0,113.0,40.11,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",2.0,Yes,,,Celecoxib|Metoprolol|Losartan|Topiramate|Esomeeprazole|Calcium 1000|Glucosamine-Chondroitin|Hydrocortisone|Nexium,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1595.0,,,1595.0,,Unknown,Unknown,Unknown,Unknown,Complete Remission,No,,,,,,,,,,,,,,,0.0,1595.0,0.0,0.0
C3N-00574,LUAD,C3N-00574-T,C3N-00574-N,,,0.0,CPT0090900004,CPT0090860003,CPT0090860006,CPT0090900007,CPT0090860013,CPT0090900010,CPT0090980002,40,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Right,Unifocal,3.0,Adenosquamous carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,4,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,162.0,57.0,21.72,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,397.0,,,392.0,,No,Yes,No,Persistent Disease,,Yes,199.0,Locoregional Recurrence,Other,Columnar Bone and Pleura,Convincing Image (i.e. CT/PET/MRI),No,,RX: Presence of Residual Tumor cannot be assessed,No,No,Unknown,,,199.0,1.0,397.0,0.0,-5.0
11LU035,LUAD,11LU035-T,,,,0.0,,CPT0051690004,['CPT0051690007'],,CPT0051690010,,CPT0034540002,59,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Right,Unifocal,3.0,not specified,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,3,IHC staining not done,0,cM0,Staging Incomplete,none,R0:No residual tumor,,168.0,57.0,20.2,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,5.0,No or minimal exposure to secondhand smoke,,,,,Yes,7.0,,,0.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,7.0,0.0,-7.0
C3N-01071,LUAD,C3N-01071-T,C3N-01071-N,,,0.0,CPT0070080003,CPT0070060003,['CPT0070060009'],CPT0070080006,CPT0070060006,CPT0070080009,CPT0070160002,48,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Right,Unifocal,2.5,Acinar adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,4,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,165.0,57.0,20.94,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,30.0,No or minimal exposure to secondhand smoke,,,,,No,44.0,,,9.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,44.0,0.0,-35.0
C3N-00550,LUAD,C3N-00550-T,C3N-00550-N,,,0.0,CPT0067770003,CPT0067620003,['CPT0067620009'],CPT0067770006,CPT0067620006,CPT0067770009,CPT0067850002,52,Female,Unknown,Unknown,East_Asian,Vietnam,No,,Left,Unifocal,4.0,Papillary adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,20,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,173.0,72.0,24.06,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,401.0,,,396.0,,Yes,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,401.0,0.0,-5.0
C3N-00167,LUAD,C3N-00167-T,C3N-00167-N,,,0.0,CPT0013630003,CPT0013600003,['CPT0013600013'],CPT0013630006,CPT0013600009,CPT0013630009,CPT0016510002,64,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Right,Unifocal,2.5,Acinar adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN1,7,IHC staining not done,4,cM0,No pathologic evidence of distant metastasis,Not documented,R0:No residual tumor,,168.0,50.0,17.72,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,842.0,,,835.0,,Yes,Yes,No,Persistent Disease,,Yes,336.0,Distant Metastasis,Bone,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,,,336.0,1.0,842.0,0.0,-7.0
C3L-00001,LUAD,C3L-00001-T,C3L-00001-N,,,0.0,CPT0001590003,CPT0001580009,CPT0001580164,CPT0001590005,CPT0001580165,CPT0001590008,CPT0000150163,61,Female,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,3.7,Adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,8,IHC staining not done,1,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,,180.0,72.0,22.03,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Yes,,,Restasis|hydroxychloroquine|pilocarpine|Calcium 600 + D|Omega-3|triamcinolone acetonide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1837.0,,,1837.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1837.0,0.0,0.0
C3N-01074,LUAD,C3N-01074-T,,,,0.0,,CPT0105270003,CPT0105270006,,CPT0105270009,,CPT0107740002,56,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Left,Unifocal,4.0,Solid adenocarcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,3,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,157.0,62.0,25.15,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,229.0,229.0,Unknown,,225.0,Unknown,Unknown,Unknown,Patient Deceased,,Unknown,,,,,,,,,,,,,,,0.0,229.0,1.0,-4.0
C3L-01632,LUAD,C3L-01632-T,C3L-01632-N,,,0.0,CPT0086770003,CPT0086750003,CPT0086750006,CPT0086770006,CPT0086750009,CPT0086770009,CPT0087410002,60,Female,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,3.5,"Adenocarcinoma, micropapillary and acinar",G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,11,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,,177.0,127.0,40.67,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,NovoLog|Levemir|Acetaminophen-oxycodone|Aspirin|Hydrochlorothiazide|Lovastatin,Self Report|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,717.0,717.0,Main malignancy,,717.0,No,Yes,No,Persistent Disease,,Yes,298.0,Distant Metastasis,Bone,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,Yes,No,No,,,298.0,1.0,717.0,1.0,0.0
C3N-02155,LUAD,C3N-02155-T,C3N-02155-N,,,0.0,CPT0118830003,CPT0118810003,CPT0118810009,CPT0118830006,CPT0118810006,CPT0118830009,CPT0120050002,45,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Not specified,Left,Unifocal,6.0,Adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Cannot be assessed,Seventh Edition (2010),pT3,pN0,11,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,165.0,56.0,20.57,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,5.0,No or minimal exposure to secondhand smoke,,,,,No,423.0,,,416.0,,Yes,Yes,No,Persistent Disease,,Yes,338.0,Distant Metastasis,Brain,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,Yes,No,No,,,338.0,1.0,423.0,0.0,-7.0
C3N-00217,LUAD,C3N-00217-T,C3N-00217-N,,,0.0,CPT0090600003,CPT0090570004,CPT0090570007,CPT0090600006,CPT0090570010,CPT0090600009,CPT0092500002,59,Female,Unknown,Unknown,European,Bulgaria,No,,Left,Unifocal,3.2,Acinar adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,17,IHC staining not done,0,cM0,Staging Incomplete,not specified,R0:No residual tumor,,165.0,70.0,25.71,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,29.0,Exposure to secondhand smoke history not available,,,,,No,668.0,,,668.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,668.0,0.0,0.0
C3N-02002,LUAD,C3N-02002-T,C3N-02002-N,,,0.0,CPT0109710003,CPT0109720004,CPT0109720007,CPT0109710006,CPT0109720010,CPT0109710009,CPT0139130002,76,Male,Unknown,Unknown,East_Asian,China,No,,Right,Multifocal,2.8,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,15,IHC staining not done,0,cM0,Staging Incomplete,no,R0:No residual tumor,"HER2（weak +）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,10％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（+），P40（-） Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-）,CDX2（-）,SPA（+）,NapsinA（+）,CK20（-）,CK5/6（-）",171.0,64.0,21.89,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,prostate cancer,Surgery,Bicalutamide|ZoLadex,Medical Record|Medical Record,No,355.0,,,358.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,355.0,0.0,3.0
C3N-02145,LUAD,C3N-02145-T,C3N-02145-N,,,0.0,CPT0118600003,CPT0118570003,CPT0118570009,CPT0118600006,CPT0118570006,CPT0118600008,CPT0119810002,68,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other Not specified,,Unifocal,3.0,Acinar adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT2a,pN0,9,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,153.0,55.0,23.5,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,405.0,,,399.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,405.0,0.0,-6.0
C3N-02586,LUAD,C3N-02586-T,C3N-02586-N,,,0.0,CPT0148000003,CPT0147980004,CPT0147980007,CPT0148000006,CPT0147980010,CPT0148000009,CPT0148010002,73,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,3.1,Adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,23,IHC staining not done,2,cM0,Staging Incomplete,no,R0:No residual tumor,HER2（-），TTF1（+），EGFR（+），CK7（+），Ki-67（+，5%），β-Cat（membrane +），P63（-），ERCC1（-），RRM1（partly week+），Syn（-），P40(-) Immunohistochemistry:GATA3（-），ALK(Ventana)（-），ALK-Neg-Tissue（-），CDX2（-），SPA（focal +），NapsinA（+），CK20（-），CK5/6（-）,176.0,74.0,23.89,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,41.0,Exposure to secondhand smoke history not available,,,aspirin|simvastatin|enalapril,Medical Record|Medical Record|Medical Record,No,30.0,30.0,Unknown,,41.0,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,30.0,1.0,11.0
C3L-02219,LUAD,C3L-02219-T,C3L-02219-N,,,0.0,CPT0104650003,CPT0104630003,CPT0104630006,CPT0104650006,CPT0104630009,CPT0104650009,CPT0105160002,77,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,4.5,Acinar adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,9,IHC staining not done,4,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor," TTF-1: Positive, consisten with lung origin. PAX8: Negative PD-L1: Negative, TPS: 0%",170.0,94.0,32.53,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,20.0,Exposure to secondhand smoke history not available,,,"aspirin |atorvastatin (LIPITOR)|Carboxymethylcellul-Glycerin (REFRESH OPTIVE)|clopidogrel (PLAVIX)|cyanocobalamin injection|HYDROcodone-acetaminophen (NORCO)|  lisinopril (PRINIVIL,ZESTRIL)|metoprolol tartrate (LOPRESSOR)|omeprazole (PRILOSEC) |PENTASA |potassium chloride SA",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,931.0,931.0,Main malignancy,,931.0,No,No,Yes,Persistent Disease,,Yes,217.0,Locoregional Recurrence,Lung,,Convincing Image (i.e. CT/PET/MRI),No,,RX: Presence of Residual Tumor cannot be assessed,No,No,Yes,,,217.0,1.0,931.0,1.0,0.0
C3N-00180,LUAD,C3N-00180-T,C3N-00180-N,,,0.0,CPT0066810003,CPT0066780003,['CPT0066780009'],CPT0066810006,CPT0066780006,CPT0066810009,CPT0071670002,56,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Hilar area,Left,Multifocal,4.5,Solid adenocarcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,7,IHC staining not done,1,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,170.0,50.0,17.3,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,7.5,No or minimal exposure to secondhand smoke,,,,,No,355.0,355.0,Unknown,,347.0,Unknown,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,355.0,1.0,-8.0
C3L-01862,LUAD,C3L-01862-T,,,,0.0,,CPT0092530003,CPT0092530006,,CPT0092530009,,CPT0093710002,81,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,2.7,Adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN2,14,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:No residual tumor,CDX-2 and TTF-1 are positive Histochemical Stains: Reticulin stain shows intact pleural elastic layer,177.0,88.0,28.09,Yes,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,Basal cell skin cancer ,Unknown,Aspirin|Erythromycin with ethanol|Fluticasone|Gabapentin|Multi Vitamins|Neomycin-polymyxin-dexameth|Omeprazole|Simvastatin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,581.0,594.0,Main malignancy,,594.0,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,594.0,1.0,0.0
C3N-00704,LUAD,C3N-00704-T,C3N-00704-N,,,0.0,CPT0062810003,CPT0055100004,['CPT0055100014'],CPT0062810006,CPT0055100010,,CPT0062910002,68,Female,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,1.5,Acinar adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,0,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,147.0,51.0,23.65,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,50.0,Exposure to secondhand smoke history not available,,,Ancodipine|Symbicort|Plavix|Insulin,Medical Record|Medical Record|Medical Record|Medical Record,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3N-02158,LUAD,C3N-02158-T,C3N-02158-N,,,0.0,CPT0118890003,CPT0118880003,CPT0118880009,CPT0118890006,CPT0118880006,CPT0118890009,CPT0120110002,54,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other Not specified,,Unifocal,6.0,Acinar adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Cannot be assessed,Seventh Edition (2010),pT3,pN2,7,IHC staining not done,1,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,155.0,56.0,23.31,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,423.0,,,417.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,423.0,0.0,-6.0
C3N-02421,LUAD,C3N-02421-T,C3N-02421-N,,,0.0,CPT0146800003,CPT0146780004,CPT0146780007,CPT0146800006,CPT0146780010,CPT0146800009,CPT0146810002,58,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,2.5,Adenocarcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,16,IHC staining not done,0,cM0,Staging Incomplete,no,R0:No residual tumor,,168.0,62.0,21.97,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,40.0,Exposure to secondhand smoke history not available,,,irbesartan,Medical Record,No,1171.0,,,1176.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,1171.0,0.0,5.0
C3N-00556,LUAD,C3N-00556-T,C3N-00556-N,,,0.0,CPT0090720003,CPT0090700003,CPT0090700006,CPT0090720006,CPT0090700009,CPT0090720009,CPT0090800002,69,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Left,Unifocal,6.0,"Adenosquamous carcinoma (approx. 75% adeno, 25% squamous)",G3 Poorly differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,5,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,170.0,48.0,16.61,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,394.0,,,390.0,,No,Yes,No,Not Applicable,,Yes,341.0,Both Locoregional and Distant Metastasis,Other,"Cervical and mediastinal lymph node, Columnar Bone",Biopsy with Histologic Confirmation,No,No,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,,,341.0,1.0,394.0,0.0,-4.0
C3N-00294,LUAD,C3N-00294-T,,,,0.0,,CPT0008450003,['CPT0008450009'],,CPT0008450006,,CPT0008490002,57,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,6.0,Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN1,14,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,none,R0:No residual tumor,,168.0,80.0,28.0,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",29.3,Exposure to secondhand smoke history not available,,,,,Yes,1848.0,,,1848.0,,No,No,No,Complete Remission,Patient Deceased,Yes,244.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),,Unknown,RX: Presence of Residual Tumor cannot be assessed,Unknown,Unknown,Unknown,,,244.0,1.0,1848.0,0.0,0.0
C3N-01072,LUAD,C3N-01072-T,C3N-01072-N,,,0.0,CPT0084170003,CPT0084140003,CPT0084140006,CPT0084170006,CPT0084140009,CPT0084170009,CPT0084190002,62,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Left,Unifocal,2.5,Acinar adenocarcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,2,IHC staining not done,1,cM0,Staging Incomplete,Not known,R0:No residual tumor,,165.0,55.0,20.2,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,449.0,,,442.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,449.0,0.0,-7.0
C3L-00094,LUAD,C3L-00094-T,C3L-00094-N,,,0.0,CPT0000930003,CPT0000920017,['CPT0000920012'],CPT0000930006,CPT0000920005,CPT0000930009,CPT0003900002,69,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,2.5,Adenocarcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,10,IHC staining not done,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,,188.0,128.0,36.1,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,48.0,Exposure to secondhand smoke history not available,,,Lotrel|Lipitor|Toprol XL|Glucophage|Saw Palmetto|Glucosamine Chondroitin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,889.0,889.0,Main malignancy,,889.0,No,No,No,Unknown,,Yes,638.0,New Primary Tumor,Lung,,Biopsy with Histologic Confirmation,No,,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,,,638.0,1.0,889.0,1.0,0.0
C3L-00144,LUAD,C3L-00144-T,C3L-00144-N,,,0.0,CPT0001970003,CPT0001960003,['CPT0001960008'],CPT0001970006,CPT0001960012,CPT0001970009,CPT0003980002,58,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,2.0,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,26,IHC staining not done,0,cM0,Staging Incomplete,Not applicable,RX:Presence of residual tumor cannot be assessed,,165.0,71.0,26.08,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,42.0,Exposure to secondhand smoke history not available,,,nicodern|lisinopril|ipratropium|omeprazole|motrin|flexeril|hydrodiuril|Albuterol|Advair Diskus,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,578.0,,,578.0,,No,Yes,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,578.0,0.0,0.0
C3N-00223,LUAD,C3N-00223-T,C3N-00223-N,,,0.0,CPT0111480003,CPT0111300003,CPT0111300006,CPT0111480006,CPT0111300009,CPT0111480008,CPT0111560002,69,Female,Asian,Not Hispanic or Latino,East_Asian,United States,No,,Right,Unifocal,3.1,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),"pT2a: Tumor> 3 cm but <= 4 cm in greatest dimension or tumor involving the main bronchus, invading the visceral pleura and with associated atelectasis or obstructive pneumonitis",pNO: No regional node involvement ,27,IHC staining not done,0,Unknown,Presence of metastatic disease cannot be assessed,,RX:Presence of residual tumor cannot be assessed,,150.0,50.0,22.21,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Lipid reducing medication|Anti-hypertensive medication,Self Report|Self Report,No,49.0,,,50.0,,No,No,No,Unknown,,No,,,,,,,,,,,,,,,0.0,49.0,0.0,1.0
C3N-02380,LUAD,C3N-02380-T,C3N-02380-N,,,0.0,CPT0146700003,CPT0146680004,CPT0146680007,CPT0146700006,CPT0146680010,CPT0146700009,CPT0146710002,56,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,5.0,Adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,34,IHC staining not done,0,cM0,Staging Incomplete,NO,R0:No residual tumor,,165.0,81.0,29.75,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,8.1,Exposure to secondhand smoke history not available,,,,,No,1059.0,,,1066.0,,No,Yes,No,Persistent Disease,,Yes,237.0,New Primary Tumor,Lung,,Convincing Image (i.e. CT/PET/MRI),,,R0: No Residual Tumor,No,No,No,,,237.0,1.0,1059.0,0.0,7.0
C3L-01924,LUAD,C3L-01924-T,C3L-01924-N,,,0.0,CPT0114690003,CPT0114660004,CPT0114660007,CPT0114690006,CPT0114660010,CPT0114690009,CPT0116660002,68,Female,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,2.1,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,5,0,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:No residual tumor,"TTF-1, napsin A and CK7, and  negative for p63 supporting the above diagnosis. Additionally, an elastic  stain      (VVG) was performed on block B4 as reveals no definite  involvement of the visceral pleura PD-L1: positive (70%); high PD-L1 expression ",163.0,83.0,31.43,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,25.0,Exposure to secondhand smoke history not available,,,Albuterol|Norvasc|Neurontin|Remicade|Cozaar,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1133.0,,,1133.0,,No,No,No,Complete Remission,Persistent Disease,No,,,,,,,,,,,,,,,0.0,1133.0,0.0,0.0
C3N-00433,LUAD,C3N-00433-T,C3N-00433-N,,,0.0,CPT0021490003,CPT0021450003,['CPT0021450006'],CPT0021490006,CPT0021450009,CPT0021490008,CPT0021500002,57,Male,Unknown,Unknown,European,Ukraine,No,,Right,Unifocal,3.5,Adenocarcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,8,0,0,cM0,Staging Incomplete,No.,R0:No residual tumor,,169.0,83.0,29.06,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,60.0,,,10.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,60.0,0.0,-50.0
C3L-01683,LUAD,C3L-01683-T,C3L-01683-N,,,0.0,CPT0111590003,CPT0110980004,CPT0110980007,CPT0111590006,CPT0110980010,CPT0111590009,CPT0112390002,77,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Multifocal,3.3,Adenocarcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,7,0,0,cM0,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,183.0,79.0,23.73,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,33.8,Yes,,,Diovan|Crestor|Xanax,Self Report|Self Report|Self Report,No,1046.0,1046.0,Unknown,,1053.0,No,No,No,Not Applicable,,Yes,704.0,New Primary Tumor,Other,"Skin, Right Flank",Biopsy with Histologic Confirmation,,,,No,No,No,,,704.0,1.0,1046.0,1.0,7.0
C3N-00293,LUAD,C3N-00293-T,C3N-00293-N,,,0.0,CPT0008420003,CPT0008410003,['CPT0008410006'],CPT0008420006,CPT0008410009,CPT0008420009,CPT0008430002,73,Male,Unknown,Unknown,European,Poland,No,,Right,Unifocal,3.5,Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,28,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,none,R0:No residual tumor,,178.0,83.0,26.0,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,Yes,1832.0,,,1870.0,,No,No,No,Unknown,Unknown,Unknown,,,,,,,,,,,,,,,0.0,1832.0,0.0,38.0
C3L-00009,LUAD,C3L-00009-T,C3L-00009-N,,,0.0,CPT0001390003,CPT0001380003,CPT0001380164,CPT0001390013,CPT0001380005,CPT0001390009,CPT0000100163,76,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,1.8,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,10,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:No residual tumor,,172.0,85.0,28.67,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,62.0,Exposure to secondhand smoke history not available,,,atrovastatin|budesonide-formoterol|insulin|albuterol|bisacodyl,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,545.0,577.0,Unknown,,586.0,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,577.0,1.0,9.0
C3N-00546,LUAD,C3N-00546-T,C3N-00546-N,,,0.0,CPT0067110003,CPT0067070003,['CPT0067070013'],CPT0067110006,CPT0067070006,CPT0067110009,CPT0067190002,58,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Not Applicable,Left,Unifocal,6.0,Solid adenocarcinoma,G3 Poorly differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,3,IHC staining not done,0,cM0,Staging Incomplete,Not known,R0:No residual tumor,,170.0,52.0,17.99,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,3.8,No or minimal exposure to secondhand smoke,,,,,No,382.0,,,375.0,,No,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,382.0,0.0,-7.0
C3N-01414,LUAD,C3N-01414-T,C3N-01414-N,,,0.0,CPT0105610003,CPT0105600003,CPT0105600006,CPT0105610006,CPT0105600009,CPT0105610009,CPT0108040002,59,Male,Unknown,Unknown,East_Asian,Vietnam,No,,Left,Unifocal,5.0,Acinar adenocarcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,1,IHC staining not done,0,cM0,Staging Incomplete,Not Specified,R0:No residual tumor,,160.0,50.0,19.53,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,820.0,,,449.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,820.0,0.0,-371.0
C3N-02087,LUAD,C3N-02087-T,C3N-02087-N,,,0.0,CPT0118240003,CPT0118200003,CPT0118200006,CPT0118240006,CPT0118200009,CPT0118240009,CPT0119450002,61,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other Unspecified,,Unifocal,4.0,Acinar adenocarcinoma,G3 Poorly differentiated,Stage III,Not identified,Cannot be assessed,Seventh Edition (2010),pT2a,pN2,7,IHC staining not done,2,cM0,Staging Incomplete,Unspecified,R0:No residual tumor,,150.0,50.0,22.22,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,303.0,303.0,Main malignancy,,296.0,Yes,Yes,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,303.0,1.0,-7.0
C3L-00140,LUAD,C3L-00140-T,C3L-00140-N,,,0.0,CPT0001810003,CPT0001800013,['CPT0001800008'],CPT0001810006,CPT0001800005,CPT0001810009,CPT0003960002,70,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,1.9,Papillary adenocarcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN0,8,0,0,cM0,Staging Incomplete,Not Applicable ,R0:No residual tumor,,180.0,68.0,20.99,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,2.5,Exposure to secondhand smoke history not available,,,Ipratropium-Albuterol|Allopurinol|Atenolol|Hydrochlorothiazide|Vitamin D|Amlodipine|Aspirin|Lovastatin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1802.0,,,1802.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1802.0,0.0,0.0
C3N-02529,LUAD,C3N-02529-T,C3N-02529-N,,,0.0,CPT0147500003,CPT0147480004,CPT0147480007,CPT0147500006,CPT0147480010,CPT0147500009,CPT0147510002,79,Female,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,4.0,Adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,27,IHC staining not done,1,cM0,Staging Incomplete,no,R0:No residual tumor,"HER2（+）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,60％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（-），P40（-） Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（+），NapsinA（+），CK20（-），CK5/6（-）",156.0,57.0,23.42,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,664.0,849.0,Unknown,,855.0,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,849.0,1.0,6.0
C3L-00368,LUAD,C3L-00368-T,C3L-00368-N,,,0.0,CPT0063750003,CPT0063730003,['CPT0063730009'],CPT0063750006,['CPT0063730006'],CPT0063750009,CPT0065310002,67,Female,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,2.5,Adenocarcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,9,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,,157.0,72.0,29.21,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",25.0,Exposure to secondhand smoke history not available,Breast,Surgery,Cartia XT|melatonin|valerian Root|B-complex-c|Theralith XR|Apixaban|Lipitor|Cardizem CD|Aldactone|coreg|celexa|tamsulosin|Aspirin 81mg,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,141.0,,,141.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,141.0,0.0,0.0
C3N-02067,LUAD,C3N-02067-T,C3N-02067-N,,,0.0,CPT0109850003,CPT0109830004,CPT0109830007,CPT0109850006,CPT0109830010,CPT0109850009,CPT0139390002,37,Female,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,2.0,Adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a,pN2,11,IHC staining not done,8,cM0,Staging Incomplete,NO,R0:No residual tumor,"HER2（focal +）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,10％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（-），P40（-） Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（partially+），NapsinA（+），CK20（-），CK5/6（-）",164.0,65.0,24.17,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,1081.0,,,1086.0,,Yes,Yes,No,Complete Remission,,Yes,112.0,Distant Metastasis,Bone,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,Yes,Yes,No,,,112.0,1.0,1081.0,0.0,5.0
C3N-02422,LUAD,C3N-02422-T,,,,0.0,,CPT0146880004,CPT0146880007,,CPT0146880010,,CPT0146910002,56,Female,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,3.8,Adenocarcinoma,G3 Poorly differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN1,14,IHC staining not done,3,cM1b,pM1b,no,R0:No residual tumor,,161.0,65.0,25.08,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,nifedipine,Self Report,No,552.0,650.0,Main malignancy,,653.0,No,Yes,No,Persistent Disease,,Yes,118.0,Distant Metastasis,"Bone, Liver, Other",adrenal gland,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,No,No,,,118.0,1.0,650.0,1.0,3.0
C3L-00080,LUAD,C3L-00080-T,C3L-00080-N,,,0.0,CPT0001070003,CPT0001060010,CPT0001060164,CPT0001070006,CPT0001060005,CPT0001070009,CPT0000020163,58,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,3.5,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,6,IHC staining not done,0,cM0,Staging Incomplete,Not applicable,R0:No residual tumor,,170.0,88.0,30.62,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,40.0,Exposure to secondhand smoke history not available,,,Lopressor|coumadin|celexa|Lipitor|Flomax|Asa,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1805.0,,,1805.0,,Yes,Yes,No,Complete Remission,Persistent Disease,Yes,1000.0,Distant Metastasis,Brain,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,Yes,No,No,,,1000.0,1.0,1805.0,0.0,0.0
C3N-00547,LUAD,C3N-00547-T,C3N-00547-N,,,0.0,CPT0067290003,CPT0067250003,['CPT0067250009'],CPT0067290006,CPT0067250006,CPT0067290009,CPT0067370002,60,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Left,Unifocal,5.0,Acinar adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,7,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,170.0,51.0,17.65,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,3.0,No or minimal exposure to secondhand smoke,,,,,No,474.0,,,468.0,,Yes,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,474.0,0.0,-6.0
C3N-01023,LUAD,C3N-01023-T,C3N-01023-N,,,0.0,CPT0105190003,CPT0105060003,CPT0105060006,CPT0105190006,CPT0105060009,CPT0105190009,CPT0107620002,58,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Right,Unifocal,6.0,Solid adenocarcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,17,IHC staining not done,3,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,170.0,48.0,16.61,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,422.0,,,415.0,,Yes,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,422.0,0.0,-7.0
C3N-01024,LUAD,C3N-01024-T,C3N-01024-N,,,0.0,CPT0105250003,CPT0105230003,CPT0105230006,CPT0105250006,CPT0105230009,CPT0105250009,CPT0107680002,66,Female,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Right,Unifocal,5.5,Adenocarcinoma,G3 Poorly differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,8,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not specified,R0:No residual tumor,,160.0,46.0,17.97,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,419.0,,,412.0,,No,Yes,No,Persistent Disease,,Yes,413.0,Locoregional Recurrence,Other,Inguinal lymph nodes and pleura,Biopsy with Histologic Confirmation,No,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,,,413.0,1.0,419.0,0.0,-7.0
C3L-00973,LUAD,C3L-00973-T,C3L-00973-N,,,0.0,CPT0102480003,CPT0102450003,CPT0102450006,CPT0102480006,CPT0102450009,CPT0102480009,CPT0101050002,76,Male,Unknown,Unknown,European,Russia,No,,Right,Unifocal,5.0,Adenocarcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,8,IHC staining not done,0,cM0,Staging Incomplete,Not documented,R0:No residual tumor,,169.0,176.0,61.62,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Losartan,Self Report,No,1435.0,,,1414.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1435.0,0.0,-21.0
C3L-02348,LUAD,C3L-02348-T,C3L-02348-N,,,0.0,CPT0115090003,CPT0115070003,CPT0115070006,CPT0115090006,CPT0115070009,CPT0115090009,CPT0115320002,58,Female,White,Not Hispanic or Latino,European,United States,No,,Right,Multifocal,6.5,Adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN0,13,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:No residual tumor,,152.0,63.0,27.27,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,71.8,Exposure to secondhand smoke history not available,,,"Symbicort|claritin|Glucophage|Proventil, ventolin proair|Budesonide",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1425.0,,,1425.0,,No,Yes,No,Unknown,Unknown,No,,,,,,,,,,,,,,,0.0,1425.0,0.0,0.0
C3L-02508,LUAD,C3L-02508-T,C3L-02508-N,,,0.0,CPT0125830003,CPT0125810003,CPT0125810006,CPT0125830006,CPT0125810009,CPT0125830009,CPT0124270002,65,Male,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,Left,Unifocal,4.0,"Lepidic adenocarcinoma, Invasive mucinous adenocarcinoma",G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,14,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,170.0,74.0,25.42,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,"Valsartan|omega-3, polyunsaturated fatty acids|Ranitidine|Atorvastatin|Atenolol|Amlodipine",Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1013.0,,,1013.0,,No,No,No,Unknown,Unknown,Unknown,,,,,,,,,,,,,,,0.0,1013.0,0.0,0.0
C3N-00560,LUAD,C3N-00560-T,C3N-00560-N,,,0.0,CPT0068830003,CPT0068800003,['CPT0068800009'],CPT0068830006,CPT0068800006,CPT0068830009,CPT0068910002,55,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Right,Unifocal,5.0,Adenocarcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,9,IHC staining not done,2,cM0,Staging Incomplete,Not known,R0:No residual tumor,,160.0,62.0,24.22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,7.0,No or minimal exposure to secondhand smoke,,,,,No,378.0,,,378.0,,No,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,378.0,0.0,0.0
C3L-00604,LUAD,C3L-00604-T,C3L-00604-N,,,0.0,CPT0063840003,CPT0063810003,['CPT0063810009'],CPT0063840006,CPT0063810006,CPT0063840009,CPT0065330002,61,Female,White,Not Hispanic or Latino,European,United States,No,,Right,Multifocal,3.2,Acinar adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN2,12,IHC staining not done,7,cM0,No pathologic evidence of distant metastasis,Not applicable ,R0:No residual tumor,,170.0,63.0,21.75,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Zovirax|Multi Vitamin|Vitamin D|Synthroid,Medical Record|Medical Record|Medical Record|Medical Record,No,1801.0,,,1801.0,,Yes,Yes,Yes,Persistent Disease,Persistent Disease,Yes,332.0,Locoregional Recurrence,Lung,,Biopsy with Histologic Confirmation,No,,RX: Presence of Residual Tumor cannot be assessed,No,No,Yes,,,332.0,1.0,1801.0,0.0,0.0
C3N-00199,LUAD,C3N-00199-T,C3N-00199-N,,,0.0,CPT0014290003,CPT0014260003,['CPT0014260009'],CPT0014290006,CPT0014260006,CPT0014290009,CPT0015050002,65,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,2.8,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,7,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,175.0,87.0,28.35,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",15.0,Exposure to secondhand smoke history not available,,,levothyroxine|finasteride|melatonin|tramadol|testosterone|gabapentin|anastrozole|omeprazole|lisinopril,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1721.0,,,1693.0,,No,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1721.0,0.0,-28.0
C3N-00579,LUAD,C3N-00579-T,C3N-00579-N,,,0.0,CPT0069550003,CPT0069520003,['CPT0069520006'],CPT0069550006,CPT0069520009,CPT0069550009,CPT0069630002,67,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Unknown,Right,Unifocal,3.5,Acinar adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,1,IHC staining not done,0,cM0,Staging Incomplete,Not specified,R0:No residual tumor,,160.0,61.0,23.83,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,477.0,,,477.0,,Yes,Yes,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,477.0,0.0,0.0
C3N-02582,LUAD,C3N-02582-T,C3N-02582-N,,,0.0,CPT0147900003,CPT0147880004,CPT0147880007,CPT0147900006,CPT0147880010,CPT0147900009,CPT0147910002,77,Male,Unknown,Unknown,East_Asian,China,No,,Left,Unifocal,5.8,Adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN1,37,IHC staining not done,1,cM0,Staging Incomplete,no,R0:No residual tumor,"HER2（partly weak+）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,10％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（-），P40（-） Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（+），NapsinA（+），CK20（-），CK5/6（-）",177.0,73.0,23.3,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",31.0,Exposure to secondhand smoke history not available,,,,,No,802.0,888.0,Unknown,,899.0,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,888.0,1.0,11.0
C3L-02350,LUAD,C3L-02350-T,C3L-02350-N,,,0.0,CPT0104760003,CPT0104750003,CPT0104750006,CPT0104760006,CPT0104750009,CPT0104760009,CPT0105180002,69,Male,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,3.0,Acinar adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,7,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:No residual tumor,,178.0,91.0,28.69,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",12.0,Exposure to secondhand smoke history not available,Testicular Cancer|Lung ,"Radiation,Surgery,Chemotherapy|Surgery",eliquis|monopril ,Medical Record|Medical Record,No,1418.0,,,1418.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1418.0,0.0,0.0
C3N-00738,LUAD,C3N-00738-T,C3N-00738-N,,,0.0,CPT0112080003,CPT0112060003,CPT0112060006,CPT0112080006,CPT0112060009,CPT0112080009,CPT0112180002,70,Female,Black or African American,Not Hispanic or Latino,African,United States,No,,Right,Unifocal,2.2,Adenocarcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b,pN0,28,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,157.0,55.0,22.43,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,25.0,Exposure to secondhand smoke history not available,,,Albuterol|Xarelto,Medical Record|Medical Record,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3N-00959,LUAD,C3N-00959-T,C3N-00959-N,,,0.0,CPT0079850003,CPT0079830003,['CPT0079830006'],CPT0079850005,CPT0079830009,CPT0079850008,CPT0080770002,66,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,4.0,Acinar adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,12,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:Presence of residual tumor cannot be assessed,,170.0,74.0,25.37,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",19.0,Exposure to secondhand smoke history not available,,,amlodipine|atorvastatin|naproxen sodium|Mens Multivitamin,Medical Record|Medical Record|Medical Record|Medical Record,No,1641.0,,,1591.0,,No,Yes,No,Complete Remission,Complete Remission,Yes,911.0,New Primary Tumor,Other,Bladder,Convincing Image (i.e. CT/PET/MRI),,,,No,Yes,No,,,911.0,1.0,1641.0,0.0,-50.0
C3N-02003,LUAD,C3N-02003-T,C3N-02003-N,,,0.0,CPT0109760003,CPT0109740004,CPT0109740007,CPT0109760006,CPT0109740010,CPT0109760009,CPT0139170002,56,Male,Unknown,Unknown,East_Asian,China,No,,Right,Unifocal,4.0,Adenocarcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,10,IHC staining not done,3,cM0,Staging Incomplete,NO,R0:No residual tumor,"HER2（partial +）, TTF1（+）, EGFR（+），CK7（+），Ki-67（+,80％），β-Cat（membranous +）, P63（-）, ERCC1（+）, RRM1（+）, Syn（-），P40（-） Immunohistochemistry:GATA3（-）, ALK(Ventana)（-）, ALK-Neg-Tissue（-），CDX2（-），SPA（partial +），NapsinA（+），CK20（-），CK5/6（-）",161.0,68.0,26.23,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,56.0,Exposure to secondhand smoke history not available,,,hypotensor,Self-reported and Medical Record,No,353.0,,,358.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,353.0,0.0,5.0
C3N-00175,LUAD,C3N-00175-T,C3N-00175-N,,,0.0,CPT0013910003,CPT0013880003,['CPT0013880006'],CPT0013910005,CPT0013880009,CPT0013910008,CPT0016600002,72,Male,Unknown,Unknown,East_Asian,Vietnam,No,Other Not specified,Right,Unifocal,4.5,Adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN0,9,IHC staining not done,0,cM0,Staging Incomplete,Not documented,R0:No residual tumor,,171.0,49.0,16.76,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,7.0,No or minimal exposure to secondhand smoke,,,,,No,308.0,308.0,Unknown,,301.0,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,308.0,1.0,-7.0
C3N-01823,LUAD,C3N-01823-T,C3N-01823-N,,,0.0,CPT0097600003,CPT0097580003,CPT0097580006,CPT0097600006,CPT0097580009,CPT0097600009,CPT0097610002,63,Male,Unknown,Unknown,European,Ukraine,No,,Left,Unifocal,4.0,Adenocarcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2a,pN2,21,IHC staining not done,17,cM0,Staging Incomplete,No,R0:No residual tumor,,173.0,75.0,25.06,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,351.0,351.0,Main malignancy,,351.0,No,Yes,No,Complete Remission,,Yes,181.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),,No,RX: Presence of Residual Tumor cannot be assessed,No,No,No,,,181.0,1.0,351.0,1.0,0.0
C3L-02549,LUAD,C3L-02549-T,C3L-02549-N,,,0.0,CPT0113220003,CPT0113210003,CPT0113210006,CPT0113220006,CPT0113210009,CPT0113220009,CPT0115250002,69,Male,White,Not Hispanic or Latino,European,United States,No,,Left,Unifocal,12.0,Lepidic adenocarcinoma,G1 Well differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,17,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not Applicable ,R0:No residual tumor,,180.0,96.0,29.63,Yes,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,Prostate Cancer,Surgery,Lipitor|Lexapro,Medical Record|Medical Record,No,447.0,447.0,Main malignancy,,447.0,No,Yes,No,Unknown,,Yes,216.0,Locoregional Recurrence,Lung,,Biopsy with Histologic Confirmation,Yes,,RX: Presence of Residual Tumor cannot be assessed,No,Yes,Yes,216.0,,216.0,1.0,447.0,1.0,0.0
C3L-02365,LUAD,C3L-02365-T,C3L-02365-N,,,0.0,CPT0114880003,CPT0114840003,CPT0114840006,CPT0114880009,CPT0114840009,CPT0114880006,CPT0116900002,62,Female,White,Not Hispanic or Latino,European,United States,No,,Right,Unifocal,4.2,Adenocarcinoma,G3 Poorly differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2b,pN1,3,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,,RX:Presence of residual tumor cannot be assessed,,155.0,53.0,21.92,No,Lifelong non-drinker,Current reformed smoker within past 15 years,47.0,Yes,,,Hydrocodone-acetaminophen|Albuterol Sulfate|fluticasone-vilanterol,Medical Record|Medical Record|Medical Record,No,625.0,627.0,Main malignancy,,635.0,No,Yes,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,627.0,1.0,8.0
02OV032,HGSC,02OV032-T,,,,0.0,,0c87932d-b6fd-4eb5-b86a-a34d07_D5,0c87932d-b6fd-4eb5-b86a-a34d07_D7_1,,0c87932d-b6fd-4eb5-b86a-a34d07_D6_1,,38bc3eb3-b978-43c0-a2be-50eeda_D1_1,57,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,347.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,347.0,0.0,
04OV057,HGSC,04OV057-T,,,,0.0,,7069e990-4a4e-4984-a66d-4d835a_D5,7069e990-4a4e-4984-a66d-4d835a_D7,,7069e990-4a4e-4984-a66d-4d835a_D6,,cced71f0-58dc-4e46-a02c-2af508_D1,63,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,982.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,982.0,0.0,
04OV028,HGSC,04OV028-T,,,,0.0,,41d0619e-b299-42e2-ac32-29e784_D5,41d0619e-b299-42e2-ac32-29e784_D7_1,,41d0619e-b299-42e2-ac32-29e784_D6_1,,1cec1511-2570-4921-bac0-5ceea7_D1_1,59,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,,,,,,No,,,,,,No,,,,420.0,,,,,No,Yes,No,Complete Response,,Yes,,Locoregional Recurrence,Abdomen;,,,No,,,,Yes,Yes,,,,1.0,420.0,0.0,
15OV001,HGSC,15OV001-T,15OV001-N,,,0.0,7edfd606-4bee-4529-9fec-1ca7f0_D5,7c7ce2d7-6c8a-424e-8e6c-d14ad1_D5,7c7ce2d7-6c8a-424e-8e6c-d14ad1_D7_1,,7c7ce2d7-6c8a-424e-8e6c-d14ad1_D6_1,,60daddeb-d877-481a-9901-883bb8_D1_1,44,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,366.0,,,,,No,No,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,366.0,0.0,
17OV011,HGSC,17OV011-T,,,,0.0,,cfd76f9a-ce60-4ec7-8e6b-a8fc31_D2,cfd76f9a-ce60-4ec7-8e6b-a8fc31_D7,,cfd76f9a-ce60-4ec7-8e6b-a8fc31_D6,,d606e01a-a0b6-4126-ade0-dd9fba_D1_1,79,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,271.0,,,,,No,Yes,No,Progressive Disease,,No,,,,,,,,,,,,,,,0.0,271.0,0.0,
01OV007,HGSC,01OV007-T,01OV007-N,,,0.0,1abbcb28-f221-4cd4-8c01-37b9bb_D1_D5,9b90eb78-2f50-4aeb-b010-d642f9_D5,9b90eb78-2f50-4aeb-b010-d642f9_D7,,9b90eb78-2f50-4aeb-b010-d642f9_D6,,31178af6-5271-4859-a086-f74006_D1,68,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,,,,,,No,,,,,,No,,,,369.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,369.0,0.0,
04OV018,HGSC,04OV018-T,,,,0.0,,f6c215ea-5381-4521-bb61-be8e97_D5,f6c215ea-5381-4521-bb61-be8e97_D7_1,,f6c215ea-5381-4521-bb61-be8e97_D6,,5d9282ce-5954-476d-ba32-aa73d0_D1_1,63,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,greater than 20 mm,,,,,No,,,,,,No,,,,387.0,,,,,No,Yes,No,Progressive Disease,,Yes,,Locoregional Recurrence,Abdomen;,,,No,,,,No,Yes,,,,1.0,387.0,0.0,
04OV063,HGSC,04OV063-T,,,,0.0,,bd266bdd-12e4-42cb-9c49-911bfc_D5,bd266bdd-12e4-42cb-9c49-911bfc_D7,,bd266bdd-12e4-42cb-9c49-911bfc_D6,,1c7e6865-4a6b-41ee-8e3b-456330_D1,50,Female,Asian,Not Hispanic or Latino,South_Asian,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,,,,,,No,,,,,,No,,,,1397.0,,,,,No,Yes,No,Complete Response,,Yes,,Locoregional Recurrence,Pelvis;Abdomen;,,,No,,,,No,No,,,,1.0,1397.0,0.0,
17OV003,HGSC,,17OV003-N,1.0,Did not meet histology criteria. Curls exist but no genomics. Excluded by GDC,0.0,b9c1f22e-61f7-45ed-b3b4-5094c7_D5,,,,,,,55,Female,White,Not Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,No,Yes,No,Progressive Disease,,Yes,,Distant Metastasis,Other (specify);Chest;,,,,No,,,Yes,No,,,,1.0,,0.0,
01OV023,HGSC,01OV023-T,01OV023-N,,,0.0,2b73e01c-347a-4dae-a71d-752aeb_D5,d38f40fb-dd78-43b2-8b7b-4b6977_D5,d38f40fb-dd78-43b2-8b7b-4b6977_D7,,d38f40fb-dd78-43b2-8b7b-4b6977_D6,,cd900fda-2bc7-495e-8e11-3ef2ac_D1,58,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,376.0,,,,,No,Yes,No,Partial Response,,No,,,,,,,,,,,,,,,0.0,376.0,0.0,
17OV039,HGSC,17OV039-T,,,,0.0,,ce1e5dfc-2ef1-4633-af93-5ea4d9_D5,ce1e5dfc-2ef1-4633-af93-5ea4d9_D7,,ce1e5dfc-2ef1-4633-af93-5ea4d9_D6,,0dadc0a2-6f5f-4fe1-81bf-62a50a_D1,54,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,Not Reported/ Unknown,,,,,No,,,,,,No,,,,155.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,155.0,0.0,
17OV015,HGSC,17OV015-T,,,,0.0,,6530147a-efe9-4df6-ac2f-03ece3_D5,6530147a-efe9-4df6-ac2f-03ece3_D7,,6530147a-efe9-4df6-ac2f-03ece3_D6,,63e27b5b-492d-455a-9881-185955_D1,63,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,284.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,284.0,0.0,
17OV017,HGSC,17OV017-T,,,,0.0,,49bd51fe-48a1-4828-b66e-b30c38_D5,49bd51fe-48a1-4828-b66e-b30c38_D7,,32b962ad-4f52-4778-90eb-0ef7d5_D6,,012ff650-0db2-41a2-a309-383835_D1,79,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,,,,,,,,,11-20 mm,,,,,"Yes, History of Other Cancer Greater Than One Year Ago",,,,,,No,,,,360.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,360.0,0.0,
17OV005,HGSC,,17OV005-N,1.0,Did not meet histology criteria. Curls exist but no genomics. Excluded by GDC,0.0,8df6697b-56a1-4ff0-97cf-42b966_D5,,,,,,,71,Female,White,Not Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,No,Yes,No,Unknown,,No,,,,,,,,,,,,,,,0.0,,1.0,
17OV028,HGSC,17OV028-T,,,,0.0,,52c064a7-78d9-4a1a-85b4-27c6d1_D5,52c064a7-78d9-4a1a-85b4-27c6d1_D7,,d4377e17-ca1c-4411-a386-8d5f4c_D6,,80a5ccde-c851-47fb-8c0d-238b16_D1,57,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,Not Reported/ Unknown,,,,,No,,,,,,No,,,,,29.0,,,,No,Yes,No,Not Reported/ Unknown,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,29.0,1.0,
02OV008,HGSC,02OV008-T,,,,0.0,,fbb41c94-aabd-49cc-90b2-882c3e_D5,fbb41c94-aabd-49cc-90b2-882c3e_D7,,fbb41c94-aabd-49cc-90b2-882c3e_D6,,5ffd8c6c-0807-4be5-b0d1-dc475f_D1,50,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,greater than 20 mm,,,,,No,,,,,,No,,,,449.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,449.0,0.0,
04OV005,HGSC,04OV005-T,,,,0.0,,3d3e1888-d67e-4c69-ba83-112d0f_D5,3d3e1888-d67e-4c69-ba83-112d0f_D7,,3d3e1888-d67e-4c69-ba83-112d0f_D6,,cade384a-f9d2-4e3b-9aa5-a0e64e_D1,72,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,,,,,,No,,,,,,No,,,,352.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,352.0,0.0,
01OV017,HGSC,01OV017-T,01OV017-N,,,0.0,1556af7e-c2ae-4fce-9aae-87c459_D1_D5,1a10c200-3895-4648-b951-94f99f_D5,1a10c200-3895-4648-b951-94f99f_D7,,1a10c200-3895-4648-b951-94f99f_D6,,cd0c6f13-08d2-4a74-846b-3872e0_D1,56,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,396.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,396.0,0.0,
02OV001,HGSC,02OV001-T,,1.0,Did not meet histology criteria. Curls exist but no genomics. Excluded by GDC,0.0,,9a7a86d3-bbf2-4d36-941d-c75c03_D1_D5,,,,,,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
11OV002,HGSC,11OV002-T,11OV002-N,,,0.0,6e81377c-d0d6-4881-87f6-01c909_D5,665f4f0f-130c-4b09-9762-cd0696_D2,665f4f0f-130c-4b09-9762-cd0696_D7_1,,665f4f0f-130c-4b09-9762-cd0696_D6_1,,af8fcd15-fda9-49e8-9e04-5ce523_D1_1,65,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Serous Adenocarcinoma,G2 Moderately differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
02OV041,HGSC,02OV041-T,,,,0.0,,5b5c81b1-4e73-48d3-9469-108edd_D2,5b5c81b1-4e73-48d3-9469-108edd_D7,,5b5c81b1-4e73-48d3-9469-108edd_D6,,2315af2e-1e3c-45ca-b4f0-ce2f23_D1,41,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,,,,,,No,,,,,,No,,,,290.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,290.0,0.0,
17OV025,HGSC,17OV025-T,,,,0.0,,e7b656bf-3c34-4ba1-bdf3-c7eefe_D5,e7b656bf-3c34-4ba1-bdf3-c7eefe_D7,,e7b656bf-3c34-4ba1-bdf3-c7eefe_D6,,05256b36-6dfa-4f41-b13b-df0a38_D1,66,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,Not Reported/ Unknown,,,,,No,,,,,,No,,,,303.0,,,,,No,Yes,Not Reported/ Unknown,Stable Disease,,No,,,,,,,,,,,,,,,0.0,303.0,0.0,
17OV018,HGSC,17OV018-T,,,,0.0,,28d0abdb-f682-4bd3-9425-a9c508_D5,28d0abdb-f682-4bd3-9425-a9c508_D7,,28d0abdb-f682-4bd3-9425-a9c508_D6,,4fb7c54a-fefd-4a43-9dcc-f59e89_D1,62,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G2 Moderately differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,352.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,352.0,0.0,
01OV029,HGSC,01OV029-T,01OV029-N,1.0,Excluded by GDC. Failed QC,0.0,340a3769-3031-41ae-bb08-a2f696_D5,51a4ce2f-4166-4c6b-a7e0-942d0a_D5,51a4ce2f-4166-4c6b-a7e0-942d0a_D7,,51a4ce2f-4166-4c6b-a7e0-942d0a_D6,,d726284d-b766-4653-9245-738d99_D1,48,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
17OV010,HGSC,17OV010-T,,,,0.0,,7c2aeacf-a30d-4104-b60a-7545ee_D2,7c2aeacf-a30d-4104-b60a-7545ee_D7_1,,7c2aeacf-a30d-4104-b60a-7545ee_D6_1,,a1941d5e-aa5a-46d1-b995-3d4278_D1_1,65,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,greater than 20 mm,,,,,No,,,,,,No,,,,355.0,,,,,No,Yes,No,Progressive Disease,,No,,,,,,,,,,,,,,,0.0,355.0,0.0,
17OV027,HGSC,17OV027-T,,,,0.0,,38f29517-c046-4da5-ba0d-67d614_D2,38f29517-c046-4da5-ba0d-67d614_D7,,38f29517-c046-4da5-ba0d-67d614_D6,,dc7c7f4c-af59-44eb-ae32-2e4228_D1,51,Female,White,Unknown,European,,No,,,,,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,greater than 20 mm,,,,,No,,,,,,No,,,,118.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,118.0,0.0,
20OV005,HGSC,20OV005-T,,,,0.0,,3a380577-c134-47ba-a1ce-988d7c_D5,3a380577-c134-47ba-a1ce-988d7c_D7,,3a380577-c134-47ba-a1ce-988d7c_D6,,e20828d6-1399-43d5-96de-21ae37_D1,70,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,"Yes, History of Other Cancer Greater Than One Year Ago",,,,,,No,,,,358.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,358.0,0.0,
14OV011,HGSC,14OV011-T,14OV011-N,,,0.0,1db5574d-aca7-403c-8100-6e705f_D5,2115808b-6a0d-49bc-a8d7-b83bde_D5,2115808b-6a0d-49bc-a8d7-b83bde_D7_1,,2115808b-6a0d-49bc-a8d7-b83bde_D6_1,,554dab31-c7f5-4765-a1e3-9ceb94_D1_1,58,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,,,,,,,,,greater than 20 mm,,,,,No,,,,,,No,,,,498.0,,,,,No,Yes,No,Complete Response,,Yes,,Locoregional Recurrence,Abdomen;,,,Yes,,,,No,No,,,,1.0,498.0,0.0,
02OV006,HGSC,02OV006-T,,,,0.0,,8120e7d6-bd09-4334-841c-70a214_D2,8120e7d6-bd09-4334-841c-70a214_D7,,8120e7d6-bd09-4334-841c-70a214_D6,,45698791-f0d6-4ab7-9b4a-3d8bf4_D1,44,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,455.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,455.0,0.0,
26OV009,HGSC,26OV009-T,,,,0.0,,35a345a4-e954-4c81-ae3f-7797cd_D5,35a345a4-e954-4c81-ae3f-7797cd_D7,,35a345a4-e954-4c81-ae3f-7797cd_D6,,266c4207-1a8e-4343-bf1f-3304d0_D1,60,Female,White,Unknown,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,Yes,,,,727.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,727.0,0.0,
02OV036,HGSC,02OV036-T,,,,0.0,,3b044c9b-ac09-4b4b-8f37-462411_D2,97cab1b7-a9ba-4c11-9f39-c8c54d_D7,,3b044c9b-ac09-4b4b-8f37-462411_D6,,936e1c41-7756-465c-b292-29d4a0_D1,55,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,357.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,357.0,0.0,
26OV008,HGSC,26OV008-T,,,,0.0,,2433b136-fc7b-4cea-b958-bc6efb_D5,2433b136-fc7b-4cea-b958-bc6efb_D7,,2433b136-fc7b-4cea-b958-bc6efb_D6,,4179faf1-53d6-40ba-9d58-f111a7_D1,65,Female,White,Unknown,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,11-20 mm,,,,,No,,,,,,Yes,,,,,400.0,,,,No,Yes,No,Progressive Disease,,Not Applicable,,,,,,,,,,,,,,,0.0,400.0,1.0,
17OV004,HGSC,,17OV004-N,1.0,Did not meet histology criteria. Curls exist but no genomics. Excluded by GDC,0.0,3fbf076a-824b-4eac-b6dc-bf5e59_D5,,,,,,,62,Female,American Indian or Alaska Native,Not Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,,0.0,
02OV023,HGSC,02OV023-T,,,,0.0,,2ed8beb2-bc63-4bad-b5fe-1916a0_D5,2ed8beb2-bc63-4bad-b5fe-1916a0_D7,,2ed8beb2-bc63-4bad-b5fe-1916a0_D6,,7d942a6f-236e-4659-89a2-6711ae_D1,46,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,364.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,364.0,0.0,
04OV039,HGSC,04OV039-T,,,,0.0,,7d953d1d-84b6-4ecd-b1d7-1ed865_D5,7d953d1d-84b6-4ecd-b1d7-1ed865_D7,,1dcde92b-2a59-427d-a7e6-48b476_D6,,d82ca4fc-d74c-4658-8920-897974_D1,46,Female,Unknown,Not Hispanic or Latino,East_Asian,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,326.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,326.0,0.0,
04OV037,HGSC,04OV037-T,,,,0.0,,e9d416e7-f661-400a-896e-388545_D5,e9d416e7-f661-400a-896e-388545_D7,,e9d416e7-f661-400a-896e-388545_D6,,5eef476a-4c66-43fe-bd3e-9d4aa5_D1,71,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,,,,,,No,,,,,,No,,,,343.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,343.0,0.0,
04OV051,HGSC,04OV051-T,,,,0.0,,76e77c6b-c80e-4391-bdbb-e1dcea_D5,76e77c6b-c80e-4391-bdbb-e1dcea_D7,,76e77c6b-c80e-4391-bdbb-e1dcea_D6,,aecb5251-5486-4adb-b842-24a6dc_D1,57,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,,,,,,No,,,,,,No,,,,924.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,924.0,0.0,
04OV040,HGSC,04OV040-T,,,,0.0,,50997c44-1c8b-4d34-b535-4a6cc2_D5,50997c44-1c8b-4d34-b535-4a6cc2_D7,,50997c44-1c8b-4d34-b535-4a6cc2_D6,,fbe99290-8eba-45ae-ad79-38442b_D1,70,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,329.0,,,,,No,Yes,No,Complete Response,,Yes,,Both Locoregional and Distant Metastasis,Abdomen;Chest;,,,,Not Reported/ Unknown,,,Not Reported/ Unknown,Not Reported/ Unknown,,,,1.0,329.0,0.0,
01OV030,HGSC,01OV030-T,,,,0.0,,5ea22f5e-307b-491d-801f-8b7fa6_D5,5ea22f5e-307b-491d-801f-8b7fa6_D7,,5ea22f5e-307b-491d-801f-8b7fa6_D6,,907f990e-2b1a-49dc-8944-48e146_D1,73,Female,White,Unknown,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,338.0,,,,,No,Yes,No,Partial Response,,No,,,,,,,,,,,,,,,0.0,338.0,0.0,
26OV002,HGSC,26OV002-T,,,,0.0,,6319b36b-533c-4e86-8e12-80552e_D2,6319b36b-533c-4e86-8e12-80552e_D7,,6319b36b-533c-4e86-8e12-80552e_D6,,70daa657-8dd1-48e7-a69b-e3d7d1_D1,57,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,greater than 20 mm,,,,,No,,,,,,No,,,,331.0,,,,,No,Yes,Yes,Not Reported/ Unknown,,No,,,,,,,,,,,,,,,0.0,331.0,0.0,
02OV046,HGSC,02OV046-T,,,,0.0,,8e6a9f67-7c53-4386-9ba0-e48101_D2,8e6a9f67-7c53-4386-9ba0-e48101_D7,,8e6a9f67-7c53-4386-9ba0-e48101_D6,,defe3f04-27ab-400d-aeac-bcd160_D1,61,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,217.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,217.0,0.0,
01OV039,HGSC,01OV039-T,01OV039-N,,,0.0,51171486-e865-4140-b726-e77088_D5,8e17b45e-6a06-4e4e-913d-7b1edb_D5,8e17b45e-6a06-4e4e-913d-7b1edb_D7_1,,8e17b45e-6a06-4e4e-913d-7b1edb_D6_1,,360dd010-08a6-40ba-adca-6b53e5_D1_1,51,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,373.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,373.0,0.0,
17OV014,HGSC,17OV014-T,,,,0.0,,46c73531-f531-4ec3-97fe-b39d9d_D5,46c73531-f531-4ec3-97fe-b39d9d_D7_1,,46c73531-f531-4ec3-97fe-b39d9d_D6,,61688352-1332-4b68-8412-b53178_D1_1,66,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,,,,,,,,,Not Reported/ Unknown,,,,,No,,,,,,No,,,,303.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,303.0,0.0,
17OV040,HGSC,17OV040-T,,,,0.0,,f4034d75-d533-47c2-8453-068e37_D2,f4034d75-d533-47c2-8453-068e37_D7,,f4034d75-d533-47c2-8453-068e37_D6,,e0fd3f72-2df3-4696-9114-a5b31b_D1,57,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,,,,,,,,,greater than 20 mm,,,,,No,,,,,,No,,,,225.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,225.0,0.0,
04OV033,HGSC,04OV033-T,,,,0.0,,285fed94-1495-448e-879b-b55de9_D5,285fed94-1495-448e-879b-b55de9_D7,,285fed94-1495-448e-879b-b55de9_D6,,ecdf88ff-20cc-4cb8-992e-5de6ac_D1,57,Female,Unknown,Not Hispanic or Latino,African,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,,,,,,No,,,,,,No,,,,367.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,367.0,0.0,
17OV033,HGSC,17OV033-T,,,,0.0,,4253f4a4-50b9-409a-b9a8-f94658_D2,4bc2d3ea-1611-4fc3-85ee-5b06c4_D7,,4253f4a4-50b9-409a-b9a8-f94658_D6,,a2a8e97b-09a2-465c-b585-16e53d_D1,75,Female,American Indian or Alaska Native,Not Hispanic or Latino,Ad_Mixed_American,,No,,,,,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,greater than 20 mm,,,,,"Yes, History of Other Cancer Greater Than One Year Ago",,,,,,No,,,,232.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,232.0,0.0,
04OV053,HGSC,04OV053-T,,,,0.0,,79b60f32-6cca-4cb6-9a1e-22a3ac_D5,79b60f32-6cca-4cb6-9a1e-22a3ac_D7,,79b60f32-6cca-4cb6-9a1e-22a3ac_D6,,46a46133-bb15-4d38-8a83-15c186_D1,63,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,,,,,,No,,,,,,No,,,,1954.0,,,,,No,Yes,No,Partial Response,,Yes,,Locoregional Recurrence,Lymph Node only (specify location);,,,Yes,,,,Yes,No,,,,1.0,1954.0,0.0,
01OV018,HGSC,01OV018-T,,,,0.0,,eb0a53df-7620-4024-8d2d-051142_D5,eb0a53df-7620-4024-8d2d-051142_D7,,eb0a53df-7620-4024-8d2d-051142_D6,,c4e10fb8-4e89-4c88-88f2-9cab9b_D1,44,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,391.0,,,,,No,Yes,No,Complete Response,,Yes,,Distant Metastasis,"vaginal cuff, right hepatorenal recess, liver, and spleen",,,,No,,,Yes,No,,,,1.0,391.0,0.0,
04OV050,HGSC,04OV050-T,,,,0.0,,0cc794c3-5bf5-4621-b238-58a0f6_D5,0cc794c3-5bf5-4621-b238-58a0f6_D7,,0cc794c3-5bf5-4621-b238-58a0f6_D6,,73f0ce85-40bf-4244-b233-d2e764_D1,73,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,1994.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,1994.0,0.0,
04OV021,HGSC,04OV021-T,,,,0.0,,fe83e13f-9754-403b-8f74-d6caf8_D5,fe83e13f-9754-403b-8f74-d6caf8_D7_1,,fe83e13f-9754-403b-8f74-d6caf8_D6,,67f382d0-dd95-4c54-8123-246343_D1_1,57,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,219.0,,,,,No,Yes,No,Not Reported/ Unknown,,No,,,,,,,,,,,,,,,0.0,219.0,0.0,
04OV054,HGSC,04OV054-T,,,,0.0,,9c8e78bf-b03e-4ba0-9909-5ff070_D5,9c8e78bf-b03e-4ba0-9909-5ff070_D7,,9c8e78bf-b03e-4ba0-9909-5ff070_D6,,80ee169f-1b99-4e16-b57c-085868_D1,43,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,330.0,,,,No,Yes,No,Progressive Disease,,Yes,,Both Locoregional and Distant Metastasis,Abdomen;Other (specify);Pelvis;,,,,No,,,Yes,No,,,,1.0,330.0,1.0,
04OV048,HGSC,04OV048-T,,,,0.0,,161317f3-1a39-438e-af45-cd2502_D5,161317f3-1a39-438e-af45-cd2502_D7,,161317f3-1a39-438e-af45-cd2502_D6,,61eae7d1-c81a-45c9-b8fa-017c02_D1,60,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,,1402.0,,,,No,Yes,No,Complete Response,,Yes,,Locoregional Recurrence,Abdomen;,,,No,,,,Yes,No,,,,1.0,1402.0,1.0,
04OV017,HGSC,04OV017-T,,,,0.0,,eb3f3494-7057-4afe-b212-e6e9a3_D5,eb3f3494-7057-4afe-b212-e6e9a3_D7_1,,eb3f3494-7057-4afe-b212-e6e9a3_D6_1,,7401f279-d5a9-4555-890d-19c38f_D1_1,65,Female,White,Hispanic or Latino,Ad_Mixed_American,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,greater than 20 mm,,,,,No,,,,,,No,,,,425.0,,,,,No,Yes,No,Complete Response,,Yes,,Locoregional Recurrence,Abdomen;,,,No,,,,Yes,No,,,,1.0,425.0,0.0,
04OV023,HGSC,04OV023-T,,,,0.0,,d4791079-c826-4fc7-9d9b-ee20ba_D5,11b5a745-03a6-4c05-9000-534bf3_D7,,11b5a745-03a6-4c05-9000-534bf3_D6,,7671658a-0610-4167-b2ba-0ba841_D1,37,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,greater than 20 mm,,,,,No,,,,,,No,,,,398.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,398.0,0.0,
04OV031,HGSC,04OV031-T,,,,0.0,,318d53c3-216b-4de1-a098-77d6dd_D5,e67153d3-61af-49d6-9402-599b39_D7,,318d53c3-216b-4de1-a098-77d6dd_D6,,3f6e343a-2105-49d1-a38f-a7e2f3_D1,59,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,381.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,381.0,0.0,
01OV013,HGSC,,01OV013-N,1.0,Proteomic/Genomic Normal but Transcriptomic Tumor,0.0,8ed739dd-ae0f-4881-971a-db3cf4_D1_D5,,95c2a5bf-a27b-4c83-8791-160e03_D7,,95c2a5bf-a27b-4c83-8791-160e03_D6,,7c01454f-a189-4a70-881f-313126_D1,69,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,411.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,411.0,0.0,
18OV001,HGSC,18OV001-T,,,,0.0,,a03d1103-b809-42c4-ad5c-5aff58_D5,a03d1103-b809-42c4-ad5c-5aff58_D7,,a03d1103-b809-42c4-ad5c-5aff58_D6,,b6a10ca7-bb8c-4d2b-a20d-19386e_D1,61,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G2 Moderately differentiated,Stage I,,,,,,,,,,,,,,,,,"Yes, History of Other Cancer Greater Than One Year Ago",,,,,,No,,,,368.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,368.0,0.0,
26OV013,HGSC,26OV013-T,,,,0.0,,0331bd9b-94a5-4d02-ae43-6288e9_D2,9bb753e1-120d-4ea8-b43c-c8fa80_D7,,0331bd9b-94a5-4d02-ae43-6288e9_D6,,6b420957-5153-4dbb-8d5d-ea4add_D1,74,Female,White,Unknown,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,Not Reported/ Unknown,,,,,No,,,,,,Yes,,,,536.0,,,,,No,No,No,Not Reported/ Unknown,,No,,,,,,,,,,,,,,,0.0,536.0,0.0,
02OV015,HGSC,02OV015-T,,,,0.0,,9e0d47e0-f633-468b-b82b-4d752d_D5,9e0d47e0-f633-468b-b82b-4d752d_D7,,9e0d47e0-f633-468b-b82b-4d752d_D6,,d3154472-d098-47a6-bd18-ed7d74_D1,74,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,greater than 20 mm,,,,,No,,,,,,No,,,,378.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,378.0,0.0,
04OV055,HGSC,04OV055-T,,,,0.0,,d109a3c0-350e-47f5-bda0-61899c_D5,d109a3c0-350e-47f5-bda0-61899c_D7,,d109a3c0-350e-47f5-bda0-61899c_D6,,99d3d57c-8487-43c1-9964-5b0f03_D1,62,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,greater than 20 mm,,,,,No,,,,,,No,,,,,977.0,,,,No,Yes,No,Not Reported/ Unknown,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,977.0,1.0,
02OV005,HGSC,02OV005-T,,,,0.0,,1772e913-f62e-446a-8cf3-720348_D5,1772e913-f62e-446a-8cf3-720348_D7,,1772e913-f62e-446a-8cf3-720348_D6,,302a6175-8bba-4efd-a492-76e0f0_D1,77,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,370.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,370.0,0.0,
17OV036,HGSC,17OV036-T,,,,0.0,,80873a0c-1f40-4d51-bab1-3f2071_D5,80873a0c-1f40-4d51-bab1-3f2071_D7,,80873a0c-1f40-4d51-bab1-3f2071_D6,,f0147adf-97a9-482c-af88-90da35_D1,63,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,1-10 mm,,,,,"Yes, History of Other Cancer Greater Than One Year Ago",,,,,,Yes,,,,204.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,204.0,0.0,
11OV010,HGSC,,11OV010-N,1.0,Proteomic/Genomic Normal but Transcriptomic Tumor,0.0,61f76fe6-a1c6-41b8-bdc2-2f9209_D5,,,,,,,52,Female,Asian,Not Hispanic or Latino,,,No,,,,,,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
04OV011,HGSC,04OV011-T,,,,0.0,,a8853382-b726-4ce8-98d5-ca89df_D5,a8853382-b726-4ce8-98d5-ca89df_D7,,a8853382-b726-4ce8-98d5-ca89df_D6,,c36b85ce-4c29-4bc4-9ae4-6fa57b_D1,85,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,"Yes, History of Other Cancer Greater Than One Year Ago",,,,,,No,,,,124.0,,,,,No,Yes,No,Unknown,,No,,,,,,,,,,,,,,,0.0,124.0,0.0,
04OV024,HGSC,04OV024-T,,,,0.0,,af95e2c6-25c4-4ab8-bf06-3e15ff_D5,af95e2c6-25c4-4ab8-bf06-3e15ff_D7_1,,af95e2c6-25c4-4ab8-bf06-3e15ff_D6_1,,beb66f4d-8bfc-4d56-abaf-4bdba1_D1_1,48,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,"Yes, History of Other Cancer Greater Than One Year Ago",,,,,,No,,,,455.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,455.0,0.0,
01OV019,HGSC,,01OV019-N,1.0,Proteomic/Genomic Normal but Transcriptomic Tumor,0.0,f02d54bd-b3c7-4375-bc82-167395_D1_D5,,2f901c90-617e-46da-9fac-d68369_D7,,2f901c90-617e-46da-9fac-d68369_D6,,a29b9c62-ac2d-4292-9085-2dbf80_D1,57,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,355.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,355.0,0.0,
01OV041,HGSC,01OV041-T,,,,0.0,,3490835c-c004-45ed-91f3-7c206f_D5,3490835c-c004-45ed-91f3-7c206f_D7_1,,3490835c-c004-45ed-91f3-7c206f_D6_1,,4f43b1d3-ad52-439a-a91e-2e568c_D1_1,70,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,11-20 mm,,,,,No,,,,,,No,,,,343.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,343.0,0.0,
04OV045,HGSC,04OV045-T,,,,0.0,,69d552be-7cb2-4bb4-b602-a27b3e_D5,69d552be-7cb2-4bb4-b602-a27b3e_D7,,69d552be-7cb2-4bb4-b602-a27b3e_D6,,67019441-8b3d-4bda-bdf4-21a297_D1,55,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,261.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,261.0,0.0,
01OV008,HGSC,,01OV008-N,1.0,Proteomic/Genomic Normal but Transcriptomic Tumor,0.0,b22659b9-e12c-4725-a7db-a833de_D1_D5,,308ad404-7079-4ff8-8232-12ee2e_D7,,308ad404-7079-4ff8-8232-12ee2e_D6,,3a7fef0d-d5e4-4154-adc0-dd19f5_D1,55,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,368.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,368.0,0.0,
01OV026,HGSC,01OV026-T,,,,0.0,,347e379b-77c0-4dd3-aa25-18c9d1_D5,347e379b-77c0-4dd3-aa25-18c9d1_D7,,347e379b-77c0-4dd3-aa25-18c9d1_D6,,6ad15aed-b0a2-4542-8cd8-4a0682_D1,77,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,112.0,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,112.0,1.0,
26OV011,HGSC,26OV011-T,,,,0.0,,44a9e976-f859-4a0d-9f4f-70b95b_D2,44a9e976-f859-4a0d-9f4f-70b95b_D7,,44a9e976-f859-4a0d-9f4f-70b95b_D6,,94fc93b5-c989-42a0-b139-8d1f92_D1,64,Female,White,Unknown,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,Yes,,,,177.0,,,,,No,No,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,177.0,0.0,
17OV029,HGSC,17OV029-T,,,,0.0,,74a45e5a-a35a-4c60-a4b4-f3f5ea_D5,74a45e5a-a35a-4c60-a4b4-f3f5ea_D7,,74a45e5a-a35a-4c60-a4b4-f3f5ea_D6,,18c969bc-5783-4667-a9cf-30149e_D1,44,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Staging is not applicable or unknown,,,,,,,,,,,,greater than 20 mm,,,,,No,,,,,,No,,,,297.0,,,,,No,Yes,No,Progressive Disease,,Yes,,Distant Metastasis,Abdomen;,,,,No,,,Yes,No,,,,1.0,297.0,0.0,
17OV013,HGSC,17OV013-T,,,,0.0,,05387aad-2a1f-42c2-8d6f-950598_D2,05387aad-2a1f-42c2-8d6f-950598_D7,,05387aad-2a1f-42c2-8d6f-950598_D6,,0a152159-6ef5-4f7b-be73-c15ec3_D1_1,49,Female,Black or African American,Not Hispanic or Latino,African,,No,,,,,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,368.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,368.0,0.0,
17OV030,HGSC,17OV030-T,,,,0.0,,cfb8cb2c-53c6-40d7-8069-a1a804_D5,cfb8cb2c-53c6-40d7-8069-a1a804_D7,,8234f8ea-bdbd-45b0-bd0b-16f1e7_D6,,ef0d574a-0abb-4e12-bef4-c01511_D1,43,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,279.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,279.0,0.0,
04OV012,HGSC,04OV012-T,,,,0.0,,08296da7-70ea-44df-8646-09f2cc_D5,08296da7-70ea-44df-8646-09f2cc_D7,,08296da7-70ea-44df-8646-09f2cc_D6,,9751077c-61c1-49df-9b6f-db7d6e_D1,58,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,328.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,328.0,0.0,
14OV029,HGSC,,14OV029-N,1.0,Proteomic/Genomic Normal but Transcriptomic Tumor,0.0,994f9b8e-46cb-413f-8ec8-2c2fed_D5,,,,,,,57,Female,White,Unknown,,,No,,,,,Serous Adenocarcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage II,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
04OV036,HGSC,04OV036-T,,,,0.0,,dd3a1c3b-6b49-4ec8-b6df-cdf22e_D5,dd3a1c3b-6b49-4ec8-b6df-cdf22e_D7,,10c2d629-0287-4511-ac25-f29031_D6,,f4bcf727-f39b-4b0d-aaa5-cdcf0b_D1,39,Female,Asian,Not Hispanic or Latino,South_Asian,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,,,,,,No,,,,,,No,,,,342.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,342.0,0.0,
13OV003,HGSC,13OV003-T,,,,0.0,,407c600a-c0ac-41a6-8d87-fd8a3c_D2,407c600a-c0ac-41a6-8d87-fd8a3c_D7_1,,407c600a-c0ac-41a6-8d87-fd8a3c_D8_1,,d571ff93-f970-4fb1-939d-432b08_D1_1,57,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G1 Well differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,,,,,,No,Yes,No,Progressive Disease,,No,,Locoregional Recurrence,,,,,,,,,,,,,0.0,,0.0,
01OV010,HGSC,,01OV010-N,1.0,Proteomic/Genomic Normal but Transcriptomic Tumor,0.0,0745488e-0bfb-4d1f-8228-dedf76_D1_D5,,a42f5b74-1bab-41cd-b5f7-0182fa_D7,,a42f5b74-1bab-41cd-b5f7-0182fa_D6,,ada95f64-bd0f-40be-b5ef-f2f483_D1,52,Female,Black or African American,Unknown,African,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,21.0,,,,,No,No,No,Unknown,,No,,,,,,,,,,,,,,,0.0,21.0,0.0,
04OV044,HGSC,04OV044-T,,,,0.0,,3dcf8b3c-c0c5-4dfa-9543-5d30fb_D5,9bff7220-903a-4afb-9a63-1dbc3c_D7,,3dcf8b3c-c0c5-4dfa-9543-5d30fb_D6,,ea3b2f6d-f072-4830-b5e8-80a57a_D1,63,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,278.0,,,,,No,Yes,No,Complete Response,,Yes,,Locoregional Recurrence,Abdomen;,,,Not Reported/ Unknown,,,,Not Reported/ Unknown,Not Reported/ Unknown,,,,1.0,278.0,0.0,
04OV013,HGSC,04OV013-T,,,,0.0,,4ccb249a-6722-491e-97e9-e3b4e7_D5,4ccb249a-6722-491e-97e9-e3b4e7_D7,,4ccb249a-6722-491e-97e9-e3b4e7_D6,,9c2d08e0-9dc3-4aec-95bb-b75855_D1,53,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,404.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,404.0,0.0,
02OV022,HGSC,02OV022-T,,,,0.0,,27f3ca2d-a86f-479d-8e7e-5307c7_D5,27f3ca2d-a86f-479d-8e7e-5307c7_D7,,27f3ca2d-a86f-479d-8e7e-5307c7_D6,,01de44a7-81fa-4e25-aba5-9b215e_D1,58,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,365.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,365.0,0.0,
17OV002,HGSC,17OV002-T,17OV002-N,,,0.0,78c151c7-0d5b-4aae-88d3-87463b_D5,627e6e36-3dca-4ee5-9755-6f3510_D5,627e6e36-3dca-4ee5-9755-6f3510_D7,,627e6e36-3dca-4ee5-9755-6f3510_D6,,c0998304-329c-46ff-9678-616f3d_D1,48,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,371.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,371.0,0.0,
04OV058,HGSC,04OV058-T,,,,0.0,,91b287fd-eadb-442d-abcd-20b741_D5,91b287fd-eadb-442d-abcd-20b741_D7,,91b287fd-eadb-442d-abcd-20b741_D6,,d035cd3d-9ecd-4c59-a1ca-a247fe_D1,71,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,1256.0,,,,No,Yes,No,Complete Response,,Yes,,Locoregional Recurrence,Abdomen;,,,No,,,,Yes,No,,,,1.0,1256.0,1.0,
04OV027,HGSC,04OV027-T,,,,0.0,,2224c03f-b7b1-4368-887e-2b4cdf_D5,2224c03f-b7b1-4368-887e-2b4cdf_D7_1,,2224c03f-b7b1-4368-887e-2b4cdf_D6_1,,a7f1dbca-1fbf-49a3-9ac4-6aa2f4_D1_1,59,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,greater than 20 mm,,,,,No,,,,,,No,,,,416.0,,,,,No,Yes,No,Partial Response,,Yes,,Both Locoregional and Distant Metastasis,Chest;Abdomen;,,,,Not Reported/ Unknown,,,Not Reported/ Unknown,Not Reported/ Unknown,,,,1.0,416.0,0.0,
01OV047,HGSC,01OV047-T,,,,0.0,,2a237fd4-f966-4563-bab1-61dbd7_D2,2a237fd4-f966-4563-bab1-61dbd7_D7,,2a237fd4-f966-4563-bab1-61dbd7_D6,,38fd7771-eaa7-4d4c-aea2-00fe7a_D1,68,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,352.0,,,,,No,Yes,No,Partial Response,,No,,,,,,,,,,,,,,,0.0,352.0,0.0,
04OV001,HGSC,04OV001-T,,,,0.0,,42d860a3-8a0c-4c44-a09a-9ad8cf_D5,42d860a3-8a0c-4c44-a09a-9ad8cf_D7,,42d860a3-8a0c-4c44-a09a-9ad8cf_D6,,02f6afea-1e5b-4151-bafd-c577d3_D1,50,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,355.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,355.0,0.0,
02OV044,HGSC,02OV044-T,,,,0.0,,6c9a5bdc-0f0e-4cc8-aec5-63091c_D2,6c9a5bdc-0f0e-4cc8-aec5-63091c_D7,,6c9a5bdc-0f0e-4cc8-aec5-63091c_D6,,3e46ddab-ce45-439a-8812-43eb90_D1,36,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,243.0,,,,,No,No,No,Not Reported/ Unknown,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,243.0,0.0,
17OV001,HGSC,17OV001-T,17OV001-N,,,0.0,bd22174a-86c1-489f-bcb7-93e12b_D5,1c9145ad-1981-4871-aa7e-8b11de_D5,1c9145ad-1981-4871-aa7e-8b11de_D7,,1c9145ad-1981-4871-aa7e-8b11de_D6,,c295497a-fc2a-43be-ad45-606652_D1,56,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G2 Moderately differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,384.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,384.0,0.0,
04OV049,HGSC,04OV049-T,,,,0.0,,15524912-685a-47ce-a824-567848_D5,15524912-685a-47ce-a824-567848_D7,,15524912-685a-47ce-a824-567848_D6,,68cd7f58-ee24-490b-b3d1-ddad43_D1,63,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,greater than 20 mm,,,,,No,,,,,,No,,,,1857.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,1857.0,0.0,
04OV008,HGSC,04OV008-T,,,,0.0,,efc971f8-54c5-4531-a792-705ecf_D5,efc971f8-54c5-4531-a792-705ecf_D7,,efc971f8-54c5-4531-a792-705ecf_D6,,cedd3881-6311-4c1d-9e9d-191243_D1,53,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,351.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,351.0,0.0,
04OV004,HGSC,04OV004-T,,,,0.0,,e3ebe010-cd31-4b5d-8fcb-b7103b_D5,e3ebe010-cd31-4b5d-8fcb-b7103b_D7,,e3ebe010-cd31-4b5d-8fcb-b7103b_D6,,0a3efca2-3684-4fc6-a20d-af55ba_D1,54,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,,,,,,No,,,,,,No,,,,285.0,,,,,No,Yes,No,Partial Response,,No,,,,,,,,,,,,,,,0.0,285.0,0.0,
02OV029,HGSC,02OV029-T,,,,0.0,,d945689a-dcf3-44f4-a42f-1ded6d_D2,d945689a-dcf3-44f4-a42f-1ded6d_D7_1,,d945689a-dcf3-44f4-a42f-1ded6d_D6_1,,e42b4c26-8c2b-444f-92f9-10c232_D1_1,48,Female,White,Not Hispanic or Latino,Ad_Mixed_American,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,177.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,177.0,0.0,
01OV002,HGSC,,,1.0,"No proteomics, partial genomics",0.0,,,467256db-a312-4346-9ac0-e49e44_D7,,467256db-a312-4346-9ac0-e49e44_D6,,2bb86ca8-2768-44d3-8dd8-ebb273_D1,45,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,415.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,415.0,0.0,
01OV045,HGSC,,,1.0,"No proteomics, partial genomics",0.0,,,62f5840e-6cd7-4200-b651-645e53_D7_1,,62f5840e-6cd7-4200-b651-645e53_D6_1,,1d5572aa-ce3a-4928-8d93-86774f_D1_1,51,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,Yes,,,,387.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,387.0,0.0,
01OV046,HGSC,,,1.0,"No proteomics, partial genomics",0.0,,,558333b0-ea23-4303-9e3c-4932b1_D7,,558333b0-ea23-4303-9e3c-4932b1_D8,,238d15a7-4791-4cef-945a-48c5e4_D1,54,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage IV,,,,,,,,,,,,,,,,,No,,,,,,No,,,,13.0,,,,,Not Reported/ Unknown,Not Reported/ Unknown,Not Reported/ Unknown,Not Reported/ Unknown,,Not Reported/ Unknown,,,,,,,,,,,,,,,0.0,13.0,0.0,
01OV049,HGSC,,,1.0,"No proteomics, partial genomics",0.0,,,256ac9f5-1e19-44b4-92fb-fef3fc_D7,,256ac9f5-1e19-44b4-92fb-fef3fc_D6,,d7a7b9e7-3121-404f-9fd4-22673a_D1,54,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,317.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,317.0,0.0,
02OV035,HGSC,,,1.0,"No proteomics, partial genomics",0.0,,,2dc28da8-7ff1-4b9b-b5bd-17cc25_D7_1,,2dc28da8-7ff1-4b9b-b5bd-17cc25_D6_1,,06ac6957-d65b-4d29-b412-9dd1e2_D1_1,61,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,336.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,336.0,0.0,
02OV040,HGSC,,,1.0,"No proteomics, partial genomics",0.0,,,927f0958-db5a-4bc5-92b7-2a3695_D7,,927f0958-db5a-4bc5-92b7-2a3695_D6,,93b7f944-b465-4778-9c86-106f96_D1,65,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,309.0,,,,,No,Yes,No,Complete Response,,Yes,,Not Reported/ Unknown,Abdomen;,,,,,,,Yes,No,,,,1.0,309.0,0.0,
02OV042,HGSC,,,1.0,"No proteomics, partial genomics",0.0,,,8d78194e-fbef-4819-a7b5-b73ae9_D7,,8d78194e-fbef-4819-a7b5-b73ae9_D6,,120aa31e-f256-4f22-baf4-873bf8_D1,56,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,254.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,254.0,0.0,
02OV045,HGSC,,,1.0,"No proteomics, partial genomics",0.0,,,ad5c848c-ae26-42c8-874e-387a09_D7,,5c3971ee-87c7-4dff-b66e-f18892_D6,,b87e9510-8002-40d0-8079-f6b8f8_D1,53,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,253.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,253.0,0.0,
04OV041,HGSC,,,1.0,"No proteomics, partial genomics",0.0,,,1b2ab076-c72f-4bbe-b9f9-657d24_D7,,1b2ab076-c72f-4bbe-b9f9-657d24_D6,,244351b1-dec2-40ef-aa8c-118072_D1,68,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,315.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,315.0,0.0,
11OV009,HGSC,,,1.0,"No proteomics, partial genomics",0.0,,,51c1c79e-5a8e-4b0a-bf92-1c0cab_D7,,51c1c79e-5a8e-4b0a-bf92-1c0cab_D6,,30bf6cbf-c613-4128-86f5-de7bf0_D1,66,Female,Asian,Not Hispanic or Latino,East_Asian,,No,,,,,Serous Adenocarcinoma,G2 Moderately differentiated,Stage I,,,,,,,,,,,,,,,,,No,,,,,,No,,,,381.0,,,,,No,No,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,381.0,0.0,
13OV004,HGSC,,,1.0,Excluded by GDC. Failed QC,0.0,,,1de8d3d8-fc0e-4be0-8aa7-127c7b_D7_1,,1de8d3d8-fc0e-4be0-8aa7-127c7b_D6_1,,5d6c64a7-34f3-416b-aa85-e01e9e_D1_1,70,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,,0.0,
17OV019,HGSC,,,1.0,Excluded by GDC. Failed QC,0.0,,,3946a96c-e0ae-442f-83b4-a9350e_D7,,3946a96c-e0ae-442f-83b4-a9350e_D6,,02ac4d5b-a5e7-4e2c-8ede-f752fc_D1,57,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G2 Moderately differentiated,Stage III,,,,,,,,,,,,1-10 mm,,,,,No,,,,,,No,,,,368.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,368.0,0.0,
17OV034,HGSC,,,1.0,Excluded by GDC. Failed QC,0.0,,,2563cb02-d58a-4286-8634-7502cd_D7,,2563cb02-d58a-4286-8634-7502cd_D6,,5918ebb7-1c63-407a-bf01-af3f09_D1,66,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,267.0,,,,,No,Yes,No,Stable Disease,,No,,,,,,,,,,,,,,,0.0,267.0,0.0,
22OV001,HGSC,,,1.0,Excluded by GDC. Failed QC,0.0,,,2b4ce90c-8036-4207-ac3e-54a76f_D7,,2b4ce90c-8036-4207-ac3e-54a76f_D6,,4b216777-ce44-45f7-9df1-9d873a_D1,60,Female,White,Not Hispanic or Latino,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,No,,,,293.0,,,,,No,Yes,No,Complete Response,,No,,,,,,,,,,,,,,,0.0,293.0,0.0,
26OV010,HGSC,,,1.0,Excluded by GDC. Failed QC,0.0,,,c17b0ff9-9057-4848-a0cc-abb25f_D7,,c17b0ff9-9057-4848-a0cc-abb25f_D6,,c4bdeb24-c38a-421e-83eb-9d1225_D1,57,Female,White,Unknown,European,,No,,,,,Serous Adenocarcinoma,G3 Poorly differentiated,Stage III,,,,,,,,,,,,,,,,,No,,,,,,Yes,,,,506.0,,,,,No,Yes,No,Not Reported/ Unknown,,No,,,,,,,,,,,,,,,0.0,506.0,0.0,
C3N-03884,PDAC,C3N-03884-T,C3N-03884-N,,,0.0,CPT0237850004,CPT0237840004,CPT0237840010,,CPT0237840007,CPT0237850007,CPT0237890002,64,Female,Unknown,Unknown,East_Asian,China,No,,,Unifocal,2.3,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,41,IHC staining not done,4,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,155.0,49.0,20.4,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,598.0,680.0,Unknown,,686.0,No,Yes,No,Complete Remission,,Yes,455.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,455.0,1.0,680.0,1.0,6.0
C3L-00589,PDAC,C3L-00589-T,C3L-00589-N,,,0.0,CPT0063990003,CPT0063970004,['CPT0063970010'],CPT0063990006,CPT0063970007,CPT0063990009,CPT0065360002,80,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,25,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,175.0,84.0,27.43,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,12.0,Exposure to secondhand smoke history not available,,,tamsulosin|lisinopril |omeprazole|levothyroxine|cymbalta|Lipitor|valtrex|zovirax|keflex,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1752.0,,,1752.0,,Yes,Yes,No,Complete Remission,Complete Response,No,,,,,,,,,,,,,,,0.0,1752.0,0.0,0.0
C3L-03123,PDAC,C3L-03123-T,C3L-03123-N,,,0.0,CPT0166780004,CPT0166760004,CPT0166760010,CPT0166780007,CPT0166760007,,CPT0166790002,60,Female,Unknown,Unknown,European,Canada,No,,,Unifocal,4.1,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,13,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,No distant metastasis,R0:  No residual tumor,,159.0,94.0,37.1,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Amlodipine|Potassium Chloride|Tramadol,Medical Record|Medical Record|Medical Record,No,1503.0,,,1510.0,,No,Yes,No,Complete Remission,Complete Response,No,,,,,,,,,,,,,,,0.0,1503.0,0.0,7.0
C3L-01687,PDAC,C3L-01687-T,C3L-01687-N,,,0.0,C3L-01687-04,CPT0094630004,CPT0094630007,,['CPT0094630010'],,CPT0094670002,78,Female,Unknown,Unknown,East_Asian,Other: TSS did not collect,No,,,Unifocal,5.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,34,IHC staining not done,23,cM0,No pathologic evidence of distant metastasis,,R1:  Microscopic residual tumor,,147.0,67.0,31.05,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,, Valsartan|Plavix|HCTZ|Fluoxetine|Diltiazem|Tylenol Arthritis|Probiotics|Vitamin D3|Slow K,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,376.0,376.0,Main malignancy,,381.0,No,Yes,No,Persistent Disease,,Yes,259.0,Distant Metastasis,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,259.0,1.0,376.0,1.0,5.0
C3L-00599,PDAC,C3L-00599-T,,,,0.0,,CPT0081260004,['CPT0081260010'],,CPT0081260007,,CPT0081300002,62,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,3.0,Ductal adenocarcinoma,G1 Well differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,17,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,pMx,R0:  No residual tumor,,176.0,78.0,25.05,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,1305.0,1305.0,Main malignancy,,1316.0,No,Yes,No,Complete Remission,,Yes,1034.0,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,1034.0,1.0,1305.0,1.0,11.0
C3L-01054,PDAC,C3L-01054-T,C3L-01054-N,,,0.0,CPT0124000003,CPT0123990003,CPT0123990006,,CPT0123990009,CPT0124000006,CPT0124920002,38,Female,Unknown,Unknown,European,Russia,No,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage IV,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,21,IHC staining not done,2,cM1,No pathologic evidence of distant metastasis,Not documented,R2:  Macroscopic residual tumor,,170.0,60.0,20.76,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,860.0,860.0,Main malignancy,,868.0,No,Yes,No,Persistent Disease,,Yes,457.0,Locoregional Recurrence,Tumor Bed,,Positive Biomarker(s),No,,,No,No,No,,,457.0,1.0,860.0,1.0,8.0
C3L-02890,PDAC,C3L-02890-T,C3L-02890-N,,,0.0,CPT0166680004,CPT0166650006,CPT0166650012,,CPT0166650009,,CPT0166690002,65,Male,Unknown,Unknown,European,Canada,No,,,Unifocal,7.5,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,10,IHC staining not done,6,cM0,No pathologic evidence of distant metastasis,No distant metastasis,R0:  No residual tumor,Cytokertains (AE1/3) and Vimentin: positive CD68: negative,170.0,64.0,22.15,No,"Consumed alcohol in the past, but currently a non-drinker",Current reformed smoker within past 15 years,,Exposure to secondhand smoke history not available,,,Ativan|Coversyl|Advair|Metformin|Trazodone|Crestor|Insulin lantus|Metoprolol|Forxiga|Lorazepam|Oxycodone|Pantoprazole|Vitamin D|ASA|Aventyl|Cannabis,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1007.0,1007.0,Main malignancy,,1022.0,No,Yes,No,Complete Remission,Progressive Disease,Yes,868.0,Distant Metastasis,Liver,,Positive Biomarker(s),No,,,No,Yes,No,,,868.0,1.0,1007.0,1.0,15.0
C3N-01379,PDAC,C3N-01379-T,,1.0,"Failed Pathology review, excluded by WG",0.0,,CPT0088840004,CPT0088840007,,CPT0088840010,,CPT0088890001,65,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,4.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Cannot be assessed,Seventh Edition (2010),pTX,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,no,RX:  Presence of residual tumor cannot be assessed,,158.0,62.0,24.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,15.0,No or minimal exposure to secondhand smoke,,,,,No,971.0,971.0,Unknown,,974.0,Yes,Yes,No,Persistent Disease,,Yes,592.0,Locoregional Recurrence,Peritoneal Surface,,Positive Biomarker(s),No,,,No,Yes,No,,,592.0,1.0,971.0,1.0,3.0
C3L-03630,PDAC,C3L-03630-T,C3L-03630-N,,,0.0,CPT0198930003,CPT0198910005,CPT0198910011,,CPT0198910008,,CPT0198940002,78,Male,Unknown,Unknown,European,Canada,No,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1,pN1,5,IHC staining not done,3,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,174.0,105.0,34.85,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,Asprin|Fosinopril|Lasix|Rosuvastatin|Lantus 36|Levothyroxine|Levodopa-carbidopa|Isosorbide|Bisoprolol|Vitalux,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,78.0,,,83.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,78.0,0.0,5.0
C3L-03356,PDAC,C3L-03356-T,C3L-03356-N,,,0.0,CPT0198440004,CPT0198420004,CPT0198420010,,CPT0198420007,,CPT0198450002,71,Male,Unknown,Unknown,European,Other: South Wales,No,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,11,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,169.0,82.0,28.71,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,Zpolicone|Metformin|Lantus insulin|Lispro insulin|Ezetimibe|Tylenol 3|Ranibizumab|Multivitamin|Lutein|Saw Palmetto|Melatonin|Diclofenac,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,550.0,,,556.0,,No,Yes,No,Complete Remission,,Yes,497.0,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,497.0,1.0,550.0,0.0,6.0
C3N-01166,PDAC,C3N-01166-T,,,,0.0,,CPT0093980004,CPT0093980007,,['CPT0093980010'],,CPT0094020002,62,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,17,IHC staining not done,7,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,171.0,53.0,18.0,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,32.0,Yes,,,,,No,679.0,,,683.0,,No,Yes,No,Persistent Disease,,Yes,745.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,745.0,1.0,679.0,0.0,4.0
C3N-04126,PDAC,C3N-04126-T,,,,0.0,,CPT0238040005,CPT0238040011,,CPT0238040008,,CPT0238100002,42,Male,Unknown,Unknown,East_Asian,China,No,,,Unifocal,3.5,Ductal adenocarcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,32,IHC staining not done,12,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,180.0,79.0,24.38,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,amlodipine|inject insulin,Medical Record|Medical Record,No,257.0,348.0,Main malignancy,,352.0,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,348.0,1.0,4.0
C3N-04283,PDAC,C3N-04283-T,C3N-04283-N,,,0.0,CPT0247050003,CPT0247040003,CPT0247040006,CPT0247050008,CPT0247040009,CPT0247050005,CPT0247080002,66,Female,Unknown,Unknown,European,Poland,No,Other head and body,,Multifocal,7.0,Ductal adenocarcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),3,2,17,IHC staining not done,8,Staging Incomplete,No pathologic evidence of distant metastasis,,R2:  Macroscopic residual tumor,,160.0,50.0,19.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,1.0,1.0,Other reasons,,8.0,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,1.0,1.0,7.0
C3L-04495,PDAC,C3L-04495-T,C3L-04495-N,,,0.0,CPT0239140004,CPT0239100009,CPT0239100015,,CPT0239100012,CPT0239140007,CPT0239150002,36,Female,Unknown,Unknown,European,Canada,No,Other Body and tail,,Unifocal,4.8,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4,pN1,11,IHC staining not done,4,cM0,No pathologic evidence of distant metastasis,Not applicable,R1:  Microscopic residual tumor,,170.0,72.0,24.91,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Morphine|Synthroid,Medical Record|Medical Record,No,288.0,288.0,Main malignancy,,288.0,No,No,No,Not Applicable,,Yes,36.0,Distant Metastasis,Liver,,Positive Biomarker(s),No,,,No,Yes,No,,,36.0,1.0,288.0,1.0,0.0
C3N-03853,PDAC,C3N-03853-T,C3N-03853-N,,,0.0,CPT0237290004,CPT0237270005,CPT0237270008,,CPT0237270011,,CPT0237330002,49,Female,Unknown,Unknown,East_Asian,China,No,,,Unifocal,3.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,39,IHC staining not done,5,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,170.0,80.0,27.68,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,259.0,393.0,Unknown,,398.0,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,393.0,1.0,5.0
C3L-02610,PDAC,C3L-02610-T,C3L-02610-N,,,0.0,CPT0125010003,CPT0124980004,CPT0124980010,CPT0125010009,CPT0124980007,CPT0125010006,CPT0125020002,80,Male,Unknown,Unknown,European,Canada,No,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),T3,N0,15,IHC staining not done,0,M0,No pathologic evidence of distant metastasis,No distant metastasis,R1:  Microscopic residual tumor,,166.0,60.0,21.63,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,Skin Cancer (squamous cell - ear),Unknown,Metoprolol|Rivaroxaban|Folic Acid|Vitamin B12|Multivitamins|Atorvastatin|Valsartan,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,190.0,190.0,Unknown,,197.0,No,No,No,Not Applicable,,Yes,151.0,Distant Metastasis,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),Yes,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,153.0,,151.0,1.0,190.0,1.0,7.0
C3N-03000,PDAC,C3N-03000-T,,,,0.0,,CPT0226490004,CPT0226490010,,CPT0226490006,,CPT0226510002,57,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,5.5,Ductal adenocarcinoma,G3 Poorly differentiated,Stage IV,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN2,17,IHC staining not done,5,Staging Incomplete,pM1,liver,R1:  Microscopic residual tumor,,175.0,85.0,27.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,487.0,487.0,Main malignancy,,495.0,No,Yes,No,Persistent Disease,,Yes,438.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,Yes,Yes,No,,,438.0,1.0,487.0,1.0,8.0
C3L-03388,PDAC,C3L-03388-T,C3L-03388-N,,,0.0,CPT0239920004,CPT0239910004,CPT0239910010,,CPT0239910007,CPT0239920007,CPT0240550002,68,Male,Unknown,Unknown,European,Russia,No,,,Unifocal,3.2,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,19,IHC staining not done,5,cM0,No pathologic evidence of distant metastasis,Not documented,R0:  No residual tumor,,174.0,80.0,26.42,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,11.0,11.0,Unknown,,18.0,No,No,No,Patient Deceased,,Unknown,,,,,,,,,,,,,,,0.0,11.0,1.0,7.0
C3L-01689,PDAC,C3L-01689-T,C3L-01689-N,,,0.0,CPT0094760003,CPT0094740004,CPT0094740007,CPT0094760009,['CPT0094740010'],CPT0094760006,CPT0094770002,62,Male,Unknown,Unknown,European,Other: Canada,No,,,Unifocal,3.6,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,16,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,,R1:  Microscopic residual tumor,,182.0,93.0,28.08,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,Pancreatic digestive enzymes|Probiotics|Multivitamin,Medical Record|Medical Record|Medical Record,No,594.0,594.0,Main malignancy,,601.0,No,Yes,No,Unknown,,Yes,289.0,Distant Metastasis,Other : Superior mesentery artery,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,289.0,1.0,594.0,1.0,7.0
C3N-02768,PDAC,C3N-02768-T,C3N-02768-N,,,0.0,CPT0207990004,CPT0207980005,CPT0207980011,CPT0207990010,CPT0207980008,CPT0207990007,CPT0208030002,46,Male,Unknown,Unknown,East_Asian,China,No,,,Unifocal,3.0,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN1,24,IHC staining not done,2,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,170.0,77.0,26.64,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,366.0,430.0,Main malignancy,,436.0,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,430.0,1.0,6.0
C3N-03430,PDAC,C3N-03430-T,,,,0.0,,CPT0226650004,CPT0226650010,,CPT0226650007,,CPT0226670002,54,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,5.0,Ductal adenocarcinoma,G2 Moderately differentiated,Staging is not applicable or unknown,Not identified,Cannot be assessed,Eighth Edition (2017),no resection,no resection,0,IHC staining not done,0,1,Staging Incomplete,"liver, peritoneum",R2:  Macroscopic residual tumor,,164.0,50.0,18.0,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,7.3,No or minimal exposure to secondhand smoke,,,,,No,30.0,39.0,Main malignancy,,49.0,No,No,No,Not Applicable,,Unknown,,,,,,,,,,,,,,,0.0,39.0,1.0,10.0
C3L-03371,PDAC,C3L-03371-T,C3L-03371-N,1.0,"Failed Pathology review, excluded by WG",0.0,CPT0275880003,CPT0275870003,CPT0275870009,,CPT0275870006,CPT0275880006,CPT0265930002,53,Male,Unknown,Unknown,,Russia,No,,,Unifocal,2.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1,pN0,25,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,168.0,67.0,23.74,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Creon|Omeprazole,Medical Record|Medical Record,No,560.0,560.0,Main malignancy,,569.0,No,Yes,No,Complete Remission,Progressive Disease,No,,,,,,,,,,,,,,,0.0,560.0,1.0,9.0
C3N-01388,PDAC,C3N-01388-T,,,,0.0,,CPT0088320003,CPT0088320006,,CPT0088320009,,CPT0088350002,53,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,46,IHC staining not done,6,Staging Incomplete,No pathologic evidence of distant metastasis,,R1:  Microscopic residual tumor,,166.0,51.0,18.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,NovoRapid Penfill - Insulini aspartum ,Self Report,No,1056.0,811.0,Main malignancy,,825.0,Yes,Yes,No,Persistent Disease,,Yes,311.0,Distant Metastasis,Tumor Bed,,Positive Biomarker(s),No,,,No,Yes,No,,,311.0,1.0,811.0,1.0,14.0
C3L-01971,PDAC,C3L-01971-T,C3L-01971-N,,,0.0,CPT0108960003,CPT0108930003,CPT0108930006,,CPT0108930009,,CPT0108360002,66,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,2.0,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,20,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,183.0,85.0,25.36,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,losartan|Omeprazole|Baby aspirin,Medical Record|Medical Record|Medical Record,No,38.0,276.0,Unknown,,276.0,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,276.0,1.0,0.0
C3N-01900,PDAC,C3N-01900-T,C3N-01900-N,1.0,"Failed Pathology review, excluded by WG",0.0,C3N-01900-04,CPT0162600005,CPT0162600011,,CPT0162600008,,CPT0162650002,53,Male,Unknown,Unknown,,Poland,No,,,Unifocal,2.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,15,IHC staining not done,3,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,,176.0,80.0,25.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,,No or minimal exposure to secondhand smoke,,,ramipril|insulin,Medical Record|Medical Record,No,831.0,831.0,Main malignancy,,832.0,No,Yes,No,Complete Remission,Not Applicable,Yes,529.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,529.0,1.0,831.0,1.0,1.0
C3L-03628,PDAC,C3L-03628-T,C3L-03628-N,,,0.0,CPT0198730004,CPT0198700005,CPT0198700011,,CPT0198700008,,CPT0198740002,69,Female,Unknown,Unknown,European,Other: Denmark,No,,,Unifocal,3.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,35,IHC staining not done,20,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,160.0,51.0,19.92,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,Candesartan|Etidronate/calcium,Medical Record|Medical Record,No,596.0,596.0,Main malignancy,,601.0,No,Yes,No,Complete Remission,,Yes,352.0,Distant Metastasis,Peritoneal Surface,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,352.0,1.0,596.0,1.0,5.0
C3N-01998,PDAC,C3N-01998-T,C3N-01998-N,,,0.0,CPT0138990003,CPT0139000004,CPT0139000007,CPT0138990009,CPT0139000010,CPT0138990006,CPT0139020002,69,Male,Unknown,Unknown,East_Asian,China,No,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,7,IHC staining not done,3,cM0,Staging Incomplete,no,R0:  No residual tumor,,165.0,55.0,20.2,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,insulin,Self-reported and Medical Record,No,4.0,186.0,Main malignancy,,193.0,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,186.0,1.0,7.0
C3L-01637,PDAC,C3L-01637-T,C3L-01637-N,,,0.0,CPT0086210003,CPT0086190004,CPT0086190007,CPT0086210009,['CPT0086190010'],CPT0086210006,CPT0087390002,78,Female,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,2.6,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,6,IHC staining not done,3,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,165.0,71.0,26.05,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",60.0,Exposure to secondhand smoke history not available,,,Biotin|lovastatin|Centrum Silver |ocuvite preservision oral tablet |Fish Oil |Vitamin E |Vitamin D  |Calcuim 600 +D|Latanoprost |lisinopril ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,715.0,715.0,Main malignancy,,715.0,Yes,Yes,No,Persistent Disease,,Yes,268.0,Distant Metastasis,Lung,,Convincing Image (i.e. CT/PET/MRI),No,,,Unknown,Unknown,Unknown,,,268.0,1.0,715.0,1.0,0.0
C3N-00249,PDAC,C3N-00249-T,C3N-00249-N,,,0.0,CPT0025760003,CPT0025750003,['CPT0025750006'],,['CPT0025750009'],CPT0025760006,CPT0028460002,71,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,4.2,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,25,IHC staining not done,3,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,165.0,76.0,27.79,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",2.0,Exposure to secondhand smoke history not available,,,Vitamin E|Omega-3 Fatty Acids|Lactobacillus ,Medical Record|Medical Record|Medical Record,No,1590.0,1590.0,Main malignancy,,1571.0,Yes,Yes,No,Complete Remission,Progressive Disease,Yes,579.0,Distant Metastasis,Peritoneal Surface,,Positive Biomarker(s),No,,,Unknown,Yes,Yes,,,579.0,1.0,1590.0,1.0,-19.0
C3N-00198,PDAC,C3N-00198-T,C3N-00198-N,,,0.0,CPT0014060003,CPT0014040003,['CPT0014040009'],CPT0014060009,['CPT0014040006'],,CPT0015030002,55,Male,White,Not Hispanic or Latino,European,United States,No,,,Multifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,32,IHC staining not done,7,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,185.0,110.0,31.92,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,pioglitazone|glimepriride|liraglutide|hydrocodone-acetaminophen|tamsulosin|Naproxen|metformin|sildenafil|amlodipine|omeprazole|ursodiol|losartan|doxycycline hyclate|fenofibrate micronized,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1592.0,,,1592.0,,Yes,Yes,No,Complete Remission,Progressive Disease,Yes,458.0,Locoregional Recurrence,Other : Right Upper Quadrant Omental Nodule,,Convincing Image (i.e. CT/PET/MRI),No,,,Unknown,Yes,Unknown,,,458.0,1.0,1592.0,0.0,0.0
C3L-03394,PDAC,C3L-03394-T,C3L-03394-N,,,0.0,CPT0224470004,CPT0224460004,CPT0224460010,,CPT0224460007,CPT0224470007,CPT0226210002,65,Female,Unknown,Unknown,European,Russia,No,,,Unifocal,1.5,Ductal adenocarcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1C,pN0,5,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,167.0,71.0,25.46,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,635.0,635.0,Main malignancy,,638.0,No,Yes,No,Complete Remission,,Yes,558.0,Locoregional Recurrence,Tumor Bed,,Positive Biomarker(s),No,,,No,No,No,,,558.0,1.0,635.0,1.0,3.0
C3N-01907,PDAC,C3N-01907-T,,1.0,"Failed Pathology review, excluded by WG",0.0,,CPT0162830005,CPT0162830011,,CPT0162830008,,CPT0162870002,62,Male,Unknown,Unknown,,Poland,No,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Cannot be assessed,Seventh Edition (2010),pTX,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,no,RX:  Presence of residual tumor cannot be assessed,,167.0,85.0,30.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,42.0,Yes,,,metformax|glibetic|suvardio|Co-Bespres ,Self Report|Self Report|Self Report|Self Report,No,407.0,440.0,Main malignancy,,440.0,Yes,Yes,No,Persistent Disease,,Yes,267.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,267.0,1.0,440.0,1.0,0.0
C3N-02971,PDAC,C3N-02971-T,,,,0.0,,CPT0185920004,CPT0185920010,,CPT0185920007,,CPT0187270002,78,Female,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,5.6,Ductal adenocarcinoma,G1 Well differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4,pN0,11,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,152.0,69.0,29.88,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,albuterol|amlodipine|amoxicillin|aspirin|dihenhydramine|doucaste|esomeprazole|fenofibrate|fluticasone-salmeterol|gabapentin|insulin aspart|losartan|metoprolol|montelukast|nystatin|rosuvastatin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,70.0,70.0,Main malignancy,,61.0,No,Yes,No,Unknown,,No,,,,,,,,,,,,,,,0.0,70.0,1.0,-9.0
C3N-03173,PDAC,C3N-03173-T,C3N-03173-N,,,0.0,CPT0186050004,CPT0186040004,CPT0186040010,CPT0186050010,CPT0186040013,CPT0186050007,CPT0187290002,64,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,2.9,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,25,IHC staining not done,4,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,174.0,91.0,30.11,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",3.0,Exposure to secondhand smoke history not available,,,diazepam|ranitidine|digestive enzymes,Medical Record|Medical Record|Medical Record,No,32.0,,,32.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,32.0,0.0,0.0
C3N-03754,PDAC,C3N-03754-T,,,,0.0,,CPT0246810003,CPT0246810013,,CPT0246810006,,CPT0246830002,44,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,2.8,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Present,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),2,2,21,IHC staining not done,10,0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,181.0,83.0,25.0,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,24.0,No or minimal exposure to secondhand smoke,,,concor|tritace,Medical Record|Medical Record,No,767.0,815.0,Main malignancy,,815.0,No,Yes,No,Persistent Disease,Progressive Disease,Yes,417.0,Distant Metastasis,Liver,,Positive Biomarker(s),No,,,No,Yes,No,,,417.0,1.0,815.0,1.0,0.0
C3L-01598,PDAC,C3L-01598-T,C3L-01598-N,,,0.0,CPT0091680003,CPT0091660003,CPT0091660006,,['CPT0091660009'],CPT0091680006,CPT0093640002,73,Female,White,Not Hispanic or Latino,European,United States,No,Other Distal pancreas,,Unifocal,2.8,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,5,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,165.0,103.0,37.79,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,bumetanide|warfarin|pravastatin|losartan|glyburide|coreg|Osteo-BI-Flex triple strength,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,913.0,913.0,Main malignancy,,913.0,Yes,Yes,No,Persistent Disease,,Yes,288.0,Distant Metastasis,Peritoneal Surface,,Biopsy with Histologic Confirmation,No,,,No,Yes,No,,,288.0,1.0,913.0,1.0,0.0
C3L-02809,PDAC,C3L-02809-T,C3L-02809-N,,,0.0,CPT0174800003,CPT0174700004,CPT0174700010,CPT0174800007,CPT0174700007,,CPT0175500002,84,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,5.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,19,IHC staining not done,2,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,170.0,98.0,33.67,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,Aspirin|Coumadin|Hydralazine|Burnex|Glipizide|Potassium|Losartan|Simvastatin|Atorvastatin|Carvedilol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,68.0,68.0,Main malignancy,,68.0,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,68.0,1.0,0.0
C3L-01453,PDAC,C3L-01453-T,C3L-01453-N,,,0.0,CPT0108410003,CPT0108400003,CPT0108400006,CPT0108410009,['CPT0108400009'],CPT0108410006,CPT0108330002,69,Male,White,Hispanic or Latino,European,United States,No,,,Unifocal,5.2,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,4,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,168.0,79.0,28.24,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Androgel|Lisinopril|Invokana|Metformin HCl ER|Colestipol HCl|Atorvastatin|Flomax|Aspirin|Multivitamin,Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report|Self Report,No,5.0,,,5.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,5.0,0.0,0.0
C3L-02109,PDAC,C3L-02109-T,,,,0.0,,CPT0109010004,CPT0109010007,,CPT0109010010,,CPT0109040002,79,Female,Unknown,Unknown,European,Canada,No,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT4,pN1,15,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,,R1:  Microscopic residual tumor,,159.0,81.0,32.04,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Amlodipine|Lumigan Eye Drops|Vitamin D|Aleve|Zopliclone,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,261.0,,,275.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,261.0,0.0,14.0
C3L-02606,PDAC,C3L-02606-T,C3L-02606-N,,,0.0,CPT0124530003,CPT0124500004,CPT0124500010,CPT0124530009,CPT0124500006,CPT0124530006,CPT0124540002,68,Female,Unknown,Unknown,European,Other: TSS did not collect,No,,,Unifocal,4.0,Adenosquamous carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,26,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,No distant metastasis,R1:  Microscopic residual tumor,,169.0,57.0,20.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,12.5,Exposure to secondhand smoke history not available,,,Morphine|Zoplicone,Medical Record|Medical Record,No,403.0,403.0,Main malignancy,,411.0,No,Yes,No,Persistent Disease,,Yes,251.0,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,Yes,No,No,,,251.0,1.0,403.0,1.0,8.0
C3N-03666,PDAC,C3N-03666-T,,,,0.0,,CPT0246720003,CPT0246720009,,CPT0246720006,,CPT0246740002,63,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),2,1,23,IHC staining not done,2,0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,165.0,71.0,26.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,lisinoratio|insulin ,Self Report|Self Report,No,701.0,701.0,Main malignancy,,711.0,No,Yes,No,Persistent Disease,,Yes,348.0,Distant Metastasis,Tumor Bed,,Positive Biomarker(s),No,,,No,Yes,No,,,348.0,1.0,701.0,1.0,10.0
C3N-01997,PDAC,C3N-01997-T,C3N-01997-N,,,0.0,CPT0138890003,CPT0138900004,CPT0138900007,,CPT0138900010,CPT0138890006,CPT0138920002,63,Male,Unknown,Unknown,East_Asian,China,No,,,Unifocal,3.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pN0,7,IHC staining not done,0,cM0,Staging Incomplete,no,R0:  No residual tumor,,168.0,52.0,18.42,No,Alcohol consumption history not available,Current reformed smoker within past 15 years,,Exposure to secondhand smoke history not available,,,,,No,1002.0,1035.0,Unknown,,1035.0,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,1035.0,1.0,0.0
C3N-02589,PDAC,C3N-02589-T,C3N-02589-N,,,0.0,CPT0162670004,CPT0162660004,CPT0162660010,CPT0162670010,CPT0162660007,CPT0162670007,CPT0162700002,71,Male,Unknown,Unknown,European,Poland,No,,,Multifocal,2.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,21,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,175.0,73.0,23.0,No,Lifelong non-drinker,"Current reformed smoker, years unknown",,No or minimal exposure to secondhand smoke,,,gliklazyd,Medical Record,No,398.0,398.0,Main malignancy,,401.0,No,Yes,No,Complete Remission,,Yes,378.0,Distant Metastasis,Peritoneal Surface,,Convincing Image (i.e. CT/PET/MRI),Yes,,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,378.0,,378.0,1.0,398.0,1.0,3.0
C3L-04479,PDAC,C3L-04479-T,C3L-04479-N,,,0.0,CPT0238940004,CPT0238920004,CPT0238920010,,CPT0238920007,CPT0238940007,CPT0238950002,66,Male,Unknown,Unknown,European,Other: TSS did not collect,No,,,Unifocal,1.7,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,11,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,174.0,89.0,29.23,Yes,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,Squamous Cell carcinoma in situ of the face,Surgery,Pantoprazole|Metoprolol|Olmesartan/hydrochlorothiazide,Medical Record|Medical Record|Medical Record,No,1104.0,,,1104.0,,No,Yes,No,Complete Remission,Complete Response,Yes,922.0,Distant Metastasis,Liver,,Positive Biomarker(s),No,,,Yes,No,No,,,922.0,1.0,1104.0,0.0,0.0
C3N-01168,PDAC,C3N-01168-T,,,,0.0,,CPT0094030003,CPT0094030006,,['CPT0094030009'],,CPT0094070002,60,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,10,IHC staining not done,3,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,,158.0,51.0,20.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,415.0,415.0,Main malignancy,,418.0,Yes,Yes,No,Persistent Disease,,Yes,320.0,Distant Metastasis,Other : spleen,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,320.0,1.0,415.0,1.0,3.0
C3L-02463,PDAC,C3L-02463-T,C3L-02463-N,,,0.0,CPT0126200003,CPT0126160004,CPT0126160007,CPT0126200009,CPT0126160010,CPT0126200006,CPT0124290002,63,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,4.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,20,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,183.0,74.0,22.22,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,Pantoprazole|Cefuroxime,Medical Record|Medical Record,No,740.0,,,741.0,,No,Yes,No,Unknown,Unknown,Unknown,,,,,,,,,,,,,,,0.0,740.0,0.0,1.0
C3L-03743,PDAC,C3L-03743-T,C3L-03743-N,,,0.0,CPT0264180003,CPT0264150003,CPT0264150006,CPT0264180009,CPT0264150009,CPT0264180006,CPT0265780002,71,Female,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,2.9,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN1,13,IHC staining not done,2,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,158.0,50.0,20.2,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Beta-carotine|Calcium|Centrum Silver|Hydochlorothiazide|Lovastatin|Vitamin C|Vitamin D3,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,48.0,732.0,Main malignancy,,732.0,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,732.0,1.0,0.0
C3L-01051,PDAC,C3L-01051-T,C3L-01051-N,,,0.0,CPT0123670003,CPT0123650003,CPT0123650006,,CPT0123650009,CPT0123670006,CPT0124870002,60,Male,Unknown,Unknown,European,Russia,No,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,17,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,Not documented,R0:  No residual tumor,,186.0,95.0,27.46,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Yes,,,,,No,0.0,,,9.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,0.0,0.0,9.0
C3N-03211,PDAC,C3N-03211-T,C3N-03211-N,,,0.0,CPT0209650004,CPT0209640005,CPT0209640011,,CPT0209640008,CPT0209650007,CPT0209690002,43,Male,Unknown,Unknown,East_Asian,China,No,,,Unifocal,4.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,17,IHC staining not done,4,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,165.0,65.0,23.88,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,278.0,286.0,Unknown,,290.0,No,Yes,No,Persistent Disease,,Yes,210.0,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,210.0,1.0,286.0,1.0,4.0
C3N-02940,PDAC,C3N-02940-T,,,,0.0,,CPT0208550005,CPT0208550011,,CPT0208550008,,CPT0208610002,64,Male,Unknown,Unknown,East_Asian,China,No,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN02,24,IHC staining not done,4,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,182.0,85.0,25.66,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,1015.0,,,1018.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,1015.0,0.0,3.0
C3L-02115,PDAC,C3L-02115-T,C3L-02115-N,,,0.0,CPT0109130003,CPT0109110004,CPT0109110007,,CPT0109110012,CPT0109130006,CPT0109140002,80,Male,Unknown,Unknown,European,Canada,No,,,Unifocal,3.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,14,IHC staining not done,11,cM0,No pathologic evidence of distant metastasis,,R1:  Microscopic residual tumor,,181.0,77.0,23.53,Yes,"Consumed alcohol in the past, but currently a non-drinker","Current reformed smoker, more than 15 years",26.0,Exposure to secondhand smoke history not available,Basal cell carcinoma,Surgery,Hydrochlorothiazide|Levothyroxine|Amlodipine|Potassium Chloride|Vitamin C|Vitamin D|Calcium Magnesium|Omega 3|Hawthorn|Saw Palmetto|Alfa caps|Ranitidine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,723.0,723.0,Main malignancy,,731.0,No,Yes,No,Complete Remission,,Yes,701.0,Distant Metastasis,Other : cervical and thoracic spine,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,701.0,1.0,723.0,1.0,8.0
C3N-00436,PDAC,C3N-00436-T,C3N-00436-N,,,0.0,CPT0077880003,CPT0077860003,['CPT0077860009'],CPT0077880009,CPT0077860006,CPT0077880006,CPT0077920002,69,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,4.5,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,11,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,,158.0,73.0,29.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,insulin,Medical Record,Yes,718.0,718.0,Main malignancy,,734.0,No,Yes,No,Persistent Disease,Progressive Disease,Yes,621.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),Yes,,R1: Microscopic Residual Tumor,No,No,No,650.0,,621.0,1.0,718.0,1.0,16.0
C3N-01716,PDAC,C3N-01716-T,,,,0.0,,CPT0125130003,CPT0125130009,,CPT0125130006,,CPT0125150002,50,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,2.5,Ductal adenocarcinoma,G3 Poorly differentiated,Stage IV,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4,pN1,35,IHC staining not done,17,cM0,pM1,no,R1:  Microscopic residual tumor,,182.0,95.0,28.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,nebilet|Xarelto Rivaroxabanum,Self Report|Self Report,No,384.0,335.0,Main malignancy,,339.0,Unknown,Yes,No,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,335.0,1.0,4.0
C3L-04475,PDAC,C3L-04475-T,C3L-04475-N,,,0.0,CPT0248320003,CPT0238820005,CPT0238820011,CPT0248320009,CPT0238820008,CPT0248320006,CPT0238860002,77,Male,Unknown,Unknown,European,Canada,No,,,Unifocal,2.7,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,21,IHC staining not done,10,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,173.0,68.0,22.55,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,,Exposure to secondhand smoke history not available,,,ASA 81|Metoprolol,Medical Record|Medical Record,No,881.0,893.0,Main malignancy,,893.0,No,Yes,No,Complete Remission,Progressive Disease,Yes,829.0,Distant Metastasis,Other : Distal femur,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,829.0,1.0,893.0,1.0,0.0
C3L-04473,PDAC,C3L-04473-T,C3L-04473-N,,,0.0,CPT0238740004,CPT0238710004,CPT0238710010,,CPT0238710007,,CPT0238750002,67,Female,Unknown,Unknown,South_Asian,Other: India,No,Other Head and body,,Unifocal,4.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,18,IHC staining not done,12,cM0,No pathologic evidence of distant metastasis,Not applicable,R1:  Microscopic residual tumor,,154.0,56.0,23.59,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,Right breast cancer,Surgery,Paliperidone|divalproex|Bupropion|sulfasalazine|folic acid|methotrexate|hydroxychloroquine|empowerplus|digestplus|manjistha supreme|pancreatic enzymes|perfect amino xp,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,290.0,290.0,Unknown,,245.0,No,No,No,Not Applicable,,Yes,164.0,Locoregional Recurrence,Other : Retroperitoneal,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,164.0,1.0,290.0,1.0,-45.0
C3N-00516,PDAC,C3N-00516-T,,,,0.0,,CPT0078090004,['CPT0078090010'],,CPT0078090007,,CPT0078150002,68,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,4.0,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,11,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,165.0,60.0,22.04,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,38.0,No or minimal exposure to secondhand smoke,,,,,No,1152.0,1152.0,Main malignancy,,1166.0,No,Yes,No,Complete Remission,,Yes,403.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,403.0,1.0,1152.0,1.0,14.0
C3L-03129,PDAC,C3L-03129-T,,1.0,"Failed Pathology review, excluded by WG",0.0,,CPT0166930004,CPT0166930014,,CPT0166930007,,CPT0166970002,68,Male,Unknown,Unknown,,China,No,,,Unifocal,5.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,12,IHC staining not done,4,cM0,No pathologic evidence of distant metastasis,No distant metastasis,R0:  No residual tumor,,183.0,82.0,24.55,No,"Consumed alcohol in the past, but currently a non-drinker","Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,Nicorette gum|AndroGel,Medical Record|Medical Record,No,1421.0,,,1428.0,,No,Yes,No,Complete Remission,Stable Disease,Yes,579.0,New Primary Tumor,Other : pancreatic head,,Positive Biomarker(s),Yes,,R0: No Residual Tumor,No,Yes,No,635.0,,579.0,1.0,1421.0,0.0,7.0
C3L-04848,PDAC,C3L-04848-T,C3L-04848-N,,,0.0,CPT0248440003,CPT0248410004,CPT0248410010,,CPT0248410007,,CPT0248450002,71,Female,Unknown,Unknown,European,Canada,No,,,Unifocal,4.7,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,15,IHC staining not done,3,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,164.0,81.0,30.12,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,L-thyroxine|rosuvastatin|nifedipine|Pantoprazole|telmisartan|hydrochlorothiazide|atenolol|zopiclone,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,196.0,196.0,Unknown,,196.0,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,196.0,1.0,0.0
C3L-00881,PDAC,C3L-00881-T,C3L-00881-N,,,0.0,CPT0017130003,CPT0017040004,['CPT0017040010'],,CPT0017040007,CPT0017130006,CPT0015340002,80,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,2.2,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,24,1,1,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,175.0,91.0,29.6,No,Lifelong non-drinker,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,3.0,,,11.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,3.0,0.0,8.0
C3L-00277,PDAC,C3L-00277-T,C3L-00277-N,,,0.0,CPT0011540003,CPT0011520003,CPT0011520009,,CPT0011520006,CPT0011540010,CPT0012450002,69,Male,White,Unknown,European,United States,No,,,Unifocal,5.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,15,IHC staining not done,1,Staging Incomplete,Staging Incomplete,,R2:  Macroscopic residual tumor,,183.0,80.0,24.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Zinacef|NaCl 0.9%|Metformin|Prilosec|Bupivacaine|Diphenhydramine|Omeprazole,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,730.0,610.0,Main malignancy,,615.0,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,610.0,1.0,5.0
C3N-00513,PDAC,C3N-00513-T,C3N-00513-N,,,0.0,CPT0077810003,CPT0077790004,['CPT0077790010'],,CPT0077790007,CPT0077810006,CPT0077850001,63,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,3.5,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,17,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,170.0,52.0,17.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,28.5,No or minimal exposure to secondhand smoke,,,,,No,394.0,394.0,Main malignancy,,414.0,Yes,Yes,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,394.0,1.0,20.0
C3N-02579,PDAC,C3N-02579-T,,,,0.0,,CPT0207780004,CPT0207780007,,CPT0207780010,,CPT0207830002,51,Female,Unknown,Unknown,East_Asian,China,No,,,Unifocal,0.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1a,pN0,9,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,156.0,55.0,22.6,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,melbine (DMBG),Medical Record,No,245.0,358.0,Unknown,,363.0,No,Yes,No,Persistent Disease,,Yes,195.0,Distant Metastasis,Other : abdominal wall,,Convincing Image (i.e. CT/PET/MRI),Yes,,R0: No Residual Tumor,No,No,No,225.0,,195.0,1.0,358.0,1.0,5.0
C3L-01037,PDAC,C3L-01037-T,C3L-01037-N,,,0.0,CPT0170260004,CPT0170240004,CPT0170240010,,CPT0170240007,CPT0170260007,CPT0167230002,42,Male,Unknown,Unknown,European,Russia,No,,,Unifocal,4.5,Undifferentiated carcinoma,G4 Undifferentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,29,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,Not documented,R0:  No residual tumor,,178.0,84.0,26.51,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,300.0,300.0,Main malignancy,,308.0,No,No,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,300.0,1.0,8.0
C3L-03395,PDAC,C3L-03395-T,C3L-03395-N,,,0.0,CPT0276030003,CPT0276010003,CPT0276010009,,CPT0276010006,CPT0276030009,CPT0265950002,78,Male,Unknown,Unknown,European,Russia,No,,,Unifocal,3.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT2,pN2,11,IHC staining not done,6,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,154.0,57.0,24.03,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,88.0,88.0,Unknown,,92.0,No,Yes,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,88.0,1.0,4.0
C3N-03780,PDAC,C3N-03780-T,C3N-03780-N,,,0.0,CPT0246950003,CPT0246940003,CPT0246940009,CPT0246950009,CPT0246940006,CPT0246950006,CPT0246980002,69,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,3.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),2,0,2,IHC staining not done,0,IB,IB,no,R1:  Microscopic residual tumor,,160.0,77.0,30.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,amlodypine|levotyroxin|kandesartan|hydrochlorothiazyde|betaksolol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,20.0,20.0,Other reasons,,28.0,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,20.0,1.0,8.0
C3L-01036,PDAC,C3L-01036-T,C3L-01036-N,,,0.0,CPT0123460003,CPT0123440003,CPT0123440009,,CPT0123440006,CPT0123460006,CPT0124820002,64,Male,Unknown,Unknown,European,Russia,No,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,12,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,Not documented,R0:  No residual tumor,,178.0,80.0,25.25,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,1247.0,881.0,Main malignancy,,888.0,No,Yes,No,Persistent Disease,,Yes,351.0,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,351.0,1.0,881.0,1.0,7.0
C3L-02897,PDAC,C3L-02897-T,,,,0.0,,CPT0217700004,CPT0217700010,,CPT0217700007,,CPT0219810002,80,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,2.7,Ductal adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,15,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,178.0,93.0,29.55,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,Creon ,Medical Record,No,256.0,,,256.0,,No,No,No,Not Applicable,,Unknown,,,,,,,,,,,,,,,0.0,256.0,0.0,0.0
C3N-03439,PDAC,C3N-03439-T,,,,0.0,,CPT0246260004,CPT0246260007,,CPT0246260010,,CPT0246300002,56,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,1.7,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),1c,1,12,IHC staining not done,1,0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,,163.0,47.0,17.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,458.0,458.0,Main malignancy,,462.0,No,Yes,No,Persistent Disease,,Yes,204.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,204.0,1.0,458.0,1.0,4.0
C3N-00957,PDAC,C3N-00957-T,C3N-00957-N,,,0.0,CPT0089750004,CPT0089720003,CPT0089720006,,['CPT0089720009'],CPT0089750007,CPT0091380002,74,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,5.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,9,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,173.0,77.0,25.69,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",11.8,Exposure to secondhand smoke history not available,,,ammonium lactate|aspirin|Vitamin B|clopidogrel|diclofenac sodium transderm gel|Dutasteride|fluticasone|losartan|Loastatin|metoprolol|Nitroglycerin|tamsulosin|Vitamin D3,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1189.0,,,1167.0,,Unknown,Yes,Unknown,Complete Remission,,No,,,,,,,,,,,,,,,0.0,1189.0,0.0,-22.0
C3L-00819,PDAC,C3L-00819-T,C3L-00819-N,,,0.0,CPT0064110003,CPT0064090003,['CPT0064090009'],CPT0064110006,CPT0064090006,CPT0064110009,CPT0065380002,74,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,2.8,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,20,IHC staining not done,3,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:  No residual tumor,,183.0,100.0,29.86,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Finasteride|Loratadine|Mylanta|Irbesartan|Tylenol|Lomotil,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,601.0,603.0,Main malignancy,,603.0,Yes,Yes,No,Unknown,,Yes,327.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,327.0,1.0,603.0,1.0,0.0
C3N-04282,PDAC,C3N-04282-T,C3N-04282-N,,,0.0,CPT0247000003,CPT0246990003,CPT0246990009,,CPT0246990006,,CPT0247030002,75,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,4.0,Ductal adenocarcinoma,G3 Poorly differentiated,Stage IV,Present,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),3,1,9,IHC staining not done,2,Staging Incomplete,1,liver,R1:  Microscopic residual tumor,,169.0,47.0,16.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,45.0,Exposure to secondhand smoke history not available,,,formoterol|euphylin|triamcynolon,Medical Record|Medical Record|Medical Record,No,303.0,303.0,Main malignancy,,312.0,Yes,Yes,No,Persistent Disease,,Yes,95.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,95.0,1.0,303.0,1.0,9.0
C3N-03086,PDAC,C3N-03086-T,,,,0.0,,CPT0209310004,CPT0209310014,,CPT0209310007,CPT0209320007,CPT0209360002,69,Male,Unknown,Unknown,East_Asian,China,No,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,22,IHC staining not done,2,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,165.0,56.0,20.57,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,733.0,,,737.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,733.0,0.0,4.0
C3N-03428,PDAC,C3N-03428-T,,,,0.0,,CPT0226680005,CPT0226680011,,CPT0226680008,,CPT0226720002,63,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,4.0,Ductal adenocarcinoma,G2 Moderately differentiated,Staging is not applicable or unknown,Not identified,Cannot be assessed,Eighth Edition (2017),no resection,no resection,0,IHC staining not done,0,1,1,liver,R2:  Macroscopic residual tumor,,161.0,60.0,23.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,184.0,286.0,Main malignancy,,295.0,No,Yes,No,Persistent Disease,,Yes,49.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,49.0,1.0,286.0,1.0,9.0
C3L-03635,PDAC,C3L-03635-T,,,,0.0,,CPT0238530005,CPT0238530011,,CPT0238530008,,CPT0238560002,63,Male,Unknown,Unknown,European,Other: TSS did not collect,No,,,Unifocal,3.2,Ductal adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,Unknown value,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,168.0,73.0,25.94,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Ventolin|Finasteride|Paroxetine|Rosuvastatin|Percocet,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,854.0,854.0,Main malignancy,,826.0,No,Yes,No,Complete Remission,Progressive Disease,Yes,565.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,565.0,1.0,854.0,1.0,-28.0
C3L-00625,PDAC,C3L-00625-T,,,,0.0,,CPT0081470004,CPT0081470010,,CPT0081470007,CPT0081500010,CPT0081510001,34,Female,Unknown,Unknown,European,Other: Canada,No,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,19,IHC staining not done,5,cM0,No pathologic evidence of distant metastasis,No distant metastasis,R0:  No residual tumor,,167.0,62.0,22.23,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,2.5,Exposure to secondhand smoke history not available,,,Tylenol 3|Tramadol|Ativan,Medical Record|Medical Record|Medical Record,No,1198.0,1198.0,Main malignancy,,1198.0,No,Yes,No,Complete Remission,,Yes,417.0,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,Yes,Yes,No,,,417.0,1.0,1198.0,1.0,0.0
C3L-00189,PDAC,C3L-00189-T,C3L-00189-N,,,0.0,C3L-00189-04,CPT0081060004,['CPT0081060007'],,CPT0081060010,,CPT0081100002,68,Female,Unknown,Unknown,European,Other: Canada,No,,,Unifocal,2.7,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,13,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,pMx,R1:  Microscopic residual tumor,,157.0,84.0,34.28,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,Verapamil|Aspirin,Medical Record|Medical Record,No,1036.0,1036.0,Main malignancy,,1043.0,No,Yes,No,Complete Remission,,Yes,424.0,Distant Metastasis,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,424.0,1.0,1036.0,1.0,7.0
C3N-03061,PDAC,C3N-03061-T,C3N-03061-N,,,0.0,CPT0208850004,CPT0208840004,CPT0208840010,,CPT0208840014,,CPT0208890002,62,Female,Unknown,Unknown,East_Asian,China,No,,,Unifocal,3.0,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN1,8,IHC staining not done,1,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,150.0,43.0,19.11,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,120.0,139.0,Unknown,,142.0,No,Yes,No,Persistent Disease,,Yes,33.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,33.0,1.0,139.0,1.0,3.0
C3N-03440,PDAC,C3N-03440-T,C3N-03440-N,,,0.0,CPT0246220004,CPT0246210004,CPT0246210007,CPT0246220010,CPT0246210010,CPT0246220007,CPT0246250002,54,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,4.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),2,0,6,IHC staining not done,0,0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,170.0,65.0,22.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,315.0,,,317.0,,No,Yes,No,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,315.0,0.0,2.0
C3L-01662,PDAC,C3L-01662-T,,,,0.0,,CPT0092630003,CPT0092630006,,CPT0092630009,,CPT0093720002,60,Female,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,3.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,17,IHC staining not done,10,cM0,No pathologic evidence of distant metastasis,Not Applicable,R1:  Microscopic residual tumor,,160.0,72.0,28.13,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,"Pancrelipase, Lip-Prot-Amyl",Medical Record,No,322.0,344.0,Main malignancy,,344.0,Yes,Yes,No,Unknown,,Yes,272.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,272.0,1.0,344.0,1.0,0.0
C3N-00303,PDAC,C3N-00303-T,,,,0.0,,CPT0008800003,['CPT0008800009'],,CPT0008800006,,CPT0008850002,65,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,5.0,Ductal adenocarcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,20,IHC staining not done,4,cM0,No pathologic evidence of distant metastasis,x,R0:  No residual tumor,,164.0,69.0,25.0,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,21.5,Yes,,,,,Yes,599.0,599.0,Main malignancy,,613.0,No,Yes,No,Persistent Disease,,Yes,97.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,97.0,1.0,599.0,1.0,14.0
C3L-01703,PDAC,C3L-01703-T,,,,0.0,,CPT0094940004,CPT0094940007,CPT0094960008,['CPT0094940010'],CPT0094960010,CPT0094970002,62,Male,Unknown,Unknown,European,Other: Canada,No,Other Body and tail,,Unifocal,6.5,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,6,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,171.0,79.0,27.02,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,,,No,287.0,287.0,Main malignancy,,293.0,No,No,No,Not Applicable,,Yes,175.0,Distant Metastasis,Peritoneal Surface,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,175.0,1.0,287.0,1.0,6.0
C3L-03632,PDAC,C3L-03632-T,C3L-03632-N,,,0.0,C3L-03632-04,CPT0238440005,CPT0238440011,,CPT0238440008,,CPT0238470002,74,Male,Unknown,Unknown,European,Other: TSS did not collect,No,,,Unifocal,2.1,Ductal adenocarcinoma,G1 Well differentiated,Stage I,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,12,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,172.0,77.0,26.03,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Clonazepam|Oralair|Tylenol|cholestyramine/sucrose|olanzapine|clomipramine|Esomeprazole|Ramipril|Latanoprostye drops|Vitamin supplements,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1121.0,,,1121.0,,No,No,No,Not Applicable,Not Applicable,No,,,,,,,,,,,,,,,0.0,1121.0,0.0,0.0
C3N-01383,PDAC,C3N-01383-T,,,,0.0,,CPT0094230004,CPT0094230007,,CPT0094230010,,CPT0094270002,80,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,4.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,12,IHC staining not done,7,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,,168.0,90.0,31.0,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",60.0,No or minimal exposure to secondhand smoke,,,metformin|telmistartan|nebivolol|fluticasone+solmeterol|glikopironium,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,791.0,791.0,Main malignancy,,805.0,No,Yes,No,Persistent Disease,Not Applicable,Yes,477.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,477.0,1.0,791.0,1.0,14.0
C3N-02010,PDAC,C3N-02010-T,C3N-02010-N,,,0.0,CPT0241510004,CPT0241500004,CPT0241500010,CPT0241510007,CPT0241500007,,CPT0241760002,62,Female,Black or African American,Not Hispanic or Latino,African,United States,No,,,Unifocal,4.1,Ductal adenocarcinoma,G3 Poorly differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN2,36,IHC staining not done,5,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,157.0,93.0,37.73,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,25.0,Exposure to secondhand smoke history not available,,,acetaminophen|ibuprofen|meclizine|omeprazole,Medical Record|Medical Record|Medical Record|Medical Record,No,449.0,,,449.0,,No,Yes,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,449.0,0.0,0.0
C3L-01124,PDAC,C3L-01124-T,C3L-01124-N,,,0.0,CPT0218220004,CPT0218200004,CPT0218200010,,CPT0218200007,CPT0218220007,CPT0220240002,70,Female,Unknown,Unknown,European,Russia,No,,,Unifocal,2.2,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),PT2,PN2,15,IHC staining not done,5,CM0,Staging Incomplete,Not documented,R0:  No residual tumor,,154.0,67.0,28.25,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,399.0,,,378.0,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,399.0,0.0,-21.0
C3N-01382,PDAC,C3N-01382-T,,,,0.0,,CPT0094180003,CPT0094180006,,CPT0094180009,,CPT0094220002,74,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,2.5,Ductal adenocarcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,37,IHC staining not done,4,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,,160.0,78.0,30.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,734.0,734.0,Main malignancy,,738.0,No,Yes,No,Persistent Disease,,Yes,379.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,379.0,1.0,734.0,1.0,4.0
C3N-00302,PDAC,C3N-00302-T,,,,0.0,,CPT0008750003,['CPT0008750009'],,['CPT0008750012'],,CPT0008790002,58,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,4.0,Ductal adenocarcinoma,G3 Poorly differentiated,Stage IV,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,14,IHC staining not done,9,cM1,pM1,liver,R1:  Microscopic residual tumor,,168.0,80.0,28.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,Yes,323.0,323.0,Main malignancy,,331.0,No,Yes,No,Persistent Disease,,Unknown,,,,,,,,,,,,,,,0.0,323.0,1.0,8.0
C3L-00102,PDAC,C3L-00102-T,C3L-00102-N,,,0.0,CPT0001750003,CPT0001730017,['CPT0001730008'],CPT0001750006,CPT0001730005,CPT0001750009,CPT0003940002,42,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,3.0,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,6,IHC staining not done,5,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,,183.0,90.0,26.93,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Norco|morphine|Lantus Solotar|NovolognFlex Pen,Medical Record|Medical Record|Medical Record|Medical Record,No,249.0,249.0,Main malignancy,,249.0,No,Yes,No,Persistent Disease,,Yes,172.0,Distant Metastasis,Other : abdomen,,Convincing Image (i.e. CT/PET/MRI),Yes,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,239.0,,172.0,1.0,249.0,1.0,0.0
C3L-04080,PDAC,C3L-04080-T,,,,0.0,,CPT0221470005,CPT0221470011,CPT0221490010,CPT0221470008,CPT0221490007,CPT0220550002,70,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,3.5,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2,pN1,19,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,185.0,98.0,28.63,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Yes,,,Atenolol|diltiazem|Tylenol PM Extra Strength|insulin|lisinopril|oxycodone,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,20.0,20.0,Main malignancy,,26.0,No,No,No,Patient Deceased,,Unknown,,,,,,,,,,,,,,,0.0,20.0,1.0,6.0
C3N-00518,PDAC,C3N-00518-T,C3N-00518-N,,,0.0,CPT0078030003,CPT0078000003,['CPT0078000009'],CPT0078030009,CPT0078000006,CPT0078030006,CPT0078080002,69,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,6.0,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,2,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,175.0,80.0,26.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,422.0,427.0,Main malignancy,,448.0,No,Yes,No,Persistent Disease,,Yes,340.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,Yes,Yes,No,,,340.0,1.0,427.0,1.0,21.0
C3L-02116,PDAC,C3L-02116-T,,,,0.0,,CPT0109200004,CPT0109200007,,CPT0109200010,CPT0109230006,CPT0109240002,67,Male,Unknown,Unknown,East_Asian,China,No,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,14,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,170.0,76.0,26.3,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,Bisoprolol|Metformin|Lantus Insulin|Tinzaparin|Ferrous Fumarate,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1024.0,1063.0,Main malignancy,,1105.0,No,No,No,Not Applicable,Not Applicable,Yes,673.0,Distant Metastasis,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,Unknown,Yes,No,,,673.0,1.0,1063.0,1.0,42.0
C3N-03665,PDAC,C3N-03665-T,,,,0.0,,CPT0226760004,CPT0226760010,,CPT0226760007,,CPT0226800002,63,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),2,2,43,IHC staining not done,4,0,0,no,R0:  No residual tumor,,174.0,76.0,25.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,8.3,No or minimal exposure to secondhand smoke,,,tolura|insulin ,Self Report|Self Report,No,728.0,,,737.0,,No,Yes,No,Complete Remission,,Yes,412.0,Distant Metastasis,Peritoneal Surface,,Positive Biomarker(s),No,,,No,Yes,No,,,412.0,1.0,728.0,0.0,9.0
C3L-04072,PDAC,C3L-04072-T,C3L-04072-N,,,0.0,CPT0221250004,CPT0221240004,CPT0221240010,CPT0221250007,CPT0221240007,,CPT0220470002,55,Male,Black or African American,Not Hispanic or Latino,African,United States,No,,,Unifocal,4.9,Ductal adenocarcinoma,G3 Poorly differentiated,Stage III,Present,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN2,27,IHC staining not done,6,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,173.0,42.0,13.99,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,,No or minimal exposure to secondhand smoke,,,Magnesium Oxide|Metoprolol Tartrate|Oxycodone|Pantoprazole|Sodium Bicarbonate|Calcitonin|Bisacodyl|Cefuroxime axetil|Enoxaparin|Lidocaine % patch|Docusate,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,213.0,225.0,Main malignancy,,229.0,No,Yes,No,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,225.0,1.0,4.0
C3N-02998,PDAC,C3N-02998-T,,,,0.0,,CPT0187930005,CPT0187930011,,CPT0187930008,,CPT0187950002,64,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,5.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,N2,19,IHC staining not done,13,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,158.0,72.0,28.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,levotyroxin,Medical Record,No,122.0,122.0,Main malignancy,,132.0,No,Yes,No,Persistent Disease,,Yes,179.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,179.0,1.0,122.0,1.0,10.0
C3N-03840,PDAC,C3N-03840-T,C3N-03840-N,,,0.0,CPT0236800004,CPT0236780005,CPT0236780011,,CPT0236780008,CPT0236800010,CPT0236840002,59,Female,Unknown,Unknown,East_Asian,China,No,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Cannot be assessed,Eighth Edition (2017),pT2,pN1,27,IHC staining not done,1,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,158.0,62.0,24.84,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,696.0,,,702.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,696.0,0.0,6.0
C3L-00928,PDAC,C3L-00928-T,C3L-00928-N,,,0.0,CPT0063580003,CPT0063570003,['CPT0063570006'],,CPT0063570009,CPT0063580006,CPT0065280002,58,Female,White,Not Hispanic or Latino,European,United States,No,Other Distal pancreas,,Unifocal,4.5,Ductal adenocarcinoma,G1 Well differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,11,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,168.0,129.0,45.83,No,Lifelong non-drinker,Current reformed smoker within past 15 years,31.0,Exposure to secondhand smoke history not available,,,desvenlafaxine|escitalopram|furosemide|humalog|invanz|pantoprazole|seroquel|singulair chewables|sucralfate|synthroid|trihexyphenidyl,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,755.0,761.0,Main malignancy,,761.0,Yes,Yes,No,Unknown,,Yes,683.0,Distant Metastasis,Peritoneal Surface,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,683.0,1.0,761.0,1.0,0.0
C3N-00517,PDAC,C3N-00517-T,C3N-00517-N,,,0.0,CPT0093880003,CPT0093860003,CPT0093860006,CPT0093880009,CPT0093860009,CPT0093880006,CPT0093920002,69,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,4.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,10,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,,170.0,65.0,22.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,18.0,No or minimal exposure to secondhand smoke,,,,,No,1142.0,1142.0,Main malignancy,,1147.0,No,Yes,No,Not Applicable,,Yes,351.0,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,351.0,1.0,1142.0,1.0,5.0
C3L-02112,PDAC,C3L-02112-T,,,,0.0,,CPT0124410004,CPT0124410010,CPT0124430008,CPT0124410007,CPT0124430011,CPT0124440002,66,Male,Unknown,Unknown,European,Canada,No,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,9,IHC staining not done,5,cM0,No pathologic evidence of distant metastasis,No distant metastasis,R0:  No residual tumor,,174.0,66.0,21.67,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,37.6,Exposure to secondhand smoke history not available,Non-Hodgkins Lymphoma,Chemotherapy,Metformin|Gliclazide|Rosuvastatin|Telmisartan|ASA,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1338.0,,,1357.0,,No,Yes,No,Complete Remission,Complete Response,No,,,,,,,,,,,,,,,0.0,1338.0,0.0,19.0
C3L-00598,PDAC,C3L-00598-T,,,,0.0,,CPT0019410004,['CPT0019410007'],,['CPT0019410010'],,CPT0019480002,61,Female,Unknown,Unknown,European,Other: Canada,No,,,Unifocal,3.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Present,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,32,IHC staining not done,13,cM0,No pathologic evidence of distant metastasis,not applicable,R0:  No residual tumor,,163.0,42.0,16.0,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,4.2,Exposure to secondhand smoke history not available,,,Etidrocal|Multivitamin|Calcium with vitamin D|Vitamin C|Melatonin|Ferrous Sulfate|Ibuprofen,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,422.0,422.0,Main malignancy,,425.0,No,Yes,No,Complete Remission,,Yes,348.0,Distant Metastasis,Non-Regional Lymph Nodes / Distant Lymph Nodes,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,348.0,1.0,422.0,1.0,3.0
C3N-02585,PDAC,C3N-02585-T,C3N-02585-N,,,0.0,CPT0183770004,CPT0183750005,CPT0183750011,,CPT0183750008,CPT0183770007,CPT0183810002,65,Male,Unknown,Unknown,East_Asian,China,No,,,Unifocal,2.0,Ductal adenocarcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1c,pN0,4,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,160.0,48.0,18.75,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,melbine (DMBG),Medical Record,No,1051.0,,,1054.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,1051.0,0.0,3.0
C3N-03426,PDAC,C3N-03426-T,C3N-03426-N,,,0.0,CPT0226610004,CPT0226600004,CPT0226600010,,CPT0226600007,,CPT0226640002,68,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,5.0,Ductal adenocarcinoma,G2 Moderately differentiated,Staging is not applicable or unknown,Present,Cannot be assessed,Eighth Edition (2017),no resection,1,1,IHC staining not done,1,1,1,liver,R2:  Macroscopic residual tumor,,155.0,67.0,27.89,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Bisocard,Self Report,No,31.0,123.0,Main malignancy,,128.0,No,Yes,No,Persistent Disease,,Unknown,,,,,,,,,,,,,,,0.0,123.0,1.0,5.0
C3N-01714,PDAC,C3N-01714-T,,,,0.0,,CPT0124360003,CPT0124360009,,CPT0124360006,,CPT0124390002,63,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,3.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,36,IHC staining not done,16,cM0,No pathologic evidence of distant metastasis,no,RX:  Presence of residual tumor cannot be assessed,,168.0,70.0,24.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Bisocard,Self Report,No,448.0,435.0,Main malignancy,,446.0,No,Yes,No,Patient Deceased,,Yes,386.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,386.0,1.0,435.0,1.0,11.0
C3N-03039,PDAC,C3N-03039-T,,,,0.0,,CPT0235230004,CPT0235230010,,CPT0235230007,CPT0235260007,CPT0235410002,73,Female,White,Not Hispanic or Latino,European,United States,No,,,,,Ductal adenocarcinoma,G2 Moderately differentiated,Staging is not applicable or unknown,,,,,,,,,,,,,,,,,,,,,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3N-01165,PDAC,C3N-01165-T,,,,0.0,,CPT0093930004,CPT0093930007,,['CPT0093930010'],,CPT0093970002,63,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,25,IHC staining not done,4,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,,164.0,64.0,23.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,241.0,241.0,Main malignancy,,246.0,No,Yes,No,Persistent Disease,,Unknown,,,,,,,,,,,,,,,0.0,241.0,1.0,5.0
C3N-01502,PDAC,C3N-01502-T,,,,0.0,,CPT0065570003,['CPT0065570006'],,['CPT0065570009'],,CPT0070700002,75,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,4.6,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT4,pN1,16,IHC staining not done,3,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,170.0,69.0,23.82,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",6.0,Exposure to secondhand smoke history not available,,,acetaminophen|alum Hydroxide-MAg Carbonate|asorbic acid|aspirin|vitamin D|coenzyme Q10|dicyclomine|diphenhydramine|fluticasone|omeprazole|prednisone|simvastatin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1695.0,,,1695.0,,Yes,Yes,No,Complete Remission,Complete Response,No,,,,,,,,,,,,,,,0.0,1695.0,0.0,0.0
C3N-01380,PDAC,C3N-01380-T,,,,0.0,,CPT0088260004,CPT0088260007,,['CPT0088260010'],,CPT0088300002,65,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,3.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage IV,Present,Cannot be assessed,Seventh Edition (2010),pT3,pN1,16,1,4,cM0,pM1,metastasis to the duodenum,RX:  Presence of residual tumor cannot be assessed,,176.0,80.0,25.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",67.5,Exposure to secondhand smoke history not available,,,sectral|Tialorid|Apo-Doxan|Xarelto,Self Report|Self Report|Self Report|Self Report,No,426.0,400.0,Main malignancy,,416.0,Yes,No,Yes,Persistent Disease,,Unknown,,,,,,,,,,,,,,,0.0,400.0,1.0,16.0
C3L-02604,PDAC,C3L-02604-T,,,,0.0,,CPT0161770004,CPT0161770010,,CPT0161770007,,CPT0162550002,84,Female,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,2.5,Ductal adenocarcinoma,G1 Well differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,9,IHC staining not done,2,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,160.0,62.0,24.22,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",29.0,Exposure to secondhand smoke history not available,,,celebrex|cozaar|Aldactone|prilosec|synthroid|Flonase|zofran-odt,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,110.0,118.0,Main malignancy,,118.0,Yes,Yes,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,118.0,1.0,0.0
C3N-02944,PDAC,C3N-02944-T,C3N-02944-N,,,0.0,CPT0208710004,CPT0208690004,CPT0208690010,,CPT0208690013,CPT0208710007,CPT0208750002,61,Female,Unknown,Unknown,East_Asian,China,No,,,Unifocal,3.2,Ductal adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,27,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,158.0,53.0,21.23,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,609.0,,,612.0,,No,Yes,No,Complete Remission,,Yes,391.0,Distant Metastasis,Other : uterus,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,391.0,1.0,609.0,0.0,3.0
C3N-04119,PDAC,C3N-04119-T,C3N-04119-N,,,0.0,CPT0237920004,CPT0237910004,CPT0237910010,,CPT0237910007,CPT0237920007,CPT0237960002,54,Male,Unknown,Unknown,East_Asian,China,No,,,Unifocal,3.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN1,19,IHC staining not done,2,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,172.0,70.0,23.66,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Telmisartan,Medical Record,No,270.0,305.0,Main malignancy,,305.0,No,Yes,No,Persistent Disease,,Yes,179.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,179.0,1.0,305.0,1.0,0.0
C3N-02592,PDAC,C3N-02592-T,C3N-02592-N,,,0.0,CPT0162780004,CPT0162760003,CPT0162760009,,CPT0162760006,,CPT0162820002,63,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,N1,33,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,154.0,79.0,33.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,294.0,294.0,Main malignancy,,299.0,No,Yes,No,Persistent Disease,,Yes,129.0,Locoregional Recurrence,Unknown,,Convincing Image (i.e. CT/PET/MRI),Yes,,RX: Presence of Residual Tumor cannot be assessed,No,No,No,283.0,,129.0,1.0,294.0,1.0,5.0
C3L-04853,PDAC,C3L-04853-T,C3L-04853-N,,,0.0,CPT0248620003,CPT0248590004,CPT0248590014,,CPT0248590007,,CPT0248630002,85,Female,Unknown,Unknown,European,Canada,No,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN0,3,IHC staining not done,0,cM0,pM0,Not applicable,R0:  No residual tumor,,162.0,52.0,19.89,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,"Breast cancer, left|Breast cancer, right",Surgery|Surgery,Losartan|Amlodipine|Merformin|Atorvastatin|Eliquis|Metoprolol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,251.0,279.0,Main malignancy,,260.0,No,No,No,Persistent Disease,,Yes,185.0,Distant Metastasis,Lung,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,185.0,1.0,279.0,1.0,-19.0
C3N-03007,PDAC,C3N-03007-T,,,,0.0,,CPT0226570004,CPT0226570010,,CPT0226570013,,CPT0226590002,59,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,2.8,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),2,2,47,IHC staining not done,12,0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,167.0,63.0,22.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,,Exposure to secondhand smoke history not available,,,biosotal|amlessa,Self Report|Self Report,No,58.0,58.0,Unknown,,36.0,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,58.0,1.0,-22.0
C3N-04284,PDAC,C3N-04284-T,,,,0.0,,CPT0247090003,CPT0247090013,,CPT0247090006,,CPT0247130002,80,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,3.0,Ductal adenocarcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),2,2,8,IHC staining not done,8,IIB,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,,154.0,56.0,23.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,metoprolol|digoxinum|cliazapril|ryworoksaban,Medical Record|Medical Record|Medical Record|Self Report,No,8.0,8.0,Other reasons,,11.0,No,No,No,Patient Deceased,,Unknown,,,,,,,,,,,,,,,0.0,8.0,1.0,3.0
C3L-03639,PDAC,C3L-03639-T,C3L-03639-N,,,0.0,CPT0238640004,CPT0238610009,CPT0238610015,,CPT0238610012,,CPT0238650002,76,Male,Unknown,Unknown,East_Asian,Other: TSS did not collect,No,,,Unifocal,3.9,Ductal adenocarcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN0,13,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,159.0,66.0,26.03,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,hydromorphone epidural|hydromorphone inj|ondansetron|Pantoprazole|tamsulosin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,246.0,246.0,Main malignancy,,246.0,No,Yes,No,Complete Remission,,Yes,169.0,Distant Metastasis,Other : Retroperitoneal lymph nodes,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,169.0,1.0,246.0,1.0,0.0
C3L-00640,PDAC,C3L-00640-T,C3L-00640-N,,,0.0,CPT0064570003,CPT0064520004,['CPT0064520007'],CPT0064570006,CPT0064520010,CPT0064570009,CPT0066660002,59,Female,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,23,IHC staining not done,1,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,163.0,52.0,19.68,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,1.5,Exposure to secondhand smoke history not available,,,Zoloft|Topomax|Percoset|Ativan|Zofran|Synthroid|Flonase,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,594.0,,,594.0,,Yes,Yes,No,Complete Remission,Progressive Disease,Yes,585.0,Locoregional Recurrence,Other : Omentum and Mesentery and Vascular and Colonic,,Biopsy with Histologic Confirmation,No,,,No,No,No,,,585.0,1.0,594.0,0.0,0.0
C3N-01719,PDAC,C3N-01719-T,,,,0.0,,CPT0161990005,CPT0161990011,CPT0125160010,CPT0161990008,CPT0125160007,CPT0125200002,63,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Cannot be assessed,Seventh Edition (2010),pT3,pNX,0,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,no,RX:  Presence of residual tumor cannot be assessed,,158.0,50.0,20.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,547.0,547.0,Main malignancy,,547.0,No,Yes,No,Persistent Disease,Progressive Disease,Yes,42.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,42.0,1.0,547.0,1.0,0.0
C3N-00514,PDAC,C3N-00514-T,C3N-00514-N,,,0.0,CPT0077950003,CPT0077930004,['CPT0077930010'],,CPT0077930007,CPT0077950006,CPT0077990002,60,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,4.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,20,IHC staining not done,5,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,,161.0,83.0,32.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,55.0,Yes,,,,,No,795.0,795.0,Main malignancy,,809.0,No,Yes,No,Complete Remission,,Yes,621.0,Distant Metastasis,Lung,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,621.0,1.0,795.0,1.0,14.0
C3L-00017,PDAC,C3L-00017-T,,,,0.0,,CPT0000250017,['CPT0000250008'],CPT0000270006,CPT0000250005,CPT0000270008,CPT0000580002,69,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,4.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,42,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,172.0,84.0,28.36,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current reformed smoker within past 15 years,,Yes,,,NaCl 0.9%|Cefuroxime|Chlorhexidine Gluconate|Atenolol|Omeprazole|Docusate|Lovastatin|Hydrochlorothiazide|Lisinopril|Metformin|Acetaminophen-Oxycodone|Gabapentin|Aspirin|TNF Medication,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,426.0,,,426.0,,No,Yes,No,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,426.0,0.0,0.0
C3N-03670,PDAC,C3N-03670-T,,,,0.0,,CPT0246840003,CPT0246840013,,CPT0246840006,CPT0246850006,CPT0246880002,60,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Present,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),2,2,33,IHC staining not done,7,0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,176.0,76.0,24.0,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,lymphoma ,Unknown,,,No,1113.0,,,1126.0,,No,Yes,No,Complete Remission,Progressive Disease,Yes,785.0,Locoregional Recurrence,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),Yes,,R0: No Residual Tumor,Unknown,Yes,Unknown,807.0,,785.0,1.0,1113.0,0.0,13.0
C3L-01328,PDAC,C3L-01328-T,,,,0.0,,CPT0083270003,['CPT0083270009'],CPT0083290009,CPT0083270006,CPT0083290006,CPT0081770002,71,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,3.4,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,12,IHC staining not done,1,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,174.0,81.0,26.85,Yes,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,Prostate Cancer,Unknown,Tamsulosin|Lorazepam|Trihexyphenidyl|Aspirin|Clopidogrel|Furosemide|Atenolol|Lisinopril|Ezetimibe|Atorvastatin|Carbidopa-levodopa|glipizide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,271.0,,,271.0,,No,Yes,No,Unknown,,Yes,250.0,Distant Metastasis,Liver,,Biopsy with Histologic Confirmation,No,,,Unknown,Unknown,Unknown,,,250.0,1.0,271.0,0.0,0.0
C3N-02295,PDAC,C3N-02295-T,C3N-02295-N,,,0.0,CPT0187540004,CPT0187550004,CPT0187550010,,CPT0187550007,CPT0187540007,CPT0187580002,56,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,3.5,Ductal adenocarcinoma,G1 Well differentiated,Stage III,Not identified,Cannot be assessed,Seventh Edition (2010),pTX,pNX,1,IHC staining not done,0,cM0,Staging Incomplete,no,RX:  Presence of residual tumor cannot be assessed,,156.0,70.0,28.0,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,5.3,No or minimal exposure to secondhand smoke,,,amlopin|euthyrox,Self-reported and Medical Record|Self-reported and Medical Record,No,383.0,371.0,Main malignancy,,372.0,Unknown,Unknown,Unknown,Not Applicable,,Unknown,,,,,,,,,,,,,,,0.0,371.0,1.0,1.0
C3N-02573,PDAC,C3N-02573-T,C3N-02573-N,,,0.0,C3N-02573-03,CPT0183450005,CPT0183450011,,CPT0183450008,,CPT0183510002,41,Female,Unknown,Unknown,East_Asian,China,No,Other body and tail,,Unifocal,6.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3,pN2,13,IHC staining not done,2,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,160.0,53.0,20.7,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,479.0,,,483.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,479.0,0.0,4.0
C3L-01052,PDAC,C3L-01052-T,C3L-01052-N,,,0.0,CPT0123770003,CPT0123750003,CPT0123750009,,CPT0123750006,CPT0123770006,CPT0124880002,64,Female,Unknown,Unknown,European,Russia,No,,,Unifocal,2.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,19,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not documented,R0:  No residual tumor,,165.0,57.0,20.94,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Yes,,,,,No,725.0,743.0,Main malignancy,,716.0,No,Yes,No,Complete Remission,,Yes,565.0,Distant Metastasis,Tumor Bed,,Positive Biomarker(s),No,,,No,No,No,,,565.0,1.0,743.0,1.0,-27.0
C3L-00622,PDAC,C3L-00622-T,,,,0.0,,CPT0081360004,['CPT0081360010'],CPT0081390006,CPT0081360007,,CPT0081400002,72,Male,Unknown,Unknown,European,Other: Canada,No,,,Unifocal,3.5,Ductal adenocarcinoma,G1 Well differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN1,22,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,pMx,R1:  Microscopic residual tumor,,174.0,86.0,28.74,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,Synthroid|Candesartan|Atorvastatin|Omeprazole|Tylenol|Centrum Multi-vitamin|Aspirin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1041.0,1041.0,Main malignancy,,1047.0,No,Yes,No,Persistent Disease,,Yes,172.0,Distant Metastasis,Liver,,Positive Biomarker(s),No,,,No,Yes,No,,,172.0,1.0,1041.0,1.0,6.0
C3N-00709,PDAC,C3N-00709-T,C3N-00709-N,,,0.0,C3N-00709-06,CPT0203850004,CPT0203850010,,CPT0203850007,,CPT0203890002,81,Male,White,Not Hispanic or Latino,European,United States,No,,,,,Ductal adenocarcinoma,G2 Moderately differentiated,Staging is not applicable or unknown,,,,,,,,,,,,,,,,,,,,,,,,,,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3L-04027,PDAC,C3L-04027-T,,,,0.0,,CPT0254680003,CPT0254680009,CPT0254740009,CPT0254680006,CPT0254740006,CPT0254840002,69,Male,Unknown,Unknown,European,Other: Serbia,No,,,Unifocal,2.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1,pN0,10,IHC staining not done,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,180.0,75.0,23.15,No,"Consumed alcohol in the past, but currently a non-drinker",Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,ramipril,Self-reported and Medical Record,No,240.0,,,254.0,,No,Yes,No,Persistent Disease,,Unknown,,,,,,,,,,,,,,,0.0,240.0,0.0,14.0
C3L-02701,PDAC,C3L-02701-T,,,,0.0,,CPT0227930004,CPT0227930010,,CPT0227930007,,CPT0228080006,72,Male,Unknown,Unknown,European,Bulgaria,No,Other Body and tail,,Unifocal,3.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2,pNX,Unknown value,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,172.0,83.0,28.06,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Telmisartan,Self Report,No,304.0,243.0,Unknown,,227.0,Yes,No,No,Persistent Disease,,Unknown,,,,,,,,,,,,,,,0.0,243.0,1.0,-16.0
C3L-01031,PDAC,C3L-01031-T,C3L-01031-N,,,0.0,CPT0127290003,CPT0127270003,CPT0127270009,,CPT0127270006,CPT0127290006,CPT0128520002,64,Female,Unknown,Unknown,European,Russia,No,Other Body and Tail,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN0,10,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,Not documented,R0:  No residual tumor,,168.0,79.0,27.99,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,369.0,,,376.0,,No,Yes,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,369.0,0.0,7.0
C3L-01053,PDAC,C3L-01053-T,C3L-01053-N,,,0.0,CPT0123890003,CPT0123860003,CPT0123860006,,CPT0123860009,CPT0123890006,CPT0124900002,76,Female,Unknown,Unknown,European,Russia,No,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,12,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,Not documented,R0:  No residual tumor,,162.0,85.0,32.39,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,20.0,191.0,Main malignancy,,171.0,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,191.0,1.0,-20.0
C3N-03190,PDAC,C3N-03190-T,,,,0.0,,CPT0236560004,CPT0236560010,,CPT0236560007,,CPT0236610002,31,Male,Unknown,Unknown,East_Asian,China,No,,,Unifocal,3.0,Ductal adenocarcinoma,G1 Well differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,pN1,10,IHC staining not done,1,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,167.0,54.0,19.36,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,286.0,398.0,Unknown,,402.0,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,398.0,1.0,4.0
C3N-01715,PDAC,C3N-01715-T,,,,0.0,,CPT0125090003,CPT0125090009,,CPT0125090006,,CPT0125120002,61,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,7.0,Ductal adenocarcinoma,G3 Poorly differentiated,Stage III,Not identified,Cannot be assessed,Seventh Edition (2010),pTX,pNX,0,IHC staining not done,0,cM0,Staging Incomplete,no,RX:  Presence of residual tumor cannot be assessed,,170.0,80.0,27.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,insulin ,Self Report,No,283.0,109.0,Main malignancy,,109.0,No,No,No,Persistent Disease,,Unknown,,,,,,,,,,,,,,,0.0,109.0,1.0,0.0
C3N-01012,PDAC,C3N-01012-T,,,,0.0,,CPT0241320005,CPT0241320011,,CPT0241320008,,CPT0241740002,71,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,N0,27,IHC staining not done,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,175.0,84.0,27.43,No,"Consumed alcohol in the past, but currently a non-drinker",Current smoker: Includes daily and non-daily smokers,37.5,Exposure to secondhand smoke history not available,,,aspirin|fluticasone-salmeterol|heparin injection|montelukast,Medical Record|Medical Record|Medical Record|Medical Record,No,1352.0,,,1352.0,,No,Yes,No,Complete Remission,Complete Response,No,,,,,,,,,,,,,,,0.0,1352.0,0.0,0.0
C3N-01167,PDAC,C3N-01167-T,,,,0.0,,CPT0087890004,CPT0087890007,,['CPT0087890010'],,CPT0087930002,77,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,21,IHC staining not done,1,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,163.0,70.0,26.35,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,NEBIVOLOL|AMLODYPIN,Self Report|Self Report,No,754.0,754.0,Main malignancy,,754.0,Yes,Yes,No,Persistent Disease,Not Applicable,Yes,306.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,306.0,1.0,754.0,1.0,0.0
C3L-00401,PDAC,C3L-00401-T,C3L-00401-N,,,0.0,C3L-00401-04,CPT0019300004,['CPT0019300007'],,CPT0019300010,,CPT0019380002,62,Female,Unknown,Unknown,European,Other: Canada,No,,,Unifocal,2.8,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,40,IHC staining not done,3,cM0,No pathologic evidence of distant metastasis,pMx,R0:  No residual tumor,,164.0,60.0,22.42,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Multivitamin|Calcium citrate + vitamin D|Omega fish oils|Aspirin|Ibuprofen,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,Yes,1262.0,1262.0,Main malignancy,,1270.0,No,Yes,No,Complete Remission,,Yes,532.0,Distant Metastasis,Lung,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,532.0,1.0,1262.0,1.0,8.0
C3N-01011,PDAC,C3N-01011-T,C3N-01011-N,,,0.0,CPT0066020003,CPT0065640003,['CPT0065640006'],CPT0066020009,CPT0065640009,CPT0066020006,CPT0070720002,77,Female,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,4.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,31,IHC staining not done,7,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,158.0,68.0,27.41,Yes,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,3.0,Exposure to secondhand smoke history not available,Uterine Cancer,Surgery,Baby Aspirin|metformin|Naproxen|simvastatin|lisinopril|hydrochlorothiazide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1068.0,,,1037.0,,No,Yes,No,Complete Remission,Progressive Disease,Yes,623.0,Locoregional Recurrence,Other : Retroperitoneal lymph node,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,623.0,1.0,1068.0,0.0,-31.0
C3N-03839,PDAC,C3N-03839-T,C3N-03839-N,,,0.0,CPT0236710004,CPT0236700005,CPT0236700011,,CPT0236700008,,CPT0236770002,54,Female,Unknown,Unknown,East_Asian,China,No,,,Unifocal,4.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Cannot be assessed,Eighth Edition (2017),pT2,pN1,29,IHC staining not done,1,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,168.0,66.0,23.38,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,irbesartan|glimepiride|diformin tablet,Medical Record|Medical Record|Medical Record,No,696.0,,,702.0,,No,Yes,No,Complete Remission,,Yes,430.0,Locoregional Recurrence,Peritoneal Surface,,Convincing Image (i.e. CT/PET/MRI),No,,,Yes,No,No,,,430.0,1.0,696.0,0.0,6.0
C3N-01375,PDAC,C3N-01375-T,,,,0.0,,CPT0088180004,CPT0088180007,,CPT0088180010,,CPT0088220002,70,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,43,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,152.0,53.0,22.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Euthyrox N|Alvesco|Nebilet ,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record,No,396.0,143.0,Unknown,,144.0,No,Yes,No,Patient Deceased,,Unknown,,,,,,,,,,,,,,,0.0,143.0,1.0,1.0
C3N-01381,PDAC,C3N-01381-T,,,,0.0,,CPT0094130004,CPT0094130007,,CPT0094130010,,CPT0094170002,43,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,2.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,17,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,,174.0,64.0,21.14,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,18.0,No or minimal exposure to secondhand smoke,,,,,No,297.0,455.0,Main malignancy,,457.0,Unknown,Yes,Unknown,Persistent Disease,,Yes,157.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,Unknown,Yes,Unknown,,,157.0,1.0,455.0,1.0,2.0
C3L-03350,PDAC,,C3L-03350-N,1.0,"Normal only, no matched tumor",0.0,CPT0198340004,,CPT0198310011,,CPT0198310008,,CPT0198350002,63,Male,Unknown,Unknown,,Canada,No,,,Unifocal,7.4,Colloid carcinoma (Mucinous noncystic carcinoma),G2 Moderately differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT4,pN1,12,IHC staining not done,5,cM0,No pathologic evidence of distant metastasis,Not applicable,R1:  Microscopic residual tumor,,167.0,64.0,22.95,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Valsartan,Medical Record,No,588.0,613.0,Main malignancy,,618.0,No,Yes,No,Complete Remission,,Yes,301.0,Locoregional Recurrence,Peritoneal Surface,,Convincing Image (i.e. CT/PET/MRI),No,,,No,No,No,,,301.0,1.0,613.0,1.0,5.0
C3L-02118,PDAC,C3L-02118-T,,,,0.0,,CPT0109300004,CPT0109300007,,CPT0109300010,,CPT0109340002,67,Female,Unknown,Unknown,East_Asian,China,No,,,Unifocal,2.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT2,N0,11,IHC staining not done,0,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,146.0,56.0,26.45,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,Breast,"Radiation,Surgery,Chemotherapy",Irbesartan|Janumet|ACT Etidrocal|Tiazac XC|Hydralazine|Caltrate|Vitamin D,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,631.0,632.0,Unknown,,638.0,No,Yes,No,Complete Remission,,Yes,517.0,Distant Metastasis,Tumor Bed,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,517.0,1.0,632.0,1.0,6.0
C3N-00511,PDAC,C3N-00511-T,,,,0.0,,CPT0078250003,['CPT0078250009'],,['CPT0078250006'],,CPT0078310002,45,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,3.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,9,IHC staining not done,2,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,165.0,70.0,25.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,,,No,991.0,991.0,Main malignancy,,1001.0,No,Yes,No,Persistent Disease,,Yes,621.0,Distant Metastasis,Liver,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,621.0,1.0,991.0,1.0,10.0
C3L-02613,PDAC,C3L-02613-T,,,,0.0,,CPT0124610004,CPT0124610010,CPT0124630009,CPT0124610007,CPT0124630006,CPT0124640002,52,Female,Unknown,Unknown,East_Asian,Canada,No,,,Unifocal,6.0,Ductal adenocarcinoma,G3 Poorly differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),T3,N1,13,IHC staining not done,2,M0,No pathologic evidence of distant metastasis,No distant metastasis,R1:  Microscopic residual tumor,,158.0,67.0,26.84,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Candesartan|Hydrochlorothiazide|Echinacea|Vitamin C|Alvesco Inhaler,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,211.0,211.0,Unknown,,215.0,No,Yes,No,Persistent Disease,,Yes,54.0,Distant Metastasis,Non-Regional Lymph Nodes / Distant Lymph Nodes,,Convincing Image (i.e. CT/PET/MRI),No,,,No,Yes,No,,,54.0,1.0,211.0,1.0,4.0
C3N-03069,PDAC,C3N-03069-T,C3N-03069-N,,,0.0,CPT0236360004,CPT0236340004,CPT0236340010,CPT0236360010,CPT0236340006,CPT0236360007,CPT0236400002,50,Female,Unknown,Unknown,East_Asian,China,No,,,Unifocal,6.5,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Present,Cannot be assessed,Eighth Edition (2017),pT3,pN2,31,IHC staining not done,6,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,158.0,43.0,17.22,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,10.0,20.0,Unknown,,24.0,No,No,No,Unknown,,No,,,,,,,,,,,,,,,0.0,20.0,1.0,4.0
C3N-00512,PDAC,C3N-00512-T,C3N-00512-N,,,0.0,CPT0078180003,CPT0078160004,['CPT0078160010'],,CPT0078160007,CPT0078180006,CPT0078220002,42,Male,Unknown,Unknown,European,Poland,No,,,Unifocal,3.8,Ductal adenocarcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3,pN1,26,IHC staining not done,10,cM0,No pathologic evidence of distant metastasis,no,R1:  Microscopic residual tumor,,184.0,95.0,28.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,24.0,No or minimal exposure to secondhand smoke,,,,,No,1006.0,1006.0,Main malignancy,,1021.0,No,Yes,No,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,1006.0,1.0,15.0
C3L-02899,PDAC,C3L-02899-T,C3L-02899-N,,,0.0,CPT0197440004,CPT0197420004,CPT0197420010,CPT0197440010,CPT0197420007,CPT0197440007,CPT0199150002,73,Male,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,7.0,Ductal adenocarcinoma,G2 Moderately differentiated,Stage IV,Not identified,Margin(s) involved by invasive carcinoma,Eighth Edition (2017),pT3,pN2,16,IHC staining not done,11,Staging Incomplete,pM1,aortocaval lymph node,RX:  Presence of residual tumor cannot be assessed,,190.0,70.0,19.25,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,Skin Cancer,Unknown,Lipitor|Aspirin|Atenolol|Glucosamine-Chondroitin ,Medical Record|Medical Record|Medical Record|Medical Record,No,44.0,91.0,Main malignancy,,91.0,No,Yes,No,Patient Deceased,,No,,,,,,,,,,,,,,,0.0,91.0,1.0,0.0
C3N-03006,PDAC,C3N-03006-T,,,,0.0,,CPT0226530004,CPT0226530014,,CPT0226530007,,CPT0226560002,64,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,3.3,Ductal adenocarcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),2,1,18,IHC staining not done,3,0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,,153.0,43.0,18.0,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,betaloc|doreta,Self Report|Self Report,No,708.0,,,726.0,,No,Yes,No,Persistent Disease,,Unknown,,,,,,,,,,,,,,,0.0,708.0,0.0,18.0
C3L-03513,PDAC,,C3L-03513-N,1.0,"Normal no matched tumor, no genomic data - excluded by WG",0.0,CPT0355180003,,,,,,,69,Female,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Smoking history not available,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3L-03514,PDAC,,C3L-03514-N,1.0,"Normal no matched tumor, no genomic data - excluded by WG",0.0,CPT0355200003,,,,,,,65,Female,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Smoking history not available,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3L-03515,PDAC,,C3L-03515-N,1.0,"Normal no matched tumor, no genomic data - excluded by WG",0.0,CPT0355190003,,,,,,,65,Male,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Smoking history not available,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3L-07032,PDAC,,C3L-07032-N,1.0,"Normal no matched tumor, no genomic data - excluded by WG",0.0,CPT0347760002,,,,,,,76,Male,White,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3L-07033,PDAC,,C3L-07033-N,1.0,"Normal no matched tumor, no genomic data - excluded by WG",0.0,CPT0347790002,,,,,,,72,Male,White,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3L-07034,PDAC,,C3L-07034-N,1.0,"Normal no matched tumor, no genomic data - excluded by WG",0.0,CPT0347820002,,,,,,,75,Male,White,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3L-07035,PDAC,,C3L-07035-N,1.0,"Normal no matched tumor, no genomic data - excluded by WG",0.0,CPT0347850002,,,,,,,68,Male,Unknown,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3L-07036,PDAC,,C3L-07036-N,1.0,"Normal no matched tumor, no genomic data - excluded by WG",0.0,CPT0347880002,,,,,,,79,Male,White,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,"Current reformed smoker, more than 15 years",,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3N-01001,UCEC,,,1.0,Excluded by WG - not treatment Naive,0.0,,,['CPT0078880006'],,CPT0078880009,,CPT0078920002,72,Female,Unknown,Unknown,European,Poland,Yes,,,Unifocal,9.5,Endometrioid carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN0,0,0,0,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,154.0,105.0,44.27,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,Colon cancer|Breast Cancer,"Surgery|Surgery,Chemotherapy",Citabax|Lerivon|Salmex|Atrodil|Polocard|Metformin|Betaloc|Co-Amlessa|Ridlip|Fragmin|Perfalgan|Morfinum|Citrofleet,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,588.0,,,601.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,588.0,0.0,13.0
C3L-00084,UCEC,,,1.0,Failed Pathology review - Carcinosarcoma,0.0,,,['CPT0000820008'],,CPT0000820005,,CPT0003880002,74,Female,White,Not Hispanic or Latino,European,United States,Yes,,,Unifocal,4.5,Endometrioid carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,25,,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,,162.0,130.0,49.23,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",5.0,Exposure to secondhand smoke history not available,,,Coreg|Prilosec|Dyazide|Prinicil|Norvasc|Cholecalciperol|Fish oil|Multiple Vitamins|Tylenol|glucosamine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,335.0,,,335.0,,No,Yes,No,Unknown,,No,,,,,,,,,,,,,,,0.0,335.0,0.0,0.0
C3L-01284,UCEC,,,1.0,Failed Pathology review - Carcinosarcoma,0.0,,,['CPT0079570006'],,CPT0079570009,,CPT0080140002,49,Female,Asian,Not Hispanic or Latino,East_Asian,United States,Yes,Other Both anterior and posterior,,Unifocal,7.0,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,16,,0,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:  No residual tumor,,155.0,51.0,21.23,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,Calcium - Vitamin D PO|Multi Vitamin,Medical Record|Medical Record,No,357.0,,,357.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,357.0,0.0,0.0
C3N-01825R,UCEC,,,1.0,No data available,0.0,,,,,,,,,Female,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3N-00858,UCEC,C3N-00858-T,C3N-00858-N,,,0.0,CPT0078360001,CPT0078320004,['CPT0078320007'],CPT0078360006,CPT0078320010,CPT0078360009,CPT0078420002,65,Female,Unknown,Unknown,European,Poland,No,,,Multifocal,11.0,Endometrioid carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3b (FIGO IIIB),pN0,2,0,0,cM0,No pathologic evidence of distant metastasis,no,R0:  No residual tumor,,158.0,92.0,36.0,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,colon cancer,Surgery,Molsydamina|Bisoprolol|Enalapril|Aspirin|Concor|Axtil|Fragmin|Fortrans,Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,736.0,,,749.0,,Yes,No,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,736.0,0.0,13.0
C3L-01252,UCEC,C3L-01252-T,C3L-01252-N,,,0.0,CPT0080620001,CPT0080610003,['CPT0080610006'],,CPT0080610009,,CPT0080660002,76,Female,White,Unknown,European,United States,No,,,Unifocal,0.9,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,157.0,95.0,38.41,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Insulin (Novolog) |cloNIDine HCl (CATAPRES|metoprolol tartrate (LOPRESSOR,Medical Record|Medical Record|Medical Record,No,1581.0,,,1552.0,,No,No,No,Complete Remission,Not Applicable,No,,,,,,,,,,,,,,,0.0,1581.0,0.0,-29.0
C3L-00947,UCEC,C3L-00947-T,C3L-00947-N,,,0.0,CPT0027430001,CPT0027420003,['CPT0027420006'],,CPT0027420009,,CPT0027480002,71,Female,White,Unknown,European,United States,No,,,Multifocal,1.8,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,22,,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,,155.0,88.0,36.84,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Lisinopril|Hydrochlorothiazide |Humulin,Medical Record|Medical Record|Medical Record,No,1426.0,,,1393.0,,No,No,No,Complete Remission,Not Applicable,No,,,,,,,,,,,,,,,0.0,1426.0,0.0,-33.0
C3N-00734,UCEC,C3N-00734-T,,,,0.0,,CPT0026030004,['CPT0026030007'],,CPT0026030010,,CPT0028500002,53,Female,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,4.0,Endometrioid carcinoma,G1 Well differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT3a (FIGO IIIA),pN0,28,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,168.0,110.0,38.97,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,atenolol|ciprofloxacin|hydrochlorothiazide|lamotrigine|lorazepam|lurasidone|potassium chloride|pravastatin|sertraline|valsartan,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1094.0,,,1094.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,1094.0,0.0,0.0
C3L-01248,UCEC,C3L-01248-T,,,,0.0,,CPT0080300003,['CPT0080300009'],,CPT0080300006,,CPT0080340001,42,Female,White,Unknown,European,United States,No,,,Unifocal,6.3,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,150.0,134.0,59.78,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,798.0,,,764.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,798.0,0.0,-34.0
C3N-00850,UCEC,C3N-00850-T,,,,0.0,,CPT0027810003,['CPT0027810006'],,CPT0027810009,,CPT0027890002,65,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity,,Multifocal,1.0,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,5,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,158.0,72.0,28.84,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,682.0,,,628.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,682.0,0.0,-54.0
C3L-00361,UCEC,C3L-00361-T,C3L-00361-N,,,0.0,CPT0002450001,CPT0002430011,['CPT0002430005'],CPT0002450006,['CPT0002430008'],CPT0002450009,CPT0004400002,64,Female,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,2.7,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,,165.0,117.0,42.98,Yes,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,Melanoma,Surgery,Simvastatin|Valsartan|Pioglitazone|Glyburide|Fluticasone|Loratadine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1707.0,,,1707.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1707.0,0.0,0.0
C3L-01249,UCEC,C3L-01249-T,C3L-01249-N,,,0.0,CPT0080890001,CPT0080880003,['CPT0080880006'],,CPT0080880009,,CPT0080920002,65,Female,White,Unknown,European,United States,No,Other Tumor occupies 75% of endometrial surface,,Unifocal,6.5,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a (FIGO IA),pN0,24,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,168.0,109.0,38.89,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,1517.0,,,1465.0,,No,No,No,Complete Remission,Not Applicable,No,,,,,,,,,,,,,,,0.0,1517.0,0.0,-52.0
C3N-00383,UCEC,C3N-00383-T,C3N-00383-N,,,0.0,CPT0022850001,CPT0022830003,['CPT0022830009'],CPT0022850006,CPT0022830006,CPT0022850009,CPT0020790002,61,Female,Unknown,Unknown,European,Ukraine,No,Other Uterine cavity,,Unifocal,4.0,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,8,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,157.0,114.0,46.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,790.0,,,679.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,790.0,0.0,-111.0
C3L-00949,UCEC,C3L-00949-T,,,,0.0,,CPT0016370003,['CPT0016370009'],,CPT0016370006,,CPT0016440002,64,Female,White,Unknown,European,United States,No,Other along anterior and posterior surface,,Unifocal,2.5,Endometrioid carcinoma,G1 Well differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,152.0,88.0,37.69,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Atenolol|Glipizide|Metformin (GLUCOPHAGE)|Naproxen,Medical Record|Medical Record|Medical Record|Medical Record,No,1522.0,,,1490.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1522.0,0.0,-32.0
C3L-00032,UCEC,C3L-00032-T,,,,0.0,,CPT0001420009,CPT0001420164,,CPT0001420005,,CPT0000110163,50,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior and Posterior endometrium,,Unifocal,4.5,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,18,,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,,163.0,136.0,51.19,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",3.0,Exposure to secondhand smoke history not available,,,,,No,1710.0,,,1710.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1710.0,0.0,0.0
C3L-01744,UCEC,C3L-01744-T,C3L-01744-N,,,0.0,CPT0093290000,CPT0093280003,CPT0093280006,,CPT0093280009,,CPT0093320002,62,Female,White,Unknown,European,United States,No,,,Unifocal,2.2,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,150.0,104.0,46.45,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,oxybutynin (DITROPAN-XL,Medical Record,No,953.0,,,936.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,953.0,0.0,-17.0
C3L-01311,UCEC,C3L-01311-T,C3L-01311-N,,,0.0,CPT0077780001,CPT0077770003,['CPT0077770006'],CPT0077780006,['CPT0077770013'],CPT0077780009,CPT0080090002,55,Female,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,3.0,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,160.0,95.0,37.11,Yes,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,Basal cell carcinoma,Unknown,Calcium|Vitamin D-3|Aygestin|Lopressor|Paxil|Hyzaar|Ferrous Sulfate|Arava,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1785.0,,,1785.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1785.0,0.0,0.0
C3L-01256,UCEC,C3L-01256-T,C3L-01256-N,,,0.0,CPT0073460001,CPT0073450003,['CPT0073450006'],,CPT0073450009,,CPT0073470002,75,Female,White,Unknown,European,United States,No,,,Unifocal,4.3,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT1b (FIGO IB),pN0,14,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,152.0,80.0,34.37,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,,Exposure to secondhand smoke history not available,,,losartan-hydrochlorothiazide (HYZAAR) ,Medical Record,No,1435.0,,,1371.0,,No,No,No,Complete Remission,Not Applicable,No,,,,,,,,,,,,,,,0.0,1435.0,0.0,-64.0
C3L-00358,UCEC,C3L-00358-T,,,,0.0,,CPT0002210011,['CPT0002210005'],,CPT0002210008,,CPT0004360002,>=90,Female,White,Not Hispanic or Latino,European,United States,No,Other Both anterior and posterior endometrium,,Unifocal,4.5,Serous carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,,0,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,,168.0,74.0,26.22,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,multivitamin |cholecalciferol|vitamin E |levothyroxine |Lotrel|Vitamin C |Osteo Bi-Flex Triple Strength|Probiotic|calcium (as carbonate)-vitamin D,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,164.0,,,164.0,,No,No,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,164.0,0.0,0.0
C3L-00942,UCEC,C3L-00942-T,,,,0.0,,CPT0016830003,['CPT0016830009'],,CPT0016830006,,CPT0016970001,64,Female,White,Unknown,European,United States,No,,,Unifocal,4.5,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,163.0,83.0,31.58,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Allopurinol |Atenolol,Medical Record|Medical Record,No,1382.0,,,1323.0,,No,No,No,Complete Remission,Not Applicable,No,,,,,,,,,,,,,,,0.0,1382.0,0.0,-59.0
C3N-00389,UCEC,C3N-00389-T,,,,0.0,,CPT0026270003,['CPT0026270006'],,['CPT0026270009'],,CPT0026370002,62,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity,,Multifocal,1.5,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,9,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,164.0,48.0,17.85,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,671.0,,,665.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,671.0,0.0,-6.0
C3L-01307,UCEC,C3L-01307-T,C3L-01307-N,,,0.0,CPT0064320001,CPT0064290004,['CPT0064290010'],CPT0064320006,CPT0064290007,CPT0064320009,CPT0065410002,74,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior and Posterior,,Unifocal,3.5,Endometrioid carcinoma,G3 Poorly differentiated,Stage IV,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM1,pM1,omentum,RX:  Presence of residual tumor cannot be assessed,,162.0,83.0,31.63,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,xarelto|glucophage XR|vitamin E,Medical Record|Medical Record|Medical Record,No,181.0,205.0,Main malignancy,,205.0,No,Yes,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,205.0,1.0,0.0
C3L-01282,UCEC,C3L-01282-T,C3L-01282-N,,,0.0,CPT0077660001,CPT0077650003,['CPT0077650009'],CPT0077660006,CPT0077650006,CPT0077660009,CPT0080070001,64,Female,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,3.0,Endometrioid carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,176.0,99.0,31.96,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,red yease rice 600mg|triamcinolone 0.1% cream |Fish oil|Vitamin B12|Vitamin B6,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1784.0,,,1784.0,,Yes,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1784.0,0.0,0.0
C3L-01304,UCEC,C3L-01304-T,C3L-01304-N,,,0.0,CPT0064240001,CPT0064210003,['CPT0064210009'],CPT0064240006,CPT0064210006,CPT0064240009,CPT0065400002,68,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior and Posterior,,Unifocal,3.7,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,149.0,92.0,41.44,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,ProAir HFA|HCTZ|Quinapril HCI|Levothyroxine Sodium|Sertraline HCI|MetFORMIN HCI|Crestor|Fenofibrate|Advair HFA|Evista|RaNITidine HCI|Calcium 600 +D|Mult for HER 50+|CPAP machine,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1862.0,,,1862.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1862.0,0.0,0.0
C3L-00946,UCEC,C3L-00946-T,,,,0.0,,CPT0027520003,['CPT0027520006'],,CPT0027520009,,CPT0027580002,64,Female,White,Unknown,European,United States,No,,,Multifocal,3.9,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,7,,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,159.0,44.0,17.64,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,45.0,Exposure to secondhand smoke history not available,,,,,No,995.0,,,971.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,995.0,0.0,-24.0
C3N-00322,UCEC,C3N-00322-T,,,,0.0,,CPT0010430003,['CPT0010430009'],,CPT0010430006,,CPT0077050001,70,Female,Unknown,Unknown,European,Ukraine,No,Other Entire Uterine Cavity,,Multifocal,2.6,Serous carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,147.0,68.0,31.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,694.0,,,668.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,694.0,0.0,-26.0
C3N-00337,UCEC,C3N-00337-T,,,,0.0,,CPT0018960003,['CPT0018960013'],,CPT0018960006,,CPT0019100002,67,Female,Unknown,Unknown,European,Ukraine,No,Other Entire Uterine Cavity,,Multifocal,1.3,Serous carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,,172.0,86.0,29.07,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,701.0,,,668.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,701.0,0.0,-33.0
C3N-00333,UCEC,C3N-00333-T,C3N-00333-N,,,0.0,CPT0011020003,CPT0011000003,['CPT0011000009'],CPT0011020005,CPT0011000006,,CPT0011100002,65,Female,Unknown,Unknown,European,Ukraine,No,Other Entire Uterine Cavity,,Multifocal,1.0,Serous carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,7,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,158.0,78.0,31.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,674.0,,,654.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,674.0,0.0,-20.0
C3L-00006,UCEC,C3L-00006-T,C3L-00006-N,,,0.0,CPT0001470001,CPT0001460012,CPT0001460164,CPT0001470006,CPT0001460007,CPT0001470009,CPT0000120163,64,Female,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,2.9,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,31,,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,,152.0,90.0,38.88,No,Alcohol consumption history not available,"Current reformed smoker, more than 15 years",5.0,Exposure to secondhand smoke history not available,,,proventil|coreg|lasix|micro-K|prilosec|ditropan|ventolin inhaler|singulair|lipitor|diovan|Fluticasone-Salmeterol|Atrovent HFA|Levothroxine Sodium|Calcium 500 |ASA 81mg,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,737.0,,,737.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,737.0,0.0,0.0
C3L-00769,UCEC,C3L-00769-T,C3L-00769-N,,,0.0,CPT0026540001,CPT0026530003,['CPT0026530006'],,CPT0026530009,,CPT0026590002,56,Female,White,Unknown,European,United States,No,,,Multifocal,4.5,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,15,,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,,168.0,131.0,46.64,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,4.0,Exposure to secondhand smoke history not available,,,Amlodipine|Losartan,Medical Record|Medical Record,No,1507.0,,,1450.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1507.0,0.0,-57.0
C3L-00362,UCEC,C3L-00362-T,,,,0.0,,CPT0002500011,['CPT0002500005'],,CPT0002500008,,CPT0002850002,38,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior and Posterior endometrium,,Unifocal,13.5,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,6,,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,,178.0,177.0,55.86,No,Lifelong non-drinker,Current reformed smoker within past 15 years,20.0,Exposure to secondhand smoke history not available,,,Protonix|Lipitor|Glucophage XR|Lexapro|Lantus Solostar|Mobic|Topamax|Thiamine|Novolog|actos|Zantac|Vitamin D|losartan-hydrochlorothiazide,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1745.0,,,1745.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1745.0,0.0,0.0
C3L-01312,UCEC,C3L-01312-T,,,,0.0,,CPT0063670003,['CPT0063670009'],,CPT0063670006,,CPT0065300002,56,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior and Posterior,,Unifocal,4.0,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,165.0,87.0,31.96,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Smoking history not available,,Exposure to secondhand smoke history not available,,,Progesterone Micronized |Armour thyroid,Medical Record|Medical Record,No,1784.0,,,1784.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1784.0,0.0,0.0
C3L-00449,UCEC,C3L-00449-T,,,,0.0,,CPT0007100003,['CPT0007100006'],,CPT0007100009,,CPT0002770002,59,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior and Posterior endometrium,,Unifocal,7.0,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,15,,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,,162.0,73.0,27.82,No,Alcohol consumption history not available,Current smoker: Includes daily and non-daily smokers,38.0,Exposure to secondhand smoke history not available,,,Valium|Norco|Motrin|Keflex|colace,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1749.0,,,1749.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1749.0,0.0,0.0
C3L-00601,UCEC,C3L-00601-T,C3L-00601-N,,,0.0,CPT0007660001,CPT0007600003,['CPT0007600006'],CPT0007660006,CPT0007600009,CPT0007660009,CPT0002900002,57,Female,White,Not Hispanic or Latino,European,United States,No,Other Both anterior and posterior,,Unifocal,3.5,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,,157.0,62.0,25.03,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Multivitamin ,Medical Record,No,1722.0,,,1722.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1722.0,0.0,0.0
C3N-00729,UCEC,C3N-00729-T,C3N-00729-N,,,0.0,CPT0064950001,CPT0064930004,['CPT0064930007'],,CPT0064930010,,CPT0070650002,86,Female,White,Not Hispanic or Latino,European,United States,No,Other both anterior and posterior,,Multifocal,4.0,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1b,pN0,4,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,165.0,81.0,29.62,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,amlodipine (norvasc)|aspirin (ecotrin)|clopidogrel (plavix)|ezetimibe (zetia)|fenofibrate (Tricor)|fluticasone|furosemide (lasix)|levothyroxine|loratadine (claritin)|metoprolol (toprol xl)|Niacin Antihyperlipidemic (niaspan)|nitroglycerin (nitrostat)|polyethyl glycol-propyl gycol|ranitidine HCI (Zantac)|rosuvastatin calcium (crestor)|tramadol (ultram),Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,873.0,,,848.0,,Yes,No,No,Persistent Disease,,Yes,347.0,Locoregional Recurrence,Other: vaginal vault,,,No,,,No,No,No,,,347.0,1.0,873.0,0.0,-25.0
C3L-00586,UCEC,C3L-00586-T,C3L-00586-N,,,0.0,CPT0023640001,CPT0023630003,['CPT0023630009'],CPT0023640006,CPT0023630006,CPT0023640009,CPT0024590002,50,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior and posterior endometrium,,Unifocal,6.0,Endometrioid carcinoma,G1 Well differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN2 (FIGO IIIC2),18,,4,cM0,Staging Incomplete,Not applicable,RX:  Presence of residual tumor cannot be assessed,,170.0,62.0,21.45,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Paxil|vitamin D-3|Leci-Sitosteral-Nia-Betn-Chit,Medical Record|Medical Record|Medical Record,No,1801.0,,,1801.0,,Yes,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1801.0,0.0,0.0
C3N-01212,UCEC,C3N-01212-T,,,,0.0,,CPT0075380003,['CPT0075380006'],,CPT0075380009,,CPT0075440002,63,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity,,Unifocal,1.5,Endometrioid carcinoma,G2 Moderately differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a (FIGO IIIA),pNX,0,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,161.0,79.0,30.48,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,680.0,,,666.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,680.0,0.0,-14.0
C3N-00836,UCEC,C3N-00836-T,,,,0.0,,CPT0023810003,['CPT0023810006'],,CPT0023810009,,CPT0023910002,75,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity,,Multifocal,1.0,Serous carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,,160.0,78.0,30.47,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,665.0,,,642.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,665.0,0.0,-23.0
C3N-00339,UCEC,C3N-00339-T,,,,0.0,,CPT0020530003,['CPT0020530006'],,CPT0020530009,,CPT0020600002,45,Female,Unknown,Unknown,European,Ukraine,No,Other Uterine cavity,,Multifocal,1.3,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,10,,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,,163.0,58.0,21.83,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,701.0,,,701.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,701.0,0.0,0.0
C3L-01246,UCEC,C3L-01246-T,C3L-01246-N,,,0.0,CPT0080990001,CPT0080980003,CPT0080980006,,CPT0080980009,,CPT0081030002,62,Female,White,Unknown,European,United States,No,,,Unifocal,2.3,Clear cell carcinoma,G3 Poorly differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a (FIGO IA),pN0,5,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,160.0,100.0,39.14,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",18.0,Exposure to secondhand smoke history not available,,,lisinopril-hydrochlorothiazide (PRINZIDE) ,Medical Record,No,1538.0,,,1524.0,,Yes,Yes,No,Unknown,Complete Remission,No,,,,,,,,,,,,,,,0.0,1538.0,0.0,-14.0
C3L-01257,UCEC,C3L-01257-T,C3L-01257-N,,,0.0,CPT0073530001,CPT0073520003,['CPT0073520013'],,CPT0073520009,,CPT0073580002,71,Female,White,Unknown,European,United States,No,Other Tumor involves 75% of endometrial cavity per diagnostic pathology report,,Unifocal,8.0,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT1a (FIGO IA),pN0,15,,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,168.0,48.0,17.11,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,rosuvastatin,Medical Record,No,603.0,,,580.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,603.0,0.0,-23.0
C3L-00780,UCEC,C3L-00780-T,,,,0.0,,CPT0070330004,['CPT0070330007'],,CPT0070330010,,CPT0071010002,69,Female,White,Hispanic or Latino,European,United States,No,Other Posterior and Anterior Endometrium,,Unifocal,1.7,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT1a,pNX,0,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,160.0,119.0,46.41,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,furosemide|amlodipine|losartan|levothyroxine|atenolol|ibuprofen|NPH 58/58|Insulin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1053.0,,,1033.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,1053.0,0.0,-20.0
C3L-00930,UCEC,,C3L-00930-N,1.0,"No Tumor sample, no genomics data",0.0,CPT0027020001,,['CPT0027010006'],,CPT0027010009,,CPT0027070002,72,Female,White,Not Hispanic or Latino,European,United States,Yes,,,Multifocal,4.5,Mixed cell adenocarcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,11,0,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,,165.0,69.0,25.29,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,24.0,Exposure to secondhand smoke history not available,,,levothyroxine,Medical Record,No,,,,,,,,,,,,,,,,,,,,,,,,,,0.0,,,
C3N-01217,UCEC,C3N-01217-T,,,,0.0,,CPT0076500003,['CPT0076500009'],,CPT0076500006,,CPT0076580002,58,Female,Unknown,Unknown,European,Ukraine,No,Other Endometrium,,Multifocal,0.8,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,,162.0,95.0,36.2,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,715.0,,,682.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,715.0,0.0,-33.0
C3N-00323,UCEC,C3N-00323-T,,,,0.0,,CPT0010610003,['CPT0010610009'],,CPT0010610006,,CPT0010760002,78,Female,Unknown,Unknown,European,Ukraine,No,Other Uterine cavity,,Multifocal,4.0,Serous carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,168.0,78.0,27.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,1195.0,,,1130.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,1195.0,0.0,-65.0
C3L-00918,UCEC,C3L-00918-T,,,,0.0,,CPT0063790003,['CPT0063790009'],,CPT0063790006,,CPT0065320002,68,Female,White,Not Hispanic or Latino,European,United States,No,Other Both anterior and posterior endometrium,,Unifocal,3.0,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,No pathologic evidence of distant metastasis,Not Applicable,R0:  No residual tumor,,163.0,114.0,43.0,No,"Consumed alcohol in the past, but currently a non-drinker","Current reformed smoker, more than 15 years",22.0,Exposure to secondhand smoke history not available,,,Synthroid|Gabapentin|Lantus Solostar Pen|Zocor|Zoloft|Aspirin Enteric Coated|Calcium Carbonate|Norvasc|Nystatin|Atorvastatin|Tramadol,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1176.0,1192.0,Main malignancy,,1192.0,No,No,No,Not Applicable,Patient Deceased,Yes,1042.0,New Primary Tumor,Other: ear acoustic neuroma tumor non cancerous,,,No,,,Yes,No,No,,,1042.0,1.0,1192.0,1.0,0.0
C3N-00866,UCEC,C3N-00866-T,C3N-00866-N,,,0.0,CPT0063110001,CPT0063090003,['CPT0063090006'],CPT0063110004,CPT0063090009,,CPT0063210002,77,Female,White,Not Hispanic or Latino,European,United States,No,"Other Anterior, posterior and fundus",,Multifocal,3.0,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,No pathologic evidence of distant metastasis,Unknown,R0:  No residual tumor,,165.0,65.0,23.88,Yes,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,13.5,Exposure to secondhand smoke history not available,Clear cell Renal Carcinoma,Surgery,atenolol|lisinopril|metformin|simvastatin (ZOCOR) 20 MG tablet|warfarin (COUMADIN) 5 MG tablet,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,511.0,,,524.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,511.0,0.0,13.0
C3L-00932,UCEC,C3L-00932-T,C3L-00932-N,,,0.0,CPT0027130001,CPT0027120003,['CPT0027120006'],CPT0027130006,CPT0027120009,CPT0027130009,CPT0027180002,67,Female,White,Not Hispanic or Latino,European,United States,No,Other left cornu,,Unifocal,1.0,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,14,,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,,160.0,122.0,47.82,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Lisinopril,Medical Record,No,1502.0,,,1475.0,,No,No,No,Complete Remission,Not Applicable,No,,,,,,,,,,,,,,,0.0,1502.0,0.0,-27.0
C3L-00963,UCEC,C3L-00963-T,C3L-00963-N,,,0.0,CPT0016530001,CPT0016490003,['CPT0016490009'],,CPT0016490006,,CPT0016580002,59,Female,White,Unknown,European,United States,No,Other Tumor occupies 70% of the anterior endometrium and 50% of the posterior endometrium per the pathology report,,Unifocal,2.6,Endometrioid carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pNX,22,,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,160.0,89.0,34.89,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",6.3,Exposure to secondhand smoke history not available,,,,,No,810.0,,,750.0,,Yes,Yes,No,Unknown,Complete Remission,No,,,,,,,,,,,,,,,0.0,810.0,0.0,-60.0
C3N-00335,UCEC,C3N-00335-T,,,,0.0,,CPT0018790003,['CPT0018790009'],,['CPT0018790006'],,CPT0018910002,57,Female,Unknown,Unknown,European,Ukraine,No,Other Uterine cavity,,Multifocal,2.5,Serous carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,7,,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,,154.0,70.0,29.52,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,686.0,,,667.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,686.0,0.0,-19.0
C3N-00326,UCEC,C3N-00326-T,,,,0.0,,CPT0022530003,['CPT0022530009'],,['CPT0022530006'],,CPT0019690002,45,Female,Unknown,Unknown,European,Ukraine,No,Other Uterine cavity,,Multifocal,1.3,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,175.0,109.0,35.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,682.0,,,644.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,682.0,0.0,-38.0
C3L-00961,UCEC,C3L-00961-T,,,,0.0,,CPT0027320003,['CPT0027320006'],,CPT0027320009,,CPT0027380002,59,Female,White,Unknown,European,United States,No,,,Multifocal,4.5,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,9,,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,,170.0,83.0,28.5,No,Alcohol consumption more than 2 drinks per day for men and more than 1 drink per day for women,Current smoker: Includes daily and non-daily smokers,9.5,Exposure to secondhand smoke history not available,,,,,No,1289.0,1290.0,Other reasons,,1277.0,No,No,No,Complete Remission,Not Applicable,No,,,,,,,,,,,,,,,0.0,1290.0,1.0,-13.0
C3L-00770,UCEC,C3L-00770-T,C3L-00770-N,,,0.0,CPT0026660001,CPT0026650003,['CPT0026650006'],,CPT0026650009,,CPT0026710002,73,Female,White,Not Hispanic or Latino,European,United States,No,,,Multifocal,2.7,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,,163.0,121.0,45.83,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,Renal Clear cell carcinoma ,Surgery,Glimipiride|Lisinopril|Simvastatin,Medical Record|Medical Record|Medical Record,No,1547.0,,,1476.0,,No,No,No,Not Applicable,Not Applicable,No,,,,,,,,,,,,,,,0.0,1547.0,0.0,-71.0
C3N-00200,UCEC,C3N-00200-T,C3N-00200-N,,,0.0,CPT0017930001,CPT0017870003,['CPT0017870009'],,CPT0017870006,,CPT0028400002,72,Female,Black or African American,Not Hispanic or Latino,African,United States,No,Other anterior and posterior endometrial cavity,,Multifocal,9.0,Mixed cell adenocarcinoma,G3 Poorly differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN1 (FIGO IIIC1),10,,1,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,168.0,132.0,46.85,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",8.3,Exposure to secondhand smoke history not available,,,atorvastatin|chlordiazepoxide|docusate|enalapril|hydrochlorothiazide|insulin |verapamil,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,732.0,732.0,Main malignancy,,593.0,No,No,No,Complete Remission,,Yes,722.0,Locoregional Recurrence,Other: peritoneum and mesentery,,,No,,,No,No,No,,,722.0,1.0,732.0,1.0,-139.0
C3N-00379,UCEC,C3N-00379-T,,,,0.0,,CPT0015520003,['CPT0015520006'],,CPT0015520009,,CPT0015740002,41,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity.,,Multifocal,2.5,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,8,,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,,164.0,99.0,36.81,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,658.0,,,642.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,658.0,0.0,-16.0
C3L-01275,UCEC,C3L-01275-T,,,,0.0,,CPT0073730003,['CPT0073730006'],,CPT0073730009,,CPT0073760002,65,Female,Unknown,Unknown,European,United States,No,Other 100 PERCENT OF ENDOMETRIAL SURFACE INVOLVED,,Unifocal,5.0,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Present,Cannot be assessed,Seventh Edition (2010),pT1b (FIGO IB),pN0,26,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,160.0,82.0,32.06,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,levothyroxine (Levothroid),Medical Record,No,1485.0,,,1450.0,,Yes,No,No,Complete Remission,Complete Remission,Yes,657.0,Locoregional Recurrence,Other: vaginal bleeding,,,No,,,No,Yes,No,,,657.0,1.0,1485.0,0.0,-35.0
C3N-01003,UCEC,C3N-01003-T,,,,0.0,,CPT0078610003,['CPT0078610006'],CPT0078620004,CPT0078610009,,CPT0078650002,73,Female,Unknown,Unknown,European,Poland,No,,,Multifocal,3.0,Endometrioid carcinoma,G3 Poorly differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Eighth Edition (2017),pT3b (FIGO IIIB),0,6,0,0,cM1,pM1,omentum,R0:  No residual tumor,,164.0,86.0,31.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Fraxiparine|Metocard|Siofor|Glibetic|Omeprazol|Digoxin|Phlebodia|Acenocumarol|Fortrans,Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self-reported and Medical Record|Self Report|Self Report|Self Report|Self Report|Medical Record,No,606.0,759.0,Main malignancy,,772.0,No,Yes,No,Complete Remission,,Yes,440.0,Distant Metastasis,Other: peritoneal carcinomatosis,,,Unknown,,,Unknown,Unknown,Unknown,,,440.0,1.0,759.0,1.0,13.0
C3N-00386,UCEC,C3N-00386-T,,,,0.0,,CPT0016220003,['CPT0016220006'],,CPT0016220009,,CPT0016770002,44,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity.,,Multifocal,2.3,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,169.0,78.0,27.31,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,673.0,,,664.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,673.0,0.0,-9.0
C3L-00145,UCEC,C3L-00145-T,,,,0.0,,CPT0002630003,['CPT0002630006'],,CPT0002630009,,CPT0007990002,59,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior and Posterior endometrium,,Unifocal,4.7,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,Staging Incomplete,Staging Incomplete,,R0:  No residual tumor,,167.0,102.0,36.57,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",5.0,Exposure to secondhand smoke history not available,,,Benadryl|Adderall|Cymbalta|Toprol-XL|Toujeo Solostar|Victoza|Glucophage|Lipitor|Flonase|Vitamin D|Asa 81mg|Iron,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1799.0,,,1799.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1799.0,0.0,0.0
C3N-01211,UCEC,C3N-01211-T,C3N-01211-N,,,0.0,CPT0075940001,CPT0075900003,['CPT0075900006'],,CPT0075900009,,CPT0076020002,59,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity,,Multifocal,1.4,Endometrioid carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN0,8,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,180.0,127.0,39.2,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,740.0,,,670.0,,Yes,Yes,No,Complete Remission,,Yes,637.0,Distant Metastasis,Liver,,,No,,,No,Yes,No,,,637.0,1.0,740.0,0.0,-70.0
C3L-01247,UCEC,C3L-01247-T,,1.0,Low tumor purity. Excluded by WG,0.0,,CPT0080700003,['CPT0080700006'],,CPT0080700009,,CPT0080800002,63,Female,White,Unknown,European,United States,No,"Other If Other, specify: Tumor occupies 100% of endometrial surface",,Unifocal,11.0,Serous carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN1 (FIGO IIIC1),13,,2,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,160.0,98.0,38.44,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,1464.0,,,1464.0,,Yes,Yes,No,Complete Remission,Persistent Disease,Yes,1310.0,Locoregional Recurrence,Other: endometrium,,,No,,,No,Yes,No,,,1310.0,1.0,1464.0,0.0,0.0
C3N-00340,UCEC,C3N-00340-T,,,,0.0,,CPT0022620003,['CPT0022620009'],,['CPT0022620006'],,CPT0020710002,60,Female,Unknown,Unknown,European,Ukraine,No,Other Uterine cavity,,Multifocal,3.5,Serous carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a (FIGO IIIA),pN1 (FIGO IIIC1),13,,1,cM0,Staging Incomplete,No,R0:  No residual tumor,,158.0,69.0,27.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,722.0,,,700.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,722.0,0.0,-22.0
C3N-01825,UCEC,C3N-01825-T,,,,0.0,,CPT0097710003,"['CPT0097730009', 'CPT0097710006']",,"['CPT0097730006', 'CPT0097710009']",,CPT0097750002,70,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity,,Unifocal,5.0,Serous carcinoma,G3 Poorly differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,10,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,167.0,95.0,34.06,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,687.0,,,661.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,687.0,0.0,-26.0
C3N-01267,UCEC,C3N-01267-T,,,,0.0,,CPT0027970003,['CPT0027970006'],,CPT0027970009,,CPT0028110002,57,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity,,Multifocal,1.2,Endometrioid carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN1 (FIGO IIIC1),6,,6,cM0,Staging Incomplete,No,R0:  No residual tumor,,159.0,78.0,30.85,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,663.0,,,646.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,663.0,0.0,-17.0
C3N-00321,UCEC,C3N-00321-T,,,,0.0,,CPT0010260003,['CPT0010260013'],,CPT0010260006,,CPT0010380002,64,Female,Unknown,Unknown,European,Ukraine,No,Other Uterine cavity,,Multifocal,1.5,Serous carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,7,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,157.0,66.0,26.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,59.0,,,42.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,59.0,0.0,-17.0
C3L-00905,UCEC,C3L-00905-T,,,,0.0,,CPT0063380003,['CPT0063380006'],,CPT0063380009,,CPT0065250002,64,Female,White,Not Hispanic or Latino,European,United States,No,Other anterior and posterior,,Unifocal,4.5,Endometrioid carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN1 (FIGO IIIC1),2,2,2,Staging Incomplete,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,165.0,122.0,44.81,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,meloxicam|Amlodipine |Benazepril|mulivitamin |simvastatin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1749.0,,,1756.0,,Yes,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1749.0,0.0,7.0
C3L-01253,UCEC,C3L-01253-T,,1.0,Low tumor purity. Excluded by WG,0.0,,CPT0080400003,['CPT0080400006'],,CPT0080400009,,CPT0080440002,77,Female,White,Unknown,European,United States,No,Other Both anterior and posterior endometrium are remarkable for tumor,,Unifocal,5.0,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,11,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,152.0,74.0,31.83,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Metoprolol|liraglutide (VICTOZA 2-PAK,Medical Record|Medical Record,No,1532.0,,,1512.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1532.0,0.0,-20.0
C3L-00771,UCEC,C3L-00771-T,C3L-00771-N,,,0.0,CPT0026780001,CPT0026770003,['CPT0026770006'],,CPT0026770009,,CPT0026830002,86,Female,White,Not Hispanic or Latino,European,United States,No,,,Multifocal,6.0,Endometrioid carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a (FIGO IIIA),pN0,4,,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,,157.0,57.0,22.86,No,Alcohol consumption history not available,Smoking history not available,,Exposure to secondhand smoke history not available,,,Metoprolol|levothyroxine|Atorvastatin,Medical Record|Medical Record|Medical Record,No,134.0,134.0,Unknown,,13.0,No,No,No,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,134.0,1.0,-121.0
C3L-00563,UCEC,C3L-00563-T,C3L-00563-N,,,0.0,CPT0063260001,CPT0063250003,['CPT0063250006'],,CPT0063250009,,CPT0065230002,62,Female,Asian,Not Hispanic or Latino,South_Asian,United States,No,Other Both anterior and posterior,,Unifocal,3.0,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,168.0,98.0,34.72,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Glyburide|Atorvastatin|Metoprolol tartrate|Levothyroxine|Pioglitazone|Aspirin|Ferrous sulfate|Metformin|Vitamin D PO,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1785.0,,,1785.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1785.0,0.0,0.0
C3L-00356,UCEC,C3L-00356-T,,1.0,Failed Pathology review - Carcinosarcoma,0.0,,CPT0002130003,['CPT0002130006'],,CPT0002130009,,CPT0004350002,73,Female,White,Not Hispanic or Latino,European,United States,No,Other Both anterior and posterior endometrium,,Unifocal,3.9,Serous carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,27,0,0,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,,162.0,67.0,25.37,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Levothyroxine|Amlodipine|Losartan-hydrochlorothiazide|Magnesium,Medical Record|Medical Record|Medical Record|Medical Record,No,1351.0,1351.0,Main malignancy,,1351.0,Yes,Yes,No,Complete Remission,,Yes,934.0,Locoregional Recurrence,Other: right pelvic lymphadenopathy,,,No,,,No,Yes,Yes,,,934.0,1.0,1351.0,1.0,0.0
C3L-00139,UCEC,C3L-00139-T,,,,0.0,,CPT0001850012,['CPT0001850008'],,CPT0001850005,,CPT0003950002,83,Female,White,Not Hispanic or Latino,European,United States,No,Other Both anterior and posterior,,Unifocal,4.0,Serous carcinoma,"GX Grading is not applicable, cannot be assessed or not specified",Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a (FIGO IIIA),pNX,0,,,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,,163.0,57.0,21.57,No,Alcohol consumption history not available,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Calcium|Multi Vitamin |Esomeprazole,Medical Report|Medical Report|Medical Report,No,422.0,422.0,Main malignancy,,422.0,Yes,Yes,No,Persistent Disease,,No,,,,,,,,,,,,,,,0.0,422.0,1.0,0.0
C3N-00324,UCEC,C3N-00324-T,,,,0.0,,CPT0010820003,['CPT0010820009'],,CPT0010820006,,CPT0010950002,66,Female,Unknown,Unknown,European,Ukraine,No,Other Uterine cavity,,Multifocal,2.3,Endometrioid carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN0,10,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,160.0,90.0,35.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,710.0,,,645.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,710.0,0.0,-65.0
C3L-00605,UCEC,C3L-00605-T,C3L-00605-N,,,0.0,CPT0063900001,CPT0063890003,['CPT0063890009'],,CPT0063890006,,CPT0065340002,73,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior and Posterior,,Unifocal,2.7,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,157.0,95.0,38.54,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,ibuprofen|tylenol 325|Aspirin 81mg|Lipitor|lisinopril |Nexium|Synthroid|Calcium 6000 +D|mult. vitamin  with minerals,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1795.0,,,1795.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1795.0,0.0,0.0
C3N-00743,UCEC,C3N-00743-T,,,,0.0,,CPT0062940003,['CPT0062940006'],,CPT0062940009,,CPT0063060002,53,Female,Black or African American,Not Hispanic or Latino,African,United States,No,"Other Involves fundus, anterior and posterior walls",,Multifocal,3.5,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,24,,0,cM0,No pathologic evidence of distant metastasis,Unknown,RX:  Presence of residual tumor cannot be assessed,,159.0,122.0,48.46,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Current smoker: Includes daily and non-daily smokers,19.5,Exposure to secondhand smoke history not available,,,Albuterol|Ferrous Gluconate,Medical Record|Medical Record,No,584.0,,,590.0,,No,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,584.0,0.0,6.0
C3N-01219,UCEC,C3N-01219-T,,,,0.0,,CPT0076160003,['CPT0076160009'],,CPT0076160006,,CPT0076220002,58,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity,,Unifocal,5.0,Endometrioid carcinoma,G3 Poorly differentiated,Stage III,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a (FIGO IIIA),pN0,4,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,154.0,62.0,26.14,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,738.0,,,683.0,,No,No,No,Complete Remission,,Yes,591.0,Locoregional Recurrence,Other: Locoregional recurrence,,,No,,,No,Yes,No,,,591.0,1.0,738.0,0.0,-55.0
C3N-01520,UCEC,C3N-01520-T,,,,0.0,,CPT0076860003,['CPT0076860006'],,CPT0076860009,,CPT0076940002,69,Female,Unknown,Unknown,European,Ukraine,No,Other Endometrium,,Multifocal,1.0,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,164.0,79.0,29.37,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,287.0,287.0,Other reasons,,278.0,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,287.0,1.0,-9.0
C3L-00090,UCEC,C3L-00090-T,,,,0.0,,CPT0001140003,CPT0001140164,,CPT0001140005,,CPT0000040163,75,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior and Posterior endometrium,,Unifocal,3.5,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,165.0,89.0,32.69,Yes,Alcohol consumption history not available,Current reformed smoker within past 15 years,7.5,Exposure to secondhand smoke history not available,"Skin Cancer , Unspecified ",Unknown,synthroid|Tylenol Extra Strength,Medical Record|Medical Record,No,1279.0,1281.0,Other reasons,,1287.0,Yes,Yes,No,Persistent Disease,,Yes,50.0,New Primary Tumor,Lung,,,No,,,Yes,Yes,No,,,50.0,1.0,1281.0,1.0,6.0
C3N-00880,UCEC,C3N-00880-T,,,,0.0,,CPT0078710004,['CPT0078710007'],,CPT0078710010,,CPT0078790002,61,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,3.2,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,8,0,0,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,170.0,80.0,27.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Triplixam|Beto  ZK 25|Atrox 20|Cardilopin 5|Fragmin|Fortrans,Medical Record|Medical Record|Self Report|Medical Record|Medical Record|Medical Record,No,1757.0,,,1769.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1757.0,0.0,12.0
C3N-00328,UCEC,C3N-00328-T,,,,0.0,,CPT0019840003,['CPT0019840006'],,CPT0019840009,,CPT0020410002,62,Female,Unknown,Unknown,European,Ukraine,No,Other Uterine cavity,,Multifocal,3.0,Endometrioid carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,10,,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,,165.0,85.0,31.22,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,697.0,,,644.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,697.0,0.0,-53.0
C3L-00767,UCEC,C3L-00767-T,,,,0.0,,CPT0026430003,['CPT0026430006'],,CPT0026430009,,CPT0026490002,56,Female,White,Not Hispanic or Latino,European,United States,No,,,Multifocal,2.3,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,,160.0,168.0,65.71,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,,,Hydrochlorothiazide |Lisinopril,Medical Record|Medical Record,No,419.0,,,273.0,,No,No,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,419.0,0.0,-146.0
C3N-01346,UCEC,C3N-01346-T,C3N-01346-N,,,0.0,CPT0116570003,CPT0116550004,CPT0116550010,CPT0116570009,CPT0116550007,CPT0116570006,CPT0116610002,63,Female,Unknown,Unknown,European,Poland,No,,,Unifocal,5.5,Serous carcinoma,G3 Poorly differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN2 (FIGO IIIC2),25,,4,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,162.0,90.0,34.0,No,Lifelong non-drinker,Current smoker: Includes daily and non-daily smokers,,Yes,,,Eltroxin|Torvacard|Essentix|Zaldiar|Ketonal|Paracetamol|cyclonamine|Exacyl|Poltram|Clexane|fortrans|Potassium Chloride,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1348.0,,,1366.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1348.0,0.0,18.0
NX1,UCEC,,NX1-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX1,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NX2,UCEC,,NX2-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX2,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3N-00388,UCEC,C3N-00388-T,,,,0.0,,CPT0016940003,['CPT0016940006'],,CPT0016940008,,CPT0017290002,59,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity.,,Multifocal,4.0,Serous carcinoma,G2 Moderately differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,10,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,168.0,58.0,20.55,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,645.0,,,650.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,645.0,0.0,5.0
C3N-01537,UCEC,C3N-01537-T,,,,0.0,,CPT0097010003,CPT0097010006,,CPT0097010009,,CPT0097050002,74,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity,,Unifocal,1.5,Serous carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN0,7,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,154.0,84.0,35.42,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,698.0,,,671.0,,No,No,No,Complete Remission,,Yes,58.0,Locoregional Recurrence,Other: Vagina,,,Yes,,RX: Presence of Residual Tumor cannot be assessed,No,Yes,No,62.0,,58.0,1.0,698.0,0.0,-27.0
C3L-00413,UCEC,C3L-00413-T,,,,0.0,,CPT0009980003,['CPT0009980009'],,CPT0009980006,,CPT0019850002,60,Female,White,Not Hispanic or Latino,European,United States,No,Other Both anterior and posterior,,Unifocal,3.2,Endometrioid carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN0,33,,0,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,,160.0,108.0,42.19,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",,Exposure to secondhand smoke history not available,,,Hydrocodone-acetaminophen|Venlafaxine|Levothyroxine Sodium|Meloxicam|Alprazolam|Amlodipine|Triamterene-hydrochlorothiazide|Amlodipine-atorvastatatin |IRON PO|Multivitamin,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1767.0,,,1767.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1767.0,0.0,0.0
C3L-00157,UCEC,C3L-00157-T,,1.0,Failed Pathology review - Clear Cell,0.0,,CPT0002560003,['CPT0002560006'],,CPT0002560009,,CPT0008040002,60,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,,,Unifocal,4.2,Serous carcinoma,G3 Poorly differentiated,Stage III,Not identified,Cannot be assessed,Seventh Edition (2010),pT3a (FIGO IIIA),pN2 (FIGO IIIC2),45,,17,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,,162.0,92.0,34.84,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Tramadol|Omeprazole|Proctofoam HC,Medical Record|Medical Record|Medical Record,No,1396.0,1396.0,Main malignancy,,1396.0,Yes,Yes,No,Complete Remission,Patient Deceased,Yes,1337.0,Distant Metastasis,Other: peritoneal,,,No,,,No,No,No,,,1337.0,1.0,1396.0,1.0,0.0
C3L-00161,UCEC,C3L-00161-T,,,,0.0,,CPT0070380004,['CPT0070380010'],,CPT0070380007,,CPT0070970002,46,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,Other Anterior and Posterior Endometrium,,Unifocal,7.0,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Not identified,Cannot be assessed,Seventh Edition (2010),pT1b (FIGO IB),pN0,0,,0,Staging Incomplete,No pathologic evidence of distant metastasis,,RX:  Presence of residual tumor cannot be assessed,,155.0,164.0,68.39,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Provera|Tramadol|Colace|Remeron|Coumadin|Lovanox|Pepcid|Prilosec,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1775.0,,,1775.0,,Yes,Yes,No,Complete Remission,Persistent Disease,Yes,1369.0,Locoregional Recurrence,Other: lymph nodes,,,No,,,No,Yes,No,,,1369.0,1.0,1775.0,0.0,0.0
C3N-01349,UCEC,C3N-01349-T,,,,0.0,,CPT0116630003,CPT0116630009,,CPT0116630006,,CPT0116700002,77,Female,Unknown,Unknown,European,Poland,No,,,Multifocal,5.0,Serous carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,6,,6,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,165.0,86.0,31.0,Yes,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,No or minimal exposure to secondhand smoke,sarcoma of the left leg,Surgery,acenokumarol|Clexane|Betaloc|metformax|diaprel|lisiprol|dironorm|fortrans,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,850.0,555.0,Main malignancy,,570.0,Unknown,Unknown,Unknown,Unknown,,Yes,405.0,Distant Metastasis,Other: lymph nodes,,,Unknown,,,Unknown,Unknown,Unknown,,,405.0,1.0,555.0,1.0,15.0
NX3,UCEC,,NX3-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX3,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NX4,UCEC,,NX4-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX4,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3N-01521,UCEC,C3N-01521-T,,,,0.0,,CPT0076680003,['CPT0076680006'],,CPT0076680009,,CPT0076760002,75,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity,,Unifocal,4.2,Endometrioid carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,167.0,82.0,29.4,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,No,728.0,,,681.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,728.0,0.0,-47.0
C3L-00098,UCEC,C3L-00098-T,,,,0.0,,CPT0000980012,['CPT0000980008'],,CPT0000980005,,CPT0003930002,63,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior  and Posterior endometrium,,Unifocal,6.0,Endometrioid carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,,157.0,50.0,20.28,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,claritin|Ultram|adderall|prilosec|norco|lasix|potassium|citracal |Vitamin D ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1748.0,,,1748.0,,No,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1748.0,0.0,0.0
C3N-00334,UCEC,C3N-00334-T,,,,0.0,,CPT0018570003,['CPT0018570009'],,['CPT0018570006'],,CPT0018720002,68,Female,Unknown,Unknown,European,Ukraine,No,Other Uterine cavity,,Multifocal,1.4,Serous carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pN0,8,,0,cM0,Staging Incomplete,No.,R0:  No residual tumor,,159.0,83.0,32.83,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,674.0,,,659.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,674.0,0.0,-15.0
C3N-00377,UCEC,C3N-00377-T,,,,0.0,,CPT0021650003,['CPT0021650006'],,CPT0021650009,,CPT0021710002,64,Female,Unknown,Unknown,European,Ukraine,No,Other Uterine cavity,,Multifocal,1.0,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,153.0,80.0,34.0,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,707.0,,,670.0,,Yes,No,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,707.0,0.0,-37.0
C3L-00143,UCEC,C3L-00143-T,,,,0.0,,CPT0001910016,['CPT0001910008'],,CPT0001910012,,CPT0003970002,69,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior and Posterior endometrium,,Unifocal,5.2,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1 (FIGO I),pN0,19,,0,cM0,Staging Incomplete,not applicable,R0:  No residual tumor,,170.0,99.0,34.26,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",1.0,Exposure to secondhand smoke history not available,,,synthroid|cozaar|lipitor|glucophage|aygestin|hygroten|glucosamine|probiotic|vitamin D|vitamin C|fish oil,Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report,No,1708.0,,,1708.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1708.0,0.0,0.0
C3N-01510,UCEC,C3N-01510-T,,,,0.0,,CPT0079650003,['CPT0079650006'],,CPT0079650009,,CPT0080750002,53,Female,White,Not Hispanic or Latino,European,United States,No,Other Bulky tumor involving both anterior and posterior walls,,Multifocal,8.5,Endometrioid carcinoma,G2 Moderately differentiated,Stage II,Not identified,Cannot be assessed,Seventh Edition (2010),pT2 (FIGO II),pNX,0,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,158.0,101.0,40.72,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,acetaminophen|albuterol|atorvastatin|cholecalciferol|fenofibrate|glipizide|ibuprofen|indapamide|levothroxine|losartan|metformin|sertraline,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1100.0,,,1044.0,,Yes,No,No,Complete Remission,,Unknown,,,,,,,,,,,,,,,0.0,1100.0,0.0,-56.0
C3L-01925,UCEC,C3L-01925-T,,,,0.0,,CPT0113690003,CPT0113690006,,CPT0113690009,,CPT0114410002,65,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior and posterior endometrium,,Unifocal,4.5,Serous carcinoma,G3 Poorly differentiated,Stage IV,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3b (FIGO IIIB),pN1 (FIGO IIIC1),3,0,2,Staging Incomplete,pM1,Omentum,R0:  No residual tumor,,165.0,75.0,27.66,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Acetaminophen|ascorbic acid|Vitamin D3|coQ10|Green Tea Leaf Extract|melatonin|Multivitamin|Prasterone (DHEA)|Bone Restore/Triple cruciferous vegetable extract/mushroom extract/Biocuncumin/NK Cell Activator|Quercetin Dihydrate,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1351.0,,,1338.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,1351.0,0.0,-13.0
NX5,UCEC,,NX5-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX5,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NX6,UCEC,,NX6-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX6,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3L-00921,UCEC,C3L-00921-T,,,,0.0,,CPT0064150004,['CPT0064150010'],,CPT0064150007,,CPT0065390002,66,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior and Posterior,,Unifocal,4.0,Endometrioid carcinoma,G2 Moderately differentiated,Stage II,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN0,6,,0,cM0,No pathologic evidence of distant metastasis,Not applicable,R0:  No residual tumor,,165.0,88.0,32.32,No,Lifelong non-drinker,"Current reformed smoker, more than 15 years",16.0,Exposure to secondhand smoke history not available,,,nystatin|Stool softner|Advil,Medical Record|Medical Record|Medical Record,No,1776.0,,,1776.0,,Yes,No,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1776.0,0.0,0.0
C3L-00156,UCEC,C3L-00156-T,,,,0.0,,CPT0002080011,['CPT0002080005'],,CPT0002080008,,CPT0004340002,56,Female,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,2.2,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,,173.0,83.0,27.83,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Naproxen Sodium|Ibuprofen|Hydrochlorothiazide|Amlodipine|Multi Vitamin |Insulin Lispro,Medical Report|Medical Report|Medical Report|Medical Report|Medical Report|Medical Report,No,1776.0,,,1776.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1776.0,0.0,0.0
C3L-00938,UCEC,C3L-00938-T,,1.0,Low tumor purity. Excluded by WG,0.0,,CPT0016260003,['CPT0016260009'],,CPT0016260006,,CPT0016330002,53,Female,White,Unknown,European,United States,No,Other both anterior and posterior,,Unifocal,5.5,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pNX,0,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,155.0,109.0,45.53,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Atenolol|levothyroxine,Medical Record|Medical Record,No,1561.0,,,1529.0,,Yes,Unknown,Unknown,Unknown,Complete Remission,No,,,,,,,,,,,,,,,0.0,1561.0,0.0,-32.0
C3L-00137,UCEC,C3L-00137-T,,,,0.0,,CPT0002010011,['CPT0002010005'],,CPT0002010008,,CPT0003870002,60,Female,White,Not Hispanic or Latino,European,United States,No,Other Both anterior and posterior,,Unifocal,5.0,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,Not Applicable,R0:  No residual tumor,,165.0,70.0,25.68,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Doxycycline|Cetirizine,Medical Record|Medical Record,No,823.0,,,823.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,823.0,0.0,0.0
C3N-00848,UCEC,C3N-00848-T,,,,0.0,,CPT0024130003,['CPT0024130006'],,CPT0024130009,,CPT0024210002,66,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity,,Multifocal,3.0,Endometrioid carcinoma,G2 Moderately differentiated,Stage I,Present,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,158.0,84.0,33.65,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,658.0,,,636.0,,Yes,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,658.0,0.0,-22.0
NX7,UCEC,,NX7-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX7,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3L-00781,UCEC,C3L-00781-T,,,,0.0,,CPT0070260003,['CPT0070260006'],,CPT0070260009,,CPT0071030002,48,Female,White,Hispanic or Latino,Ad_Mixed_American,United States,No,Other Anterior and Posterior Endometrium,,Unifocal,5.5,Endometrioid carcinoma,G3 Poorly differentiated,Stage II,Not identified,Cannot be assessed,Seventh Edition (2010),pT2 (FIGO II),pN0,13,0,0,cM0,No pathologic evidence of distant metastasis,,R0:  No residual tumor,,160.0,83.0,32.59,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Dexamethasone|Morphine,Medical Record|Medical Record,No,1519.0,,,1519.0,,Yes,Yes,No,Complete Remission,Complete Remission,No,,,,,,,,,,,,,,,0.0,1519.0,0.0,0.0
NX8,UCEC,,NX8-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX8,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NX9,UCEC,,NX9-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX9,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
C3N-01802,UCEC,C3N-01802-T,,,,0.0,,CPT0080030003,['CPT0080030006'],,CPT0080030009,,CPT0080810002,85,Female,Black or African American,Not Hispanic or Latino,African,United States,No,Other entire uterine cavity,,Unifocal,3.8,Serous carcinoma,G3 Poorly differentiated,Stage II,Not identified,Margin(s) involved by invasive carcinoma,Seventh Edition (2010),pT2 (FIGO II),pN0,5,,0,Staging Incomplete,Staging Incomplete,,RX:  Presence of residual tumor cannot be assessed,,163.0,64.0,24.32,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,ferrous sulfate|lisinopril|vitamin D3,Medical Record|Medical Record|Medical Record,No,775.0,,,740.0,,Yes,No,No,Complete Remission,,Yes,598.0,Locoregional Recurrence,Other: left lower abdomen,,,No,,,No,No,No,,,598.0,1.0,775.0,0.0,-35.0
C3N-00151,UCEC,C3N-00151-T,,,,0.0,,CPT0066620003,['CPT0066620009'],,CPT0066620006,,CPT0071660002,60,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity,,Unifocal,0.0,Endometrioid carcinoma,G3 Poorly differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1b (FIGO IB),pN0,8,,0,cM0,No pathologic evidence of distant metastasis,Not known,R0:  No residual tumor,,163.0,72.0,27.1,No,Lifelong non-drinker,Smoking history not available,,Exposure to secondhand smoke history not available,,,,,No,0.0,,,,,Unknown,Unknown,Unknown,Unknown,,Unknown,,,,,,,,,,,,,,,0.0,0.0,0.0,
C3L-00136,UCEC,C3L-00136-T,,,,0.0,,CPT0000730011,['CPT0000730005'],,CPT0000730008,,CPT0003860002,50,Female,White,Not Hispanic or Latino,European,United States,No,Other Anterior and Posterior endometrium,,Unifocal,4.5,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,,162.0,147.0,55.67,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,Ibuprofen|Alprazolam|aspirin 81mg|Oxycodone|tylenol ,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,1794.0,,,1794.0,,No,No,No,Not Applicable,Complete Remission,No,,,,,,,,,,,,,,,0.0,1794.0,0.0,0.0
C3L-00008,UCEC,C3L-00008-T,,,,0.0,,CPT0001300009,CPT0001300164,,CPT0001300005,,CPT0000080163,58,Female,White,Not Hispanic or Latino,European,United States,No,,,Unifocal,3.5,Endometrioid carcinoma,G1 Well differentiated,Stage I,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT1a (FIGO IA),pNX,0,,0,cM0,Staging Incomplete,Not applicable,R0:  No residual tumor,,162.0,105.0,39.76,No,Alcohol consumption equal to or less than 2 drinks per day for men and 1 drink or less per day for women,"Current reformed smoker, more than 15 years",19.0,Exposure to secondhand smoke history not available,,,Synthroid|celexa|nizoral|Microzide|vitamin D|vitamin B|flaxseed,Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record|Medical Record,No,898.0,,,898.0,,No,No,No,Not Applicable,,No,,,,,,,,,,,,,,,0.0,898.0,0.0,0.0
C3N-00847,UCEC,C3N-00847-T,,,,0.0,,CPT0027650003,['CPT0027650006'],,CPT0027650009,,CPT0027740002,65,Female,Unknown,Unknown,European,Ukraine,No,Other Entire uterine cavity,,Multifocal,4.3,Endometrioid carcinoma,G2 Moderately differentiated,Stage III,Not identified,Margins uninvolved by invasive carcinoma,Seventh Edition (2010),pT3a (FIGO IIIA),pN0,4,,0,cM0,Staging Incomplete,No,R0:  No residual tumor,,165.0,94.0,34.53,No,Lifelong non-drinker,Lifelong non-smoker: Less than 100 cigarettes smoked in lifetime,,Exposure to secondhand smoke history not available,,,,,Yes,682.0,,,628.0,,No,Yes,No,Complete Remission,,No,,,,,,,,,,,,,,,0.0,682.0,0.0,-54.0
NX12,UCEC,,NX12-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX12,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NX17,UCEC,,NX17-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX17,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NX13,UCEC,,NX13-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX13,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NX14,UCEC,,NX14-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX14,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NX10,UCEC,,NX10-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX10,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NX16,UCEC,,NX16-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX16,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NX18,UCEC,,NX18-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX18,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NX11,UCEC,,NX11-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX11,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
NX15,UCEC,,NX15-N,1.0,Mixed normal - only proteomic no matched tumors,0.0,NX15,,,,,,,,Female (mixed normal),,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,,
